
<html lang="en"     class="pb-page"  data-request-id="076d97e8-6623-447d-8084-3bf373d71f29"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2012.55.issue-21;website:website:acspubs;article:article:10.1021/jm300991n;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="New Aminoimidazoles as β-Secretase (BACE-1) Inhibitors Showing Amyloid-β (Aβ) Lowering in Brain" /></meta><meta name="dc.Creator" content="Ylva  Gravenfors" /></meta><meta name="dc.Creator" content="Jenny  Viklund" /></meta><meta name="dc.Creator" content="Jan  Blid" /></meta><meta name="dc.Creator" content="Tobias  Ginman" /></meta><meta name="dc.Creator" content="Sofia  Karlström" /></meta><meta name="dc.Creator" content="Jacob  Kihlström" /></meta><meta name="dc.Creator" content="Karin  Kolmodin" /></meta><meta name="dc.Creator" content="Johan  Lindström" /></meta><meta name="dc.Creator" content="Stefan  von Berg" /></meta><meta name="dc.Creator" content="Fredrik  von Kieseritzky" /></meta><meta name="dc.Creator" content="Can  Slivo" /></meta><meta name="dc.Creator" content="Britt-Marie  Swahn" /></meta><meta name="dc.Creator" content="Lise-Lotte  Olsson" /></meta><meta name="dc.Creator" content="Patrik  Johansson" /></meta><meta name="dc.Creator" content="Susanna  Eketjäll" /></meta><meta name="dc.Creator" content="Johanna  Fälting" /></meta><meta name="dc.Creator" content="Fredrik  Jeppsson" /></meta><meta name="dc.Creator" content="Kia  Strömberg" /></meta><meta name="dc.Creator" content="Juliette  Janson" /></meta><meta name="dc.Creator" content="Fredrik  Rahm" /></meta><meta name="dc.Description" content="Amino-2H-imidazoles are described as a new class of BACE-1 inhibitors for the treatment of Alzheimer’s disease. Synthetic methods, crystal structures, and structure–activity relationships for targe..." /></meta><meta name="Description" content="Amino-2H-imidazoles are described as a new class of BACE-1 inhibitors for the treatment of Alzheimer’s disease. Synthetic methods, crystal structures, and structure–activity relationships for targe..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 3, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm300991n" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm300991n" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm300991n" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm300991n" /></link>
        
    
    

<title>New Aminoimidazoles as β-Secretase (BACE-1) Inhibitors Showing Amyloid-β (Aβ) Lowering in Brain | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm300991n" /></meta><meta property="og:title" content="New Aminoimidazoles as β-Secretase (BACE-1) Inhibitors Showing Amyloid-β (Aβ) Lowering in Brain" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/large/jm-2012-00991n_0010.jpeg" /></meta><meta property="og:description" content="Amino-2H-imidazoles are described as a new class of BACE-1 inhibitors for the treatment of Alzheimer’s disease. Synthetic methods, crystal structures, and structure–activity relationships for target activity, permeability, and hERG activity are reported and discussed. Compound (S)-1m was one of the most promising compounds in this report, with high potency in the cellular assay and a good overall profile. When guinea pigs were treated with compound (S)-1m, a concentration and time dependent decrease in Aβ40 and Aβ42 levels in plasma, brain, and CSF was observed. The maximum reduction of brain Aβ was 40–50%, 1.5 h after oral dosing (100 μmol/kg). The results presented highlight the potential of this new class of BACE-1 inhibitors with good target potency and with low effect on hERG, in combination with a fair CNS exposure in vivo." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm300991n"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm300991n">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm300991n&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm300991n&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm300991n&amp;href=/doi/10.1021/jm300991n" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 9297-9311</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm300973k" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm301034u" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/jm301629c"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">New Aminoimidazoles as β-Secretase (BACE-1) Inhibitors Showing Amyloid-β (Aβ) Lowering in Brain</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ylva++Gravenfors">Ylva Gravenfors</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jenny++Viklund">Jenny Viklund</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jan++Blid">Jan Blid</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tobias++Ginman">Tobias Ginman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sofia++Karlstr%C3%B6m">Sofia Karlström</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jacob++Kihlstr%C3%B6m">Jacob Kihlström</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karin++Kolmodin">Karin Kolmodin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Johan++Lindstr%C3%B6m">Johan Lindström</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefan++von+Berg">Stefan von Berg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fredrik++von+Kieseritzky">Fredrik von Kieseritzky</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Can++Slivo">Can Slivo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Britt-Marie++Swahn">Britt-Marie Swahn</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lise-Lotte++Olsson">Lise-Lotte Olsson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrik++Johansson">Patrik Johansson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susanna++Eketj%C3%A4ll">Susanna Eketjäll</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Johanna++F%C3%A4lting">Johanna Fälting</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fredrik++Jeppsson">Fredrik Jeppsson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kia++Str%C3%B6mberg">Kia Strömberg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Juliette++Janson">Juliette Janson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fredrik++Rahm">Fredrik Rahm</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Department of Medicinal Chemistry, <sup>‡</sup>Department of Neuroscience, and <sup>§</sup>Department of DMPK, AstraZeneca R&D Södertälje, SE-151 85 Södertälje, Sweden</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">∥</span> <span class="aff-text">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden</span></div><div class="corresp-info"><strong>*</strong>Phone: +46 (0) 70 672 48 97. E-mail: <a href="/cdn-cgi/l/email-protection#3f4653495e11584d5e495a5159504d4c7f57504b525e5653115c5052"><span class="__cf_email__" data-cfemail="e69f8a9087c881948790838880899495a68e89928b878f8ac885898b">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm300991n&amp;href=/doi/10.1021%2Fjm300991n" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 9297–9311</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 27, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>9 July 2012</li><li><span class="item_label"><b>Published</b> online</span>3 October 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 November 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm300991n" title="DOI URL">https://doi.org/10.1021/jm300991n</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9297%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYlva%2BGravenfors%252C%2BJenny%2BViklund%252C%2BJan%2BBlid%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D21%26contentID%3Djm300991n%26title%3DNew%2BAminoimidazoles%2Bas%2B%25CE%25B2-Secretase%2B%2528BACE-1%2529%2BInhibitors%2BShowing%2BAmyloid-%25CE%25B2%2B%2528A%25CE%25B2%2529%2BLowering%2Bin%2BBrain%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9311%26publicationDate%3DNovember%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm300991n"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2661</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">55</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm300991n" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;New Aminoimidazoles as β-Secretase (BACE-1) Inhibitors Showing Amyloid-β (Aβ) Lowering in Brain&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ylva&quot;,&quot;last_name&quot;:&quot;Gravenfors&quot;},{&quot;first_name&quot;:&quot;Jenny&quot;,&quot;last_name&quot;:&quot;Viklund&quot;},{&quot;first_name&quot;:&quot;Jan&quot;,&quot;last_name&quot;:&quot;Blid&quot;},{&quot;first_name&quot;:&quot;Tobias&quot;,&quot;last_name&quot;:&quot;Ginman&quot;},{&quot;first_name&quot;:&quot;Sofia&quot;,&quot;last_name&quot;:&quot;Karlström&quot;},{&quot;first_name&quot;:&quot;Jacob&quot;,&quot;last_name&quot;:&quot;Kihlström&quot;},{&quot;first_name&quot;:&quot;Karin&quot;,&quot;last_name&quot;:&quot;Kolmodin&quot;},{&quot;first_name&quot;:&quot;Johan&quot;,&quot;last_name&quot;:&quot;Lindström&quot;},{&quot;first_name&quot;:&quot;Stefan&quot;,&quot;last_name&quot;:&quot;von Berg&quot;},{&quot;first_name&quot;:&quot;Fredrik&quot;,&quot;last_name&quot;:&quot;von Kieseritzky&quot;},{&quot;first_name&quot;:&quot;Can&quot;,&quot;last_name&quot;:&quot;Slivo&quot;},{&quot;first_name&quot;:&quot;Britt-Marie&quot;,&quot;last_name&quot;:&quot;Swahn&quot;},{&quot;first_name&quot;:&quot;Lise-Lotte&quot;,&quot;last_name&quot;:&quot;Olsson&quot;},{&quot;first_name&quot;:&quot;Patrik&quot;,&quot;last_name&quot;:&quot;Johansson&quot;},{&quot;first_name&quot;:&quot;Susanna&quot;,&quot;last_name&quot;:&quot;Eketjäll&quot;},{&quot;first_name&quot;:&quot;Johanna&quot;,&quot;last_name&quot;:&quot;Fälting&quot;},{&quot;first_name&quot;:&quot;Fredrik&quot;,&quot;last_name&quot;:&quot;Jeppsson&quot;},{&quot;first_name&quot;:&quot;Kia&quot;,&quot;last_name&quot;:&quot;Strömberg&quot;},{&quot;first_name&quot;:&quot;Juliette&quot;,&quot;last_name&quot;:&quot;Janson&quot;},{&quot;first_name&quot;:&quot;Fredrik&quot;,&quot;last_name&quot;:&quot;Rahm&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;03&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;9297-9311&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm300991n&quot;},&quot;abstract&quot;:&quot;Amino-2H-imidazoles are described as a new class of BACE-1 inhibitors for the treatment of Alzheimer’s disease. Synthetic methods, crystal structures, and structure–activity relationships for target activity, permeability, and hERG activity are reported and discussed. Compound (S)-1m was one of the most promising compounds in this report, with high potency in the cellular assay and a good overall profile. When guinea pigs were treated with compound (S)-1m, a concentration and time dependent decrease in Aβ40 and Aβ42 levels in plasma, brain, and CSF was observed. The maximum reduction of brain Aβ was 40–50%, 1.5 h after oral dosing (100 μmol/kg). The results presented highlight the potential of this new class of BACE-1 inhibitors with good target potency and with low effect on hERG, in combination with a fair CNS exposure in vivo.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300991n&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300991n" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300991n&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300991n" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300991n&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300991n" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm300991n&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300991n&amp;href=/doi/10.1021/jm300991n" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm300991n" /></input><a href="/doi/pdf/10.1021/jm300991n" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm300991n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm300991n%26sid%3Dliteratum%253Aachs%26pmid%3D23017051%26genre%3Darticle%26aulast%3DGravenfors%26date%3D2012%26atitle%3DNew%2BAminoimidazoles%2Bas%2B%25CE%25B2-Secretase%2B%2528BACE-1%2529%2BInhibitors%2BShowing%2BAmyloid-%25CE%25B2%2B%2528A%25CE%25B2%2529%2BLowering%2Bin%2BBrain%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D21%26spage%3D9297%26epage%3D9311%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292610" title="Antibiotic resistance">Antibiotic resistance</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=292504" title="Permeability">Permeability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jmcmar.2012.55.issue-21/production/jmcmar.2012.55.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/medium/jm-2012-00991n_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/large/jm-2012-00991n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300991n&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Amino-2<i>H</i>-imidazoles are described as a new class of BACE-1 inhibitors for the treatment of Alzheimer’s disease. Synthetic methods, crystal structures, and structure–activity relationships for target activity, permeability, and hERG activity are reported and discussed. Compound (<i>S</i>)-<b>1m</b> was one of the most promising compounds in this report, with high potency in the cellular assay and a good overall profile. When guinea pigs were treated with compound (<i>S</i>)-<b>1m</b>, a concentration and time dependent decrease in Aβ40 and Aβ42 levels in plasma, brain, and CSF was observed. The maximum reduction of brain Aβ was 40–50%, 1.5 h after oral dosing (100 μmol/kg). The results presented highlight the potential of this new class of BACE-1 inhibitors with good target potency and with low effect on hERG, in combination with a fair CNS exposure in vivo.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="specialIssueNotice" class="extra-info-sec articleNote"><h4>SPECIAL ISSUE</h4><p class="last">This article is part of the <a href="/toc/jmcmar/55/21"><issue-title>Alzheimer's Disease</issue-title></a> special issue.</p></div><div class="extra-info-sec articleNote"><h4><span>⊥</span> Author Present Address</h4><p class="last">Sprint Bioscience Teknikringen 38A, SE-114 28 Stockholm, Sweden. Phone: +46 (0)70 497 41 18. E-mail: <a href="/cdn-cgi/l/email-protection#f99f8b9c9d8b9092d78b989194b98a898b90978d9b90968a9a909c979a9cd79a9694"><span class="__cf_email__" data-cfemail="2640544342544f4d0854474e4b665556544f4852444f4955454f434845430845494b">[email protected]</span></a>.</p></div><div class="extra-info-sec articleNote withdrawn"><h4><span></span> Accession Codes</h4><p class="last">New protein/ligand coordinates for (<i>S</i>)-<b>1m</b> and (<i>R</i>)-<b>1t</b> have been deposited in the PDB with codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4b1d">4b1d</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4b1c">4b1c</a>, respectively.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32370" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32370" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Collected statistics regarding Alzheimer’s disease (AD) predict a negative socioeconomic effect from the increasing number of AD patients via growth in the aging population.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> The drug therapies available today treat the symptoms and do not address the underlying neuropathology.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> There is a huge need for research in the area to find treatments to prevent or halt the progression of the disease.</div><div class="NLM_p">During the progression of AD, neurons degenerate, leading to significant shrinkage of the brain and an imbalance of the different neurotransmitters. In post-mortem AD brains, insoluble proteins in the form of plaques and tangles are accumulated.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> The plaques contain amyloid-β peptide (Aβ), generated from proteolytic cleavage of amyloid precursor protein (APP).<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The first step in the processing of APP to generate Aβ is cleavage by the aspartyl protease β-secretase, or BACE-1 (β-site APP cleaving enzyme).<a onclick="showRef(event, 'ref6 ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8 ref9 ref10">(6-10)</a> This step is followed by γ-secretase cleavage, resulting in Aβ of different lengths. One form of the degradation product, Aβ42, is thought to be particularly pathogenic. Early onset AD is associated with genetic alterations in presenilin-1 (PS1, part of the γ-secretase complex) and APP, which implicates the amyloid pathway and alterations in the production of Aβ as important for disease.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The BACE-1 homologue BACE-2 is expressed at very low levels in neurons, and a role of BACE-2 in APP processing or contributing to disease remains uncertain.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Taken together, these data indicate that BACE-1 inhibition, to stop or reduce the production of Aβ, is an attractive approach to modify Alzheimer’s disease.<a onclick="showRef(event, 'ref5 ref12'); return false;" href="javascript:void(0);" class="ref ref5 ref12">(5, 12)</a></div><div class="NLM_p">Despite extensive research, the identification of a potent BACE-1 inhibitor, efficacious in man, has proven to be a challenge.<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13-15)</a> Two main structural classes of BACE-1 inhibitors are described in the literature: transition state isosteres of the peptide substrate<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> and smaller cyclic structures with an amidine or guanidine moiety, interacting with the two catalytic aspartates of BACE-1.<a onclick="showRef(event, 'ref18 ref19 ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21 ref22 ref23">(18-23)</a> The substrate transition state isosteres give potent inhibitors but have often had limitations in physicochemical properties being large, flexible, and polar. However, this compound class was developed into hydroxyethylamine isosteres that have recently achieved brain Aβ lowering in animal models.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a> One compound in this family of BACE-1 inhibitors has shown cognitive performance improvement in transgenic mice after subcutaneous administration.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> BACE-1 inhibitors containing an amidine or guanidine moiety have been identified from fragment-based or high throughput screens.<a onclick="showRef(event, 'ref18 ref20 ref22 ref23 ref27'); return false;" href="javascript:void(0);" class="ref ref18 ref20 ref22 ref23 ref27">(18, 20, 22, 23, 27)</a> These compounds have, after extensive optimization, shown brain Aβ lowering in animal models<a onclick="showRef(event, 'ref22 ref28'); return false;" href="javascript:void(0);" class="ref ref22 ref28">(22, 28)</a> and CSF Aβ-reduction in rat<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> or humans.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Another BACE-1 inhibitor, from a different structural class, has shown cognition improvement in mice and rat.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> However, disease modification from BACE-1 inhibition in humans is still not reported.</div><div class="NLM_p">During our in-house research in developing BACE-1 inhibitors, we have investigated different amidine-containing structures of the types depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>.<a onclick="showRef(event, 'ref19 ref22 ref27'); return false;" href="javascript:void(0);" class="ref ref19 ref22 ref27">(19, 22, 27)</a> Although these structural classes share the same chemical motif important for BACE-1 inhibition, they have different physicochemical properties, and thus some chemical series have been more permeable and less susceptible to efflux than others.<a onclick="showRef(event, 'ref19 ref22'); return false;" href="javascript:void(0);" class="ref ref19 ref22">(19, 22)</a> A low efflux has been shown to be most important to achieve brain exposure in vivo.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> In addition, the generic pharmacophore of many of the described BACE-1 inhibitors, which feature a basic functionality and two to four aromatic rings, overlaps with published pharmacophores of the human ether-a-go-go-related gene (hERG) encoded potassium ion channel,<a onclick="showRef(event, 'ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34">(32-34)</a> and we have reported inhibitory values.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><div class="NLM_p">Part of our strategy was to look into modifications of the amidine-containing core structure in order to investigate if new BACE-1 inhibitors with different profiles could be discovered. Amino-2<i>H</i>-imidazole (<b>core-1</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) is differentiated from the earlier reported cores with regard to polarity and size, factors that could influence target potency, permeability, and hERG activity. The aim of this work was to evaluate <b>core-1</b> by investigating the profiles of analogues from this core, with respect to the above-mentioned properties. We will discuss the synthesis, SAR, and the first in vivo studies of this new class of BACE-1 inhibitors.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/medium/jm-2012-00991n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/large/jm-2012-00991n_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Examples of cyclic amidine cores of BACE-1 inhibitors previously investigated in-house: dihydroisocytosines, bicyclic aminoimidazoles, and aminoisoindoles (X = CH, CR, or N). (B) Amino-2<i>H</i>-imidazole, <b>core-1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/large/jm-2012-00991n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300991n&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Synthesis</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17562" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17562" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The first reported synthesis of the amino-2<i>H</i>-imidazole <b>core-1</b> was described by Asinger in 1963.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The amino-2<i>H</i>-imidazoles were formed as a byproduct during the synthesis of imidazothiones <b>3</b>, which were efficiently prepared by a sequential synthesis, as described in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/medium/jm-2012-00991n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/large/jm-2012-00991n_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. First Practical Synthesis of Amino-2<i>H</i>-imidazole Precursor <b>3</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/large/jm-2012-00991n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300991n&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of the synthetic method illustrated above and a similar procedure also described by Asinger,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> new routes (methods A, B, and C) were developed for synthesizing the various amino-2<i>H</i>-imidazoles <b>1</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38, 39)</a> The methods of preparation for compounds <b>1a</b>–<b>t</b> are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> (for <b>1u</b> and <b>1v</b>, see Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/medium/jm-2012-00991n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/large/jm-2012-00991n_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Various Methods for Preparing Amino-2<i>H</i>-imidazoles <b>1</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/large/jm-2012-00991n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300991n&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>5</b>, 7 M NH<sub>3</sub> in methanol, 120 °C; (b) P<sub>2</sub>S<sub>5</sub>, pyridine; (c) <i>t</i>-BuOOH, NH<sub>3</sub>; (d) boronic acid or stannane reactant, Pd catalyst; (e) ethanebis(thioamide) <b>8</b>, 7 M NH<sub>3</sub> in methanol; (f) MeI, THF; (g) MeMgBr, ZnI<sub>2</sub>, cat. Pd<sub>2</sub>Cl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, THF or MeMgBr, cat. Ni(dppp)Cl<sub>2</sub>, PhMe; (h) H<sub>2</sub>S, Et<sub>3</sub>N, 2-methyl THF; (i) <b>4</b>, if X = O, 7 M NH<sub>3</sub> in methanol or if X = NH, methanol.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Synthesized Amino-2<i>H</i>-imidazoles, <b>1</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/medium/jm-2012-00991n_0009.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">product</th><th class="colsep0 rowsep0" align="center">method</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1a</b></td><td class="colsep0 rowsep0" align="left">A<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">pyridin-3-yl</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1b</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">pyridin-3-yl</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1c</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">3-methoxyphenyl</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1d</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">pyridin-3-yl</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1e</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">pyrimidin-5-yl</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1f</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">4-methoxyphenyl</td><td class="colsep0 rowsep0" align="left">pyrimidin-5-yl</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1g</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">pyridin-3-yl</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1h</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">pyridin-4-yl</td><td class="colsep0 rowsep0" align="left">3-methoxyphenyl</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1i</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">4-fluorophenyl</td><td class="colsep0 rowsep0" align="left">pyridin-3-yl</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1j</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">4-methoxyphenyl</td><td class="colsep0 rowsep0" align="left">pyrimidin-5-yl</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1k</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">4-methoxyphenyl</td><td class="colsep0 rowsep0" align="left">pyridin-3-yl</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1l</b></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">3-methyl-4-methoxyphenyl</td><td class="colsep0 rowsep0" align="left">pyrimidin-5-yl</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1m</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">3,5-dimethyl-4-methoxyphenyl</td><td class="colsep0 rowsep0" align="left">pyrimidin-5-yl</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1n</b></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">3,5-dimethyl-4-methoxyphenyl</td><td class="colsep0 rowsep0" align="left">5-(prop-1-ynyl)pyridin-3-yl</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1o</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">benzyl</td><td class="colsep0 rowsep0" align="left">pyrimidin-5-yl</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1p</b></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">cyclopropyl</td><td class="colsep0 rowsep0" align="left">5-chloropyridin-3-yl</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1q</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">cyclohexyl</td><td class="colsep0 rowsep0" align="left">pyridin-3-yl</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1r</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">tetrahydro-2<i>H</i>-pyran-4-yl</td><td class="colsep0 rowsep0" align="left">3-methoxyphenyl</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1s</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">4-acylpiperidin-4-yl</td><td class="colsep0 rowsep0" align="left">3-methoxyphenyl</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1t</b></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">cyclopropyl</td><td class="colsep0 rowsep0" align="left">5-(prop-1-ynyl)pyridin-3-yl</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last"><b>1a</b> was prepared by a slightly altered procedure; see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div></div></div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/medium/jm-2012-00991n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/large/jm-2012-00991n_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Amino-2<i>H</i>-imidazoles <b>1u</b> and <b>1v</b> were prepared using method C (see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/large/jm-2012-00991n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300991n&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40122" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40122" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compounds <b>1a</b>–<b>v</b> were evaluated for BACE-1 inhibition in one enzymatic and one cellular assay (hBACE-1, TR-FRET, and SH-SY5Y sAPPβ release assays, respectively). The cell-based assay for BACE-1 inhibition used specific antibodies to monitor reduction of sAPPβ release from human neuronal-derived SH-SY5Y cells. Other measured properties were permeability estimations (<i>P</i><sub>app</sub>(A→B) values and efflux classifications), hERG activity, p<i>K</i><sub>a</sub> values, lipophilicity (experimentally determined as an estimated log <i>D</i> value<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a>), and aqueous solubility. The efflux of the compounds was measured in MDCK-MDR1 cells to estimate P-gp-mediated transport. The compounds are classified depending on their measured efflux values, as low (efflux ratio of <2.5), medium, or high (efflux ratio of >3.5). All data together with some calculated values are reported in Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>.</div><div class="NLM_p">The first synthesized amino-2<i>H</i>-imidazoles <b>1a</b> (R<sup>1</sup> = Ph) and <b>1b</b> (R<sup>1</sup> = isopropyl) did not show any, or showed very little, activity in the TR-FRET assay (no IC<sub>50</sub> could be derived). When the size of R<sup>1</sup> was decreased, as for <b>1c</b> and <b>1d</b> (R<sup>1</sup> = Me), IC<sub>50</sub> values were measured as 3.5 and 13 μM, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The p<i>K</i><sub>a</sub> values of these compounds were measured as 6.5 and 6.7, respectively, which is within a range that has been reported to yield active compounds for BACE-1 inhibition.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Addition of aryls as R<sup>2</sup>-substituents (<b>1e</b>–<b>k)</b> gave the first compounds with submicromolar potencies in the TR-FRET assay. A small substituent as R<sup>1</sup> was beneficial for BACE-1 inhibition (compare <b>1f</b> and <b>1j</b>). As previously reported for compounds with an acceptor motif reaching out toward Trp76,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> potency increased, and the combination of a methyl as R<sup>1</sup> together with a larger R<sup>2</sup> showed promising biochemical data, e.g., <b>1h</b> (IC<sub>50</sub> = 0.17 μM; ligand efficiency,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> LE = 0.34) and <b>1j</b> (IC<sub>50</sub> = 0.27 μM; LE = 0.33). By stepwise introduction of methyl groups in the 3 and 5 positions in which R<sup>2</sup> is 4-methoxyphenyl (from <b>1j</b> to <b>1l</b> and <b>1m</b>), we observed a 3-fold increase in potency for each methyl group, both in the TR-FRET and in the SH-SY5Y assay.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Aminoimidazoles <b>1a</b>–<b>n</b>, Measurements of BACE-1 Potency in TR-FRET Assay and SH-SY5Y Assay, Permeability Estimations (<i>P</i><sub>app</sub>(A→B) in Caco-2 Cells, Efflux Classifications from MDCK-MDR1 Cells), hERG, p<i>K</i><sub>a</sub>, ElogD, Solubility, PSA, and LE<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">BACE-1TR-FRET,<a class="ref internalNav" href="#t2fn1" aria-label="b">b</a> IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">BACE-1SH-SY5Y,<a class="ref internalNav" href="#t2fn1" aria-label="b">b</a> IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center"><i>P</i><sub>app</sub>(10<sup>–6</sup> cm/s)<a class="ref internalNav" href="#t2fn2" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">efflux classification<a class="ref internalNav" href="#t2fn3" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">hERG,<a class="ref internalNav" href="#t2fn4" aria-label="e">e</a> IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">p<i>K</i><sub>a</sub> <a class="ref internalNav" href="#t2fn5" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center">ElogD<a class="ref internalNav" href="#t2fn6" aria-label="g">g</a></th><th class="colsep0 rowsep0" align="center">solubility<a class="ref internalNav" href="#t2fn7" aria-label="h">h</a> (μM)</th><th class="colsep0 rowsep0" align="center">PSA (Å<sup>2</sup>)</th><th class="colsep0 rowsep0" align="center">LE<a class="ref internalNav" href="#t2fn8" aria-label="i">i</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1a</b></td><td class="colsep0 rowsep0" align="left">not active</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">46</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">>33</td><td class="colsep0 rowsep0" align="left">5.4</td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="left">199</td><td class="colsep0 rowsep0" align="left">57</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1b</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">38</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">>33</td><td class="colsep0 rowsep0" align="left">5.9</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">400</td><td class="colsep0 rowsep0" align="left">57</td><td class="colsep0 rowsep0" align="left"><0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1c</b></td><td class="colsep0 rowsep0" align="left">3.5</td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="left">34</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">16.7</td><td class="colsep0 rowsep0" align="left">6.5</td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="left">157</td><td class="colsep0 rowsep0" align="left">56</td><td class="colsep0 rowsep0" align="left">0.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1d</b></td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">4.3</td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">medium</td><td class="colsep0 rowsep0" align="left">>33</td><td class="colsep0 rowsep0" align="left">6.7</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left">383</td><td class="colsep0 rowsep0" align="left">57</td><td class="colsep0 rowsep0" align="left">0.33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1e</b></td><td class="colsep0 rowsep0" align="left">18</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">>33</td><td class="colsep0 rowsep0" align="left">5.2</td><td class="colsep0 rowsep0" align="left">2.4</td><td class="colsep0 rowsep0" align="left">45</td><td class="colsep0 rowsep0" align="left">68</td><td class="colsep0 rowsep0" align="left">0.24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1f</b></td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">26.8</td><td class="colsep0 rowsep0" align="left">5.3</td><td class="colsep0 rowsep0" align="left">2.4</td><td class="colsep0 rowsep0" align="left">338</td><td class="colsep0 rowsep0" align="left">77</td><td class="colsep0 rowsep0" align="left">0.27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1g</b></td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">63</td><td class="colsep0 rowsep0" align="left">57</td><td class="colsep0 rowsep0" align="left">0.32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1h</b></td><td class="colsep0 rowsep0" align="left">0.17</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">67</td><td class="colsep0 rowsep0" align="left">0.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1i</b></td><td class="colsep0 rowsep0" align="left">0.49</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">41</td><td class="colsep0 rowsep0" align="left">high</td><td class="colsep0 rowsep0" align="left">>33</td><td class="colsep0 rowsep0" align="left">4.9</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">35</td><td class="colsep0 rowsep0" align="left">57</td><td class="colsep0 rowsep0" align="left">0.33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1j</b></td><td class="colsep0 rowsep0" align="left">0.27</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left">high</td><td class="colsep0 rowsep0" align="left">>33</td><td class="colsep0 rowsep0" align="left">5.2</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">358</td><td class="colsep0 rowsep0" align="left">77</td><td class="colsep0 rowsep0" align="left">0.33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1k</b></td><td class="colsep0 rowsep0" align="left">0.33</td><td class="colsep0 rowsep0" align="left">0.81</td><td class="colsep0 rowsep0" align="left">28</td><td class="colsep0 rowsep0" align="left">high</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">5.7</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">317</td><td class="colsep0 rowsep0" align="left">67</td><td class="colsep0 rowsep0" align="left">0.33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1l</b></td><td class="colsep0 rowsep0" align="left">0.097</td><td class="colsep0 rowsep0" align="left">0.17</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">high</td><td class="colsep0 rowsep0" align="left">>33</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">255</td><td class="colsep0 rowsep0" align="left">77</td><td class="colsep0 rowsep0" align="left">0.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1m</b></td><td class="colsep0 rowsep0" align="left">0.032</td><td class="colsep0 rowsep0" align="left">0.049</td><td class="colsep0 rowsep0" align="left">28</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">>33</td><td class="colsep0 rowsep0" align="left">5.3</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">271</td><td class="colsep0 rowsep0" align="left">77</td><td class="colsep0 rowsep0" align="left">0.35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-<b>1m</b></td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left">high</td><td class="colsep0 rowsep0" align="left">>33</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">259</td><td class="colsep0 rowsep0" align="left">77</td><td class="colsep0 rowsep0" align="left">0.27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>1m</b></td><td class="colsep0 rowsep0" align="left">0.012</td><td class="colsep0 rowsep0" align="left">0.024</td><td class="colsep0 rowsep0" align="left">22</td><td class="colsep0 rowsep0" align="left">high</td><td class="colsep0 rowsep0" align="left">>33</td><td class="colsep0 rowsep0" align="left">5.2</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">258</td><td class="colsep0 rowsep0" align="left">77</td><td class="colsep0 rowsep0" align="left">0.37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1n</b></td><td class="colsep0 rowsep0" align="left">0.026</td><td class="colsep0 rowsep0" align="left">0.014</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">17.5</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">3.7</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">67</td><td class="colsep0 rowsep0" align="left">0.32</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">nd: not determined.</p></div><div class="footnote" id="t2fn1"><sup>b</sup><p class="last">IC<sub>50</sub> values are the mean of at least two experiments.</p></div><div class="footnote" id="t2fn2"><sup>c</sup><p class="last"><i>P</i><sub>app</sub> is the measured permeability (A→B) through Caco-2 cells.</p></div><div class="footnote" id="t2fn3"><sup>d</sup><p class="last">Efflux ratio is <i>P</i><sub>app</sub>(B-A)/<i>P</i><sub>app</sub>(A–B) in MDCK-MDR1 cells.</p></div><div class="footnote" id="t2fn4"><sup>e</sup><p class="last">Measured in hERG-expressing CHO cells using IonWorks technology.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></p></div><div class="footnote" id="t2fn5"><sup>f</sup><p class="last">Determined by pressure-assisted capillary electrophoresis.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42, 43)</a></p></div><div class="footnote" id="t2fn6"><sup>g</sup><p class="last">Determined by reversed phase liquid chromatography.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></p></div><div class="footnote" id="t2fn7"><sup>h</sup><p class="last">Determined by dried DMSO, a rapid throughput equilibrium solubility measurement.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></p></div><div class="footnote" id="t2fn8"><sup>i</sup><p class="last">Ligand efficiency (LE)<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> calculated from TR-FRET data.</p></div></div></div><div class="NLM_p">To further improve interaction with the protein, we hypothesized that an alkyne moiety, on the aromatic ring in R<sup>3</sup>, could expand into the S3sp (S3 subpocket).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> There was a clear increase in potency in the cellular assay for <b>1n</b> in comparison with <b>1m</b>.</div><div class="NLM_p">Compounds <b>1h</b>–<b>l</b> were more potent in the TR-FRET assay than compound <b>1g</b>, although this gain in potency in the biochemical assay for <b>1h</b>–<b>k</b> (though not <b>1l</b>) was not observed in the cellular assay. This difference between enzymatic and cellular potency has been observed before<a onclick="showRef(event, 'ref19 ref46'); return false;" href="javascript:void(0);" class="ref ref19 ref46">(19, 46)</a> and is reported to be correlated to the p<i>K</i><sub>a</sub> of the inhibitors. Indeed, the p<i>K</i><sub>a</sub> values for the compounds with R<sup>2</sup>-aryl were reduced 1 log unit compared to the early R<sup>2</sup>-methyl (<b>1d</b>, p<i>K</i><sub>a</sub> = 6.7 and <b>1k</b>, p<i>K</i><sub>a</sub> = 5.7), which we hypothesized to have caused this reduction in cellular potency.</div><div class="NLM_p">As reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, the compounds with aryls in R<sup>2</sup> showed a good hERG profile with most compounds inactive at the highest concentration tested (33 μM). A matched pair analysis between compound <b>1j</b> (hERG IC<sub>50</sub> > 33 μM) and 4-fluoro-1-(4-methoxyphenyl)-1-(3-(pyrimidin-5-yl)phenyl)-1<i>H</i>-isoindol-3-amine<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> (hERG IC<sub>50</sub> = 0.5 μM) from an earlier published series shows that compound <b>1j</b> is more than 65 times less prone to interact with this potassium channel. The weak interaction with hERG could be explained by the decreased lipophilicity and p<i>K</i><sub>a</sub> (ElogD = 1.1 and p<i>K</i><sub>a</sub> = 5.2 for <b>1j</b>, compared to ElogD = 2.4 and p<i>K</i><sub>a</sub> = 8.2 for 4-fluoro-1-(4-methoxyphenyl)-1-(3-(pyrimidin-5-yl)phenyl)-1<i>H</i>-isoindol-3-amine).<a onclick="showRef(event, 'ref22 ref47'); return false;" href="javascript:void(0);" class="ref ref22 ref47">(22, 47)</a></div><div class="NLM_p">The Caco-2 permeability for the compounds was good, with <i>P</i><sub>app</sub>(A→B) values ranging from 12 × 10<sup>–6</sup> to 41 × 10<sup>–6</sup> cm/s. However, the P-glycoprotein (P-gp) mediated efflux values (as determined with the in vitro MDCK-MDR1, ABBA cell assay) were classified as medium or high, for most of the compounds tested (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). One reason for the good Caco-2 permeability could be the relatively low p<i>K</i><sub>a</sub> of the compounds, leading to a higher percentage of uncharged molecules at physiological pH.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42, 43)</a></div><div class="NLM_p">One of the most promising compounds was <b>1m</b>, showing a good overall profile. The enantiomers of compound <b>1m</b> were separated and profiled, and it became clear that the <i>S</i>-enantiomer was primarily responsible for the BACE-1 inhibition. Compound (<i>S</i>)-<b>1m</b> achieved potencies of 12 and 24 nM in the TR-FRET and SH-SY5Y assays, respectively.</div><div class="NLM_p">To investigate whether the cellular potency and permeability profile could be further improved for this new structure class, we aimed to increase the lipophilicity and p<i>K</i><sub>a</sub> of the compounds. An increase in lipophilicity has been reported to increase the chance of a high permeability.<a onclick="showRef(event, 'ref22 ref48'); return false;" href="javascript:void(0);" class="ref ref22 ref48">(22, 48)</a> As described above, we wanted to take advantage of the increased potency in the cellular assay by increasing p<i>K</i><sub>a</sub> of the compounds. Since the R<sup>2</sup> substituents are directly adjacent to the core, modifications to R<sup>2</sup> were predicted to give the largest impact on p<i>K</i><sub>a</sub>. Thus, R<sup>2</sup> substitution was varied with electron donating groups (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Adding a plain benzyl group, (<i>R</i>)-<b>1o</b> (isolated active enantiomer), increased the p<i>K</i><sub>a</sub> to 6.0. The potency in the TR-FRET assay decreased (e.g., compared to <b>1j</b>) probably because of the loss of the hydrogen bond interaction with Trp76. However, in the cellular assay (<i>R</i>)-<b>1o</b> gave increased potency, likely driven by the increase in p<i>K</i><sub>a</sub>. Four more analogues (<b>1p</b>–<b>s</b>) with alkyl/heteroalkyl substituents in the R<sup>2</sup>-position were prepared and showed potencies in the low micromolar to high nanomolar range. Compounds <b>1r</b> and <b>1s</b> contain a hydrogen-bond acceptor moiety in R<sup>2</sup>, but the lack of potency improvement points to an unoptimized interaction to Trp76 (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). As seen with <b>1n</b>, by introduction of an S3sp alkyne substituent in R<sup>3</sup>, the potency was increased more than 3-fold in both BACE-1 inhibition assays when going from <b>1p</b> (R<sup>3</sup> = 5-chloropyridin-3-yl, TR-FRET IC<sub>50</sub> = 0.31 μM) to <b>1t</b> (R<sup>3</sup> = 5-(prop-1-ynyl)pyridin-3-yl, TR-FRET IC<sub>50</sub> = 0.079 μM).</div><div class="NLM_p">The highest LE of the reported compounds was seen for <b>1t</b> (R<sup>2</sup> = cyclopropyl, LE = 0.39). This can be compared to the analogue <b>1n</b> (R<sup>2</sup> = 3,5-dimethyl-4-methoxyphenyl, LE = 0.32). From the crystal structure of <b>1t</b> (only the <i>R</i>-enantiomer of the compound interacted with the protein to give a crystal structure) it became clear that the small cyclopropyl substituent (R<sup>2</sup>) allowed the protein to maintain the intramolecular hydrogen bond between Trp76 and Tyr71, and the cyclopropyl is engaged in a hydrophobic interaction with Tyr71 (3.6 Å).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> This should be compared to compounds with larger R<sup>2</sup>-substituents like (<i>S</i>)-<b>1m</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/medium/jm-2012-00991n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/large/jm-2012-00991n_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structure of (<i>R</i>)-<b>1t</b> (orange) and (<i>S</i>)-<b>1m</b> (cyan) complexed with BACE-1. For ligand (<i>R</i>)-<b>1t</b> with a small substituent, (R<sup>2</sup> = cyclopropyl) the internal hydrogen bond between Trp76 and Tyr71 was retained. Also shown is the interaction of Trp76 with the R<sup>2</sup> 4-methoxy group for (<i>S</i>)-<b>1m</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/large/jm-2012-00991n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300991n&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In summary, the compounds with R<sup>2</sup> = alkyl/heteroalkyl had increased (about 1 log unit) p<i>K</i><sub>a</sub> values compared to the compounds with R<sup>2</sup> = aryl. The relative potency in the cellular assay compared to the TR-FRET assay increased, but for these compounds the overall potencies were lower presumably because of the loss of the hydrogen bond interaction to Trp76 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). In addition, the hERG affinity increased for these more lipophilic compounds. The permeability profile for the compounds with R<sup>2</sup> = alkyl/heteroalkyl improved, with examples of low and medium efflux, e.g., (<i>R</i>)-<b>1o</b> and <b>1q</b>. A trend for these compounds was observed in which a low polar surface area (PSA) in combination with high ElogD values gave better permeability. In particular, the permeability for <b>1p</b> and <b>1q</b> was good.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Aminoimidazoles (<i>R</i>)-<b>1o</b>–<b>t</b>, measurements of BACE-1 Potency in TR-FRET Assay and SH-SY5Y Assay, Permeability Estimations (<i>P</i><sub>app</sub>(A→B) in Caco-2 Cells and Efflux Classifications from MDCK-MDR1 Cells), hERG, p<i>K</i><sub>a</sub>, ElogD, Solubility, PSA, and LE<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">BACE-1TR-FRET,<a class="ref internalNav" href="#t3fn1" aria-label="b">b</a> IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">BACE-1SH-SY5Y,<a class="ref internalNav" href="#t3fn1" aria-label="b">b</a> IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center"><i>P</i><sub>app</sub>(10<sup>–6</sup> cm/s)<a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">efflux classification<a class="ref internalNav" href="#t3fn3" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">hERG,<a class="ref internalNav" href="#t3fn4" aria-label="e">e</a> IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">p<i>K</i><sub>a</sub> <a class="ref internalNav" href="#t3fn5" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center">ElogD<a class="ref internalNav" href="#t3fn6" aria-label="g">g</a></th><th class="colsep0 rowsep0" align="center">solubility<a class="ref internalNav" href="#t3fn7" aria-label="h">h</a> (μM)</th><th class="colsep0 rowsep0" align="center">PSA (Å<sup>2</sup>)</th><th class="colsep0 rowsep0" align="center">LE<a class="ref internalNav" href="#t3fn8" aria-label="i">i</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-<b>1o</b></td><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left">0.71</td><td class="colsep0 rowsep0" align="left">31</td><td class="colsep0 rowsep0" align="left">low</td><td class="colsep0 rowsep0" align="left">>33</td><td class="colsep0 rowsep0" align="left">6.0</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">233</td><td class="colsep0 rowsep0" align="left">68</td><td class="colsep0 rowsep0" align="left">0.29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1p</b></td><td class="colsep0 rowsep0" align="left">0.31</td><td class="colsep0 rowsep0" align="left">0.69</td><td class="colsep0 rowsep0" align="left">57</td><td class="colsep0 rowsep0" align="left">high</td><td class="colsep0 rowsep0" align="left">12.4</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">62</td><td class="colsep0 rowsep0" align="left">57</td><td class="colsep0 rowsep0" align="left">0.38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1q</b></td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">0.66</td><td class="colsep0 rowsep0" align="left">41</td><td class="colsep0 rowsep0" align="left">medium</td><td class="colsep0 rowsep0" align="left">28.8</td><td class="colsep0 rowsep0" align="left">6.2</td><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left">59</td><td class="colsep0 rowsep0" align="left">57</td><td class="colsep0 rowsep0" align="left">0.32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1r</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">22</td><td class="colsep0 rowsep0" align="left">high</td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left">6.0</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">272</td><td class="colsep0 rowsep0" align="left">65</td><td class="colsep0 rowsep0" align="left">0.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1s</b></td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">high</td><td class="colsep0 rowsep0" align="left">>33</td><td class="colsep0 rowsep0" align="left">5.7</td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="left">257</td><td class="colsep0 rowsep0" align="left">76</td><td class="colsep0 rowsep0" align="left">0.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1t</b></td><td class="colsep0 rowsep0" align="left">0.079</td><td class="colsep0 rowsep0" align="left">0.19</td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">high</td><td class="colsep0 rowsep0" align="left">14.4</td><td class="colsep0 rowsep0" align="left">5.8</td><td class="colsep0 rowsep0" align="left">2.3</td><td class="colsep0 rowsep0" align="left">67</td><td class="colsep0 rowsep0" align="left">57</td><td class="colsep0 rowsep0" align="left">0.39</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">nd: not determined.</p></div><div class="footnote" id="t3fn1"><sup>b</sup><p class="last">IC<sub>50</sub> values are the mean of at least two experiments.</p></div><div class="footnote" id="t3fn2"><sup>c</sup><p class="last"><i>P</i><sub>app</sub> is the measured permeability (A→B) through Caco-2 cells.</p></div><div class="footnote" id="t3fn3"><sup>d</sup><p class="last">Efflux ratio is <i>P</i><sub>app</sub>(B–A)/<i>P</i><sub>app</sub>(A–B) in MDCK-MDR1 cells.</p></div><div class="footnote" id="t3fn4"><sup>e</sup><p class="last">Measured in hERG-expressing CHO cells using IonWorks technology.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></p></div><div class="footnote" id="t3fn5"><sup>f</sup><p class="last">Determined by pressure-assisted capillary electrophoresis.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42, 43)</a></p></div><div class="footnote" id="t3fn6"><sup>g</sup><p class="last">Determined by reversed phase liquid chromatography.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></p></div><div class="footnote" id="t3fn7"><sup>h</sup><p class="last">Determined by dried DMSO, a rapid throughput equilibrium solubility measurement.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></p></div><div class="footnote" id="t3fn8"><sup>i</sup><p class="last">Ligand efficiency (LE)<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> calculated from TR-FRET data.</p></div></div></div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/medium/jm-2012-00991n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/large/jm-2012-00991n_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Correlation between potency change (pIC<sub>50</sub> SH-SY5Y - pIC<sub>50</sub> TR-FRET) and p<i>K</i><sub>a</sub> for the compounds <b>1a</b>–<b>v</b> (correlation factor <i>R</i><sup>2</sup> = 0.55). R<sup>2</sup>-alkyl/heteroalkyl gives in general higher p<i>K</i><sub>a</sub> values than R<sup>2</sup>-aryl.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/large/jm-2012-00991n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300991n&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To further increase the potency of compounds with alkyl/heteroalkyl as R<sup>2</sup>, we investigated the possibility of introducing a new interaction with the protein. From the crystal structures it seemed possible to establish a donor interaction between the S1 phenyl and the backbone carbonyl of Phe108 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Indeed, the introduction of a hydroxyl group to <b>1t</b> to give <b>1u</b> gave an additional 3-fold potency gain in the cellular assay compared to <b>1t</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Unfortunately and possibly because of the extra hydrogen bond donor, the Caco-2 permeability decreased significantly.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> The permeability <i>P</i><sub>app</sub>(A→B) in Caco-2 cells dropped from 27 for <b>1t</b> to 2.2 for <b>1u</b>, and the efflux ratio (in Caco-2 cells) increased from 0.8 for <b>1t</b> to 17 for <b>1u</b>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Aminoimidazoles <b>1u</b> and <b>1v</b>, Measurements of BACE-1 Potency in TR-FRET Assay and SH-SY5Y Assay, Permeability Estimations (<i>P</i><sub>app</sub>(A→B) and Efflux Ratios in Caco-2 Cells), hERG, p<i>K</i><sub>a</sub>, ElogD, Solubility, PSA, and LE<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">BACE-1TR-FRET,<a class="ref internalNav" href="#t4fn1" aria-label="b">b</a> IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">BACE-1SH-SY5Y,<a class="ref internalNav" href="#t4fn1" aria-label="b">b</a> IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center"><i>P</i><sub>app</sub>(10<sup>–6</sup> cm/s)<a class="ref internalNav" href="#t4fn2" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">efflux ratio<a class="ref internalNav" href="#t4fn3" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">hERG,<a class="ref internalNav" href="#t4fn4" aria-label="e">e</a> IC<sub>50</sub> μM</th><th class="colsep0 rowsep0" align="center">p<i>K</i><sub>a</sub><a class="ref internalNav" href="#t4fn5" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center">ElogD<a class="ref internalNav" href="#t4fn6" aria-label="g">g</a></th><th class="colsep0 rowsep0" align="center">solubility<a class="ref internalNav" href="#t4fn7" aria-label="h">h</a> (μM)</th><th class="colsep0 rowsep0" align="center">PSA (Å<sup>2</sup>)</th><th class="colsep0 rowsep0" align="center">LE<a class="ref internalNav" href="#t4fn8" aria-label="i">i</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1u</b></td><td class="colsep0 rowsep0" align="left">0.061</td><td class="colsep0 rowsep0" align="left">0.058</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">24.5</td><td class="colsep0 rowsep0" align="left">5.9</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">400</td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">0.38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1v</b></td><td class="colsep0 rowsep0" align="left">0.13</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">0.36</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">nd; not determined.</p></div><div class="footnote" id="t4fn1"><sup>b</sup><p class="last">IC<sub>50</sub> values are the mean of at least two experiments.</p></div><div class="footnote" id="t4fn2"><sup>c</sup><p class="last"><i>P</i><sub>app</sub> is the measured permeability (A→B) through Caco-2 cells.</p></div><div class="footnote" id="t4fn3"><sup>d</sup><p class="last">Efflux ratio is <i>P</i><sub>app</sub>(B–A)/<i>P</i><sub>app</sub>(A–B) in Caco-2 cells.</p></div><div class="footnote" id="t4fn4"><sup>e</sup><p class="last">Measured in hERG-expressing CHO cells using IonWorks technology.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></p></div><div class="footnote" id="t4fn5"><sup>f</sup><p class="last">Determined by pressure-assisted capillary electrophoresis.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42, 43)</a></p></div><div class="footnote" id="t4fn6"><sup>g</sup><p class="last">Determined by reversed phase liquid chromatography.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></p></div><div class="footnote" id="t4fn7"><sup>h</sup><p class="last">Determined by dried DMSO, a rapid throughput equilibrium solubility measurement.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></p></div><div class="footnote" id="t4fn8"><sup>i</sup><p class="last">Ligand efficiency (LE)<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> calculated from TR-FRET data.</p></div></div></div><div class="NLM_p">In an effort to increase the permeability by tuning the hydrogen bond donor strength of the hydroxyl group, the position of the pyridine nitrogen in the biaryl moiety was shifted to allow for a possible intramolecular hydrogen bond (<b>1v</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49, 50)</a> Indeed, permeability was improved for <b>1v</b> (Caco-2 cell data: <i>P</i><sub>app</sub> = 19 × 10<sup>–6</sup> cm/s and efflux ratio is 0.5), but the potency for <b>1v</b> is approximately 2-fold lower than for <b>1u</b> possibly because the hydroxyl is no longer as available for hydrogen bonding to the protein.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Selectivity</h3><div class="NLM_p">Prior to further investigation, the selectivity toward cathepsin-D and BACE-2 was measured for a few compounds (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). For cathepsin-D all compounds tested showed less than 30% inhibition at the highest concentration tested (100 μM). The BACE-2 activity showed higher variation, with 70-fold selectivity for (<i>S</i>)-<b>1m</b> but no selectivity for <b>1p</b> and <b>1t</b>. Selectivity data for more compounds will be needed in order to fully understand the selectivity profile for this new class of BACE-1 inhibitors.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Amino-2<i>H</i>-imidazoles <b>1</b>, Selectivity</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">BACE-1 FRET,<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> IC<sub>50</sub> (μM) </th><th class="colsep0 rowsep0" align="center">BACE-2 FRET,<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">cath-D  FRET,<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a> % inhibition</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>1m</b></td><td class="colsep0 rowsep0" align="left">0.012</td><td class="colsep0 rowsep0" align="left">0.84</td><td class="colsep0 rowsep0" align="left">30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1p</b></td><td class="colsep0 rowsep0" align="left">0.31</td><td class="colsep0 rowsep0" align="left">0.11</td><td class="colsep0 rowsep0" align="left">21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1t</b></td><td class="colsep0 rowsep0" align="left">0.079</td><td class="colsep0 rowsep0" align="left">0.030</td><td class="colsep0 rowsep0" align="left">8.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are the mean of at least two experiments.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">% inhibition at highest concentration tested (100 μM).</p></div></div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Brain Exposure and in Vivo Efficacy Studies</h3><div class="NLM_p">To evaluate this core further and to understand the impact of the high efflux mentioned above, the brain exposure in mice was examined. Correction for blood content in brain was made by subtracting 1.3% of the plasma concentration from the total brain concentration. Free brain and plasma concentrations were calculated using brain and plasma protein binding data determined ex vivo. Compounds <b>1k</b>, (<i>S</i>)-<b>1m</b>, and <b>1t</b> had a low free brain/plasma ratio of 0.08, 0.05, and 0.07, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). This was slightly improved with compound <b>1p</b> (0.16). However, <b>1p</b> had a lower potency in the TR-FRET and SH-SY5Y assays; therefore, compound (<i>S</i>)-<b>1m</b>, with a good overall profile, was selected for further in vivo studies.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Mouse Plasma and Brain Exposure and Free Brain Plasma Ratio at 1.5 h after Intravenous (iv) or Oral (po) Dose<a class="ref internalNav" href="#tbl6-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">dose, μmol/kg</th><th class="colsep0 rowsep0" align="center">dose route</th><th class="colsep0 rowsep0" align="center">rime after dose, h</th><th class="colsep0 rowsep0" align="center"><i>n</i></th><th class="colsep0 rowsep0" align="center">plasma concn, μmol/L</th><th class="colsep0 rowsep0" align="center">PPB, % free</th><th class="colsep0 rowsep0" align="center">free plasma concn, μmol/L</th><th class="colsep0 rowsep0" align="center">brain concn, μmol/L</th><th class="colsep0 rowsep0" align="center">brain binding, % free</th><th class="colsep0 rowsep0" align="center">free brain concn, nmol/L</th><th class="colsep0 rowsep0" align="center">free brain plasma ratio</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1k</b></td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">11.5 ± 9.8</td><td class="colsep0 rowsep0" align="left">6.3</td><td class="colsep0 rowsep0" align="left">0.72 ± 0.62</td><td class="colsep0 rowsep0" align="left">0.71 ± 0.60</td><td class="colsep0 rowsep0" align="left">7.6</td><td class="colsep0 rowsep0" align="left">54 ± 45</td><td class="colsep0 rowsep0" align="left">0.08 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1p</b></td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">1.2 ± 0.4</td><td class="colsep0 rowsep0" align="left">4.6</td><td class="colsep0 rowsep0" align="left">0.06 ± 0.02</td><td class="colsep0 rowsep0" align="left">0.18 ± 0.08</td><td class="colsep0 rowsep0" align="left">4.8</td><td class="colsep0 rowsep0" align="left">9 ± 4</td><td class="colsep0 rowsep0" align="left">0.16 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1t</b></td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3.7 ± 0.8</td><td class="colsep0 rowsep0" align="left">8.2</td><td class="colsep0 rowsep0" align="left">0.31 ± 0.06</td><td class="colsep0 rowsep0" align="left">0.98 ± 0.25</td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="left">21 ± 6</td><td class="colsep0 rowsep0" align="left">0.07 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>1m</b></td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">4.5 ± 1.9</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">0.49 ± 0.20</td><td class="colsep0 rowsep0" align="left">0.23 ± 0.06</td><td class="colsep0 rowsep0" align="left">8.2</td><td class="colsep0 rowsep0" align="left">19 ± 5</td><td class="colsep0 rowsep0" align="left">0.05 ± 0.02</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl6-fn1"><div class="footnote" id="tbl6-fn1"><sup>a</sup><p class="last">Mean ± SD.</p></div></div></div><div class="NLM_p">As a consequence of the low exposure in mice, the pharmacodynamic effects of (<i>S</i>)-<b>1m</b> were studied in vivo in guinea pigs. Male guinea pigs (<i>n</i> = 6) received vehicle or (<i>S</i>)-<b>1m</b>, 50 or 100 μmol/kg, via oral gavage, and then plasma, cerebrospinal fluid (CSF), and brain samples were collected between 0.5 and 6 h after dose. Compound (<i>S</i>)-<b>1m</b> demonstrated a time- and dose-dependent reduction of Aβ in plasma, brain, and CSF (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, dose response data not shown). Maximum reductions of brain Aβ40 and Aβ42 (∼50% and ∼40%, respectively) were observed 1.5 h after dose, and the maximum plasma Aβ40 and Aβ42 diminutions (∼70% and ∼80%, respectively) were observed 3 h after dose. CSF Aβ40 displayed maximum effect 3 h after dose and was only statistically significantly reduced, compared to vehicle, at this time point. This could be due to a larger individual variation of the basal levels of CSF Aβ and/or a delay in CSF effect versus brain. Six hours after dose the Aβ levels in brain and CSF were returning back to baseline, while plasma Aβ still was reduced (40–60%).</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/medium/jm-2012-00991n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/large/jm-2012-00991n_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vivo efficacy of (<i>S</i>)-<b>1m</b>. Time response effect on brain Aβ40/42 (A) and plasma Aβ40/42 (B) after an oral dose, 100 μmol/kg, of (<i>S</i>)-<b>1m</b> to male guinea pigs. The right <i>y</i>-axes show free compound exposure in brain and plasma (open circles and dotted line, respectively). Time response effects on CSF Aβ40 (C). CSF Aβ40 reached a statistical significant reduction compared to vehicle 3 h after an 100 μmol/kg dose (∗, <i>P</i> < 0.05). Data shown are the mean and standard error of the mean (SEM) as % of vehicle Aβ levels.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/large/jm-2012-00991n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300991n&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The exposure of (<i>S</i>)-<b>1m</b> was also measured in guinea pig plasma and brain samples to allow quantification of the PK/PD relationship for (<i>S</i>)-<b>1m</b>. The brain Aβ40 EC<sub>20</sub> for unbound compound (<i>S</i>)-<b>1m</b> was estimated (using brain tissue binding; see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>) to be 23 nM. Compound (<i>S</i>)-<b>1m</b> exhibited brain penetration with a ratio of 0.16 free exposure in brain versus the free exposure in plasma.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67012" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67012" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Amino-2<i>H</i>-imidazoles (<b>1</b>) represent a new class of BACE-1 inhibitors. The core structure differs from earlier reported cores regarding polarity, size, and p<i>K</i><sub>a</sub> of the amidine. In this report we present new synthetic methods toward diverse amino-2<i>H</i>-imidazoles, with three different methods used to prepare the 24 compounds for which data on primary activity, hERG activity, and permeability estimations are reported. These new compounds show good BACE-1 inhibition in both the enzymatic and cellular assays with nanomolar IC<sub>50</sub> values. By variation of the R<sup>2</sup>-substituent, it was possible to tune the p<i>K</i><sub>a</sub> of the compounds to effect an increase in potency in the cellular assay. In a matched pair analysis, one analogue with this new core showed an improved hERG profile compared to an earlier reported series. The permeability for this series was good, while the P-gp-mediated efflux was medium to high. Compound (<i>S</i>)-<b>1m</b> displayed an IC<sub>50</sub> of 24 nM in a cellular assay, and in an animal study this compound produced a concentration and time dependent decrease in Aβ40 and Aβ42 levels in plasma, brain, and CSF. Future research will elucidate the further potential of this series.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64885" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64885" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> BACE-1 TR-FRET Assay</h3><div class="NLM_p last">The soluble part of human β-secretase (AA1-AA460) diluted in reaction buffer (sodium acetate, CHAPS, Triton X-100, EDTA, pH 4.5) was mixed with the test compound diluted in DMSO. After a preincubation period of 10 min, substrate (europium)CEVNLDAEFK(Qsy7) was added and the reaction allowed to proceed for 15 min at room temperature. The reaction was stopped by addition of 7 μL of sodium acetate, pH 9. The fluorescence of the product was measured on a Victor II plate reader with an excitation wavelength of 340 nm and an emission wavelength of 615 nm. The final concentration of the enzyme was 2.7 μg/mL. The final concentration of substrate was 100 nM. Reported values are the mean of <i>n</i> ≥ 2 determinations, with standard deviation up to 10%.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Cell sAPPβ Release Assay</h3><div class="NLM_p last">SH-SY5Y cells (human neuroblastoma cell line) were cultured in DMEM/F-12 with Glutamax, 10% FCS, and 1% nonessential amino acids (InVitrogen). The test compound was incubated with cells for 16 h at 37 °C, 5% CO<sub>2</sub>. Meso Scale Discovery (MSD) plates were used for the detection of sAPPβ release according to the manufacturer’s instructions, and the plates were read in a SECTOR Imager. In addition, the cells incubated with test compound were further lyophilized and analyzed for any cytotoxic effects of the compounds using the ViaLight Plus cell proliferation/cytotoxicity kit (Cambrex BioScience) according to the manufacturer’s instructions. Reported values are the mean of <i>n</i> ≥ 2 determinations, with standard deviation up to 10%.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> BACE-2 TR-FRET Assay</h3><div class="NLM_p last">This assay is as described for the BACE-1 TR-FRET assay above but utilizing the soluble part of human β-secretase 2 enzyme (AA1-AA473).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> hCathepsin-D FRET Assay</h3><div class="NLM_p last">Cathepsin-D enzyme (Calbiochem) and substrate (Ac-Glu-Asp(EDANS)-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Gly-Lys(DABCYL)-Glu-NH2) (Bachem) were separately diluted in glycine–HCl buffer. The cathepsin-D solution was mixed with compound in DMSO and preincubated for 10 min. The substrate solution was added, and the reaction mixture was incubated for 15 min in darkness at 22 °C. The fluorescent signal was measured in a Wallac 1420 multilabel counter Victor2 at 355 nm excitation and 460 nm emission.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Protein Crystallography</h3><div class="NLM_p">The human BACE-1, CID1328 14-453, was cloned, expressed, refolded, activated, and purified according to previously published protocols.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> The protein buffer was exchanged to 20 mM Tris, pH 8.5, 150 mM NaCl and concentrated to 3.5 mg/mL. Concentrated protein was mixed 1:1 with a stock of 11% PEG6k and 100 mM sodium acetate, pH 5.0, at room temperature and crystallized using vapor diffusion techniques in combination with seeding. The crystals were soaked with 10 mM (<i>S</i>)-<b>1m</b> and <b>1t</b>, respectively, 10% DMSO, 18% PEG6000, 90 mM sodium acetate, pH 4.85, 18 mM Tris, pH 8.5, and 135 mM NaCl for 24 h and flash frozen in liquid nitrogen using 20% glycerol as a cryoprotectant.</div><div class="NLM_p last">Data of (<i>S</i>)-<b>1m</b> and <b>1t</b> soaked crystals were collected on a Rigaku FR-E+ SuperBright rotating anode and a HTC imaging plate to 1.95 Å resolution. All data were indexed and integrated with MOSFLM<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> and scaled with SCALA<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> in space group <i>P</i>212121, with cell dimensions of about [48, 76, 105 Å], giving a Matthews coefficient of 2.2 Å<sup>3</sup>/Da with one monomer per asymmetric unit. The (<i>S</i>)-<b>1m</b> and <b>1t</b> structures were solved by rigid body refinement of a previously determined BACE-1 structure based on the published <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FKN">1FKN</a> structure<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> using Refmac5.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> The initial models were further refined by alternative cycles of model rebuilding in Coot<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> and refinement in Refmac5 and AutoBuster.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> The (<i>S</i>)-<b>1m</b> and <b>1t</b> compounds were placed in the refined omit maps by Flynn.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Final refinement of the BACE-1 inhibitor complexes was performed in Refmac5 and AutoBuster. Resulting 2<i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> maps of the compounds (<i>S</i>)-<b>1m</b> and (<i>R</i>)-<b>1t</b> can be seen in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Figures 1 and 2">Supporting Information Figures 1 and 2</a>. Full data collection and refinement statistics can be found in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Table 1">Supporting Information Table 1</a>.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Permeability Assays</h3><div class="NLM_p">Caco-2 cells were grown for 14–21 days to achieve confluency and polarization before being used for transport experiments. For both apical to basolateral (A–B) and basolateral to apical (B–A) transport directions, the pH was adjusted to 7.4. All compounds were investigated at 10 μM. Buffer volumes in the 42-well plates were 0.20 mL on the apical side and 0.80 mL on the basolateral side. Samples were withdrawn after 30 or 60 min. The integrity of the epithelial cell monolayer was monitored by measuring the passive transmembrane diffusion of [<sup>14</sup>C]mannitol. Concentrations of compounds in donor and receiver samples were analyzed by liquid chromatography–tandem mass spectrometry. Liquid scintillation was used for analysis of [<sup>14</sup>C]mannitol. The apparent permeability coefficient <i>P</i><sub>app</sub> was calculated according to <i>P</i><sub>app</sub> = (d<i>Q</i>/d<i>t</i>)/(<i>A</i><i>C</i><sub>0</sub>), where d<i>Q</i>/d<i>t</i> is the slope at 30 or 60 min of the graph of the cumulative amount transported vs time, <i>A</i> is the surface area of the membrane, and <i>C</i><sub>0</sub> is the starting concentration. The efflux ratio is the ratio <i>P</i><sub>app</sub>(B–A)/<i>P</i><sub>app</sub>(A–B).</div><div class="NLM_p last">MDCK-MDR1 efflux data were generated using a Transwell assay as described by Ledonne et al.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> with minor adaptations. Cells were sown at 400 000–600 000 cells per well in a 96-well plate and cultured for 3–5 days. Testing was at 1 μM compound concentration, and the efflux incubation time was 2.5 h. This was shortened to 60 min when the compound concentration was 10 μM. In each format the compounds were classified as low (efflux ratio of <2.5), medium (efflux ratio between 2.5 and 3.5), or high (efflux ratio of >3.5) efflux.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Plasma Protein and Brain Tissue Binding</h3><div class="NLM_p">Compounds were added to mouse or guinea pig plasma to a final concentration of 10 μM. An aliquot of 180 μL was transferred to a dialysis plate with phosphate buffer on the other site and incubated for 18 h at 37 °C. Proteins were removed from aliquots (50 μL) of plasma and buffer samples. The internal standard was added, and the samples were analyzed with LC–MS/MS. The unbound fraction in plasma was calculated from the ratio of the MS area of compound in buffer divided by sum of the areas of compound in buffer and plasma. Recovery and stability in plasma were controlled.</div><div class="NLM_p last">To determine brain tissue binding, 300 μm thick coronal rat brain slices were incubated for 5 h in 10 mL of an artificial interstitial fluid buffer containing 1 μM compound. Following the incubation, slices were weighted and homogenized, proteins were removed, and LC–MS/MS analysis was performed. The unbound fraction in brain was calculated as described earlier.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Mouse and guinea pig total brain concentrations were converted to free concentrations by multiplying with the unbound fraction.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Animals and Animal Handling</h3><div class="NLM_p last">All animal experimentations were performed in accordance with relevant guidelines and regulations provided by the Swedish Board of Agriculture. The ethical permissions were provided by an ethical board specializing in animal experimentations, the Stockholm Norra Animal Research Ethical Board.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Mice Exposure Studies</h3><div class="NLM_p last">To study brain exposure, female C57BL/6 mice purchased from Harlan Laboratories, The Netherlands, were sacrificed 1.5 h after an intravenous (iv) dose with 30 μmol/kg <b>1k</b> in 0.1 M gluconic acid or with 30 μmol/kg <b>1p</b> in 5% dimethylacetamide and 0.1 M meglumine or with 30 μmol/kg <b>1t</b> in 5% dimethylacetamide and 0.1 M gluconic acid, 3 mice per compound. Six female C57BL/6 mice were dosed by oral gavage (po) with 100 μmol/kg (<i>S</i>)-<b>1m</b> in 5% dimethylacetamide, 20% hydroxypropyl β-cyclodextrin in 0.3 M gluconic acid, pH 4, and sacrificed 1.5 h after dose. Animals were anesthetized before plasma and brain samples were collected. Plasma was isolated from blood collected by cardiac puncture into EDTA tubes and was centrifuged for 10 min at approximately 3000<i>g</i> at 4 °C within 20 min of sampling. Animals were then sacrificed by decapitation to collect brains.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> In Vivo Pharmacokinetic Assay</h3><div class="NLM_p last">Brain and plasma exposure and plasma protein and brain tissue binding were performed as previously described.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Briefly, right brain hemispheres of guinea pig or whole brains of mice were homogenized in 2 volumes (w/v) of Ringer solution. Aliquots of plasma (25 μL) and brain homogenate (50 μL) were precipitated with 150 μL of acetonitrile containing a generic internal standard (200 nmol/L warfarin). Samples were mixed, centrifuged, appropriately diluted with mobile phase, and analyzed on a LC–MS/MS system. Brain exposure was corrected for compound exposure in plasma/blood present in the brain sample, since no brain perfusion was performed, by assuming 1.3% blood/plasma in brain.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> In Vivo Efficacy Assay</h3><div class="NLM_p">Male 5- to 11-week-old Dunkin–Hartley (DH) guinea pigs purchased from HB Lidköping Kaninfarm (Lidköping, Sweden) were used. The guinea pigs (six in each experimental group) received vehicle or compound (<i>S</i>)-<b>1m</b> at 50 or 100 μmol/kg via oral gavage. As vehicle, 20% HPβCD in 0.3 M gluconic acid (pH 5) were used.</div><div class="NLM_p">Animals were anesthetized 0.5, 1.5, 3, 4.5, or 6 h after administration of vehicle or drug and were then kept under isoflurane anesthesia during the rest of the procedures. Cerebrospinal fluid (CSF) was aspirated from the cisterna magna, and plasma was isolated from blood collected by cardiac puncture into EDTA tubes. All samples were centrifuged for 10 min at approximately 3000<i>g</i> at 4 °C within 20 min of sampling to remove cells or debris. Animals were then sacrificed by decapitation, and brains were dissected into hemispheres.</div><div class="NLM_p">The left brain hemispheres from the guinea pigs were homogenized in 0.2% diethylamine (DEA) with 50 mM NaCl, followed by ultracentrifugation. Recovered supernatants were neutralized to pH 8.0 with 2 M Tris-HCl. Prior to analysis the buffer was exchanged to sample diluents enclosed in commercial ELISA kits. In addition samples for Aβ40 analysis were concentrated 2 times and samples for Aβ42 analysis diluted 2 times. Aβ40 and Aβ42 levels in brain extracts, CSF, and plasma were analyzed using commercial Aβ1-40 (no. KMB3481, Invitrogen, Camarillo, CA) and Aβ1-42 (80177 RUO, Innogenetics, Gent, Belgium) ELISA kits.</div><div class="NLM_p last">Analysis of Aβ data was performed using Prism 4 (GraphPad, U.S.), with one-way ANOVA followed by Dunnett’s multiple comparison test or Bonferroni’s multiple comparison test. Level of significance was set at <i>P</i> < 0.05.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Pharmacokinetic/Pharmacodynamic Analysis of in Vivo Exposure and Effect Data in Guinea Pig</h3><div class="NLM_p last">The relationship between plasma exposure and brain Aβ40 effect data was analyzed by fitting the plasma PK profile and letting the fitted plasma profile drive the PD effect using Pharsight WinNonlin 5.2 software. A reparametrized indirect response model with inhibition on the production rate<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> was used to estimate the plasma concentration, giving 20% inhibition from baseline (IC<sub>20</sub>). This plasma EC<sub>20</sub> was converted to free brain concentration using plasma protein and brain binding and brain exposure data.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Chemistry</h3><div class="NLM_p">All solvents used were commercially available and were used without further purification. Reactions were typically run using anhydrous solvents under an inert atmosphere of nitrogen or argon. Starting materials used were available from commercial sources or prepared as described in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. Room temperature refers to 20–25 °C. Microwave heating was performed in a Biotage Initiator microwave synthesizer at the indicated temperature in the recommended microwave tubes.</div><div class="NLM_p"><sup>1</sup>H NMR spectra were recorded in the indicated deuterated solvent at 400 MHz, and the spectra were obtained unless stated otherwise, using a Bruker av400 NMR spectrometer equipped with a 3 mm flow injection SEI <sup>1</sup>H/D–<sup>13</sup>C probe head with Z-gradients, using a BEST 215 liquid handler for sample injection or using a Bruker DPX400 NMR spectrometer equipped with a four-nucleus probe head (<sup>19</sup>F) with Z-gradients. 500 MHz spectra were recorded using a Bruker 500 MHz Avance III NMR spectrometer. Chemical shifts are given in ppm downfield and upfield from TMS. Resonance multiplicities are denoted s, d, t, q, m, and br for singlet, doublet, triplet, quartet, multiplet, and broad, respectively.</div><div class="NLM_p">Preparative HPLC was performed on a Waters Auto purification HPLC–UV system with a diode array detector using a Waters XTerra MS C<sub>8</sub> column (19 mm × 300 mm, 7 μm), and a linear gradient of mobile phase B was applied. Mobile phase A was 0.1 M ammonium acetate in water/acetonitrile (95:5), and mobile phase B was acetonitrile. Flow rate was 20 mL/min. Flash chromatography was performed using Merck silica gel 60 (0.040–0.063 mm) or employing a Combi Flash Companion system using RediSep normal-phase flash columns.</div><div class="NLM_p">Column chromatography was performed using Merck silica gel 60 (0.040–0.063 mm).</div><div class="NLM_p">LC–MS analyses were performed on an LC–MS instrument consisting of a Waters sample manager 2777C, a Waters 1525μ binary pump, a Waters 1500 column oven, a Waters ZQ single quadrupole mass spectrometer, a Waters PDA 2996 diode array detector, and a Sedex 85 ELS detector. The mass spectrometer was equipped with an electrospray ion source (ES) operated in positive and negative ion modes. For separation a linear gradient was applied starting at 100% 0.1% NH<sub>3</sub> in Milli-Q ending at 100% methanol. The column used was an XBridge C18, 3.0 mm × 50 mm, 5 μm, which was run at a flow rate of 2 mL/min. Or an LC–MS system was used consisting of a Waters Alliance 2795 HPLC, a Waters PDA 2996 diode array detector, a Sedex 85 ELS detector, and a ZQ single quadrupole mass spectrometer. The mass spectrometer was equipped with an electrospray ion source (ES) operated in positive and negative ion modes. Separation was performed on an XBridge C18, 3.0 mm × 50 mm, 3.5 μm, at a flow rate of 1 mL/min. A linear gradient was applied starting at 100% 0.1% NH<sub>3</sub> in Milli-Q and ending at 100% methanol.</div><div class="NLM_p">Purity analyses were performed on an Agilent HP1100 system consisting of a G1322A microvacuum degasser, a G1312A binary pump, a G1367A well-plate autosampler, a G1316A thermostated column compartment, a G1315C diode array detector, and a 6120, G1978B mass spectrometer. The mass spectrometer was configured with an atmospheric pressure chemical ionization (APCI) ion source operated in positive and negative ion modes. The column used was an XBridge C18 3.0 mm × 100 mm, 3 μm run at a flow rate of 1.0 mL/min. A linear gradient was used for both the blank and the sample, starting at 100% 10 mM NH<sub>4</sub>OAc in 5% CH<sub>3</sub>CN and ending at 95% CH<sub>3</sub>CN. The blank run was subtracted from the sample run. All tested compounds were purified to >95% purity as determined by reversed phase HPLC.</div><div class="NLM_p">SFC purity analysis was run on a SFC Berger Analytix system with Agilent 1100 PDA detector. The column was a Chiralpak AD-H, 5 μm, 4.6 mm × 250 mm. The column temperature was set to 50 °C. An isocratic condition of 20–30% methanol + 0.1% DEA and 70–80% CO<sub>2</sub> was applied at a flow rate of 3.0 mL/min. The PDA was set to scan from 190 to 600 nm, and the data at 220 nm were extracted for purity determination. All tested compounds were purified to >99% enantiomeric purity as determined by SFC.</div><div class="NLM_p last">SFC preparative chromatography was run on a SFC Berger Multigram II system with a Knauer K-2501 UV detector. The column was a Chiralpak AD-H, 5 μm, 21.2 mm × 250 mm. The column temperature was set to 35 °C. An isocratic condition of 20–30% methanol + 0.1% DEA and 70–80% CO<sub>2</sub> was applied at a flow rate of 50.0 mL/min. The UV detector was set to scan at 220 nm. The UV signal determined the fraction collection.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 2-Methyl-5-phenyl-2-(3-(pyridin-3-yl)phenyl)-2<i>H</i>-imidazol-4-amine (<b>1a</b>)</h3><div class="NLM_p last"><i>N</i>-Allyl-2-(3-bromophenyl)-2-methyl-5-phenyl-2<i>H</i>-imidazol-4-amine (<b>11</b>) (31 mg, 80 μmol), pyridin-3-ylboronic acid (16 mg, 0.13 mmol), and bis(triphenylphosphine)palladium(II) chloride (4 mg, 6 μmol) were taken up in DME (0.5 mL) and water (0.25 mL). Sodium carbonate (1 M) (0.21 mL, 0.21 mmol) was added, and the mixture was heated at 80 °C for 2.5 h. Pyridin-3-ylboronic acid (12 mg) and bis(triphenylphosphine)palladium(II) chloride (3 mg) were added, and the mixture continued heating for 2 h. The reaction mixture was evaporated and the residue treated with water and extracted with chloroform (3 × 3 mL). The dried (Na<sub>2</sub>SO<sub>4</sub>) organic phases were combined and evaporated in vacuo. To the product (30 mg) were added 1,3-dimethylbarbituric acid (77 mg, 0.49 mmol), tetrakis(triphenylphosphine)palladium(0) (9 mg, 8 μmol), and dichloromethane (0.8 mL) under argon, and the resulting mixture was subjected to microwave irradiation at 100 °C for 30 min. More 1,3-dimethylbarbituric acid (30 mg) and tetrakis(triphenylphosphine)palladium(0) (9 mg, 8 μmol) were added, and the mixture was subjected to microwave irradiation at 100 °C for another 30 min. The evaporated residue was dissolved in methanol and filtered. Reversed phase preparative-HPLC gave 7 mg (28%, over two steps) of the title compound. <sup>1</sup>H NMR (500 MHz, acetonitrile-<i>d</i><sub>3</sub>) δ ppm 8.85 (d, <i>J</i> = 1.9 Hz, 1 H), 8.56 (dd, <i>J</i> = 5.0, 1.6 Hz, 1 H), 7.96–8.01 (m, 1 H), 7.91 (t, <i>J</i> = 1.6 Hz, 1 H), 7.74–7.80 (m, 2 H), 7.68 (ddd, <i>J =</i> 7.7, 1.6, 1.4 Hz, 1 H), 7.50–7.59 (m, 4 H), 7.46 (t, <i>J =</i> 7.7 Hz, 1 H), 7.42 (dd, <i>J =</i> 7.6, 4.4 Hz, 1 H), 1.74 (s, 3 H); MS (ES+) <i>m</i>/<i>z</i> 327 [M + H]<sup>+</sup>.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 5-Isopropyl-2-methyl-2-(3-(pyridin-3-yl)phenyl)-2<i>H</i>-imidazol-4-amine (<b>1b</b>)</h3><div class="NLM_p last">2-(3-Bromophenyl)-5-isopropyl-2-methyl-2<i>H</i>-imidazol-4-amine (<b>7b</b>) (25 mg, 80 μmol), pyridin-3-ylboronic acid (26 mg, 0.2 mmol), and bis(triphenylphosphine)palladium(II) chloride (12 mg, 20 μmol) were taken up in DME (2 mL) and water (1 mL). Sodium carbonate (1 M in water) (0.2 mL, 0.2 mmol) was added, and the mixture was heated at 80 °C for 2 h. Reversed phase preparative-HPLC gave 24 mg (81%) of the title compound. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i><sub>3</sub>) δ ppm 1.33 (dd, <i>J</i> = 12.1, 6.8 Hz, 6 H), 1.76 (s, 3 H), 2.83 (dt, <i>J</i> = 13.6, 6.8 Hz, 1 H), 7.37 (dd, <i>J</i> = 7.6, 4.8 Hz, 1 H), 7.40–7.52 (m, 2 H), 7.62 (d, <i>J</i> = 7.6 Hz, 1 H), 7.81 (s, 1 H), 7.92 (dt, <i>J</i> = 7.9, 2.0 Hz, 1 H), 8.59 (dd, <i>J</i> = 4.8, 1.3 Hz, 1 H), 8.86 (d, <i>J</i> = 1.8 Hz, 1 H); MS (ES+) <i>m</i>/<i>z</i> 293 [M + H]<sup>+</sup>.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 2-(3′-Methoxybiphenyl-3-yl)-2,5-dimethyl-2<i>H</i>-imidazol-4-amine (<b>1c</b>)</h3><div class="NLM_p last">2-(3-Bromophenyl)-2,5-dimethyl-2<i>H</i>-imidazol-4-ol (<b>6c</b>) (76 mg, 0.28 mmol) was dissolved in pyridine (1.5 mL), and phosphorus pentasulfide (76 mg, 0.17 mmol) was added. The mixture was heated at 120 °C for 1 h. Ammonia (7 M in methanol) (4 mL, 28 mmol) and <i>tert</i>-butyl hydroperoxide (0.586 mL, 4.27 mmol) were added, and the mixture was stirred at room temperature for 16 h. The solvents were evaporated, and reversed phase preparative-HPLC gave 41 mg of the intermediate cyclic thioamide. The purified material, 3-methoxyphenylboronic acid (28 mg, 0.19 mmol), and bis(triphenylphosphine)palladium(II) chloride (11 mg, 20 μmol) were taken up in DME (2 mL) and water (1 mL). Sodium carbonate (1 M in water) (0.4 mL, 0.4 mmol) was added, and the mixture was heated at 80 °C for 2 h. Reversed phase preparative-HPLC gave 21 mg (26%, over two steps) of the title compound. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i><sub>3</sub>) δ ppm 7.85 (t, <i>J</i> = 1.64 Hz, 1 H), 7.58–7.64 (m, <i>J</i> = 7.58, 1.26, 0.88, 0.88 Hz, 1 H), 7.46–7.51 (m, <i>J</i> = 7.74, 1.26, 0.93, 0.93 Hz, 1 H), 7.40 (t, <i>J</i> = 7.71 Hz, 1 H), 7.35 (t, <i>J</i> = 7.96 Hz, 1 H), 7.20 (ddd, <i>J</i> = 7.64, 1.58, 0.88 Hz, 1 H), 7.15 (dd, <i>J</i> = 2.53, 1.77 Hz, 1 H), 6.89 (ddd, <i>J</i> =.15, 2.59, 0.88 Hz, 1 H), 3.87 (s, 3 H), 2.29 (s, 3 H), 1.74 (s, 3 H); MS (ES+) <i>m</i>/<i>z</i> 294 [M + H]<sup>+</sup>.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 2,5-Dimethyl-2-(3-(pyridin-3-yl)phenyl)-2<i>H</i>-imidazol-4-amine (<b>1d</b>)</h3><div class="NLM_p last">2-(3-Bromophenyl)-2,5-dimethyl-2<i>H</i>-imidazol-4-ol (<b>6c</b>) (0.14 g, 0.52 mmol) was dissolved in pyridine (1.5 mL), and phosphorus pentasulfide (0.14 g, 0.31 mmol) was added. The mixture was heated at 120 °C for 1 h. Ammonia (7 M in methanol) (4 mL, 28 mmol) and <i>tert</i>-butyl hydroperoxide (1.1 mL, 7.8 mmol) were added, and the mixture was stirred at room temperature for 16 h. The solvents were evaporated, and reversed phase preparative-HPLC gave 95 mg of the intermediate cyclic thioamide. A portion of the purified material (40 mg), pyridin-3-ylboronic acid (37 mg, 0.30 mmol), and bis(triphenylphosphine)palladium(II) chloride (11 mg, 20 μmol) was taken up in DME (1 mL) and water (0.5 mL). Sodium carbonate (1 M in water) (0.376 mL, 0.38 mmol) was added, and the mixture was heated at 80 °C for 2 h. Reversed phase preparative-HPLC gave 30 mg (22%, over two steps) of the title compound. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i><sub>3</sub>) δ ppm 8.85 (d, <i>J</i> = 1.52 Hz, 1 H), 8.58 (d, <i>J</i> = 3.79 Hz, 1 H), 7.92 (dd, <i>J</i> = 6.06, 2.02 Hz, 1 H), 7.81 (s, 1 H), 7.63 (d, <i>J</i> = 7.33 Hz, 1 H), 7.47 (dt, <i>J</i> = 15.41, 7.71 Hz, 2 H), 7.37 (dd, <i>J</i> = 7.83, 4.80 Hz, 1 H), 2.32 (s, 3 H), 1.76 (s, 3 H); MS (ES+) <i>m</i>/<i>z</i> 265 [M + H]<sup>+</sup>.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 5-Isopropyl-2-phenyl-2-(3-(pyrimidin-5-yl)phenyl)-2<i>H</i>-imidazol-4-amine (<b>1e</b>)</h3><div class="NLM_p last">(3-Bromophenyl)(phenyl)methanone (0.23 g, 0.86 mmol) was dissolved in ammonia (7 M in methanol) (4 mL, 28 mmol), and the mixture was heated at 150 °C for 1 h by microwave irradiation. Ethyl 3-methyl-2-oxobutyrate (1 mL, 6.9 mmol) was added in four portions (4 × 250 μL), and the mixture was stirred at 150 °C after each addition. The solvent was evaporated, and silica column chromatography (0:1 → 3:10, EtOAc/heptane) gave 49 mg of the cyclic amide. The purified material was dissolved in pyridine (1.5 mL), and phosphorus pentasulfide (50 mg, 0.11 mmol) was added. The mixture was heated at 120 °C for 1 h. Methanol (3 mL), ammonia (35% in water) (1 mL, 18 mmol), and <i>tert</i>-butyl hydroperoxide (0.28 mL, 2 mmol) were added, and the mixture was stirred at room temperature for 16 h. The solvents were evaporated, and reversed phase preparative-HPLC gave 16 mg of the intermediate aminoimidazole. The purified material, pyrimidin-5-ylboronic acid (11 mg, 90 μmol), and bis(triphenylphosphine)palladium(II) chloride (6 mg, 9 μmol) were taken up in DME (1 mL) and water (0.5 mL). Sodium carbonate (1 M in water) (0.11 mL, 0.11 mmol) was added, and the mixture was heated at 80 °C for 2 h. Reversed phase preparative-HPLC gave 13 mg (4%, over three steps) of the title compound. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i><sub>3</sub>) δ ppm 9.19 (s, 1 H), 8.93 (s, 2 H), 7.79 (s, 1 H), 7.67 (td, <i>J</i> = 4.48, 1.64 Hz, 1 H), 7.53–7.59 (m, 2 H), 7.43–7.47 (m, 2 H), 7.21–7.33 (m, 3 H), 5.30 (br s, 2 H), 2.82 (dt, <i>J</i> = 13.64, 6.82 Hz, 1 H), 1.37 (d, 6 H); MS (ES+) <i>m</i>/<i>z</i> 356 [M + H]<sup>+</sup>.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 5-Isopropyl-2-(4-methoxyphenyl)-2-(3-(pyrimidin-5-yl)phenyl)-2<i>H</i>-imidazol-4-amine (<b>1f</b>)</h3><div class="NLM_p last">(3-Bromophenyl)(4-methoxyphenyl)methanone (0.4 g, 1.4 mmol) was dissolved in ammonia (7 M in methanol) (3.9 mL, 27 mmol), and ethyl 3-methyl-2-oxobutyrate (1 mL, 6.9 mmol) was added in five portions (5 × 200 μL). The mixture was stirred at 150 °C for 1 h with microwave irradiation after each addition. The solvent was evaporated, and reversed phase preparative-HPLC followed by silica column chromatography (0:1 → 1:0, EtOAc/heptane) gave 7 mg of the intermediate cyclic amide. The purified material was dissolved in pyridine (1 mL), and phosphorus pentasulfide (50 mg, 0.11 mmol) was added. The mixture was heated at 120 °C for 1 h. Ammonia (33% in water) (0.25 mL, 4.26 mmol) and <i>tert</i>-butyl hydroperoxide (0.3 mL, 2.18 mmol) were added, and the mixture was stirred at room temperature for 16 h. The solvents were evaporated, and reversed phase preparative-HPLC gave 6 mg of the intermediate aminoimidazole. The purified material, pyrimidin-5-ylboronic acid (4 mg, 30 μmol), and bis(triphenylphosphine)palladium(II) chloride (2 mg, 3 μmol) were taken up in DME (1 mL) and water (0.5 mL). Sodium carbonate (1 M in water) (40 μL, 4 μmol) was added, and the mixture was heated at 80 °C for 2 h. Reversed phase preparative-HPLC gave 5 mg (1%, over three steps) of the title compound. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i><sub>3</sub>) δ ppm 9.19 (s, 1 H), 8.92 (s, 2 H), 7.76 (s, 1 H), 7.61–7.68 (m, 1 H), 7.48 (d, <i>J</i> = 8.84 Hz, 2 H), 7.41–7.45 (m, 2 H), 6.83 (d, <i>J</i> = 8.84 Hz, 2 H), 3.78 (s, 3 H), 2.81 (dt, <i>J</i> = 13.64, 6.82 Hz, 1 H), 1.36 (d, <i>J</i> = 6.82 Hz, 6 H); MS (ES+) <i>m</i>/<i>z</i> 386 [M + H]<sup>+</sup>.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 5-Methyl-2-phenyl-2-(3-(pyridin-3-yl)phenyl)-2<i>H</i>-imidazol-4-amine (<b>1g</b>)</h3><div class="NLM_p last">(3-Bromophenyl)(phenyl)methanone (0.28 g, 1.1 mmol) was dissolved in ammonia (7 M in methanol) (4 mL, 28 mmol) and heated at 150 °C for 1 h with microwave irradiation. Ethyl 2-oxopropanoate (1 mL, 9 mmol) was added in five portions (5 × 200 μL), and the mixture was stirred at 150 °C for 1 h with microwave irradiation after each addition. The solvent was evaporated, and reversed phase preparative-HPLC gave 11 mg of the cyclic amide. The purified material was dissolved in pyridine (1 mL), and phosphorus pentasulfide (50 mg, 0.11 mmol) was added. The mixture was heated at 120 °C for 1 h. Ammonia (7 M in methanol) (1 mL, 7 mmol) and <i>tert</i>-butyl hydroperoxide (0.5 mL, 3.6 mmol) were added, and the mixture was stirred at room temperature for 16 h. The solvents were evaporated, and reversed phase preparative-HPLC gave 8 mg of the intermediate aminoimidazole. The purified material, pyridin-3-ylboronic acid (6 mg, 50 μmol), and bis(triphenylphosphine)palladium(II) chloride (3 mg, 5 μmol) were taken up in DME (1 mL) and water (0.5 mL). Sodium carbonate (1 M in water) (57 μL, 60 μmol) was added, and the mixture was heated at 80 °C for 2 h. Reversed phase preparative-HPLC gave 2 mg (0.4%, over three steps) of the title compound. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i><sub>3</sub>) δ ppm 8.82 (br s, 1 H), 8.57 (d, <i>J</i> = 3.79 Hz, 1 H), 7.86 (dt, <i>J</i> = 7.83, 1.89 Hz, 1 H), 7.81 (s, 1 H), 7.57–7.65 (m, 3 H), 7.37–7.47 (m, 2 H), 7.21–7.36 (m, 4 H), 2.36 (s, 3 H); MS (ES+) <i>m</i>/<i>z</i> 327 [M + H]<sup>+</sup>.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 2-(3′-Methoxybiphenyl-3-yl)-5-methyl-2-(pyridin-4-yl)-2<i>H</i>-imidazol-4-amine (<b>1h</b>)</h3><div class="NLM_p last">(3-Bromophenyl)(pyridin-4-yl)methanimine (<b>4h</b>) (0.47 g, 1.8 mmol) was dissolved in ammonia (7 M in methanol) (3 mL, 21 mmol). Ethyl 2-oxopropanoate (1 mL, 9 mmol) was added in five portions (5 × 200 μL), and the mixture was stirred at 150 °C for 1 h after each addition. Reversed phase preparative-HPLC gave 22 mg of the intermediate cyclic amide. The purified material was dissolved in pyridine (1 mL), and phosphorus pentasulfide (50 mg, 0.11 mmol) was added. The mixture was heated at 120 °C for 1 h. Ammonia (35% in water) (0.16 mL, 2.7 mmol) and <i>tert</i>-butyl hydroperoxide (0.14 mL, 1.0 mmol) were added, and the mixture was stirred at room temperature for 16 h. The solvents were evaporated, and reversed phase preparative-HPLC gave 4 mg of the intermediate aminoimidazole. The purified material, 3-methoxyphenylboronic acid (4 mg, 20 μmol), and bis(triphenylphosphine)palladium(II) chloride (2 mg, 2 μmol) were taken up in DME (1 mL) and water (0.5 mL). Sodium carbonate (1 M in water) (30 μL, 30 μmol) was added, and the mixture was heated at 80 °C for 2 h. Reversed phase preparative-HPLC gave 1 mg (0.2%, over three steps) of the title compound. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i><sub>3</sub>) δ ppm 8.54 (br s, 2 H) 7.80 (s, 1 H), 7.46–7.61 (m, 4 H), 7.31–7.43 (m, 2 H), 7.15 (d, <i>J</i> = 7.83 Hz, 1 H), 7.07–7.13 (m, 1 H), 6.89 (dd, <i>J</i> = 8.34, 2.02 Hz, 1 H), 3.86 (s, 3 H), 2.40 (s, 3 H); MS (ES+) <i>m</i>/<i>z</i> 357 [M + H]<sup>+</sup>.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 2-(4-Fluorophenyl)-5-methyl-2-(3-(pyridin-3-yl)phenyl)-2<i>H</i>-imidazol-4-amine (<b>1i</b>)</h3><div class="NLM_p last">(3-Bromophenyl)(4-fluorophenyl)methanimine (<b>4i</b>) (1.0 g, 3.6 mmol) and ethanebis(thioamide) (0.58 g, 4.8 mmol) were taken up in methanol (5 mL). The mixture was heated at 90 °C for 3 days. The solvent was evaporated and the residue was purified by silica column chromatography (0:1 → 1:1, EtOAc/heptane) and reversed phase preparative-HPLC to give 0.15 g of the intermediate imidazothiol. The purified material was dissolved in THF (5 mL). Iodomethane (0.075 mL, 1.2 mmol) was added, and the mixture was heated at reflux for 8 h. The reaction mixture was filtered through a silica plug, and the solvent was evaporated. Reversed phase preparative-HPLC gave 103 mg of the intermediate S-methylated imidazothiol. To a solution of zinc iodide (522 mg, 1.63 mmol) in THF (2 mL) was added methylmagnesium bromide (0.545 mL, 1.63 mmol). To the formed slurry was then added the purified intermediate in THF (4 mL), followed by bis(triphenylphosphine)palladium(II) chloride (19 mg, 30 μmol). The reaction mixture was stirred at 40 °C for 2 h. Reversed phase preparative-HPLC gave 29 mg of the intermediate aminoimidazole. The purified material, pyridin-3-ylboronic acid (21 mg, 0.17 mmol), and bis(triphenylphosphine)palladium(II) chloride (12 mg, 20 μmol) were taken up in DME (1 mL) and water (0.5 mL). Sodium carbonate (1 M in water) (0.21 mL, 0.21 mmol) was added, and the mixture was heated at 80 °C for 2 h. Reversed phase preparative-HPLC gave 16 mg (1%, over four steps) of the title compound. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 8.74 (s, 1 H), 8.51 (d, <i>J</i> = 4.55 Hz, 1 H), 8.04 (d, <i>J</i> = 8.08 Hz, 1 H), 7.67 (s, 1 H), 7.57 (d, <i>J</i> = 7.07 Hz, 1 H), 7.38–7.53 (m, 5 H), 7.02 (t, <i>J</i> = 8.72 Hz, 2 H), 2.38 (s, 3 H); MS (ES+) <i>m</i>/<i>z</i> 345 [M + H]<sup>+</sup>.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 2-(4-Methoxyphenyl)-5-methyl-2-(3-(pyrimidin-5-yl)phenyl)-2<i>H</i>-imidazol-4-amine (<b>1j</b>)</h3><div class="NLM_p last">To a solution of zinc iodide (13 g, 41 mmol) in THF (20 mL) at 0 °C was added methylmagnesium bromide (3 M in diethyl ether) (14 mL, 42 mmol). To the formed slurry was then added 2-(3-bromophenyl)-2-(4-methoxyphenyl)-5-(methylthio)-2<i>H</i>-imidazol-4-amine (<b>10j</b>) (1.6 g, 4.1 mmol) in THF (20 mL), followed by bis(triphenylphosphine)palladium(II) chloride (0.29 g, 0.41 mmol). The reaction mixture was stirred at 50 °C for 3 h. Methanol was added to quench the reaction, and the solvent was then evaporated. Water was added resulting in a thick slurry which was extracted with dichloromethane. The combined organic phases were dried (MgSO<sub>4</sub>), filtered, and the solvent was evaporated. Silica column chromatography (0:1 → 1:0, EtOAc/dichloromethane) gave 0.88 g. A portion of the purified material (0.22 g), pyrimidin-5-ylboronic acid (95 mg, 0.76 mmol), and bis(triphenylphosphine)palladium(II) chloride (54 mg, 80 μmol) were taken up in DME (3 mL) and water (1.5 mL). Sodium carbonate (1 M in water) (0.95 mL, 0.95 mmol) was added, and the mixture was heated at 80 °C for 2 h. Reversed phase preparative-HPLC gave 36 mg (1%, over two steps) of the title compound. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i><sub>3</sub>) δ ppm 9.19 (s, 1 H), 8.93 (s, 2 H), 7.77 (s, 1 H), 7.61–7.70 (m, 1 H), 7.50 (d, <i>J</i> = 8.84 Hz, 2 H), 7.44 (d, <i>J</i> = 5.05 Hz, 2 H), 6.84 (d, <i>J</i> = 8.84 Hz, 2 H), 3.78 (s, 3 H), 2.36 (s, 3 H); MS (ES+) <i>m</i>/<i>z</i> 358 [M + H]<sup>+</sup>.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 2-(4-Methoxyphenyl)-5-methyl-2-(3-(pyridin-3-yl)phenyl)-2<i>H</i>-imidazol-4-amine (<b>1k</b>)</h3><div class="NLM_p last">To a solution of zinc iodide (13 g, 41 mmol) in THF (20 mL) at 0 °C was added methylmagnesium bromide (3 M in diethyl ether) (14 mL, 42 mmol). To the formed slurry was then added 2-(3-bromophenyl)-2-(4-methoxyphenyl)-5-(methylthio)-2<i>H</i>-imidazol-4-amine (<b>10j</b>) (1.6 g, 4.1 mmol) in THF (20 mL), followed by bis(triphenylphosphine)palladium(II) chloride (0.29 g, 0.41 mmol). The reaction mixture was stirred at 50 °C for 3 h. Methanol was added to quench the reaction, and the solvent was then evaporated. Water was added resulting in a thick slurry which was extracted with dichloromethane. The combined organic phases were dried (MgSO<sub>4</sub>), filtered, and the solvent was evaporated. Silica column chromatography (0:1 → 1:0, EtOAc/dichloromethane) gave 0.88 g. A portion the purified material (200 mg), pyridin-3-ylboronic acid (86 mg, 0.70 mmol), and bis(triphenylphosphine)palladium(II) chloride (49 mg, 70 μmol) were taken up in DME (2 mL) and water (1 mL). Sodium carbonate (1 M in water) (0.9 mL, 0.9 mmol) was added, and the mixture was heated at 80 °C for 2 h. Reversed phase preparative-HPLC gave 39 mg (1%, over two steps) of the title compound. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i><sub>3</sub>) δ ppm 8.82 (d, <i>J</i> = 1.77 Hz, 1 H), 8.57 (dd, <i>J</i> = 4.55, 1.26 Hz, 1 H), 7.86 (ddd, <i>J</i> = 7.96, 1.89, 1.77 Hz, 1 H), 7.77 (s, 1 H), 7.60 (d, <i>J</i> = 7.58 Hz, 1 H), 7.50 (d, <i>J</i> = 8.84 Hz, 2 H), 7.37–7.47 (m, 2 H), 7.34 (dd, <i>J</i> = 7.83, 4.80 Hz, 1 H), 6.83 (d, <i>J</i> = 8.84 Hz, 2 H), 5.18 (br s, 2 H), 3.77 (s, 3 H), 2.35 (s, 3 H; MS (ES+) <i>m</i>/<i>z</i> 357 [M + H]<sup>+</sup>.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 2-(4-Methoxy-3-methylphenyl)-5-methyl-2-(3-(pyrimidin-5-yl)phenyl)-2<i>H</i>-imidazol-4-amine (<b>1l</b>)</h3><div class="NLM_p last">2-(3-Bromophenyl)-2-(4-methoxy-3-methylphenyl)-5-methyl-2<i>H</i>-imidazol-4-amine (<b>7l</b>) (0.3 g, 0.8 mmol), pyrimidin-5-ylboronic acid (0.12 g, 0.97 mmol), [1,1′-bis(diphenylphosphino)ferrocene]palladium(II) chloride (33 mg, 40 μmol), potassium carbonate (2 M in water) (1.2 mL, 2.4 mmol), and dioxane (4 mL) were mixed in a vial and heated in a microwave reactor at 130 °C for 15 min. The mixture was diluted with methanol (5 mL), filtered, and purified by reversed phase preparative-HPLC to give 0.14 g (46%) the title compound. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.08 (s, 3H), 2.24 (s, 3), 3.71 (s, 3H), 6.61 (br s, 2H), 6.79 (d, <i>J</i> = 8.51 Hz, 1H), 7.29–7.50 (m, 3H), 7.50–7.70 (m, 2H), 7.82 (t, <i>J</i> = 1.73 Hz, 1H), 9.01 (s, 2H), 9.19 (s, 1H); MS (ES+) <i>m</i>/<i>z</i> 372 [M + H]<sup>+</sup>.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 2-(4-Methoxy-3,5-dimethylphenyl)-5-methyl-2-(3-(pyrimidin-5-yl)phenyl)-2<i>H</i>-imidazol-4-amine (<b>1m</b>)</h3><div class="NLM_p last">1,3-Dibromobenzene (3.0 mL, 25 mmol) was dissolved in diethyl ether (60 mL) and cooled to −78 °C. <i>n</i>-Butyllithium (2.5 M in hexane) (10 mL, 25 mmol) was added and the solution stirred for 30 min. 4-Methoxy-3,5-dimethylbenzonitrile (4.06 g, 25.20 mmol) was added in diethyl ether (40 mL) at −78 °C, and the mixture was allowed to warm to room temperature over 30 min. Methanol (20 mL) containing ammonium acetate (2 g, 26 mmol) was added. The solvents were evaporated, and the residue was taken up in dichloromethane and water. The organic layer was separated and the water phase extracted with dichloromethane. The combined organic phases were shaken with brine and dried (MgSO<sub>4</sub>), filtered, and the solvent was evaporated. The intermediate imine and ethanebis(thioamide) (2.91 g, 24.20 mmol) were taken up in ethanol (10 mL). The mixture was heated at 165 °C for 2 h by microwave irradiation. The solvent was evaporated and the residue subjected to silica column chromatography (0:1 → 1:0, EtOAc/heptane) to give the intermediate imidazothiol. The purified intermediate was taken up in THF (20 mL). Iodomethane (1.0 mL, 16 mmol) was added, and the mixture was heated at 60 °C for 24 h. The cooled solution was then subjected to silica column chromatography (0:1 → 1:0, EtOAc/heptane) to give the intermediate S-methylated imidazothiol. To a solution of zinc iodide (11 g, 35 mmol) in THF (40 mL) at 0 °C was added methylmagnesium bromide (3 M in diethyl ether) (11.6 mL, 34.8 mmol). To the formed slurry was then added the purified intermediate in THF (20 mL), followed by bis(triphenylphosphine)palladium(II) chloride (0.31 g, 0.44 mmol). The reaction mixture was stirred at 50 °C for 3 h. The reaction mixture was filtered, and the solids were rinsed with dichloromethane. The organic phase was dried (MgSO<sub>4</sub>), filtered, and the solvent was evaporated. Silica column chromatography (0:1 → 1:0, 10% acetic acid in EtOAc/dichloromethane) gave 0.4 g of the intermediate aminoimidazole. A portion of the purified material (270 mg), pyrimidin-5-ylboronic acid (0.17 g, 1.4 mmol), and bis(triphenylphosphine)palladium(II) chloride (98 mg, 0.14 mmol) were taken up in DME (8 mL) and water (4 mL). Sodium carbonate (1 M in water) (1.7 mL, 1.7 mmol) was added, and the mixture was heated at 80 °C for 2 h. The reaction mixture was extracted with dichloromethane. The combined organic phases were dried (MgSO<sub>4</sub>), filtered, and the solvent was evaporated. Reversed phase preparative-HPLC gave 88 mg (1%, over five steps) of the title compound. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 9.12 (s, 1 H), 9.02 (s, 2 H), 7.70 (s, 1 H), 7.62 (d, <i>J</i> = 7.58 Hz, 1 H), 7.51–7.56 (m, 1 H), 7.43–7.51 (m, 1 H), 7.04 (s, 2 H), 3.66 (s, 3 H), 2.37 (s, 3 H), 2.21 (s, 6 H); MS (ES+) <i>m</i>/<i>z</i> 386 [M + H]<sup>+</sup>.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (<i>S</i>)-2-(4-Methoxy-3,5-dimethylphenyl)-5-methyl-2-(3-(pyrimidin-5-yl)phenyl)-2<i>H</i>-imidazol-4-amine and (<i>R</i>)-2-(4-Methoxy-3,5-dimethylphenyl)-5-methyl-2-(3-(pyrimidin-5-yl)phenyl)-2<i>H</i>-imidazol-4-amine ((<i>S</i>)-<b>1m</b> and (<i>R</i>)-<b>1m</b>)</h3><div class="NLM_p last">2-(3-Bromophenyl)-2-(4-methoxy-3,5-dimethylphenyl)-5-methyl-2<i>H</i>-imidazol-4-amine (0.27 g, 0.70 mmol), pyrimidin-5-ylboronic acid (0.17 g, 1.4 mmol), and bis(triphenylphosphine)palladium(II) chloride (98 mg, 0.14 mmol) were taken up in DME (8 mL) and water (4 mL). Sodium carbonate (1 M in water) (1.7 mL, 1.7 mmol) was added, and the mixture was heated at 80 °C for 2 h. The solvent was evaporated, and the residue was dissolved in methanol (7.5 mL). The resulting solution was injected (15 stacked injections) on a Chiralpak AD-H column (21.2 mm × 250 mm), using methanol/CO<sub>2</sub> (10:90) + 0.1% DEA as eluent at a flow rate of 50 mL/min. The (<i>S</i>)-enantiomer was the first to elute and was concentrated in vacuo to give 30 mg (11%). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 9.12 (s, 1 H), 9.02 (s, 2 H), 7.70 (s, 1 H), 7.62 (d, <i>J</i> = 7.58 Hz, 1 H), 7.51–7.56 (m, 1 H), 7.43–7.51 (m, 1 H), 7.04 (s, 2 H), 3.66 (s, 3 H), 2.37 (s, 3 H), 2.21 (s, 6 H); MS (ES+) <i>m</i>/<i>z</i> 386 [M + H]<sup>+</sup>. The (<i>R</i>)-enantiomer was the second to elute and was concentrated in vacuo to give 29 mg (11%). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 9.12 (s, 1 H), 9.02 (s, 2 H), 7.70 (s, 1 H), 7.62 (d, <i>J</i> = 7.58 Hz, 1 H), 7.51–7.56 (m, 1 H), 7.43–7.51 (m, 1 H), 7.04 (s, 2 H), 3.66 (s, 3 H), 2.37 (s, 3 H), 2.21 (s, 6 H); MS (ES+) <i>m</i>/<i>z</i> 386 [M + H]<sup>+</sup>.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 2-(4-Methoxy-3,5-dimethylphenyl)-5-methyl-2-{3-[5-(prop-1-yn-1-yl)pyridin-3-yl]phenyl}-2<i>H</i>-imidazol-4-amine (<b>1n</b>)</h3><div class="NLM_p last">To a solution of 2-(3-bromophenyl)-2-(4-methoxy-3,5-dimethylphenyl)-5-methyl-2<i>H</i>-imidazol-4-amine (0.12 g, 0.31 mmol) in dioxane/ethanol/H<sub>2</sub>O (2 mL/0.5 mL/0.5 mL) were added [5-(prop-1-yn-1-yl)pyridin-3-yl]boronic acid (75 mg, 0.47 mmol), sodium carbonate (66 mg, 0.62 mmol), tris(dibenzylideneacetone)dipalladium(0) (12 mg), and 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (12 mg) under nitrogen atmosphere. The mixture was stirred at 100 °C overnight. Water (5 mL) was added, and the mixture was extracted with EtOAc. The combined organic layers were dried (MgSO<sub>4</sub>) and concentrated to give the product, which was purified by reversed phase preparative-HPLC to give 26 mg (20%) of the title compound. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i><sub>3</sub>) δ ppm 8.69 (d, <i>J</i> = 2.0 Hz, 1 H), 8.57 (d, <i>J</i> = 1.6 Hz, 1 H), 7.87 (s, 1 H), 7.76 (s, 1 H), 7.62 (d, <i>J</i> = 7.2 Hz, 1 H), 7.39–7.46 (m, 2 H), 7.19 (s, 2 H), 3.67 (s, 3 H), 2.37 (s, 3 H), 2.24 (s, 6 H), 2.06 (s, 3 H); MS (ES+) 423.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 2-Benzyl-5-methyl-2-(3-(pyrimidin-5-yl)phenyl)-2<i>H</i>-imidazol-4-amine ((<i>S</i>)-<b>1o</b> and (<i>R</i>)-<b>1o</b>)</h3><div class="NLM_p last">1-(3-Bromophenyl)-2-phenylethanone (1.0 g, 3.6 mmol) and ethanebis(thioamide) (1.3 g, 11 mmol) were taken up in ammonia (7 M in methanol) (15 mL, 0.11 mmol). The mixture was heated at 150 °C for 1 h by microwave irradiation. The reaction mixture was diluted with dichloromethane and filtered. Silica column chromatography (0:1 → 1:0, EtOAc/heptane) gave 1.23 g of the intermediate imidazothiol. The purified material was taken up in THF (30 mL). Iodomethane (0.64 mL, 10.3 mmol) was added, and the mixture was heated at 60 °C for 4 h. Silica column chromatography using (0:1 → 1:0, EtOAc/heptane) gave 200 mg of the intermediate S-methylated intermediate imidazothiol. The purified intermediate and 1,3-bis(diphenylphosphino)propanenickel(II) chloride (0.12 mg, 0.21 mmol) were dissolved in toluene (3 mL). Methylmagnesium bromide (3 M in diethyl ether) (1.4 mL, 4.2 mmol) was added and the resulting suspension stirred at room temperature. After 1 h water was added and the phases were separated. The water phase was extracted with dichloromethane. The combined organic phases were dried (MgSO<sub>4</sub>), filtered and the solvents evaporated. Reversed phase preparative-HPLC gave 67 mg of the intermediate aminoimidazole. The purified material, pyrimidin-5-ylboronic acid (48 mg, 0.39 mmol), and bis(triphenylphosphine)palladium(II) chloride (27 mg, 40 μmol) were taken up in DME (1 mL) and water (0.5 mL). Sodium carbonate (1 M in water) (0.5 mL, 0.5 mmol) was added, and the mixture was heated at 80 °C for 2 h. The reaction mixture was extracted with dichloromethane. The combined organic phases were dried (MgSO<sub>4</sub>), filtered, and the solvent was evaporated. Reversed phase preparative-HPLC gave 30 mg of the title compound. The purified material was dissolved in methanol (2.7 mL), and the resulting solution was injected (three stacked injections) on a LuxC2 column (21.2 mm × 250 mm), using methanol/CO<sub>2</sub> (18:82) + 0.1% DEA as eluent at a flow rate of 50 mL/min. The (<i>S</i>)-enantiomer was the first to elute and was concentrated in vacuo to give 8 mg (0.6%, over four steps). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 2.07 (s, 3 H), 3.33–3.50 (m, 2 H), 7.00–7.09 (m, 2 H), 7.11–7.21 (m, 3 H), 7.49–7.56 (m, 1 H), 7.62–7.68 (m, 1 H), 7.76 (dt, <i>J</i> = 7.83, 1.26 Hz, 1 H), 7.90 (t, <i>J</i> = 1.77 Hz, 1 H), 9.05 (s, 2 H), 9.14 (s, 1 H); MS (ES+) <i>m</i>/<i>z</i> 342 [M + H]<sup>+</sup>. The (<i>R</i>)-enantiomer was the second to elute and was concentrated in vacuo to give 8 mg (0.6%, over four steps). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 2.07 (s, 3 H), 3.33–3.50 (m, 2 H), 7.00–7.09 (m, 2 H), 7.11–7.21 (m, 3 H), 7.49–7.56 (m, 1 H), 7.62–7.68 (m, 1 H), 7.76 (dt, <i>J</i> = 7.83, 1.26 Hz, 1 H), 7.90 (t, J=1.77 Hz, 1 H), 9.05 (s, 2 H), 9.14 (s, 1 H); MS (ES+) <i>m</i>/<i>z</i> 342 [M + H]<sup>+</sup>.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 2-(3-(5-Chloropyridin-3-yl)phenyl)-2-cyclopropyl-5-methyl-2<i>H</i>-imidazol-4-amine (<b>1p</b>)</h3><div class="NLM_p last">The title compound was prepared as described for compound <b>1l</b> in 52% yield starting with 5-chloropyridin-3-ylboronic acid (68 mg, 0.43 mmol) and 2-(3-bromophenyl)-2-cyclopropyl-5-methyl-2<i>H</i>-imidazol-4-amine (<b>7p</b>) (90 mg, 0.31 mmol). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm −0.01 to 0.07 (m, 1H), 0.17–0.26 (m, 1H), 0.27–0.39 (m, 2H), 1.56–1.64 (m, 1H), 2.16 (s, 3H), 6.50 (br s, 2H), 7.40–7.46 (m, 1H), 7.65 (d, <i>J</i> = 7.65 Hz, 1H), 7.62 (d, <i>J</i> = 7.72 Hz, 1H), 7.88 (br s, 1H), 8.15 (br s, 1H), 8.63 (d, <i>J</i> = 1.89 Hz, 1H), 8.78 (br. s, 1H); MS (ES+) <i>m</i>/<i>z</i> 325 [M + H]<sup>+</sup>.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 2-Cyclohexyl-5-methyl-2-(3-(pyridin-3-yl)phenyl)-2<i>H</i>-imidazol-4-amine (<b>1q</b>)</h3><div class="NLM_p last">1,3-Dibromobenzene (3.0 mL, 25 mmol) was dissolved in diethyl ether (60 mL) and cooled to −78 °C. <i>n</i>-Butyllithium (2.5 M in hexane) (10 mL, 25 mmol) was added and the solution stirred for 30 min. Cyclohexanecarbonitrile (3.0 mL, 25 mmol) was added in diethyl ether (40 mL) at −78 °C, and the mixture was allowed to warm to room temperature over 30 min. Methanol (20 mL) containing ammonium acetate (2 g, 26 mmol) was added. The solvents were evaporated, and the residue was taken up in dichloromethane and water. The organic layer was separated and the water phase extracted with dichloromethane. The combined organic phases were shaken with brine, dried (MgSO<sub>4</sub>), and filtered and the solvent was evaporated to give the intermediate imine. The product and ethanebis(thioamide) (1.5 g, 12 mmol) were taken up in ethanol (10 mL). The mixture was heated at 165 °C for 2 h by microwave irradiation. The solvent was evaporated. Silica column chromatography (0:1 → 1:0 EtOAc/heptane) gave the intermediate imidazothiol. The purified material was taken up in THF (20 mL). Iodomethane (0.7 mL, 11 mmol) was added, and the mixture was heated at 60 °C for 24 h. Silica column chromatography (0:1 → 1:0 EtOAc/heptane) gave the intermediate S-methylated imidazothiol. To a solution of zinc iodide (5 g, 16 mmol) in THF (40 mL) at 0 °C was added methylmagnesium bromide (3 M in diethyl ether) (5.3 mL, 16 mmol). To the formed slurry was then added the purified intermediate (0.93 g, 2.5 mmol) in THF (20 mL), followed by bis(triphenylphosphine)palladium(II) chloride (0.18 g, 0.25 mmol). The reaction mixture was stirred at 50 °C for 3 h. Methanol was added to quench the reaction. The solvent was evaporated. Water was added resulting in a thick slurry which was washed with dichloromethane. The combined organic phases were dried (MgSO<sub>4</sub>), filtered, and the solvent was evaporated. Reversed phase preparative-HPLC gave 0.12 g of the intermediate aminoimidazole. A portion of the purified intermediate (60 mg), pyridin-3-ylboronic acid (44 mg, 0.36 mmol), and bis(triphenylphosphine)palladium(II) chloride (25 mg, 40 μmol) were taken up in DME (2 mL) and water (1 mL). Sodium carbonate (1 M in water) (0.45 mL, 0.45 mmol) was added and the mixture was heated at 80 °C for 2 h. Reversed phase preparative-HPLC gave 28 mg (0.7%, over five steps) of the title compound. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i><sub>3</sub>) δ ppm 8.87 (d, <i>J</i> = 2.02 Hz, 1 H), 8.58 (dd, <i>J</i> = 4.80, 1.52 Hz, 1 H), 7.92 (ddd, <i>J</i> = 7.96, 1.89, 1.77 Hz, 1 H), 7.84 (s, 1 H), 7.66 (d, <i>J</i> = 7.33 Hz, 1 H), 7.46–7.52 (m, 1 H), 7.40–7.46 (m, 1 H), 7.35 (dd, <i>J</i> = 7.71, 4.93 Hz, 1 H), 5.50 (br s, 2 H), 2.30 (s, 3 H), 2.06–2.17 (m, 1 H), 1.42–1.77 (m, 5 H), 0.86–1.25 (m, 5 H); MS (ES+) <i>m</i>/<i>z</i> 333 [M + H]<sup>+</sup>.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 2-(3′-Methoxybiphenyl-3-yl)-5-methyl-2-(tetrahydro-2<i>H</i>-pyran-4-yl)-2<i>H</i>-imidazol-4-amine (<b>1r</b>)</h3><div class="NLM_p last">1,3-Dibromobenzene (3.0 mL, 25 mmol) was dissolved in diethyl ether (60 mL) and cooled to −78 °C. <i>n</i>-Butyllithium (2.5 M in hexane) (10 mL, 25 mmol) was added and the solution stirred for 30 min. Tetrahydro-2<i>H</i>-pyran-4-carbonitrile (2.8 g, 25 mmol) was added in diethyl ether (20 mL) at −78 °C, and the mixture was stirred for 30 min. The mixture was then allowed to reach room temperature over 30 min. Methanol (20 mL) containing ammonium acetate (2.0 g, 26 mmol) was added. The solvents were evaporated, and the residue was taken up in dichloromethane and water. The organic layer was separated and the water phase extracted with dichloromethane. The combined organic phases were shaken with brine and dried (MgSO<sub>4</sub>). The mixture was filtered and the solvent evaporated to give 4.6 g of the intermediate imine. The material and ethanebis(thioamide) (2.5 g, 21 mmol) were taken up in ethanol (10 mL). The mixture was heated at 165 °C for 2 h by microwave irradiation. The reaction mixture was diluted with dichloromethane and filtered. Silica column chromatography (0:1 → 1:0 EtOAc/heptane) gave 3.7 g of the intermediate imidazothiol. The purified material was taken up in THF (20 mL). Iodomethane (2.0 mL, 31 mmol) was added, and the mixture was heated at 60 °C for 24 h. Silica column chromatography (0:1 → 1:0 EtOAc/heptane) gave 2.2 g the intermediate S-methylated imidazothiol. A portion of the purified material (0.63 g), 3-methoxyphenylboronic acid (0.26 g, 1.7 mmol), and bis(triphenylphosphine)palladium(II) chloride (0.12 g, 0.17 mmol) were taken up in DME (20 mL) and water (10 mL). Sodium carbonate (1 M in water) (4.2 mL, 4.2 mmol) was added, and the mixture was heated at 80 °C for 2 h. The reaction mixture was extracted with dichloromethane. The combined organic phases were dried (MgSO<sub>4</sub>), filtered and the solvents evaporated. Reversed phase preparative-HPLC gave 80 mg of intermediate arylated S-methylated imidazothiol. To a solution of zinc iodide (0.65 g, 2.0 mmol) in THF (10 mL) at 0 °C was added methylmagnesium bromide (3 M in diethyl ether) (0.7 mL, 2.1 mmol). To the formed slurry was then added bis(triphenylphosphine)palladium(II) chloride (28 mg, 40 μmol) followed by the purified intermediate in THF (5 mL). The reaction mixture was stirred at 80 °C for 3 h. Methanol was added to quench the reaction. Saturated NH<sub>4</sub>Cl solution was added, and the mixture was extracted with dichloromethane. The combined organic phases were dried (MgSO<sub>4</sub>), filtered, and the solvent was evaporated. Reversed phase preparative-HPLC gave 18 mg (0.2%, over five steps) of the title compound. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 7.79 (s, 1 H), 7.59–7.68 (m, 1 H), 7.47–7.58 (m, 3 H), 7.38 (t, <i>J</i> = 7.83 Hz, 1 H), 7.33 (t, <i>J</i> = 7.83 Hz, 1 H), 7.18 (d, <i>J</i> = 7.83 Hz, 1 H), 7.15 (d, <i>J</i> = 2.02 Hz, 1 H), 6.90 (dd, <i>J</i> = 8.08, 2.02 Hz, 1 H), 3.87 (d, <i>J</i> = 11.37 Hz, 2 H), 3.84 (s, 3 H), 3.24–3.37 (m, 2 H), 2.35–2.47 (m, 1 H), 2.32 (s, 3 H), 1.22–1.43 (m, 4 H); MS (ES+) <i>m</i>/<i>z</i> 364 [M + H]<sup>+</sup>.</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 1-(4-(4-Amino-2-(3′-methoxybiphenyl-3-yl)-5-methyl-2<i>H</i>-imidazol-2-yl)piperidin-1-yl)ethanone (<b>1s</b>)</h3><div class="NLM_p last">1,3-Dibromobenzene (1.4 mL, 12 mmol) was dissolved in diethyl ether (90 mL) and cooled to −78 °C. <i>n</i>-Butyllithium (2.5 M in hexane) (5 mL, 12.5 mmol) was added and the solution stirred for 30 min. <i>tert</i>-Butyl 4-cyanopiperidine-1-carboxylate (2.5 g, 12 mmol) was added in diethyl ether (40 mL) at −78 °C. The mixture was stirred for 30 min and was then allowed to warm to room temperature over 30 min. Methanol (20 mL) containing ammonium acetate (1 g, 13 mmol) was added. The solvents were evaporated, and the residue was taken up in dichloromethane and water. The organic layer was separated and the water phase extracted with dichloromethane. The combined organic phases were shaken with brine, dried (MgSO<sub>4</sub>), and filtered and the solvent was evaporated to give 2.9 g of the intermediate imine. A portion of the material (2.65 g) and ethanebis(thioamide) (1.0 g, 8.3 mmol) were taken up in ethanol (10 mL). The mixture was heated at 180 °C for 30 min by microwave irradiation. The reaction mixture was diluted with dichloromethane and filtered. Silica column chromatography (0:1 → 1:0 EtOAc/heptane) gave 0.94 g of the intermediate imidazothiol. The purified material was taken up in THF (20 mL). Iodomethane (0.39 mL, 6.2 mmol) was added, and the mixture was heated at 60 °C for 24 h. Silica column chromatography (0:1 → 1:9 0.1% ammonia in methanol/dichloromethane) gave 0.57 g of the intermediate S-methylated imidazothiol. To a solution of zinc iodide (3.4 g, 10.7 mmol) in THF (20 mL) at 0 °C was added methylmagnesium bromide (3 M in diethyl ether) (3.6 mL, 10.7 mmol). To the formed slurry was then added bis(triphenylphosphine)palladium(II) chloride (0.15 g, 0.21 mmol) followed by the purified intermediate in THF (10 mL). The mixture was stirred at 50 °C for 3 h. Methanol was added to quench the reaction. Saturated NH<sub>4</sub>Cl solution was added, and the mixture was extracted with diethyl ether. The combined organic phases were dried (MgSO<sub>4</sub>), filtered, and the solvent was evaporated. Reversed phase preparative-HPLC gave 45 mg of the intermediate aminoimidazole. The purified material, 3-methoxyphenylboronic acid (18 mg, 0.12 mmol), and bis(triphenylphosphine)palladium(II) chloride (7 mg, 10 μmol) were taken up in DME (1 mL) and water (0.5 mL). Sodium carbonate (1 M in water) (0.26 mL, 0.26 mmol) was added, and the mixture was heated at 80 °C for 2 h. The reaction mixture was filtered, and reversed phase preparative-HPLC gave 16 mg of the intermediate arylated aminoimidazole. The purified material was dissolved in dichloromethane (2 mL). Trifluoroacetic acid (1.0 mL, 13 mmol) was added, and the mixture was stirred at room temperature for 1 h. The solvent and excess reagent were evaporated. The residue was dissolved in dichloromethane (2 mL) and triethylamine (11 μL, 80 μmol). Acetic anhydride (4 μL, 40 μmol) was added, and the mixture was stirred for 16 h. The solvent was evaporated and reversed phase preparative-HPLC gave 12 mg (0.3%, over seven steps) of the title compound. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 7.80 (br s, 1 H), 7.53 (d, <i>J</i> = 7.58 Hz, 2 H), 7.39 (t, <i>J</i> = 7.45 Hz, 1 H), 7.34 (t, <i>J</i> = 7.96 Hz, 1 H), 7.18 (d, <i>J</i> = 7.83 Hz, 1 H), 7.16 (s, 1 H), 6.91 (dd, <i>J</i> = 8.21, 1.89 Hz, 1 H), 4.49 (d, <i>J</i> = 12.88 Hz, 1 H), 3.79–3.92 (m, 4 H), 2.90–3.06 (m, 1 H), 2.39–2.54 (m, 2 H), 2.33 (br s, 3 H), 2.03 (s, 3 H), 1.36–1.62 (m, 2 H), 1.25 (d, <i>J</i> = 11.87 Hz, 1 H), 0.99–1.17 (m, 1 H); MS (ES+) <i>m</i>/<i>z</i> 405 [M + H]<sup>+</sup>.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 2-Cyclopropyl-5-methyl-2-(3-(5-(prop-1-ynyl)pyridin-3-yl)phenyl)-2<i>H</i>-imidazol-4-amine (<b>1t</b>)</h3><div class="NLM_p last">The title compound was prepared as described for compound <b>1l</b> in 40% yield starting with 5-(prop-1-ynyl)pyridin-3-ylboronic acid (917471–30–8) (86 mg, 0.53 mmol) and 2-(3-bromophenyl)-2-cyclopropyl-5-methyl-2<i>H</i>-imidazol-4-amine (<b>7p</b>) (78 mg, 0.27 mmol). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm −0.02–0.07 (m, 1H), 0.16–0.26 (m, 1H), 0.27–0.39 (m, 2H), 1.55–1.62 (m, 1H), 2.12 (s, 3H), 2.16 (s, 3H), 6.50 (br s, 2H), 7.41 (t, <i>J</i> = 7.72 Hz, 1H), 7.59 (d, <i>J</i> = 7.65 Hz, 1H), 7.64 (d, <i>J</i> = 7.72 Hz, 1H), 7.85 (br s, 1H), 7.98 (br s, 1H), 8.58 (br s, 1H), 8.73–8.77 (m, 1H); MS (ES+) <i>m</i>/<i>z</i> 329 [M + H]<sup>+</sup>.</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 4-(4-Amino-2-cyclopropyl-5-methyl-2<i>H</i>-imidazol-2-yl)-2-(5-(prop-1-ynyl)pyridin-3-yl)phenol (<b>1u</b>)</h3><div class="NLM_p last">The title compound was prepared as described for compound <b>1l</b> in 28% yield starting with 4-(4-amino-2-cyclopropyl-5-methyl-2<i>H</i>-imidazol-2-yl)-2-bromophenol (<b>14</b>) (60 mg, 0.19 mmol) and 5-(prop-1-ynyl)pyridin-3-ylboronic acid (47 mg, 0.29 mmol). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm −0.07 to 0.03 (m, 1H), 0.14–0.23 (m, 1H), 0.24–0.33 (m, 2H), 1.44–1.52 (m, 1H), 2.10 (s, 3H), 2.13 (s, 3H), 6.41 (br s, 2H), 6.88 (d, <i>J</i> = 8.51 Hz, 1H), 7.42 (dd, <i>J</i> = 8.35, 2.21 Hz, 1H), 7.45 (d, <i>J</i> = 2.21 Hz, 1H), 7.85 (t, <i>J</i> = 2.05 Hz, 1H), 8.50 (d, <i>J</i> = 1.89 Hz, 1H), 8.61 (d, <i>J</i> = 2.05 Hz, 1H), 9.72 (br s, 1H); MS (ES+) <i>m</i>/<i>z</i> 345 [M + H]<sup>+</sup>.</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 4-(4-Amino-2-cyclopropyl-5-methyl-2<i>H</i>-imidazol-2-yl)-2-(4-(prop-1-ynyl)pyridin-2-yl)phenol (<b>1v</b>)</h3><div class="NLM_p last">2-Cyclopropyl-2-(4-methoxy-3-(4-(prop-1-ynyl)pyridin-2-yl)phenyl)-5-methyl-2<i>H</i>-imidazol-4-amine (<b>15</b>) (16 mg, 40 μmol) was dissolved in dichloromethane (1.0 mL) and cooled to −78 °C. Boron tribromide (15 μL, 0.16 mmol) was added dropwise, and the reaction mixture was slowly warmed to room temperature overnight. The reaction was quenched by dropwise addition of methanol (0.5 mL). Then ammonia (35% in water) (0.5 mL) was added. HCl (2 M) was added dropwise until pH 7 was obtained. The organics were evaporated, and the resulting residue was taken up in dichloromethane. The organic layer was collected and the water phase was extracted with dichloromethane. The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. Purification by reversed phase preparative HPLC gave 2 mg (14%) of the title compound. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 13.21 (s, 1H), 8.58 (d, <i>J</i> = 5.04 Hz, 1H), 8.07 (d, <i>J</i> = 2.21 Hz, 1H), 7.94 (s, 1H), 7.50 (dd, <i>J</i> = 8.51, 2.21 Hz, 1H), 7.37 (dd, <i>J</i> = 5.20, 1.10 Hz, 1H), 6.85 (d, <i>J</i> = 8.51 Hz, 1H), 6.45 (br s, 2H), 2.16 (s, 3H), 2.15 (s, 3H), 1.53 (tt, <i>J</i> = 8.04, 5.20 Hz, 1H), 0.25–0.36 (m, 2H), 0.13–0.24 (m, 1H), −0.05 to 0.05 (m, 1H); MS (ES+) <i>m</i>/<i>z</i> 345 [M + H]<sup>+</sup>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i54"><a href="/doi/suppl/10.1021/jm300991n">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78144" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78144" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Synthetic procedures and analytical data for intermediates <b>2</b>, <b>3l</b>,<b>p</b>, <b>4h</b>,<b>i</b>,<b>l</b>, <b>6c</b>,<b>b</b>, <b>7b</b>,<b>l</b>,<b>p</b>, <b>9j</b>, <b>10j</b>, <b>6a</b>, <b>11</b>–<b>15</b> (intermediates named after the corresponding compounds <b>1</b>); Table 1 listing crystallographic data; Figures 1 and 2 showing compounds bound to BACE-1 active site. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300991n/suppl_file/jm300991n_si_001.pdf">jm300991n_si_001.pdf (376.64 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm300991n" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72580" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72580" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ylva Gravenfors</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85 Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal,
Sweden</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d9a0b5afb8f7beabb8afbcb7bfb6abaa99b1b6adb4b8b0b5f7bab6b4"><span class="__cf_email__" data-cfemail="7b02170d1a551c091a0d1e151d1409083b13140f161a121755181416">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jenny Viklund</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85 Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal,
Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jan Blid</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85 Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal,
Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tobias Ginman</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85 Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal,
Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sofia Karlström</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85 Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal,
Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacob Kihlström</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85 Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal,
Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karin Kolmodin</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85 Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal,
Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Johan Lindström</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85 Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal,
Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefan von Berg</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85 Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal,
Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fredrik von Kieseritzky</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85 Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal,
Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Can Slivo</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85 Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal,
Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Britt-Marie Swahn</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85 Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal,
Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lise-Lotte Olsson</span> - <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal,
Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrik Johansson</span> - <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal,
Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susanna Eketjäll</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85 Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal,
Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Johanna Fälting</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85 Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal,
Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fredrik Jeppsson</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85 Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal,
Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kia Strömberg</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85 Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal,
Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Juliette Janson</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85 Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal,
Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fredrik Rahm</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85 Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal,
Sweden</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d980e4780-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i55">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22332" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22332" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the Physiochemical Characterization Team and the Analytical and Purification Sciences Team at the Department of Medicinal Chemistry at AstraZeneca Södertälje, Sweden, for physiochemical characterization, enantiomer separations, and purity determinations. We thank Martin Levin for FRET and sAPPβ measurements. We thank Carolina Sandman and Carrie Tsoi for Caco-2 measurements, Eva Spennare and Jenny Johansson for determination of the fraction unbound in brain and plasma protein binding, Sveinn Briem and the team for bioanalysis, and the following people involved in performing the in vivo experiments: Daniel Bergström, Ann Staflund, Anette Stålebring Löwstedt, Susanne Gustavsson, and Carina Stephan. In addition, we thank Anna Aagaard for crystallization, and we thank Safety Assessment Screening Centre at AstraZeneca Alderly Park for hERG assessments.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i56" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i56"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i57" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i57"> Abbreviations Used</h2><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">amyloid-β</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">amyloid-β precursor protein</p></td></tr><tr><td class="NLM_term">BACE</td><td class="NLM_def"><p class="first last">β-site amyloid-β precursor protein cleaving enzyme</p></td></tr><tr><td class="NLM_term">cPr</td><td class="NLM_def"><p class="first last">cyclopropyl</p></td></tr><tr><td class="NLM_term">DEA</td><td class="NLM_def"><p class="first last">diethylamine</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">efflux ratio</p></td></tr><tr><td class="NLM_term">IPA</td><td class="NLM_def"><p class="first last">isopropanol</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">pharmacodynamic</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">permeability glycoprotein</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last">per oral</p></td></tr><tr><td class="NLM_term">PSA</td><td class="NLM_def"><p class="first last">polar surface area</p></td></tr><tr><td class="NLM_term">sAPPβ</td><td class="NLM_def"><p class="first last">soluble amyloid-β precursor protein</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i58">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24167" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24167" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 62 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Querfurth, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFerla, F. M.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1056%2FNEJMra0909142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=20107219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1aqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2010&pages=329-344&author=H.+W.+Querfurthauthor=F.+M.+LaFerla&title=Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease</span></div><div class="casAuthors">Querfurth, Henry W.; LaFerla, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">329-344</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  The role of β-amyloid peptide in spontaneous self-aggregation in brain in Alzheimer's disease is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPeniV_Jn6orVg90H21EOLACvtfcHk0lhq1njT9_w4ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1aqt7s%253D&md5=c116f6a6b8fed9af9f5282cc4b755c70</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1056%2FNEJMra0909142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra0909142%26sid%3Dliteratum%253Aachs%26aulast%3DQuerfurth%26aufirst%3DH.%2BW.%26aulast%3DLaFerla%26aufirst%3DF.%2BM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D362%26spage%3D329%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span> </span><span class="NLM_article-title">2012 Alzheimer’s disease facts and figures</span>.  <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1016%2Fj.jalz.2012.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=22404854" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=2012+Alzheimer%E2%80%99s+disease+facts+and+figures.+Alzheimer%27s+Dementia+2012%2C+8%2C+131%E2%80%93168."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2012.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2012.02.001%26sid%3Dliteratum%253Aachs%26atitle%3D2012%2520Alzheimer%25E2%2580%2599s%2520disease%2520facts%2520and%2520figures%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2012%26volume%3D8%26spage%3D131%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allsop, D.</span><span> </span><span class="NLM_article-title">Amyloid deposition as the central event in the etiology of Alzheimer’s disease</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1991&pages=383-388&author=J.+Hardyauthor=D.+Allsop&title=Amyloid+deposition+as+the+central+event+in+the+etiology+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DAllsop%26aufirst%3DD.%26atitle%3DAmyloid%2520deposition%2520as%2520the%2520central%2520event%2520in%2520the%2520etiology%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1991%26volume%3D12%26spage%3D383%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goedert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span> </span><span class="NLM_article-title">Neurodegenerative tauopathies</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1121</span><span class="NLM_x">–</span> <span class="NLM_lpage">1159</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1146%2Fannurev.neuro.24.1.1121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=11520930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BD3MXls1Shsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2001&pages=1121-1159&author=V.+M.+Leeauthor=M.+Goedertauthor=J.+Q.+Trojanowski&title=Neurodegenerative+tauopathies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Neurodegenerative tauopathies</span></div><div class="casAuthors">Lee, Virginia M-Y.; Goedert, Michel; Trojanowski, John Q.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1121-1159</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with many refs.  The defining neuropathol. characteristics of Alzheimer's disease are abundant filamentous tau lesions and deposits of fibrillar amyloid β peptides.  Prominent filamentous tau inclusions and brain degeneration in the absence of β-amyloid deposits are also hallmarks of neurodegenerative tauopathies exemplified by sporadic corticobasal degeneration, progressive supra-nuclear palsy, and Pick's disease, as well as by hereditary frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).  Because multiple tau gene mutations are pathogenic for FTDP-17 and tau polymorphisms appear to be genetic risk factors for sporadic progressive supranuclear palsy and corticobasal degeneration, tau abnormalities are linked directly to the etiol. and pathogenesis of neurodegenerative disease.  Indeed, emerging data support the hypothesis that different tau gene mutations are pathogenic because they impair tau functions, promote tau fibrillization, or perturb tau gene splicing, thereby leading to formation of biochem. and structurally distinct aggregates of tau.  Nonetheless, different members of the same kindred often exhibit diverse FTDP-17 syndromes, which suggests that addnl. genetic or epigenetic factors influence the phenotypic manifestations of neurodegenerative tauopathies.  Although these and other hypothetical mechanisms of neurodegenerative tauopathies remain to be tested and validated, transgenic models are increasingly available for this purpose, and they will accelerate discovery of more effective therapies for neurodegenerative tauopathies and related disorders, including Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUKjqSk9glv7Vg90H21EOLACvtfcHk0lh2qo2uFdRT-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXls1Shsbo%253D&md5=a40a15073de6597418ef7e93145c3245</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.24.1.1121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.24.1.1121%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DGoedert%26aufirst%3DM.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26atitle%3DNeurodegenerative%2520tauopathies%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D2001%26volume%3D24%26spage%3D1121%26epage%3D1159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics</span> <span class="citation_source-journal">Science (Washington, DC, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+Hardyauthor=D.+J.+Selkoe&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+progress+and+problems+on+the+road+to+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0lh2qo2uFdRT-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520progress%2520and%2520problems%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DScience%2520%2528Washington%252C%2520DC%252C%2520U.%2520S.%2529%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Hussain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howlett, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tew, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meek, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gloger, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Southan, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingwall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christie, G.</span><span> </span><span class="NLM_article-title">Identification of a novel aspartic protease (Asp 2) as β-secretase</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">427</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1006%2Fmcne.1999.0811" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=10656250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADyaK1MXnt1Chsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1999&pages=419-427&author=I.+Hussainauthor=D.+Powellauthor=D.+R.+Howlettauthor=D.+G.+Tewauthor=T.+D.+Meekauthor=C.+Chapmanauthor=I.+S.+Glogerauthor=K.+E.+Murphyauthor=C.+D.+Southanauthor=D.+M.+Ryanauthor=T.+S.+Smithauthor=D.+L.+Simmonsauthor=F.+S.+Walshauthor=C.+Dingwallauthor=G.+Christie&title=Identification+of+a+novel+aspartic+protease+%28Asp+2%29+as+%CE%B2-secretase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase</span></div><div class="casAuthors">Hussain, Ishrut; Powell, David; Howlett, David R.; Tew, David G.; Meek, Thomas D.; Chapman, Conrad; Gloger, Israel S.; Murphy, Kay E.; Southan, Christopher D.; Ryan, Dominic M.; Smith, Trudi S.; Simmons, David L.; Walsh, Frank S.; Dingwall, Colin; Christie, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">419-427</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The Alzheimer's disease β-amyloid peptide (Aβ) is produced by excision from the type 1 integral membrane glycoprotein amyloid precursor protein (APP) by the sequential actions of β- and then γ-secretases.  Here we report that Asp 2, a novel transmembrane aspartic protease, has the key activities expected of β-secretase.  Transient expression of Asp 2 in cells expressing APP causes an increase in the secretion of the N-terminal fragment of APP and an increase in the cell-assocd. C-terminal β-secretase APP fragment.  Mutation of either of the putative catalytic aspartyl residues in Asp 2 abrogates the prodn. of the fragments characteristic of cleavage at the β-secretase site.  The enzyme is present in normal and Alzheimer's disease (AD) brain and is also found in cell lines known to produce Aβ.  Asp 2 localizes to the Golgi/endoplasmic reticulum in transfected cells and shows clear colocalization with APP in cells stably expressing the 751-amino-acid isoform of APP.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDUBbUoO6SgLVg90H21EOLACvtfcHk0lh2qo2uFdRT-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnt1Chsrs%253D&md5=aba834d907c5dae03f060d94729576e9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1006%2Fmcne.1999.0811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmcne.1999.0811%26sid%3Dliteratum%253Aachs%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DPowell%26aufirst%3DD.%26aulast%3DHowlett%26aufirst%3DD.%2BR.%26aulast%3DTew%26aufirst%3DD.%2BG.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26aulast%3DChapman%26aufirst%3DC.%26aulast%3DGloger%26aufirst%3DI.%2BS.%26aulast%3DMurphy%26aufirst%3DK.%2BE.%26aulast%3DSouthan%26aufirst%3DC.%2BD.%26aulast%3DRyan%26aufirst%3DD.%2BM.%26aulast%3DSmith%26aufirst%3DT.%2BS.%26aulast%3DSimmons%26aufirst%3DD.%2BL.%26aulast%3DWalsh%26aufirst%3DF.%2BS.%26aulast%3DDingwall%26aufirst%3DC.%26aulast%3DChristie%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520a%2520novel%2520aspartic%2520protease%2520%2528Asp%25202%2529%2520as%2520%25CE%25B2-secretase%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D1999%26volume%3D14%26spage%3D419%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Sinha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbour, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basi, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccavello, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dovey, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson-Croak, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewett, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keim, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knops, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberburg, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsuno, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seubert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suomensaari, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConlogue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, V.</span><span> </span><span class="NLM_article-title">Purification and cloning of amyloid precursor protein β-secretase from human brain</span> <span class="citation_source-journal">Nature (London)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">402</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1038%2F990114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=10591214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADyaK1MXotFKlsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=1999&pages=537-540&author=S.+Sinhaauthor=J.+P.+Andersonauthor=R.+Barbourauthor=G.+S.+Basiauthor=R.+Caccavelloauthor=D.+Davisauthor=M.+Doanauthor=H.+F.+Doveyauthor=N.+Frigonauthor=J.+Hongauthor=K.+Jacobson-Croakauthor=N.+Jewettauthor=P.+Keimauthor=J.+Knopsauthor=I.+Lieberburgauthor=M.+Powerauthor=H.+Tanauthor=G.+Tatsunoauthor=J.+Tungauthor=D.+Schenkauthor=P.+Seubertauthor=S.+M.+Suomensaariauthor=S.+Wangauthor=D.+Walkerauthor=J.+Zhaoauthor=L.+McConlogueauthor=V.+John&title=Purification+and+cloning+of+amyloid+precursor+protein+%CE%B2-secretase+from+human+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and cloning of amyloid precursor protein β-secretase from human brain</span></div><div class="casAuthors">Sinha, Sukanto; Anderson, John P.; Barbour, Robin; Basi, Guriqbal S.; Caccavello, Russell; Davis, David; Doan, Minhtam; Dovey, Harry F.; Frigon, Normand; Hong, Jin; Jacobson-Croak, Kirsten; Jewett, Nancy; Keim, Pamela; Knops, Jeroen; Lieberburg, Ivan; Power, Michael; Tan, Hua; Tatsuno, Gwen; Tung, Jay; Schenk, Dale; Seubert, Peter; Suomensaari, Susanna M.; Wang, Shuwen; Walker, Donald; Zhao, Jun; McConlogue, Lisa; John, Varghese</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">402</span>
        (<span class="NLM_cas:issue">6761</span>),
    <span class="NLM_cas:pages">537-540</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Proteolytic processing of the amyloid precursor protein (APP) generates amyloid β (AP) peptide, which is thought to be causal for the pathol. and subsequent cognitive decline in Alzheimer's disease.  Cleavage by β-secretase at the amino terminus of the Aβ peptide sequence, between residues 671 and 672 of APP, leads to the generation and extracellular release of β-cleaved sol. APP, and a corresponding cell-assocd. carboxy-terminal fragment.  Cleavage of the C-terminal fragment by γ-secretase(s) leads to the formation of Aβ.  The pathogenic mutation K670M671 → N670L671 at the β-secretase cleavage site in APP, which was discovered in a Swedish family with familial Alzheimer's disease, leads to increased β-secretase cleavage of the mutant substrate.  Here the authors describe a membrane-bound enzyme activity that cleaves full-length APP at the β-secretase cleavage site, and find it to be the predominant β-cleavage activity in human brain.  The authors have purified this enzyme activity to homogeneity from human brain using a new substrate analog inhibitor of the enzyme activity, and show that the purified enzyme has all the properties predicted for β-secretase.  Cloning and expression of the enzyme reveals that human brain β-secretase is a new membrane-bound aspartic proteinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDI4TZ3cM4orVg90H21EOLACvtfcHk0lgSKZKmoWotpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXotFKlsrc%253D&md5=819ccc5a27ec4c56128d6b6944878c42</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F990114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F990114%26sid%3Dliteratum%253Aachs%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DJ.%2BP.%26aulast%3DBarbour%26aufirst%3DR.%26aulast%3DBasi%26aufirst%3DG.%2BS.%26aulast%3DCaccavello%26aufirst%3DR.%26aulast%3DDavis%26aufirst%3DD.%26aulast%3DDoan%26aufirst%3DM.%26aulast%3DDovey%26aufirst%3DH.%2BF.%26aulast%3DFrigon%26aufirst%3DN.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DJacobson-Croak%26aufirst%3DK.%26aulast%3DJewett%26aufirst%3DN.%26aulast%3DKeim%26aufirst%3DP.%26aulast%3DKnops%26aufirst%3DJ.%26aulast%3DLieberburg%26aufirst%3DI.%26aulast%3DPower%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DTatsuno%26aufirst%3DG.%26aulast%3DTung%26aufirst%3DJ.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DSeubert%26aufirst%3DP.%26aulast%3DSuomensaari%26aufirst%3DS.%2BM.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DMcConlogue%26aufirst%3DL.%26aulast%3DJohn%26aufirst%3DV.%26atitle%3DPurification%2520and%2520cloning%2520of%2520amyloid%2520precursor%2520protein%2520%25CE%25B2-secretase%2520from%2520human%2520brain%26jtitle%3DNature%2520%2528London%2529%26date%3D1999%26volume%3D402%26spage%3D537%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendiaz, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teplow, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amarante, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeloff, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edenson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lile, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarosinski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biere, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treanor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">β-Secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE</span> <span class="citation_source-journal">Science (Washington, DC, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">735</span><span class="NLM_x">–</span> <span class="NLM_lpage">741</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1126%2Fscience.286.5440.735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=10531052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=735-741&author=R.+Vassarauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=S.+Kahnauthor=E.+A.+Mendiazauthor=P.+Denisauthor=D.+B.+Teplowauthor=S.+Rossauthor=P.+Amaranteauthor=R.+Loeloffauthor=Y.+Luoauthor=S.+Fisherauthor=J.+Fullerauthor=S.+Edensonauthor=J.+Lileauthor=M.+A.+Jarosinskiauthor=A.+L.+Biereauthor=E.+Curranauthor=T.+Burgessauthor=J.+Louisauthor=F.+Collinsauthor=J.+Treanorauthor=G.+Rogersauthor=M.+Citron&title=%CE%B2-Secretase+cleavage+of+Alzheimer%E2%80%99s+amyloid+precursor+protein+by+the+transmembrane+aspartic+protease+BACE"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE</span></div><div class="casAuthors">Vassar, Robert; Bennett, Brian D.; Babu-Khan, Safura; Kahn, Steve; Mendiaz, Elizabeth A.; Denis, Paul; Teplow, David B.; Ross, Sandra; Amarante, Patricia; Loeloff, Richard; Luo, Yi; Fisher, Seth; Fuller, Janis; Edenson, Steven; Lile, Jackson; Jarosinski, Mark A.; Biere, Anja Leona; Curran, Eileen; Burgess, Teresa; Louis, Jean-Claude; Collins, Frank; Treanor, James; Rogers, Gary; Citron, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5440</span>),
    <span class="NLM_cas:pages">735-741</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cerebral deposition of amyloid β peptide (Aβ) is an early and crit. feature of Alzheimer's disease.  Aβ generation depends on proteolytic cleavage of the amyloid precursor protein (APP) by two unknown proteases: β-secretase and γ-secretase.  These proteases are prime therapeutic targets.  A transmembrane aspartic protease with all the known characteristics of β-secretase was cloned and characterized.  Overexpression of this protease, termed BACE (for beta-site APP-cleaving enzyme) increased the amt. of β-secretase cleavage products, and these were cleaved exactly and only at known β-secretase positions.  Antisense inhibition of endogenous BACE mRNA decreased the amt. of β-secretase cleavage products, and purified BACE protein cleaved APP-derived substrates with the same sequence specificity as β-secretase.  Finally, the expression pattern and subcellular localization of BACE were consistent with that expected for β-secretase.  Future development of BACE inhibitors may prove beneficial for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSx3s1NFyByrVg90H21EOLACvtfcHk0lgSKZKmoWotpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D&md5=3f36e8e5b5e9441c7670ccaeb0d2dd4f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5440.735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5440.735%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DMendiaz%26aufirst%3DE.%2BA.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DTeplow%26aufirst%3DD.%2BB.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DAmarante%26aufirst%3DP.%26aulast%3DLoeloff%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DFisher%26aufirst%3DS.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DEdenson%26aufirst%3DS.%26aulast%3DLile%26aufirst%3DJ.%26aulast%3DJarosinski%26aufirst%3DM.%2BA.%26aulast%3DBiere%26aufirst%3DA.%2BL.%26aulast%3DCurran%26aufirst%3DE.%26aulast%3DBurgess%26aufirst%3DT.%26aulast%3DLouis%26aufirst%3DJ.%26aulast%3DCollins%26aufirst%3DF.%26aulast%3DTreanor%26aufirst%3DJ.%26aulast%3DRogers%26aufirst%3DG.%26aulast%3DCitron%26aufirst%3DM.%26atitle%3D%25CE%25B2-Secretase%2520cleavage%2520of%2520Alzheimer%25E2%2580%2599s%2520amyloid%2520precursor%2520protein%2520by%2520the%2520transmembrane%2520aspartic%2520protease%2520BACE%26jtitle%3DScience%2520%2528Washington%252C%2520DC%252C%2520U.%2520S.%2529%26date%3D1999%26volume%3D286%26spage%3D735%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Yan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bienkowski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuck, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tory, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauley, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brashler, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratman, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhl, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomasselli, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parodi, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrikson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurney, M. E.</span><span> </span><span class="NLM_article-title">Membrane-anchored aspartyl protease with Alzheimer’s disease β-secretase activity</span> <span class="citation_source-journal">Nature (London)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">402</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1038%2F990107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=10591213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADyaK1MXotFKmu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=1999&pages=533-537&author=R.+Yanauthor=M.+J.+Bienkowskiauthor=M.+E.+Shuckauthor=H.+Miaoauthor=M.+C.+Toryauthor=A.+M.+Pauleyauthor=J.+R.+Brashlerauthor=N.+C.+Stratmanauthor=W.+R.+Mathewsauthor=A.+E.+Buhlauthor=D.+B.+Carterauthor=A.+G.+Tomasselliauthor=L.+A.+Parodiauthor=R.+L.+Heinriksonauthor=M.+E.+Gurney&title=Membrane-anchored+aspartyl+protease+with+Alzheimer%E2%80%99s+disease+%CE%B2-secretase+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity</span></div><div class="casAuthors">Yan, Riqiang; Bienkowski, Michael J.; Shuck, Mary E.; Miao, Huiyi; Tory, Monica C.; Pauley, Adele M.; Brashler, John R.; Stratman, Nancy C.; Mathews, W. Rodney; Buhl, Allen E.; Carter, Donald B.; Tomasselli, Alfredo G.; Parodi, Luis A.; Heinrikson, Robert L.; Gurney, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">402</span>
        (<span class="NLM_cas:issue">6761</span>),
    <span class="NLM_cas:pages">533-537</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Mutations in the gene encoding the amyloid protein precursor (APP) cause autosomal dominant Alzheimer's disease.  Cleavage of APP by unidentified proteases, referred to as β- and γ-secretases, generates the amyloid β-peptide, the main component of the amyloid plaques found in Alzheimer's disease patients.  The disease-causing mutations flank the protease cleavage sites in APP and facilitate its cleavage.  Here the authors identify a new membrane-bound aspartyl protease (Asp2) with β-secretase activity.  The Asp2 gene is expressed widely in brain and other tissues.  Decreasing the expression of Asp2 in cells reduces amyloid β-peptide prodn. and blocks the accumulation of the carboxy-terminal APP fragment that is created by β-secretase cleavage.  Solubilized Asp2 protein cleaves a synthetic APP peptide substrate at the β-secretase site, and the rate of cleavage is increased tenfold by a mutation assocd. with early-onset Alzheimer's disease in Sweden.  Thus, Asp2 is a new protein target for drugs that are designed to block the prodn. of amyloid β-peptide peptide and the consequent formation of amyloid plaque in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd6iE74jtk5LVg90H21EOLACvtfcHk0lhBJXO1jbXSWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXotFKmu7k%253D&md5=96af7cd9b7c3315de029937497f04616</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2F990107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F990107%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26aulast%3DBienkowski%26aufirst%3DM.%2BJ.%26aulast%3DShuck%26aufirst%3DM.%2BE.%26aulast%3DMiao%26aufirst%3DH.%26aulast%3DTory%26aufirst%3DM.%2BC.%26aulast%3DPauley%26aufirst%3DA.%2BM.%26aulast%3DBrashler%26aufirst%3DJ.%2BR.%26aulast%3DStratman%26aufirst%3DN.%2BC.%26aulast%3DMathews%26aufirst%3DW.%2BR.%26aulast%3DBuhl%26aufirst%3DA.%2BE.%26aulast%3DCarter%26aufirst%3DD.%2BB.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DParodi%26aufirst%3DL.%2BA.%26aulast%3DHeinrikson%26aufirst%3DR.%2BL.%26aulast%3DGurney%26aufirst%3DM.%2BE.%26atitle%3DMembrane-anchored%2520aspartyl%2520protease%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%2520%25CE%25B2-secretase%2520activity%26jtitle%3DNature%2520%2528London%2529%26date%3D1999%26volume%3D402%26spage%3D533%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koelsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downs, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dashti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor protein</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">1456</span><span class="NLM_x">–</span> <span class="NLM_lpage">1460</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=1456-1460&author=X.+Linauthor=G.+Koelschauthor=S.+Wuauthor=D.+Downsauthor=A.+Dashtiauthor=J.+Tang&title=Human+aspartic+protease+memapsin+2+cleaves+the+%CE%B2-secretase+site+of+%CE%B2-amyloid+precursor+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DX.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DDowns%26aufirst%3DD.%26aulast%3DDashti%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DHuman%2520aspartic%2520protease%2520memapsin%25202%2520cleaves%2520the%2520%25CE%25B2-secretase%2520site%2520of%2520%25CE%25B2-amyloid%2520precursor%2520protein%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D1456%26epage%3D1460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Price, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisodia, S. S.</span><span> </span><span class="NLM_article-title">Mutant genes in familial Alzheimer’s disease and transgenic models</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">479</span><span class="NLM_x">–</span> <span class="NLM_lpage">505</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1146%2Fannurev.neuro.21.1.479" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=9530504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADyaK1cXhsFyhtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1998&pages=479-505&author=D.+L.+Priceauthor=S.+S.+Sisodia&title=Mutant+genes+in+familial+Alzheimer%E2%80%99s+disease+and+transgenic+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Mutant genes in familial Alzheimer's disease and transgenic models</span></div><div class="casAuthors">Price, Donald L.; Sisodia, Sangram S.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">479-505</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review, with 163 refs.  The most common cause of dementia occurring in mid- to late-life is Alzheimer's disease (AD).  Some cases of AD, particularly those of early onset, are familial and inherited as autosomal dominant disorders linked to the presence of mutant genes that encode the amyloid precursor protein (APP) or the presenilins (PS1 or PS2).  These mutant gene products cause dysfunction/death of vulnerable populations of nerve cells important in memory, higher cognitive processes, and behavior.  AD affects 7-10% of individuals >65 yr of age and perhaps 40% of individuals >80 yr of age.  For the late-onset cases, the principal risk factors are age and apolipoprotein (apoE) allele type, with apoE4 allele being a susceptibility factor.  In this review, we briefly discuss the clin. syndrome of AD and the neurobiol./neuropathol. of the disease and then focus attention on mutant genes linked to autosomal dominant familial AD (FAD), the biol. of the proteins encoded by these genes, and the recent exciting progress in investigations of genetically engineered animal models that express these mutant genes and develop some features of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowUt4ulmJ7ErVg90H21EOLACvtfcHk0lhBJXO1jbXSWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhsFyhtLY%253D&md5=fa1bf9dbad95faabcd6854eca46bad83</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.21.1.479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.21.1.479%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DD.%2BL.%26aulast%3DSisodia%26aufirst%3DS.%2BS.%26atitle%3DMutant%2520genes%2520in%2520familial%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520transgenic%2520models%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D1998%26volume%3D21%26spage%3D479%26epage%3D505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Hardy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, G. A.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: the amyloid cascade hypothesis</span> <span class="citation_source-journal">Science (Washington, DC, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">256</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1126%2Fscience.1566067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=1566067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADyaK38Xitlarurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1992&pages=184-185&author=J.+A.+Hardyauthor=G.+A.+Higgins&title=Alzheimer%E2%80%99s+disease%3A+the+amyloid+cascade+hypothesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease:  the amyloid cascade hypothesis</span></div><div class="casAuthors">Hardy, John A.; Higgins, Gerald A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">256</span>
        (<span class="NLM_cas:issue">5054</span>),
    <span class="NLM_cas:pages">184-5</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A review with 28 refs.  The hypotheses that deposition of amyloid β protein (AβP), the main component of the plaques, is the causative agent of Alzheimer's pathol. and that the neurofibrillary tangles, cell loss, vascular damage, and dementia follow as a direct result of this deposition are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqemkoU65i2CrVg90H21EOLACvtfcHk0lhBJXO1jbXSWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xitlarurg%253D&md5=0ad307ce9ecab261ed7b01e6d288682a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.1566067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1566067%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%2BA.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520the%2520amyloid%2520cascade%2520hypothesis%26jtitle%3DScience%2520%2528Washington%252C%2520DC%252C%2520U.%2520S.%2529%26date%3D1992%26volume%3D256%26spage%3D184%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Albert, J. S.</span><span> </span><span class="NLM_article-title">Progress in the development of β-secretase inhibitors for Alzheimer’s disease</span> <span class="citation_source-journal">Prog. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1016%2FS0079-6468%2809%2904804-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=21544959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVegs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=133-161&author=J.+S.+Albert&title=Progress+in+the+development+of+%CE%B2-secretase+inhibitors+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the development of β-secretase inhibitors for Alzheimer's disease</span></div><div class="casAuthors">Albert, Jeffrey S.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">133-161</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review on discovery and research developments toward identifying and optimizing β-secretase inhibitors for Alzheimer's disease since 2007.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgb4XX26zvcbVg90H21EOLACvtfcHk0lhBJXO1jbXSWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVegs7w%253D&md5=85997883f302b45734ba5690c1e98239</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2809%2904804-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252809%252904804-8%26sid%3Dliteratum%253Aachs%26aulast%3DAlbert%26aufirst%3DJ.%2BS.%26atitle%3DProgress%2520in%2520the%2520development%2520of%2520%25CE%25B2-secretase%2520inhibitors%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D48%26spage%3D133%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Evin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lessene, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkins, S.</span><span> </span><span class="NLM_article-title">BACE inhibitors as potential drugs for the treatment of Alzheimer’s disease: focus on bioactivity</span> <span class="citation_source-journal">Recent Pat. CNS Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=91-106&author=G.+Evinauthor=G.+Lesseneauthor=S.+Wilkins&title=BACE+inhibitors+as+potential+drugs+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+focus+on+bioactivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEvin%26aufirst%3DG.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DWilkins%26aufirst%3DS.%26atitle%3DBACE%2520inhibitors%2520as%2520potential%2520drugs%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520focus%2520on%2520bioactivity%26jtitle%3DRecent%2520Pat.%2520CNS%2520Drug%2520Discovery%26date%3D2011%26volume%3D6%26spage%3D91%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Probst, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span> </span><span class="NLM_article-title">Small-molecule BACE1 inhibitors: a patent literature review (2006–2011)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1517%2F13543776.2012.681302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=22512789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvFais7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=511-540&author=G.+Probstauthor=Y.+Xu&title=Small-molecule+BACE1+inhibitors%3A+a+patent+literature+review+%282006%E2%80%932011%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule BACE1 inhibitors: a patent literature review (2006 - 2011)</span></div><div class="casAuthors">Probst, Gary; Xu, Ying-zi</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">511-540</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Alzheimer's disease is a devastating neurodegenerative disorder for which no disease-modifying therapy exists.  The amyloid hypothesis, which implicates Aβ as the toxin initiating a biol. cascade leading to neurodegeneration, is the most prominent theory concerning the underlying cause of the disease.  BACE1 is one of two aspartyl proteinases that generate Aβ, thus inhibition of BACE1 has the potential to ameliorate the progression of Alzheimer's disease by abating the prodn. of Aβ.  Areas covered: This review chronicles small-mol. BACE1 inhibitors as described in the patent literature between 2006 and 2011 and their potential use as disease-modifying treatments for Alzheimer's disease.  Over the past half a dozen years, numerous BACE1 inhibitors have been published in the patent applications, but often these contain a paltry amt. of pertinent biol. data (e.g. potency, selectivity, and efficacy).  Fortunately, numerous relevant publications contg. important data have appeared in the journal literature during this period.  The goal in this effort was to create an amalgam of the two records to add value to this review.  Expert opinion: The pharmaceutical industry has made tremendous progress in the development of small-mol. BACE1 inhibitors that lower Aβ in the central nervous system.  Assuming the amyloid hypothesis is veracious, we anticipate a disease-modifying therapy to combat Alzheimer's disease is near.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp89KaCi3q5Z7Vg90H21EOLACvtfcHk0lji_ZuV57jPhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvFais7g%253D&md5=174bdc47fbca5aa1f8248dbf03ce402b</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1517%2F13543776.2012.681302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2012.681302%26sid%3Dliteratum%253Aachs%26aulast%3DProbst%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DY.%26atitle%3DSmall-molecule%2520BACE1%2520inhibitors%253A%2520a%2520patent%2520literature%2520review%2520%25282006%25E2%2580%25932011%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2012%26volume%3D22%26spage%3D511%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downs, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koelsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ermolieff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Design of potent inhibitors for human brain memapsin 2 (β-secretase)</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">3522</span><span class="NLM_x">–</span> <span class="NLM_lpage">3523</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja000300g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2000&pages=3522-3523&author=A.+K.+Ghoshauthor=D.+Shinauthor=D.+Downsauthor=G.+Koelschauthor=X.+Linauthor=J.+Ermolieffauthor=J.+Tang&title=Design+of+potent+inhibitors+for+human+brain+memapsin+2+%28%CE%B2-secretase%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fja000300g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja000300g%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DShin%26aufirst%3DD.%26aulast%3DDowns%26aufirst%3DD.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DErmolieff%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DDesign%2520of%2520potent%2520inhibitors%2520for%2520human%2520brain%2520memapsin%25202%2520%2528%25CE%25B2-secretase%2529%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2000%26volume%3D122%26spage%3D3522%26epage%3D3523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span> </span><span class="NLM_article-title">Design and development of BACE-1 inhibitors</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">536</span><span class="NLM_x">–</span> <span class="NLM_lpage">556</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2004&pages=536-556&author=J.+N.+Cummingauthor=U.+Iserlohauthor=M.+E.+Kennedy&title=Design+and+development+of+BACE-1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26atitle%3DDesign%2520and%2520development%2520of%2520BACE-1%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2004%26volume%3D7%26spage%3D536%26epage%3D556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span> </span><span class="NLM_article-title">Design and synthesis of 5,5′-disubstituted aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1146</span><span class="NLM_x">–</span> <span class="NLM_lpage">1158</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901414e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1146-1158&author=M.+S.+Malamasauthor=J.+Erdeiauthor=I.+Gunawanauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=R.+Chopraauthor=A.+Ollandauthor=J.+Bardauthor=S.+Jacobsenauthor=R.+L.+Magoldaauthor=M.+Pangalosauthor=A.+J.+Robichaud&title=Design+and+synthesis+of+5%2C5%E2%80%B2-disubstituted+aminohydantoins+as+potent+and+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of 5,5'-Disubstituted Aminohydantoins as Potent and Selective Human β-Secretase (BACE1) Inhibitors</span></div><div class="casAuthors">Malamas, Michael S.; Erdei, Jim; Gunawan, Iwan; Turner, Jim; Hu, Yun; Wagner, Erik; Fan, Kristi; Chopra, Rajiv; Olland, Andrea; Bard, Jonathan; Jacobsen, Steve; Magolda, Ronald L.; Pangalos, Menelas; Robichaud, Albert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1146-1158</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of small mol. aminohydantoins as potent and selective human β-secretase inhibitors is reported.  These analogs exhibit low nanomolar potency for BACE1, show comparable activity in a cell-based (ELISA) assay, and demonstrate > 100 × selectivity for the other structurally related aspartyl proteases BACE2, cathepsinD, renin, and pepsin.  On the basis of the cocrystal structure of the HTS-hit I in the BACE1 active site and by use of a structure-based drug design approach, we methodically explored the comparatively large binding pocket of the BACE1 enzyme and identified key interactions between the ligand and the protein that contributed to the affinity.  One of the more potent compds., (S)-II, displayed an IC50 value for BACE1 of 10 nM and exhibited comparable cellular activity (EC50 = 20 nM) in the ELISA assay.  Acute oral administration of (S)-II at 100 mg/kg resulted in a 69% redn. of plasma Aβ40 at 8 h in a Tg2576 mouse (p < 0.001).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovSHqfBBe70bVg90H21EOLACvtfcHk0lji_ZuV57jPhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrzN&md5=a27e4fbd64ed167ca7baae773c178fbc</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm901414e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901414e%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DJacobsen%26aufirst%3DS.%26aulast%3DMagolda%26aufirst%3DR.%2BL.%26aulast%3DPangalos%26aufirst%3DM.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%25205%252C5%25E2%2580%25B2-disubstituted%2520aminohydantoins%2520as%2520potent%2520and%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1146%26epage%3D1158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Swahn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plobeck, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotticci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehgelmeble, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S. v.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georgievska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustavsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neelissen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span> </span><span class="NLM_article-title">Aminoimidazoles as BACE-1 inhibitors: the challenge to achieve in vivo brain efficacy</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1854</span><span class="NLM_x">–</span> <span class="NLM_lpage">1859</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1854-1859&author=B.+Swahnauthor=J.+Holenzauthor=J.+Kihlstromauthor=K.+Kolmodinauthor=J.+Lindstromauthor=N.+Plobeckauthor=D.+Rotticciauthor=F.+Sehgelmebleauthor=M.+Sundstromauthor=S.+v.+Bergauthor=J.+Faltingauthor=B.+Georgievskaauthor=S.+Gustavssonauthor=J.+Neelissenauthor=M.+Ekauthor=L.+Olssonauthor=S.+Berg&title=Aminoimidazoles+as+BACE-1+inhibitors%3A+the+challenge+to+achieve+in+vivo+brain+efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwahn%26aufirst%3DB.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DKihlstrom%26aufirst%3DJ.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DLindstrom%26aufirst%3DJ.%26aulast%3DPlobeck%26aufirst%3DN.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3DSehgelmeble%26aufirst%3DF.%26aulast%3DSundstrom%26aufirst%3DM.%26aulast%3DBerg%26aufirst%3DS.%2Bv.%26aulast%3DFalting%26aufirst%3DJ.%26aulast%3DGeorgievska%26aufirst%3DB.%26aulast%3DGustavsson%26aufirst%3DS.%26aulast%3DNeelissen%26aufirst%3DJ.%26aulast%3DEk%26aufirst%3DM.%26aulast%3DOlsson%26aufirst%3DL.%26aulast%3DBerg%26aufirst%3DS.%26atitle%3DAminoimidazoles%2520as%2520BACE-1%2520inhibitors%253A%2520the%2520challenge%2520to%2520achieve%2520in%2520vivo%2520brain%2520efficacy%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1854%26epage%3D1859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martenyi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monk, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathes, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergott, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timm, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaBell, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhee, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ereshefsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocke, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span> </span><span class="NLM_article-title">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">16507</span><span class="NLM_x">–</span> <span class="NLM_lpage">16516</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1523%2FJNEUROSCI.3647-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=22090477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=16507-16516&author=P.+C.+Mayauthor=R.+A.+Deanauthor=S.+L.+Loweauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=L.+N.+Boggsauthor=S.+A.+Monkauthor=B.+M.+Mathesauthor=D.+J.+Mergottauthor=B.+M.+Watsonauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=E.+S.+LaBellauthor=C.+R.+Gonzalesauthor=M.+Nakanoauthor=S.+S.+Jheeauthor=M.+Yenauthor=L.+Ereshefskyauthor=T.+D.+Lindstromauthor=D.+O.+Calligaroauthor=P.+J.+Cockeauthor=D.+G.+Hallauthor=S.+Friedrichauthor=M.+Citronauthor=J.+E.+Audia&title=Robust+central+reduction+of+amyloid-%CE%B2+in+humans+with+an+orally+available%2C+non-peptidic+%CE%B2-secretase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span></div><div class="casAuthors">May, Patrick C.; Dean, Robert A.; Lowe, Stephen L.; Martenyi, Ferenc; Sheehan, Scott M.; Boggs, Leonard N.; Monk, Scott A.; Mathes, Brian M.; Mergott, Dustin J.; Watson, Brian M.; Stout, Stephanie L.; Timm, David E.; LaBell, Elizabeth Smith; Gonzales, Celedon R.; Nakano, Masako; Jhee, Stanford S.; Yen, Mark; Ereshefsky, Larry; Lindstrom, Terry D.; Calligaro, David O.; Cocke, Patrick J.; Hall, D. Greg; Friedrich, Stuart; Citron, Martin; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16507-16516</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">According to the amyloid cascade hypothesis, cerebral deposition of amyloid-β peptide (Aβ) is crit. for Alzheimer's disease (AD) pathogenesis.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  For more than a decade, BACE1 has been a prime target for designing drugs to prevent or treat AD.  However, development of such agents has turned out to be extremely challenging, with major hurdles in cell penetration, oral bioavailability/metabolic clearance, and brain access.  Using a fragment-based chem. strategy, we have generated LY2811376 [(S)-4-(2,4-difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazin-2-ylamine], the first orally available non-peptidic BACE1 inhibitor that produces profound Aβ-lowering effects in animals.  The biomarker changes obtained in preclin. animal models translate into man at doses of LY2811376 that were safe and well tolerated in healthy volunteers.  Prominent and long-lasting Aβ redns. in lumbar CSF were measured after oral dosing of 30 or 90 mg of LY2811376.  This represents the first translation of BACE1-driven biomarker changes in CNS from preclin. animal models to man.  Because of toxicol. findings identified in longer-term preclin. studies, this compd. is no longer progressing in clin. development.  However, BACE1 remains a viable target because the adverse effects reported here were recapitulated in LY2811376-treated BACE1 KO mice and thus are unrelated to BACE1 inhibition.  The magnitude and duration of central Aβ redn. obtainable with BACE1 inhibition positions this protease as a tractable small-mol. target through which to test the amyloid hypothesis in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqns_TvT2bZrVg90H21EOLACvtfcHk0lgOHIY81x1cHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F&md5=8f21f91ebd77e5fcf8b58b51c73a1a6b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3647-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3647-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DLaBell%26aufirst%3DE.%2BS.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DHall%26aufirst%3DD.%2BG.%26aulast%3DFriedrich%26aufirst%3DS.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DRobust%2520central%2520reduction%2520of%2520amyloid-%25CE%25B2%2520in%2520humans%2520with%2520an%2520orally%2520available%252C%2520non-peptidic%2520%25CE%25B2-secretase%2520inhibitor%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D16507%26epage%3D16516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rombouts, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spurlino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Gool, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span> </span><span class="NLM_article-title">Rational design and synthesis of aminopiperazinones as beta-secretase (BACE) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">7255</span><span class="NLM_x">–</span> <span class="NLM_lpage">7260</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1016%2Fj.bmcl.2011.10.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=22071305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFSqt7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=7255-7260&author=G.+Tresadernauthor=F.+Delgadoauthor=O.+Delgadoauthor=H.+Gijsenauthor=G.+J.+Macdonaldauthor=D.+Moecharsauthor=F.+Romboutsauthor=R.+Alexanderauthor=J.+Spurlinoauthor=M.+Van+Goolauthor=J.+A.+Vegaauthor=A.+A.+Trabanco&title=Rational+design+and+synthesis+of+aminopiperazinones+as+beta-secretase+%28BACE%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design and synthesis of aminopiperazinones as β-secretase (BACE) inhibitors</span></div><div class="casAuthors">Tresadern, Gary; Delgado, Francisca; Delgado, Oscar; Gijsen, Harrie; Macdonald, Gregor J.; Moechars, Dieder; Rombouts, Frederik; Alexander, Richard; Spurlino, John; Van Gool, Michiel; Vega, Juan Antonio; Trabanco, Andres A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7255-7260</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aminopiperazinone inhibitors of BACE were identified by rational design.  Structure based design guided idea prioritization and initial racemic hit I showed good activity.  Modification in decoration and chiral sepn. resulted in the 40 nM inhibitor, (-)-II, which showed in vivo redn. of amyloid beta peptides.  The crystal structure of (R)-I with BACE showed a binding mode driven by interaction with the catalytic aspartate dyad and distribution of the biaryl amide decoration towards S1 and S3 pockets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHSIy3VkZzlLVg90H21EOLACvtfcHk0lh5MSBsxYkDUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFSqt7fF&md5=f8f1f7b83fae2fba7f2d0e553a8cb49d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.10.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.10.050%26sid%3Dliteratum%253Aachs%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DDelgado%26aufirst%3DF.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DRombouts%26aufirst%3DF.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DSpurlino%26aufirst%3DJ.%26aulast%3DVan%2BGool%26aufirst%3DM.%26aulast%3DVega%26aufirst%3DJ.%2BA.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3DRational%2520design%2520and%2520synthesis%2520of%2520aminopiperazinones%2520as%2520beta-secretase%2520%2528BACE%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D7255%26epage%3D7260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Swahn, B.; Kolmodin, K.; Karlström, S.; von Berg, S.; Söderman, P.; Holenz, J.; Berg, S.; Lindström, J.; Sundström, M.; Turek, D.; Kihlström, J.; Slivo, C.; Andersson, L.; Pyring, D.; Rotticci, D.; Öhberg, L.; Kers, A.; Bogar, K.; Bergh, M.; Olsson, L.; Janson, J.; Eketjäll, S.; Georgievska, B.; Jeppsson, F.; Fälting, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of β-secretase (bace1) inhibitors with in vivo brain reduction of β-amyloid peptides</span>.  <span class="citation_source-journal">J. Med. Chem.</span> [Online early access]. DOI: <span class="refDoi"> DOI: 10.1021/jm3009025</span> . Published Online: Aug 27,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/jm3009025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=B.+Swahn&author=K.+Kolmodin&author=S.+Karlstr%C3%B6m&author=S.+von+Berg&author=P.+S%C3%B6derman&author=J.+Holenz&author=S.+Berg&author=J.+Lindstr%C3%B6m&author=M.+Sundstr%C3%B6m&author=D.+Turek&author=J.+Kihlstr%C3%B6m&author=C.+Slivo&author=L.+Andersson&author=D.+Pyring&author=D.+Rotticci&author=L.+%C3%96hberg&author=A.+Kers&author=K.+Bogar&author=M.+Bergh&author=L.+Olsson&author=J.+Janson&author=S.+Eketj%C3%A4ll&author=B.+Georgievska&author=F.+Jeppsson&author=J.+F%C3%A4lting&title=Design+and+synthesis+of+%CE%B2-secretase+%28bace1%29+inhibitors+with+in+vivo+brain+reduction+of+%CE%B2-amyloid+peptides&doi=10.1021%2Fjm3009025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm3009025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3009025%26sid%3Dliteratum%253Aachs%26aulast%3DSwahn%26aufirst%3DB.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520%25CE%25B2-secretase%2520%2528bace1%2529%2520inhibitors%2520with%2520in%2520vivo%2520brain%2520reduction%2520of%2520%25CE%25B2-amyloid%2520peptides%26jtitle%3DJ.%2520Med.%2520Chem.%26doi%3D10.1021%2Fjm3009025%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiaszek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Structure based design of iminohydantoin BACE1 inhibitors: identification of an orally available, centrally active BACE1 inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2444</span><span class="NLM_x">–</span> <span class="NLM_lpage">2449</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1016%2Fj.bmcl.2012.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=22390835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1ektbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2444-2449&author=J.+N.+Cummingauthor=E.+M.+Smithauthor=L.+Wangauthor=J.+Misiaszekauthor=J.+Durkinauthor=J.+Panauthor=U.+Iserlohauthor=Y.+Wuauthor=Z.+Zhuauthor=C.+Stricklandauthor=J.+Voigtauthor=X.+Chenauthor=M.+E.+Kennedyauthor=R.+Kuvelkarauthor=L.+A.+Hydeauthor=K.+Coxauthor=L.+Favreauauthor=M.+F.+Czarnieckiauthor=W.+J.+Greenleeauthor=B.+A.+McKittrickauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Structure+based+design+of+iminohydantoin+BACE1+inhibitors%3A+identification+of+an+orally+available%2C+centrally+active+BACE1+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Structure based design of iminohydantoin BACE1 inhibitors: Identification of an orally available, centrally active BACE1 inhibitor</span></div><div class="casAuthors">Cumming, Jared N.; Smith, Elizabeth M.; Wang, Lingyan; Misiaszek, Jeffrey; Durkin, James; Pan, Jianping; Iserloh, Ulrich; Wu, Yusheng; Zhu, Zhaoning; Strickland, Corey; Voigt, Johannes; Chen, Xia; Kennedy, Matthew E.; Kuvelkar, Reshma; Hyde, Lynn A.; Cox, Kathleen; Favreau, Leonard; Czarniecki, Michael F.; Greenlee, William J.; McKittrick, Brian A.; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2444-2449</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">From an initial lead 2-imino-1-methyl-4,4-diphenyl-5-imidazolidinone, a structure-based design approach led to identification of the novel, high-affinity iminohydantoin BACE1 inhibitor I that lowers CNS-derived Aβ following oral administration to rats.  SAR development in the S3 and F' subsites of BACE1 for this series, the synthetic approaches employed in this effort, and in vivo data for I are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3tWBE09QKNLVg90H21EOLACvtfcHk0lh5MSBsxYkDUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1ektbY%253D&md5=783b6cb9a6d9608ff5e9dc4f5d634397</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DSmith%26aufirst%3DE.%2BM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DDurkin%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCzarniecki%26aufirst%3DM.%2BF.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DStructure%2520based%2520design%2520of%2520iminohydantoin%2520BACE1%2520inhibitors%253A%2520identification%2520of%2520an%2520orally%2520available%252C%2520centrally%2520active%2520BACE1%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2444%26epage%3D2449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croghan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dineen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esmay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harried, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbeah-Ampiah, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaller, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreiman, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monenschein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rattan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">San, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sickmier, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, W.</span><span> </span><span class="NLM_article-title">Design and preparation of a potent series of hydroxyethylamine containing beta-secretase inhibitors that demonstrate robust reduction of central ss-amyloid</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6243</span><span class="NLM_x">–</span> <span class="NLM_lpage">6644</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6243-6644&author=M.+M.+Weissauthor=T.+Williamsonauthor=S.+Babu-Khanauthor=M.+D.+Bartbergerauthor=J.+Brownauthor=K.+Chenauthor=Y.+Chengauthor=M.+Citronauthor=M.+D.+Croghanauthor=T.+A.+Dineenauthor=J.+Esmayauthor=R.+F.+Graceffaauthor=S.+Harriedauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=D.+B.+Horneauthor=H.+Huangauthor=R.+Imbeah-Ampiahauthor=T.+Juddauthor=M.+R.+Kallerauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=V.+Liauthor=P.+Lopezauthor=S.+Louieauthor=H.+Monenscheinauthor=T.+T.+Nguyenauthor=L.+D.+Penningtonauthor=C.+Rattanauthor=M.+T.+Sanauthor=E.+A.+Sickmierauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Woodauthor=Q.+Xueauthor=B.+H.+Yangauthor=V.+F.+Patelauthor=W.+Zhong&title=Design+and+preparation+of+a+potent+series+of+hydroxyethylamine+containing+beta-secretase+inhibitors+that+demonstrate+robust+reduction+of+central+ss-amyloid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWilliamson%26aufirst%3DT.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DCroghan%26aufirst%3DM.%2BD.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DEsmay%26aufirst%3DJ.%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DHarried%26aufirst%3DS.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DHorne%26aufirst%3DD.%2BB.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DImbeah-Ampiah%26aufirst%3DR.%26aulast%3DJudd%26aufirst%3DT.%26aulast%3DKaller%26aufirst%3DM.%2BR.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DLouie%26aufirst%3DS.%26aulast%3DMonenschein%26aufirst%3DH.%26aulast%3DNguyen%26aufirst%3DT.%2BT.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DRattan%26aufirst%3DC.%26aulast%3DSan%26aufirst%3DM.%2BT.%26aulast%3DSickmier%26aufirst%3DE.%2BA.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DXue%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DB.%2BH.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DZhong%26aufirst%3DW.%26atitle%3DDesign%2520and%2520preparation%2520of%2520a%2520potent%2520series%2520of%2520hydroxyethylamine%2520containing%2520beta-secretase%2520inhibitors%2520that%2520demonstrate%2520robust%2520reduction%2520of%2520central%2520ss-amyloid%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6243%26epage%3D6644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Rueeger, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lueoend, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogel, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rondeau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobitz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machauer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staufenbiel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desrayaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumann, U.</span><span> </span><span class="NLM_article-title">Discovery of cyclic sulfone hydroxyethylamines as potent and selective β-site APP-cleaving enzyme 1 (BACE1) inhibitors: structure-based design and in vivo reduction of amyloid β-peptides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">3364</span><span class="NLM_x">–</span> <span class="NLM_lpage">3386</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300069y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3364-3386&author=H.+Rueegerauthor=R.+Lueoendauthor=O.+Rogelauthor=J.+Rondeauauthor=H.+Mobitzauthor=R.+Machauerauthor=L.+Jacobsonauthor=M.+Staufenbielauthor=S.+Desrayaudauthor=U.+Neumann&title=Discovery+of+cyclic+sulfone+hydroxyethylamines+as+potent+and+selective+%CE%B2-site+APP-cleaving+enzyme+1+%28BACE1%29+inhibitors%3A+structure-based+design+and+in+vivo+reduction+of+amyloid+%CE%B2-peptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm300069y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300069y%26sid%3Dliteratum%253Aachs%26aulast%3DRueeger%26aufirst%3DH.%26aulast%3DLueoend%26aufirst%3DR.%26aulast%3DRogel%26aufirst%3DO.%26aulast%3DRondeau%26aufirst%3DJ.%26aulast%3DMobitz%26aufirst%3DH.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DJacobson%26aufirst%3DL.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DDesrayaud%26aufirst%3DS.%26aulast%3DNeumann%26aufirst%3DU.%26atitle%3DDiscovery%2520of%2520cyclic%2520sulfone%2520hydroxyethylamines%2520as%2520potent%2520and%2520selective%2520%25CE%25B2-site%2520APP-cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520structure-based%2520design%2520and%2520in%2520vivo%2520reduction%2520of%2520amyloid%2520%25CE%25B2-peptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3364%26epage%3D3386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Chang, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downs, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirrito, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koelsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holtzman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Beta-secretase inhibitor GRL-8234 rescues age-related cognitive decline in APP transgenic mice</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">–</span> <span class="NLM_lpage">784</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=775-784&author=W.+P.+Changauthor=X.+Huangauthor=D.+Downsauthor=J.+R.+Cirritoauthor=G.+Koelschauthor=D.+M.+Holtzmanauthor=A.+K.+Ghoshauthor=J.+Tang&title=Beta-secretase+inhibitor+GRL-8234+rescues+age-related+cognitive+decline+in+APP+transgenic+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DW.%2BP.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DDowns%26aufirst%3DD.%26aulast%3DCirrito%26aufirst%3DJ.%2BR.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DHoltzman%26aufirst%3DD.%2BM.%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DBeta-secretase%2520inhibitor%2520GRL-8234%2520rescues%2520age-related%2520cognitive%2520decline%2520in%2520APP%2520transgenic%2520mice%26jtitle%3DFASEB%2520J.%26date%3D2011%26volume%3D25%26spage%3D775%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Edwards, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sylvester, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aharony, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andisik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederickson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folmer, R. H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geschwindner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koether, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krumrine, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauger, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spear, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, G.</span><span> </span><span class="NLM_article-title">Application of fragment-based lead generation to the discovery of novel, cyclic amidine β-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5912</span><span class="NLM_x">–</span> <span class="NLM_lpage">5925</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070829p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1KitrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5912-5925&author=P.+D.+Edwardsauthor=J.+S.+Albertauthor=M.+Sylvesterauthor=D.+Aharonyauthor=D.+Andisikauthor=O.+Callaghanauthor=J.+B.+Campbellauthor=R.+A.+Carrauthor=G.+Chessariauthor=M.+Congreveauthor=M.+Fredericksonauthor=R.+H.+A.+Folmerauthor=S.+Geschwindnerauthor=G.+Koetherauthor=K.+Kolmodinauthor=J.+Krumrineauthor=R.+C.+Maugerauthor=C.+W.+Murrayauthor=L.+Olssonauthor=S.+Patelauthor=N.+Spearauthor=G.+Tian&title=Application+of+fragment-based+lead+generation+to+the+discovery+of+novel%2C+cyclic+amidine+%CE%B2-secretase+inhibitors+with+nanomolar+potency%2C+cellular+activity%2C+and+high+ligand+efficiency"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Application of fragment-based lead generation to the discovery of novel, cyclic amidine β-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency</span></div><div class="casAuthors">Edwards, Philip D.; Albert, Jeffrey S.; Sylvester, Mark; Aharony, David; Andisik, Donald; Callaghan, Owen; Campbell, James B.; Carr, Robin A.; Chessari, Gianni; Congreve, Miles; Frederickson, Martyn; Folmer, Rutger H. A.; Geschwindner, Stefan; Koether, Gerard; Kolmodin, Karin; Krumrine, Jennifer; Mauger, Russell C.; Murray, Christopher W.; Olsson, Lise-Lotte; Patel, Sahil; Spear, Nate; Tian, Gaochao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5912-5925</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based lead generation has led to the discovery of a novel series of cyclic amidine-based inhibitors of β-secretase (BACE-1).  Initial fragment hits with an isocytosine core having millimolar potency were identified via NMR affinity screening.  Structure-guided evolution of these fragments using x-ray crystallog. together with potency detn. using surface plasmon resonance and functional enzyme inhibition assays afforded micromolar inhibitors.  Similarity searching around the isocytosine core led to the identification of a related series of inhibitors, the dihydroisocytosines.  By leveraging the knowledge of the ligand-BACE-1 recognition features generated from the isocytosines, the dihydroisocytosines were efficiently optimized to submicromolar potency.  Compd. (I), with an IC50 of 80 nM, a ligand efficiency of 0.37, and cellular activity of 470 nM, emerged as the lead structure for future optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmm71A2gRltrVg90H21EOLACvtfcHk0lhthIn-ipjKOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1KitrbP&md5=140f3ade2b7754f62eb73589c5de4d7b</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm070829p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070829p%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3DAlbert%26aufirst%3DJ.%2BS.%26aulast%3DSylvester%26aufirst%3DM.%26aulast%3DAharony%26aufirst%3DD.%26aulast%3DAndisik%26aufirst%3DD.%26aulast%3DCallaghan%26aufirst%3DO.%26aulast%3DCampbell%26aufirst%3DJ.%2BB.%26aulast%3DCarr%26aufirst%3DR.%2BA.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DFolmer%26aufirst%3DR.%2BH.%2BA.%26aulast%3DGeschwindner%26aufirst%3DS.%26aulast%3DKoether%26aufirst%3DG.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DKrumrine%26aufirst%3DJ.%26aulast%3DMauger%26aufirst%3DR.%2BC.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DOlsson%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DSpear%26aufirst%3DN.%26aulast%3DTian%26aufirst%3DG.%26atitle%3DApplication%2520of%2520fragment-based%2520lead%2520generation%2520to%2520the%2520discovery%2520of%2520novel%252C%2520cyclic%2520amidine%2520%25CE%25B2-secretase%2520inhibitors%2520with%2520nanomolar%2520potency%252C%2520cellular%2520activity%252C%2520and%2520high%2520ligand%2520efficiency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5912%26epage%3D5925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">White, R.; Amegadzie, A.; Bryan, M. C.; Chen, J. J.; Cheng, A. C.; Dineen, T.; Epstein, O.; Gore, V. K.; Hua, Z.; Human, J. B.; Huang, H.; Kreiman, C.; La, D.; Liu, Q.; Ma, V. V.; Marx, I.; Patel, V. F.; Qian, W.; Weiss, M.; Yuan, C. C.</span>WO2010030954A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=White%2C+R.%3B+Amegadzie%2C+A.%3B+Bryan%2C+M.+C.%3B+Chen%2C+J.+J.%3B+Cheng%2C+A.+C.%3B+Dineen%2C+T.%3B+Epstein%2C+O.%3B+Gore%2C+V.+K.%3B+Hua%2C+Z.%3B+Human%2C+J.+B.%3B+Huang%2C+H.%3B+Kreiman%2C+C.%3B+La%2C+D.%3B+Liu%2C+Q.%3B+Ma%2C+V.+V.%3B+Marx%2C+I.%3B+Patel%2C+V.+F.%3B+Qian%2C+W.%3B+Weiss%2C+M.%3B+Yuan%2C+C.+C.WO2010030954A1%2C+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DR.%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Takahashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terauchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, M.</span><span> </span><span class="NLM_article-title">Ameliorative effects of a non-competitive BACE1 inhibitor TAK-070 on Aβ peptide levels and impaired learning behavior in aged rats</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1361</span><span class="NLM_x">, </span> <span class="NLM_fpage">146</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1016%2Fj.brainres.2010.09.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=20849831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtleqtLzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1361&publication_year=2010&pages=146-156&author=H.+Takahashiauthor=H.+Fukumotoauthor=R.+Maedaauthor=J.+Terauchiauthor=K.+Katoauthor=M.+Miyamoto&title=Ameliorative+effects+of+a+non-competitive+BACE1+inhibitor+TAK-070+on+A%CE%B2+peptide+levels+and+impaired+learning+behavior+in+aged+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Ameliorative effects of a non-competitive BACE1 inhibitor TAK-070 on Aβ peptide levels and impaired learning behavior in aged rats</span></div><div class="casAuthors">Takahashi, Hideki; Fukumoto, Hiroaki; Maeda, Ryouta; Terauchi, Jun; Kato, Kaneyoshi; Miyamoto, Masaomi</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1361</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">146-156</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We examd. the effects of TAK-070, a novel non-competitive β-secretase (BACE1) inhibitor, on the levels of Aβ peptides and behavioral deficits in rats.  TAK-070 reduced sol. Aβ40 and Aβ42 levels of the cerebral cortex in a time- and dose-dependent manner in young rats.  We found that the insol. Aβ42 content increased significantly with aging from 22 mo old without changing Aβ40 content.  TAK-070 normalized the Aβ42 levels to those in young rats when they were fed chow contg. TAK-070 starting at 19 mo old for 6.5 mo.  Repeated administration of TAK-070 to aged rats for 2 wk ameliorated the impaired spatial learning in the Morris water maze task and reduced the levels of sol. and insol. Aβ peptides at doses of 0.3-1 mg/kg, (p.o.).  Interestingly, TAK-070 significantly recovered the reduced brain synaptophysin levels in aged rats to those in young rats.  Our findings support the idea that partial inhibition of BACE1 by TAK-070 exerts symptomatic as well as disease-modifying effects for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiylMf9raud7Vg90H21EOLACvtfcHk0lhthIn-ipjKOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtleqtLzJ&md5=42b672a7a3b1c3bffbe1954003893550</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2010.09.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2010.09.032%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DH.%26aulast%3DFukumoto%26aufirst%3DH.%26aulast%3DMaeda%26aufirst%3DR.%26aulast%3DTerauchi%26aufirst%3DJ.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DMiyamoto%26aufirst%3DM.%26atitle%3DAmeliorative%2520effects%2520of%2520a%2520non-competitive%2520BACE1%2520inhibitor%2520TAK-070%2520on%2520A%25CE%25B2%2520peptide%2520levels%2520and%2520impaired%2520learning%2520behavior%2520in%2520aged%2520rats%26jtitle%3DBrain%2520Res.%26date%3D2010%26volume%3D1361%26spage%3D146%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Fukumoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarui, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirode, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagayama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terauchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakihana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, M.</span><span> </span><span class="NLM_article-title">A noncompetitive BACE1 inhibitor TAK-070 ameliorates Aβ pathology and behavioral deficits in a mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">11157</span><span class="NLM_x">–</span> <span class="NLM_lpage">11166</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1523%2FJNEUROSCI.2884-10.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=20720123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFWms73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=11157-11166&author=H.+Fukumotoauthor=H.+Takahashiauthor=N.+Taruiauthor=J.+Matsuiauthor=T.+Tomitaauthor=M.+Hirodeauthor=M.+Sagayamaauthor=R.+Maedaauthor=M.+Kawamotoauthor=K.+Hiraiauthor=J.+Terauchiauthor=Y.+Sakuraauthor=M.+Kakihanaauthor=K.+Katoauthor=T.+Iwatsuboauthor=M.+Miyamoto&title=A+noncompetitive+BACE1+inhibitor+TAK-070+ameliorates+A%CE%B2+pathology+and+behavioral+deficits+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A noncompetitive BACE1 inhibitor TAK-070 ameliorates Aβ pathology and behavioral deficits in a mouse model of Alzheimer's disease</span></div><div class="casAuthors">Fukumoto, Hiroaki; Takahashi, Hideki; Tarui, Naoki; Matsui, Junji; Tomita, Taisuke; Hirode, Mitsuhiro; Sagayama, Masumi; Maeda, Ryouta; Kawamoto, Makiko; Hirai, Kazuko; Terauchi, Jun; Sakura, Yasufumi; Kakihana, Mitsuru; Kato, Kaneyoshi; Iwatsubo, Takeshi; Miyamoto, Masaomi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">11157-11166</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">We discovered a nonpeptidic compd., TAK-070, that inhibited BACE1, a rate-limiting protease for the generation of Aβ peptides that are considered causative for Alzheimer's disease (AD), in a noncompetitive manner.  TAK-070 bound to full-length BACE1, but not to truncated BACE1 lacking the transmembrane domain.  Short-term oral administration of TAK-070 decreased the brain levels of sol. Aβ, increased that of neurotrophic sAPPα by ∼20%, and normalized the behavioral impairments in cognitive tests in Tg2576 mice, an APP transgenic mouse model of AD.  Six-month chronic treatment decreased cerebral Aβ deposition by ∼60%, preserving the pharmacol. efficacy on sol. Aβ and sAPPα levels.  These results support the feasibility of BACE1 inhibition with a noncompetitive inhibitor as disease-modifying as well as symptomatic therapy for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3rSO_LMTWu7Vg90H21EOLACvtfcHk0lhthIn-ipjKOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFWms73E&md5=195c706b0243c84824d3c84ec0123bba</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2884-10.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2884-10.2010%26sid%3Dliteratum%253Aachs%26aulast%3DFukumoto%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DH.%26aulast%3DTarui%26aufirst%3DN.%26aulast%3DMatsui%26aufirst%3DJ.%26aulast%3DTomita%26aufirst%3DT.%26aulast%3DHirode%26aufirst%3DM.%26aulast%3DSagayama%26aufirst%3DM.%26aulast%3DMaeda%26aufirst%3DR.%26aulast%3DKawamoto%26aufirst%3DM.%26aulast%3DHirai%26aufirst%3DK.%26aulast%3DTerauchi%26aufirst%3DJ.%26aulast%3DSakura%26aufirst%3DY.%26aulast%3DKakihana%26aufirst%3DM.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DMiyamoto%26aufirst%3DM.%26atitle%3DA%2520noncompetitive%2520BACE1%2520inhibitor%2520TAK-070%2520ameliorates%2520A%25CE%25B2%2520pathology%2520and%2520behavioral%2520deficits%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26spage%3D11157%26epage%3D11166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quagliato, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solvibile, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhart, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M.</span><span> </span><span class="NLM_article-title">Design and synthesis of aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors with enhanced brain permeability</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6597</span><span class="NLM_x">–</span> <span class="NLM_lpage">6605</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1016%2Fj.bmcl.2010.09.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=20880704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSmsL7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6597-6605&author=M.+S.+Malamasauthor=A.+Robichaudauthor=J.+Erdeiauthor=D.+Quagliatoauthor=W.+Solvibileauthor=P.+Zhouauthor=K.+Morrisauthor=J.+Turnerauthor=E.+Wagnerauthor=K.+Fanauthor=A.+Ollandauthor=S.+Jacobsenauthor=P.+Reinhartauthor=D.+Riddellauthor=M.+Pangalos&title=Design+and+synthesis+of+aminohydantoins+as+potent+and+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors+with+enhanced+brain+permeability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors with enhanced brain permeability</span></div><div class="casAuthors">Malamas, Michael S.; Robichaud, Albert; Erdei, Jim; Quagliato, Dominick; Solvibile, William; Zhou, Ping; Morris, Koi; Turner, Jim; Wagner, Erik; Fan, Kristi; Olland, Andrea; Jacobsen, Steve; Reinhart, Peter; Riddell, David; Pangalos, Menelas</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6597-6605</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The identification of small mol. aminohydantoins as potent and selective human β-secretase inhibitors is reported.  These analogs exhibit good brain permeability (40-70%), low nanomolar potency for BACE1, and demonstrate >100-fold selectivity for the structurally related aspartyl proteases cathepsin D, renin and pepsin.  Alkyl and alkoxy groups at the meta-position of the P1 Ph, which extend toward the S3 region of the enzyme, have contributed to the ligand's reduced affinity for the efflux transporter protein P-gp, and decreased topol. polar surface area, thus resulting in enhanced brain permeability.  A fluorine substitution at the para-position of the P1 Ph has contributed to 100-fold decrease of CYP3A4 inhibition and enhancement of compd. metabolic stability.  The plasma and brain protein binding properties of these new analogs are affected by substitutions at the P1 Ph moiety.  Higher compd. protein binding was obsd. in the brain than in the plasma.  Two structurally diverse potent BACE1 inhibitors (84 and 89) reduced 30% plasma Aβ40 in the Tg2576 mice in vivo model at 30 mg/kg po.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSYkNat5QUjrVg90H21EOLACvtfcHk0lg8fYzePFJnkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSmsL7I&md5=848a1bfa79278b0c7a72749f9be45ad8</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.09.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.09.029%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DRobichaud%26aufirst%3DA.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DQuagliato%26aufirst%3DD.%26aulast%3DSolvibile%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DMorris%26aufirst%3DK.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DJacobsen%26aufirst%3DS.%26aulast%3DReinhart%26aufirst%3DP.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DPangalos%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520aminohydantoins%2520as%2520potent%2520and%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%2520with%2520enhanced%2520brain%2520permeability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6597%26epage%3D6605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Roden, D. M.</span><span> </span><span class="NLM_article-title">Drug-induced prolongation of the QT interval</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1022</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1056%2FNEJMra032426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=14999113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFGjs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2004&pages=1013-1022&author=D.+M.+Roden&title=Drug-induced+prolongation+of+the+QT+interval"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-induced prolongation of the QT interval</span></div><div class="casAuthors">Roden, Dan M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1013-1022</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA8PoMXlMg57Vg90H21EOLACvtfcHk0lg8fYzePFJnkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFGjs7Y%253D&md5=a020a545700649d9914ed8dc61910244</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1056%2FNEJMra032426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra032426%26sid%3Dliteratum%253Aachs%26aulast%3DRoden%26aufirst%3DD.%2BM.%26atitle%3DDrug-induced%2520prolongation%2520of%2520the%2520QT%2520interval%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D350%26spage%3D1013%26epage%3D1022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Ekins, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crumb, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarazan, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikel, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrighton, S. A.</span><span> </span><span class="NLM_article-title">Three-dimensional quantitative structure–activity relationship for inhibition of human ether-a-go-go-related gene potassium channel</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">301</span><span class="NLM_x">, </span> <span class="NLM_fpage">427</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1124%2Fjpet.301.2.427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=11961040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtlKjur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2002&pages=427-434&author=S.+Ekinsauthor=W.+J.+Crumbauthor=R.+D.+Sarazanauthor=J.+H.+Wikelauthor=S.+A.+Wrighton&title=Three-dimensional+quantitative+structure%E2%80%93activity+relationship+for+inhibition+of+human+ether-a-go-go-related+gene+potassium+channel"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Three-dimensional quantitative structure-activity relationship for inhibition of human ether-a-go-go-related gene potassium channel</span></div><div class="casAuthors">Ekins, Sean; Crumb, William J.; Sarazan, R. Dustan; Wikel, James H.; Wrighton, Steven A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">301</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">427-434</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The protein product of the human ether-a-go-go gene (hERG) is a potassium channel that when inhibited by some drugs may lead to cardiac arrhythmia.  Previously, a three-dimensional quant. structure-activity relationship (3D-QSAR) pharmacophore model was constructed using Catalyst with in vitro inhibition data for antipsychotic agents.  The rationale of the current study was to use a combination of in vitro and in silico technologies to further test the pharmacophore model and qual. predict whether mols. are likely to inhibit this potassium channel.  These predictions were assessed with the exptl. data using the Spearman's rho rank correlation.  The antipsychotic-based hERG inhibitor model produced a statistically significant Spearman's rho of 0.71 for 11 mols.  In addn., 15 mols. from the literature were used as a further test set and were also well ranked by the same model with a statistically significant Spearman's rho value of 0.76.  A Catalyst General hERG pharmacophore model was generated with these literature mols., which contained four hydrophobic features and one pos. ionizable feature.  Linear regression of log-transformed obsd. vs. predicted IC50 values for this training set resulted in an r2 value of 0.90.  The model based on literature data was evaluated with the in vitro data generated for the original 22 mols. (including the antipsychotics) and illustrated a significant Spearman's rho of 0.77.  Thus, the Catalyst 3D-QSAR approach provides useful qual. predictions for test set mols.  The model based on literature data therefore provides a potentially valuable tool for discovery chem. as future mols. may be synthesized that are less likely to inhibit hERG based on information provided by a pharmacophore for the inhibition of this potassium channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5gBvozbTJ2bVg90H21EOLACvtfcHk0lg8fYzePFJnkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtlKjur0%253D&md5=387bde56bd5e4c2a658de61d205395fd</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1124%2Fjpet.301.2.427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.301.2.427%26sid%3Dliteratum%253Aachs%26aulast%3DEkins%26aufirst%3DS.%26aulast%3DCrumb%26aufirst%3DW.%2BJ.%26aulast%3DSarazan%26aufirst%3DR.%2BD.%26aulast%3DWikel%26aufirst%3DJ.%2BH.%26aulast%3DWrighton%26aufirst%3DS.%2BA.%26atitle%3DThree-dimensional%2520quantitative%2520structure%25E2%2580%2593activity%2520relationship%2520for%2520inhibition%2520of%2520human%2520ether-a-go-go-related%2520gene%2520potassium%2520channel%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D301%26spage%3D427%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Diller, J. D.</span><span> </span><span class="NLM_article-title">In silico hERG modelling: challenges and progress</span> <span class="citation_source-journal">Curr. Comput.-Aided Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">106</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.2174%2F157340909788451928" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvVWrtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=106-121&author=J.+D.+Diller&title=In+silico+hERG+modelling%3A+challenges+and+progress"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">In silico hERG modeling: challenges and progress</span></div><div class="casAuthors">Diller, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Computer-Aided Drug Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">106-121</span>CODEN:
                <span class="NLM_cas:coden">CCDDAS</span>;
        ISSN:<span class="NLM_cas:issn">1573-4099</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The first generation of in silico hERG models have focused on key driving forces for hERG/ligand binding: basicity and lipophilicity.  While reducing basicity and lipophilicity are typically the first line approaches to eliminating hERG blocking activity, in many programs these are not feasible approaches because basicity and lipophilicity are frequently necessary for achieving good pharmacokinetics or primary target binding.  Thus for the second, generation of in silico hERG models, a focus on understanding the more subtle aspects of hERG binding is necessary.  Thus, the focus of this review is on extg. ideas, either qual. or quant., from the various modeling efforts as to how hERG activity might be eliminated or diminished beyond simply reducing basicity and lipophilicity.  In addn., several areas where key questions around hERG binding have not been adequately addressed by in silico work are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7wUQpyBUN-rVg90H21EOLACvtfcHk0lgAvKjNxl9R6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvVWrtbY%253D&md5=cc2f2623d70bc07fa408e83185e428fe</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.2174%2F157340909788451928&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157340909788451928%26sid%3Dliteratum%253Aachs%26aulast%3DDiller%26aufirst%3DJ.%2BD.%26atitle%3DIn%2520silico%2520hERG%2520modelling%253A%2520challenges%2520and%2520progress%26jtitle%3DCurr.%2520Comput.-Aided%2520Drug%2520Des.%26date%3D2009%26volume%3D5%26spage%3D106%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Asinger, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumgarte, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueting, P. F.</span><span> </span><span class="NLM_article-title">Concomitant action of elementary sulfur and gaseous ammonia on ketones. XXXVI. Action of sulfur and ammonia on acetophenone. II. Synthesis of 3-imidazoline-5-thiones</span> <span class="citation_source-journal">Ann.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1963</span><span class="NLM_x">, </span> <span class="NLM_volume">661</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADyaF3sXktVyqtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=661&publication_year=1963&pages=95-110&author=F.+Asingerauthor=W.+Schaeferauthor=G.+Baumgarteauthor=P.+F.+Mueting&title=Concomitant+action+of+elementary+sulfur+and+gaseous+ammonia+on+ketones.+XXXVI.+Action+of+sulfur+and+ammonia+on+acetophenone.+II.+Synthesis+of+3-imidazoline-5-thiones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Concomitant action of elementary sulfur and gaseous ammonia on ketones. XXXVI. Action of sulfur and ammonia on acetophenone. II. Synthesis of 3-imidazoline-5-thiones</span></div><div class="casAuthors">Asinger, Friedrich; Schaefer, Wofgang; Baumgarte, Guenter; Mueting, Peter F.</div><div class="citationInfo"><span class="NLM_cas:title">Annalen der Chemie, Justus Liebigs</span>
        (<span class="NLM_cas:date">1963</span>),
    <span class="NLM_cas:volume">661</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">95-110</span>CODEN:
                <span class="NLM_cas:coden">9X224Y</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">cf. CA 58, 9058c.  3-Imidazoline-5-thiones were prepd. in good yields from aryl methyl ketones and excess NH3 and S at room temp.  The reaction mechanism was discussed.  Also reported was a concurrent rearrangement of unstable primary α-oxosulfenamides, RCOCH2SNR1R2, to thioglyoxylamides, RCOCSNR1R2 (I) by the dehydrogenating influence of elementary S at room temp.  By the procedure of A., et al. (loc. cit.) was prepd. (RCOCH2S)2 (II) (R = Ph).  H2S (45 l.) introduced into 80 g. NaOH in 500 cc. H2O at 0° and the soln. treated dropwise with 185 g. AcCH2Cl at 0° with stirring gave 110 g. AcCH2SH (III), m. 95-7°. III (45 g.) suspended in 1.5 l. H2O treated with N KI-iodine at 5° to a persistent iodine reaction, the ppt. filtered off, the filtrate extd. with Et2O, the ext. dried, and evapd. in vacuo gave 22 g. II (R = Me), oil.  S (16 g.) treated with 1 drop BuNH2 and then portionwise with 52.5 g. EtCOCH2SH (CA 52, 9141c) with stirring, towards the end of H2S evolution the whole heated 1 hr. at 40°, and distd. gave 24 g. II (R =Et), b0.4 74.6° (slight decompn.).  Me2CHCOCH2SH (CA 52, 11855h) (133 g.) added to 45 g. NaOH in 450 cc. H2O, the whole treated dropwise with 135 g. (NH4)2S2O8 in 150 cc. H2O at 0° with stirring, the resulting oil isolated with Et2O, and purified by repeated freezing at -60° gave 90 g. II (R = Me2CH), oil.  To 30.2 g. II (R = Ph) in 700 cc. dry CH2Cl2 was added slowly 7.1 g. Cl (previously condensed in a cold trap and exactly weighed) at -70° with stirring by means of a current of N, the whole treated dropwise with 38 g. morpholine, kept overnight at room temp., washed with 2N HCl and H2O, dried, concd., the residue dissolved in Et2O, and the soln. cooled in ice to give 12 g. I (R = Ph, NR1R2 = morpholino) (IV), m. 113-14° (MeOH); the combined Et2O and MeOH phases concd. in vacuo, the residue (oil plus crystals) dissolved in C6H6, the soln. treated with ligroine while hot until turbid, cooled, decanted repeatedly from an oil which sepd. until solid began to sep. from soln., and the solid collected gave 7.7 g. unchanged II (R = Ph), m. 80-1° (MeOH).  II in dry CH2Cl2 treated with an exact amt. Cl (mole ratio II-Cl 1:1) at -70° with stirring by means of a stream of N, the soln. treated dropwise with the appropriate amine followed by finely powd. S, kept overnight at room temp., washed neutral with H2O, dried, concd., in vacuo, and the residue triturated with Et2O gave I.  Thus were prepd. the following I [R, NR1R2, g. II, g. I, and m.p. given]: Ph, morpholino (IV), 50.4, 49, 113-14° (MeOH); Ph, piperidino, 25.2, 8.6, 73-4° (Et2OMeOH); Ph, Me2N, 25.2, 7, 83-4°; Me, morpholino, 17.8, 7, 127° (Et2O); Et, morpholino, 10.8, 12 (the mixt. was worked up by the general procedure 3 hrs. after removal of the ice bath), 73° (petr. ether); Me2CH, morpholino, 11.7, 8 (after removal of CH2Cl2, the residue was dissolved in petr. ether, the soln. filtered through Al2O3, and the filtrate concd.), 42° (iso-Pr2O); Me2CH, Me2N, 11.7, 8 (after removal of the CH2Cl2, the residual oil was repeatedly repptd. from Et2O with petr. ether), oil.  PhAc (180 g.), 96 g. S, and the appropriate additive treated 5 hrs. with NH3 (50 l./hr.) with stirring, the mixt. treated with 1.2 l. C6H6 and 400 cc. NH4SH soln. (prepd. by satg. concd. aq. NH3 with H2S and dilg. with an equal vol. concd. aq. NH3), the phases sepd., the aq. layer extd. with 600 cc. C6H6, the combined C6H6 solns. washed with 400 cc. NH4SH soln. and with 3 1 l. portions H2O, kept 30 min., the ppt. filtered off, and washed with petr. ether gave 2-methyl-2,4-diphenyl-3-imidazoline-5-thione (V); the combined C6H6 filtrate and petr. ether washings evapd. in vacuo on a water bath, the residue triturated with 300 cc. hot petr. ether, and the whole cooled gave addnl. V, m. 182° (MeOH); the petr. ether filtrate concd. in vacuo and the residue distd. in vacuo gave unchanged PhAc and (as distn. residue) 2-methyl-2,4-diphenyl-3-thiazoline (VI) in most cases, the chief by-product of the reaction.  The following results were obtained [additive, NH3 soly. (millimoles NH3/l. at 40°), % total yield, % yield V (the difference between % total yield and % yield V was chiefly due to the formation of VI) given]: 75 cc. C6H6, 230, 20, 8; 75 cc. pyridine, 679, 74, 23; 75 cc. dioxane, 806, 45, 15; 75 cc. HCONMe2 (VII), 1186, 72, 22; 7.5 cc. VII, --, 42, 13; 75 co. MeOH, 5976, 62, 27; -- --, 37, 21; 75 g. NH4NO3, --, 53, 23; 75 g. betaine, --, 25, 6.  Varying the S content in the above reaction (1.5 moles PhAc) gave the following results [additive (75 cc.), mole ratio PhAc-S, % total yield, % yield V given]: VII, 1:0.73,47, 10; VII, 1:2, 72,22; VII, 1:4, 100,42; MeOH, 1:0.73, 30, 10; MeOH, 1:2, 62, 27; MeOH, 1:4, 80, 39.  The results of varying the MeOH content on the reaction of 0.3 mole PhAc with 1.2 g. atoms S and NH3 (30 l./hr.) at 30° during a reaction time of 5 hrs. were as follows (cc. MeOH, % total yield, and % yield V given): 15, 80, 39; 30, 84, 55; 55, 78, 55; 80, 72, 53; 150, 45, 34.  The effect of varying the duration of reaction on the reaction of 0.3 mole PhAc and S and NH3 at 30° and an excess pressure of 65 mm. NH3 was as follows [cc. MeOH, duration of reaction (hrs.), mole ratio PhAc-S, % total yield, % yield V given]: 55, 5, 1:4, 74, 55; 55, 15, 1:4, 88, 56; 80, 5, 1:8, 72, 59; 80, 24, 1:8, 99, 86; 80, 48, 1:8, 100, 86.  The effect of varying the temp. on the reaction of 0.3 mole PhAc with 2.4 g.-atoms S and an excess pressure of 65 mm. NH3 in 80 cc. MeOH for a 24-hr. reaction time was as follows (temp., % total yield, and % yield V given): 0° 57, 50; 15°, 98, 92; 30°, 99, 86; 45°, 95, 27 [in addn. to VI, 18.4% 2-methyl-2,4-diphenyl-5-imino-3-imidazoline (VIII) was also formed as by-product]; 60°, 81, 10.  By the general reaction procedure was prepd. 19 g. mixt. (IX) of V and VIII.  IX (5 g.) dissolved in 30 cc. AcOH at 100°, the hot soln. poured into 250 cc. boiling 20% AcOH with stirring, boiled until the ppt. coagulated, the ppt. filtered off, washed neutral with H2O, and dried at 90° gave 2.8 g. V, m. 181°; the AcOH filtrate neutralized with concd. aq. NaOH at the b.p., boiled, and cooled gave 1.8 g. VIII, m. 147° (cyclohexane-petr. ether).  The aryl methyl ketone (0.3 mole), 80 cc. MeOH, and 77 g. S were charged to a 250-cc. flask, an NH3 stream was introduced into the mixt. at 30°, after 24 hrs. the mixt. was shaken with 400 cc. C6H6 and 100 cc. NH4SH soln., the layers were sepd., the aq. layer was extd. with 200 cc. C6H6, the combined C6H6 solns. washed with 400 cc. H2O, kept 30 min., the ppt. (1st crop) filtered off, washed with petr. ether, the combined filtrate and washings evapd. in vacuo, the residue treated with 200 cc. warm (50°) petr. ether, the mixt. cooled, the ppt. (2nd crop) filtered off, combined with the 1st crop, and recrystd. to give the 3-imidazoline-5-thione.  The following X were thus prepd. [R, m.p. (cor), recrystn. solvent, % yield given]: Ph, 182°, EtOH, 85; 4-FC6H4, 186°, MeOH, 69; 4-ClC6H4, 161°, iso-Pr2O-MeOH, 89; 4-BrC6H4 (XI), 174°, PhMe, 75; 4IC6H4 (XII), 201°, EtOH, 82; 4-MeC6H4, 182°, MeOH, 78; 4-MeOC6H4, 187°, MeOH-Me2CO, 96; 4-EtOC6H4, 132°, isoBu2O-MeOH, 93; 4-H2NC6H4, 171°, iso-PrOH-EtOH, 74; 2-MeOC6H4, 188°, Me2CO-MeOH, 90; 4,2-Me(MeO)C6H3 (XIII), 180°, Me2CO-MeOH, 73; 3-ClC6H4, 117°, iso-Pr2OMeOH, 85; 2-thienyl, 174°, C6H6-MeOH, 38; 2-naphthyl, 185°, PhMe, 85; 1-naphthyl, 247°, PhMe, 40.  In the prepn. of XI, there was obtained 54 g. mixt. (XIV) of XI and 2-methyl-2,4-bis(4-bromophenyl)-5-imino-3-imidazoline (XV).  XIV (5 g.) dissolved in 30 cc. hot AcOH, the soln. poured into 250 cc. boiling 20% AcOH, boiled until the ppt. coagulated, and cooled gave 4.1 g. XI; the AcOH filtrate neutralized with aq. NaOH at the b.p., boiled to coagulate the ppt., and cooled gave 0.6 g. XV, m. 206° (C6H6).  In the prepn. of XII, there was obtained 71 g. mixt. (XVI) of XII and 2-methyl-2,4-bis(4-iodophenyl)-5imino-3-imidazoline (XVII), similarly sepd. to give, from 10 g. XVI, 9 g. XII, and 0.9 g. XVII, m. 224° (PhMe).  In the prepn. of XIII, there was isolated 13 g. residue which was crystd. from MeOH-EtOH-Et2CO to give 11 g. 2-methyl-2,4-bis(2-methoxy-4-methylphenyl)-3-thiazoline, m. 119°.  NH3 introduced 80 min. into 140 g. 2-HOC6H4Ac (XVIII), 100 cc. CCl4, and 50 cc. piperidine with stirring gave 123 g. XIX (R = R1 = H), m. 141° (Me2CO).  XVIII (68 g.), 50 cc. CCl4, and 44 g. BuNH2 kept 1 hr. gave 90 g. XIX (R = H, R1 = Bu), m. 70° (CCl4); picrate m. 177°. NH3 introduced 8 hrs. into 50 cc. CCl4 contg. 4,2-Me(HO)C6H4Ac gave 47 g. XIX (R = Me, R1 = H), m. 181° (Me2CO); picrate m. 200°.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozEeLMlHfD_rVg90H21EOLACvtfcHk0lgAvKjNxl9R6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3sXktVyqtrc%253D&md5=ba357687e9e51af90c5ab5e8a46f4b21</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAsinger%26aufirst%3DF.%26aulast%3DSchaefer%26aufirst%3DW.%26aulast%3DBaumgarte%26aufirst%3DG.%26aulast%3DMueting%26aufirst%3DP.%2BF.%26atitle%3DConcomitant%2520action%2520of%2520elementary%2520sulfur%2520and%2520gaseous%2520ammonia%2520on%2520ketones.%2520XXXVI.%2520Action%2520of%2520sulfur%2520and%2520ammonia%2520on%2520acetophenone.%2520II.%2520Synthesis%2520of%25203-imidazoline-5-thiones%26jtitle%3DAnn.%26date%3D1963%26volume%3D661%26spage%3D95%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Asinger, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Offermanns, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, H. D.</span><span> </span><span class="NLM_article-title">Concomitant action of elementary sulfur and gaseous ammonia on ketones. LII. Synthesis of α-oxo thio amides and substituted 3-imidazoline-5-thiones</span> <span class="citation_source-journal">Justus Liebigs Ann. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">691</span><span class="NLM_x">, </span> <span class="NLM_fpage">92</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=691&publication_year=1966&pages=92-108&author=F.+Asingerauthor=A.+Sausauthor=H.+Offermannsauthor=H.+D.+Hahn&title=Concomitant+action+of+elementary+sulfur+and+gaseous+ammonia+on+ketones.+LII.+Synthesis+of+%CE%B1-oxo+thio+amides+and+substituted+3-imidazoline-5-thiones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAsinger%26aufirst%3DF.%26aulast%3DSaus%26aufirst%3DA.%26aulast%3DOffermanns%26aufirst%3DH.%26aulast%3DHahn%26aufirst%3DH.%2BD.%26atitle%3DConcomitant%2520action%2520of%2520elementary%2520sulfur%2520and%2520gaseous%2520ammonia%2520on%2520ketones.%2520LII.%2520Synthesis%2520of%2520%25CE%25B1-oxo%2520thio%2520amides%2520and%2520substituted%25203-imidazoline-5-thiones%26jtitle%3DJustus%2520Liebigs%2520Ann.%2520Chem.%26date%3D1966%26volume%3D691%26spage%3D92%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Asinger, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haaf, F.</span><span> </span><span class="NLM_article-title">Concomitant action of elementary sulfur and gaseous ammonia on ketones. XXXVIII. Action of sulfur and ammonia on acetophenone. 3. Proof of structure and reactions of Δ-3-imidazoline-5-thiones</span> <span class="citation_source-journal">Justus Liebigs Ann. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">672</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=672&publication_year=1964&pages=134-155&author=F.+Asingerauthor=W.+Schaeferauthor=F.+Haaf&title=Concomitant+action+of+elementary+sulfur+and+gaseous+ammonia+on+ketones.+XXXVIII.+Action+of+sulfur+and+ammonia+on+acetophenone.+3.+Proof+of+structure+and+reactions+of+%CE%94-3-imidazoline-5-thiones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAsinger%26aufirst%3DF.%26aulast%3DSchaefer%26aufirst%3DW.%26aulast%3DHaaf%26aufirst%3DF.%26atitle%3DConcomitant%2520action%2520of%2520elementary%2520sulfur%2520and%2520gaseous%2520ammonia%2520on%2520ketones.%2520XXXVIII.%2520Action%2520of%2520sulfur%2520and%2520ammonia%2520on%2520acetophenone.%25203.%2520Proof%2520of%2520structure%2520and%2520reactions%2520of%2520%25CE%2594-3-imidazoline-5-thiones%26jtitle%3DJustus%2520Liebigs%2520Ann.%2520Chem.%26date%3D1964%26volume%3D672%26spage%3D134%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Blid, J.; Ginman, T.; Gravenfors, Y.; Karlstroem, S.; Kihlstroem, J.; Kolmodin, K.; Lindstroem, J.; Rahm, F.; Sundstroem, M.; Swahn, B.; Viklund, J.; von Berg, S.; von Kieseritzky, F.</span>WO 2011/002408 A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Blid%2C+J.%3B+Ginman%2C+T.%3B+Gravenfors%2C+Y.%3B+Karlstroem%2C+S.%3B+Kihlstroem%2C+J.%3B+Kolmodin%2C+K.%3B+Lindstroem%2C+J.%3B+Rahm%2C+F.%3B+Sundstroem%2C+M.%3B+Swahn%2C+B.%3B+Viklund%2C+J.%3B+von+Berg%2C+S.%3B+von+Kieseritzky%2C+F.WO+2011%2F002408+A1%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBlid%26aufirst%3DJ.%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Blid, J.; Ginman, T.; Gravenfors, Y.; Karlstroem, S.; Kolmodin, K.; Lindstroem, J.; Plobeck, N.; Rahm, F.; Swahn, B.; Viklund, J.; von Berg, S.; von Kieseritzky, D.</span>WO 2011/002407 A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Blid%2C+J.%3B+Ginman%2C+T.%3B+Gravenfors%2C+Y.%3B+Karlstroem%2C+S.%3B+Kolmodin%2C+K.%3B+Lindstroem%2C+J.%3B+Plobeck%2C+N.%3B+Rahm%2C+F.%3B+Swahn%2C+B.%3B+Viklund%2C+J.%3B+von+Berg%2C+S.%3B+von+Kieseritzky%2C+D.WO+2011%2F002407+A1%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBlid%26aufirst%3DJ.%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shalaeva, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tupper, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, F.</span><span> </span><span class="NLM_article-title">ElogDoct: a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2490</span><span class="NLM_x">–</span> <span class="NLM_lpage">2497</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0100990" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2490-2497&author=F.+Lombardoauthor=M.+Y.+Shalaevaauthor=K.+A.+Tupperauthor=F.+Gao&title=ElogDoct%3A+a+tool+for+lipophilicity+determination+in+drug+discovery.+2.+Basic+and+neutral+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm0100990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0100990%26sid%3Dliteratum%253Aachs%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DShalaeva%26aufirst%3DM.%2BY.%26aulast%3DTupper%26aufirst%3DK.%2BA.%26aulast%3DGao%26aufirst%3DF.%26atitle%3DElogDoct%253A%2520a%2520tool%2520for%2520lipophilicity%2520determination%2520in%2520drug%2520discovery.%25202.%2520Basic%2520and%2520neutral%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2490%26epage%3D2497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Bridgland-Taylor, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hargreaves, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orme, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henthorn, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heapy, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abi-Gerges, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albertson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentin, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollard, C. E.</span><span> </span><span class="NLM_article-title">Optimisation and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HT</span> <span class="citation_source-journal">J. Pharmacol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">199</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1016%2Fj.vascn.2006.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=16563806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BD28XptFChtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2006&pages=189-199&author=M.+H.+Bridgland-Taylorauthor=A.+C.+Hargreavesauthor=A.+Easterauthor=A.+Ormeauthor=D.+C.+Henthornauthor=M.+Dingauthor=A.+M.+Davisauthor=B.+G.+Smallauthor=C.+G.+Heapyauthor=N.+Abi-Gergesauthor=F.+Perssonauthor=I.+Jacobsonauthor=M.+Sullivanauthor=N.+Albertsonauthor=T.+G.+Hammondauthor=E.+Sullivanauthor=J.+P.+Valentinauthor=C.+E.+Pollard&title=Optimisation+and+validation+of+a+medium-throughput+electrophysiology-based+hERG+assay+using+IonWorks+HT"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HT</span></div><div class="casAuthors">Bridgland-Taylor, M. H.; Hargreaves, A. C.; Easter, A.; Orme, A.; Henthorn, D. C.; Ding, M.; Davis, A. M.; Small, B. G.; Heapy, C. G.; Abi-Gerges, N.; Persson, F.; Jacobson, I.; Sullivan, M.; Albertson, N.; Hammond, T. G.; Sullivan, E.; Valentin, J.-P.; Pollard, C. E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">189-199</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Introduction: Regulatory and competitive pressure to reduce the QT interval prolongation risk of potential new drugs has led to focus on methods to test for inhibition of the human ether-a-go-go-related gene (hERG)-encoded K+ channel, the primary mol. target underlying this safety issue.  Here we describe the validation of a method that combines medium-throughput with direct assessment of channel function.  Methods: The electrophysiol. and pharmacol. properties of hERG were compared using two methods: conventional, low-throughput electrophysiol. and planar-array-based, medium-throughput electrophysiol. (IonWorks HT).  A pharmacol. comparison was also made between IonWorks HT and an indirect assay (Rb+ efflux).  Results: Basic electrophysiol. properties of hERG were similar whether recorded conventionally (HEK cells) or using IonWorks HT (CHO cells): for example, tail current V1/2 - 12.1 ± 5.0 mV (32) for conventional and - 9.5 ± 6.0 mV (46) for IonWorks HT (mean ± S.D. (n)).  A key finding was that as the no. of cells per well was increased in IonWorks HT, the potency reported for a given compd. decreased.  Using the lowest possible cell concn. (250,000 cells/mL) and 89 compds. spanning a broad potency range, the pIC50 values from IonWorks HT (CHO-hERG) were found to correlate well with those obtained using conventional methodol. (HEK-hERG)(r = 0.90; p < 0.001).  Further validation using CHO-hERG cells with both methods confirmed the correlation (r = 0.94; p < 0.001).  In contrast, a comparison of IonWorks HT and Rb+ efflux data with 649 compds. using CHO-hERG cells showed that the indirect assay consistently reported compds. as being, on av., 6-fold less potent, though the differences varied depending on chem. series.  Discussion: The main finding of this work is that providing a relatively low cell concn. is used in IonWorks HT, the potency information generated correlates well with that detd. using conventional electrophysiol.  The effect on potency of increasing cell concn. may relate to a reduced free concn. of test compd. owing to partitioning into cell membranes.  In summary, the IonWorks HT hERG assay can generate pIC50 values based on a direct assessment of channel function in a timeframe short enough to influence chem. design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcBXhwRw0nLVg90H21EOLACvtfcHk0li9k5FondCRMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptFChtbw%253D&md5=730258a42517947c0b972ca87cef46b6</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2006.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2006.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DBridgland-Taylor%26aufirst%3DM.%2BH.%26aulast%3DHargreaves%26aufirst%3DA.%2BC.%26aulast%3DEaster%26aufirst%3DA.%26aulast%3DOrme%26aufirst%3DA.%26aulast%3DHenthorn%26aufirst%3DD.%2BC.%26aulast%3DDing%26aufirst%3DM.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DSmall%26aufirst%3DB.%2BG.%26aulast%3DHeapy%26aufirst%3DC.%2BG.%26aulast%3DAbi-Gerges%26aufirst%3DN.%26aulast%3DPersson%26aufirst%3DF.%26aulast%3DJacobson%26aufirst%3DI.%26aulast%3DSullivan%26aufirst%3DM.%26aulast%3DAlbertson%26aufirst%3DN.%26aulast%3DHammond%26aufirst%3DT.%2BG.%26aulast%3DSullivan%26aufirst%3DE.%26aulast%3DValentin%26aufirst%3DJ.%2BP.%26aulast%3DPollard%26aufirst%3DC.%2BE.%26atitle%3DOptimisation%2520and%2520validation%2520of%2520a%2520medium-throughput%2520electrophysiology-based%2520hERG%2520assay%2520using%2520IonWorks%2520HT%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2006%26volume%3D54%26spage%3D189%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Wan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindberg, W.</span><span> </span><span class="NLM_article-title">Rapid screening of p<i>K</i><sub>a</sub> values of pharmaceuticals by pressure-assisted capillary electrophoresis combined with short-end injection</span> <span class="citation_source-journal">J. Chromatogr., A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">979</span><span class="NLM_x">, </span> <span class="NLM_fpage">369</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=979&publication_year=2002&pages=369-377&author=H.+Wanauthor=A.+Holmenauthor=M.+Nagardauthor=W.+Lindberg&title=Rapid+screening+of+pKa+values+of+pharmaceuticals+by+pressure-assisted+capillary+electrophoresis+combined+with+short-end+injection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DH.%26aulast%3DHolmen%26aufirst%3DA.%26aulast%3DNagard%26aufirst%3DM.%26aulast%3DLindberg%26aufirst%3DW.%26atitle%3DRapid%2520screening%2520of%2520pKa%2520values%2520of%2520pharmaceuticals%2520by%2520pressure-assisted%2520capillary%2520electrophoresis%2520combined%2520with%2520short-end%2520injection%26jtitle%3DJ.%2520Chromatogr.%252C%2520A%26date%3D2002%26volume%3D979%26spage%3D369%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Wan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmen, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindberg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Englund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagard, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, R. A.</span><span> </span><span class="NLM_article-title">High-throughput screening of p<i>K</i><sub>a</sub> values of pharmaceuticals by pressure-assisted capillary electrophoresis and mass spectrometry</span> <span class="citation_source-journal">Rapid Commun. Mass Spectrom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2639</span><span class="NLM_x">–</span> <span class="NLM_lpage">2648</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1002%2Frcm.1229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=14648902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpslSiurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=2639-2648&author=H.+Wanauthor=A.+G.+Holmenauthor=Y.+Wangauthor=W.+Lindbergauthor=M.+Englundauthor=M.+B.+Nagardauthor=R.+A.+Thompson&title=High-throughput+screening+of+pKa+values+of+pharmaceuticals+by+pressure-assisted+capillary+electrophoresis+and+mass+spectrometry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput screening of pKa values of pharmaceuticals by pressure-assisted capillary electrophoresis and mass spectrometry</span></div><div class="casAuthors">Wan, Hong; Holmen, Anders G.; Wang, Yudong; Lindberg, Walter; Englund, Marie; Nagard, Mats B.; Thompson, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Rapid Communications in Mass Spectrometry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2639-2648</span>CODEN:
                <span class="NLM_cas:coden">RCMSEF</span>;
        ISSN:<span class="NLM_cas:issn">0951-4198</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A high-throughput pKa screening method based on pressure-assisted capillary electrophoresis (CE) and mass spectrometry (MS) is presented.  Effects of buffer type and ionic strength on sensitivity and pKa values were investigated.  Influence of DMSO concn. present in the sample on effective mobility measurement was examd.  A series of ten volatile buffers, covering a pH range from 2.5 to 10.5 with the same ionic strength, was employed.  The application of volatile background electrolytes resulted in significant signal increase as compared with commonly used non-volatile phosphate buffers.  In general, the CE/MS system provided a ten-fold higher sensitivity than conventional UV detection.  The newly developed CE/MS method offers high-throughput capacity by pooling a no. of compds. into a single sample.  Simultaneous measurement of more than 50 compds. was readily achieved in less than 150 min.  The measured pKa values are consistent with the published data obtained from the CE/UV method and are also in good agreement with data generated by other methods.  Other advantages of using CE/MS for pKa screening are illustrated with typical examples, including poorly sol. compds. and non-UV-absorbing compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgfrtqeDn-8LVg90H21EOLACvtfcHk0li9k5FondCRMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpslSiurs%253D&md5=28bdb030bf255c19b5f98de12d5d9310</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Frcm.1229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Frcm.1229%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DH.%26aulast%3DHolmen%26aufirst%3DA.%2BG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLindberg%26aufirst%3DW.%26aulast%3DEnglund%26aufirst%3DM.%26aulast%3DNagard%26aufirst%3DM.%2BB.%26aulast%3DThompson%26aufirst%3DR.%2BA.%26atitle%3DHigh-throughput%2520screening%2520of%2520pKa%2520values%2520of%2520pharmaceuticals%2520by%2520pressure-assisted%2520capillary%2520electrophoresis%2520and%2520mass%2520spectrometry%26jtitle%3DRapid%2520Commun.%2520Mass%2520Spectrom.%26date%3D2003%26volume%3D17%26spage%3D2639%26epage%3D2648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Alelyunas, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelosi-Kilby, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, C.</span><span> </span><span class="NLM_article-title">Application of a dried-DMSO rapid throughput 24-h equilibrium solubility in advancing discovery candidates</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">172</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1016%2Fj.ejps.2009.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=19429424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvV2ms7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=172-182&author=Y.+W.+Alelyunasauthor=R.+Liuauthor=L.+Pelosi-Kilbyauthor=C.+Shen&title=Application+of+a+dried-DMSO+rapid+throughput+24-h+equilibrium+solubility+in+advancing+discovery+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Application of a dried-DMSO rapid throughput 24-h equilibrium solubility in advancing discovery candidates</span></div><div class="casAuthors">Alelyunas, Yun W.; Liu, Ruifeng; Pelosi-Kilby, Luciana; Shen, Cindy</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">172-182</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A rapid throughput equil. soly. measurement is described.  The method utilizes central liq. storage where compds. are stored as 10 mM soln. in DMSO.  The DMSO is subsequently removed to generate solid like material used for soly. measurement.  A full range of available technologies is used including automated liq. handling, automated data collection using both HPLC/UV and LC/MS/MS.  The method is fully validated and has been used to measure soly. for over 20,000 compds. across all phases of drug discovery.  A detailed discussion on data interpretation and comparison to traditional soly. measurement using solid material is presented.  An inhouse soly. predictive model has been developed from the vast data set and has been employed successfully as part of compd. design resulting in over 30% redn. in the no. of poorly sol. compd. synthesized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqUrCZlVKS_bVg90H21EOLACvtfcHk0li9k5FondCRMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvV2ms7k%253D&md5=6ee437462b50cc0c4acfd6d2f27b6405</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2009.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2009.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DAlelyunas%26aufirst%3DY.%2BW.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DPelosi-Kilby%26aufirst%3DL.%26aulast%3DShen%26aufirst%3DC.%26atitle%3DApplication%2520of%2520a%2520dried-DMSO%2520rapid%2520throughput%252024-h%2520equilibrium%2520solubility%2520in%2520advancing%2520discovery%2520candidates%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2009%26volume%3D37%26spage%3D172%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2ebLwoqQ3eC3q7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Stachel, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coburn, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajapakse, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katharine, H., M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allison, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espeseth, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colussi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrak, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Discovery of aminoheterocycles as a novel β-secretase inhibitor class: pH dependence on binding activity part 1</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2977</span><span class="NLM_x">–</span> <span class="NLM_lpage">2980</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2977-2980&author=S.+J.+Stachelauthor=C.+A.+Coburnauthor=D.+Rushauthor=K.+L.+G.+Jonesauthor=H.+Zhuauthor=H.+Rajapakseauthor=S.+L.+Grahamauthor=A.+Simonauthor=H.%2C+M.+Katharineauthor=T.+J.+Allisonauthor=S.+K.+Munshiauthor=A.+S.+Espesethauthor=P.+Zuckauthor=D.+Colussiauthor=A.+Wolfeauthor=B.+L.+Pietrakauthor=M.+Laiauthor=J.+P.+Vacca&title=Discovery+of+aminoheterocycles+as+a+novel+%CE%B2-secretase+inhibitor+class%3A+pH+dependence+on+binding+activity+part+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStachel%26aufirst%3DS.%2BJ.%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DRush%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DK.%2BL.%2BG.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DRajapakse%26aufirst%3DH.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DSimon%26aufirst%3DA.%26aulast%3DKatharine%26aufirst%3DH.%252C%2BM.%26aulast%3DAllison%26aufirst%3DT.%2BJ.%26aulast%3DMunshi%26aufirst%3DS.%2BK.%26aulast%3DEspeseth%26aufirst%3DA.%2BS.%26aulast%3DZuck%26aufirst%3DP.%26aulast%3DColussi%26aufirst%3DD.%26aulast%3DWolfe%26aufirst%3DA.%26aulast%3DPietrak%26aufirst%3DB.%2BL.%26aulast%3DLai%26aufirst%3DM.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DDiscovery%2520of%2520aminoheterocycles%2520as%2520a%2520novel%2520%25CE%25B2-secretase%2520inhibitor%2520class%253A%2520pH%2520dependence%2520on%2520binding%2520activity%2520part%25201%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2977%26epage%3D2980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Waring, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, C.</span><span> </span><span class="NLM_article-title">A quantitative assessment of hERG liability as a function of lipophilicity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1759</span><span class="NLM_x">–</span> <span class="NLM_lpage">1764</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1016%2Fj.bmcl.2006.12.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=17239590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1yrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1759-1764&author=M.+J.+Waringauthor=C.+Johnstone&title=A+quantitative+assessment+of+hERG+liability+as+a+function+of+lipophilicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative assessment of hERG liability as a function of lipophilicity</span></div><div class="casAuthors">Waring, Michael J.; Johnstone, Craig</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1759-1764</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The impact of lipophilicity as a factor contributing to hERG potency is assessed for a large dataset of compds. of differing ionization type.  This dataset is derived from compds. tested in the Ionworks-based in vitro electrophysiol. hERG assay at AstraZeneca.  Using logistic regression, a quantification of the risk assocd. with increasing lipophilicity is presented.  The anticipated differences between acidic, basic and neutral compds. are apparent in the data but lipophilicity is shown to be a stronger driver for hERG potency than might have been expected.  Simple rules defining target lipophilicity values for minimizing hERG liability are derived.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlCr9mVGL2-LVg90H21EOLACvtfcHk0lhOIK_1184jag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1yrtb8%253D&md5=3819e045d7b773f129773f1ff567b980</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.12.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.12.061%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26aulast%3DJohnstone%26aufirst%3DC.%26atitle%3DA%2520quantitative%2520assessment%2520of%2520hERG%2520liability%2520as%2520a%2520function%2520of%2520lipophilicity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1759%26epage%3D1764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Denora, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laquintana, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopedota, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapani, G.</span><span> </span><span class="NLM_article-title">Recent advances in medicinal chemistry and pharmaceutical technology—strategies for drug delivery to the brain</span> <span class="citation_source-journal">Curr. Top. Med. Chem. (Sharjah, United Arab Emirates)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.2174%2F156802609787521571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=19200004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvVSgtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=182-196&author=N.+Denoraauthor=A.+Trapaniauthor=V.+Laquintanaauthor=A.+Lopedotaauthor=G.+Trapani&title=Recent+advances+in+medicinal+chemistry+and+pharmaceutical+technology%E2%80%94strategies+for+drug+delivery+to+the+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in medicinal chemistry and pharmaceutical technology - strategies for drug delivery to the brain</span></div><div class="casAuthors">Denora, Nunzio; Trapani, Adriana; Laquintana, Valentino; Lopedota, Angela; Trapani, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">182-196</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This paper provides a mini-review of some recent approaches for the treatment of brain pathologies examg. both medicinal chem. and pharmaceutical technol. contributions.  Medicinal chem.-based strategies are essentially aimed at the chem. modification of low mol. wt. drugs in order to increase their lipophilicity or the design of appropriate prodrugs, although this review will focus primarily on the use of prodrugs and not analog development.  Recently, interest has been focused on the design and evaluation of prodrugs that are capable of exploiting one or more of the various endogenous transport systems at the level of the blood brain barrier (BBB).  The technol. strategies are essentially non-invasive methods of drug delivery to malignancies of the central nervous system (CNS) and are based on the use of nanosystems (colloidal carriers) such as liposomes, polymeric nanoparticles, solid lipid nanoparticles, polymeric micelles and dendrimers.  The biodistribution of these nanocarriers can be manipulated by modifying their surface physico-chem. properties or by coating them with surfactants and polyethylene-glycols (PEGs).  Liposomes, surfactant coated polymeric nanoparticles, and solid lipid nanoparticles are promising systems for delivery of drugs to tumors of the CNS.  This mini-review discusses issues concerning the scope and limitations of both the medicinal chem. and technol. approaches.  Based on the current findings, it can be concluded that crossing of the BBB and drug delivery to CNS is extremely complex and requires a multidisciplinary approach such as a close collaboration and common efforts among researchers of several scientific areas, particularly medicinal chemists, biologists and pharmaceutical technologists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKLD3NcuTLa7Vg90H21EOLACvtfcHk0ljxWQ8Vw_YsqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvVSgtb0%253D&md5=61feb73997d2974a7c792cdf8c47608a</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.2174%2F156802609787521571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802609787521571%26sid%3Dliteratum%253Aachs%26aulast%3DDenora%26aufirst%3DN.%26aulast%3DTrapani%26aufirst%3DA.%26aulast%3DLaquintana%26aufirst%3DV.%26aulast%3DLopedota%26aufirst%3DA.%26aulast%3DTrapani%26aufirst%3DG.%26atitle%3DRecent%2520advances%2520in%2520medicinal%2520chemistry%2520and%2520pharmaceutical%2520technology%25E2%2580%2594strategies%2520for%2520drug%2520delivery%2520to%2520the%2520brain%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%2520%2528Sharjah%252C%2520United%2520Arab%2520Emirates%2529%26date%3D2009%26volume%3D9%26spage%3D182%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Alex, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millan, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakenhut, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitlock, G. A.</span><span> </span><span class="NLM_article-title">Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1039%2Fc1md00093d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotl2gt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=669-674&author=A.+Alexauthor=D.+S.+Millanauthor=M.+Perezauthor=F.+Wakenhutauthor=G.+A.+Whitlock&title=Intramolecular+hydrogen+bonding+to+improve+membrane+permeability+and+absorption+in+beyond+rule+of+five+chemical+space"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space</span></div><div class="casAuthors">Alex, Alexander; Millan, David S.; Perez, Manuel; Wakenhut, Florian; Whitlock, Gavin A.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">669-674</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Utilizing 'beyond rule of five' chem. space is becoming increasingly important in drug design, but is usually at odds with good oral absorption.  The formation of intramol. hydrogen bonds in drug mols. is hypothesised to shield polarity facilitating improved membrane permeability and intestinal absorption.  NMR based evidence for intramol. hydrogen bonding in several 'beyond rule of five' oral drugs is described.  Furthermore, the propensity for these drugs to form intramol. hydrogen bonds could be predicted for through modeling the lowest energy conformation in the gas phase.  The modulation of apparent lipophilicity through intramol. hydrogen bonding in these mols. is supported by intrinsic cell permeability and intestinal absorption data in rat and human.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp93l2KJMdB2bVg90H21EOLACvtfcHk0ljxWQ8Vw_YsqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotl2gt7o%253D&md5=3effbdd29832ac7b57eabbc26c66217b</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1039%2Fc1md00093d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00093d%26sid%3Dliteratum%253Aachs%26aulast%3DAlex%26aufirst%3DA.%26aulast%3DMillan%26aufirst%3DD.%2BS.%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DWakenhut%26aufirst%3DF.%26aulast%3DWhitlock%26aufirst%3DG.%2BA.%26atitle%3DIntramolecular%2520hydrogen%2520bonding%2520to%2520improve%2520membrane%2520permeability%2520and%2520absorption%2520in%2520beyond%2520rule%2520of%2520five%2520chemical%2520space%26jtitle%3DMedChemComm%26date%3D2011%26volume%3D2%26spage%3D669%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span> </span><span class="NLM_article-title">Intramolecular hydrogen bonding in medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2601</span><span class="NLM_x">–</span> <span class="NLM_lpage">2611</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100087s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1Clur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2601-2611&author=B.+Kuhnauthor=P.+Mohrauthor=M.+Stahl&title=Intramolecular+hydrogen+bonding+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular Hydrogen Bonding in Medicinal Chemistry</span></div><div class="casAuthors">Kuhn, Bernd; Mohr, Peter; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2601-2611</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The formation of intramol. hydrogen bonds has a very pronounced effect on mol. structure and properties.  We study both aspects in detail with the aim of enabling a more rational use of this class of interactions in medicinal chem.  On the basis of exhaustive searches in crystal structure databases, we derive propensities for intramol. hydrogen bond formation of five- to eight-membered ring systems of relevance in drug discovery.  A no. of motifs, several of which are clearly underutilized in drug discovery, are analyzed in more detail by comparing small mol. and protein-ligand X-ray structures.  To investigate effects on physicochem. properties, sets of closely related structures with and without the ability to form intramol. hydrogen bonds were designed, synthesized, and characterized with respect to membrane permeability, water soly., and lipophilicity.  We find that changes in these properties depend on a subtle balance between the strength of the hydrogen bond interaction, geometry of the newly formed ring system, and the relative energies of the open and closed conformations in polar and unpolar environments.  A no. of general guidelines for medicinal chemists emerge from this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdaV7tFRU4k7Vg90H21EOLACvtfcHk0ljxWQ8Vw_YsqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1Clur8%253D&md5=b9b6865dfcc9bdf7796d15218f6e8ff2</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm100087s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100087s%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DMohr%26aufirst%3DP.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DIntramolecular%2520hydrogen%2520bonding%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2601%26epage%3D2611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuillard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleasby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yon, J.</span><span> </span><span class="NLM_article-title">Apo and inhibitor complex structures of BACE (beta-secretase)</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">416</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2004&pages=407-416&author=S.+Patelauthor=L.+Vuillardauthor=A.+Cleasbyauthor=C.+W.+Murrayauthor=J.+Yon&title=Apo+and+inhibitor+complex+structures+of+BACE+%28beta-secretase%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DVuillard%26aufirst%3DL.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DYon%26aufirst%3DJ.%26atitle%3DApo%2520and%2520inhibitor%2520complex%2520structures%2520of%2520BACE%2520%2528beta-secretase%2529%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D343%26spage%3D407%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Leslie, A. G. W.</span><span> </span><span class="NLM_article-title">Recent changes to the MOSFLM package for processing film and image plate data</span> <span class="citation_source-journal">Jt. CCP4 ESF-EAMCB Newsl. Protein Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1992&pages=27&author=A.+G.+W.+Leslie&title=Recent+changes+to+the+MOSFLM+package+for+processing+film+and+image+plate+data"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26atitle%3DRecent%2520changes%2520to%2520the%2520MOSFLM%2520package%2520for%2520processing%2520film%2520and%2520image%2520plate%2520data%26jtitle%3DJt.%2520CCP4%2520ESF-EAMCB%2520Newsl.%2520Protein%2520Crystallogr.%26date%3D1992%26volume%3D26%26spage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Evans, P.</span><span> </span><span class="NLM_article-title">Scaling and assessment of data quality</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">D62</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1107%2FS0907444905036693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlant7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D62&publication_year=2006&pages=72-82&author=P.+Evans&title=Scaling+and+assessment+of+data+quality"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Scaling and assessment of data quality</span></div><div class="casAuthors">Evans, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">D62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-82</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The various phys. factors affecting measured diffraction intensities are discussed, as are the scaling models which may be used to put the data on a consistent scale.  After scaling, the intensities can be analyzed to set the real resoln. of the data set, to detect bad regions (e.g. bad images), to analyze radiation damage and to assess the overall quality of the data set.  The significance of any anomalous signal may be assessed by probability and correlation anal.  The algorithms used by the CCP4 scaling program SCALA are described.  A requirement for the scaling and merging of intensities is knowledge of the Laue group and point-group symmetries: the possible symmetry of the diffraction pattern may be detd. from scores such as correlation coeffs. between observations which might be symmetry-related.  These scoring functions are implemented in a new program POINTLESS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGravLSLU62RhLVg90H21EOLACvtfcHk0lhpiiaycKinfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlant7jM&md5=293d3876e534c0c57813990515bb3c76</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1107%2FS0907444905036693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444905036693%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DP.%26atitle%3DScaling%2520and%2520assessment%2520of%2520data%2520quality%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2006%26volume%3DD62%26spage%3D72%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koelsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terzyan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2000&pages=150-153&author=L.+Hongauthor=G.+Koelschauthor=X.+Linauthor=S.+Wuauthor=S.+Terzyanauthor=A.+K.+Ghoshauthor=X.+C.+Zhangauthor=J.+Tang&title=Structure+of+the+protease+domain+of+memapsin+2+%28beta-secretase%29+complexed+with+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DL.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DTerzyan%26aufirst%3DS.%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DZhang%26aufirst%3DX.%2BC.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DStructure%2520of%2520the%2520protease%2520domain%2520of%2520memapsin%25202%2520%2528beta-secretase%2529%2520complexed%2520with%2520inhibitor%26jtitle%3DScience%26date%3D2000%26volume%3D290%26spage%3D150%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span> </span><span class="NLM_article-title">Refinement of macromolecular structures by the maximum-likelihood method</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=15299926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=240-255&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+macromolecular+structures+by+the+maximum-likelihood+method"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. σA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial α-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0lhpiiaycKinfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520macromolecular%2520structures%2520by%2520the%2520maximum-likelihood%2520method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3D53%26spage%3D240%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0lhpiiaycKinfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span> <span class="citation_source-book">BUSTER</span>, version <span class="NLM_edition">2.11.1</span>; <span class="NLM_publisher-name">Global Phasing Ltd.</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=BUSTER%2C+version+2.11.1%3B+Global+Phasing+Ltd.%3A+Cambridge%2C+U.K.%2C+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DBUSTER%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Wlodek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skillman, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholls, A.</span><span> </span><span class="NLM_article-title">Automated ligand placement and refinement with a combined force field and shape potential</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">741</span><span class="NLM_x">–</span> <span class="NLM_lpage">749</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1107%2FS0907444906016076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=16790930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtVSnur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=741-749&author=S.+Wlodekauthor=A.+G.+Skillmanauthor=A.+Nicholls&title=Automated+ligand+placement+and+refinement+with+a+combined+force+field+and+shape+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Automated ligand placement and refinement with a combined force field and shape potential</span></div><div class="casAuthors">Wlodek, S.; Skillman, A. G.; Nicholls, A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">D62</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">741-749</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">An automated computational procedure for fitting a ligand into its electron d. with the use of the MMFF94 force field and a Gaussian shape description has been developed.  It employs a series of adiabatic optimizations of gradually increasing shape potential.  Starting from a set of energy-relaxed ligand conformations, the final results are structures realistically strained to fit the crystallog. data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbAunEGTbprrVg90H21EOLACvtfcHk0lge3yQvwdLvew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtVSnur0%253D&md5=1571b77a211aec76fb4e3a376fc95d8a</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1107%2FS0907444906016076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444906016076%26sid%3Dliteratum%253Aachs%26aulast%3DWlodek%26aufirst%3DS.%26aulast%3DSkillman%26aufirst%3DA.%2BG.%26aulast%3DNicholls%26aufirst%3DA.%26atitle%3DAutomated%2520ligand%2520placement%2520and%2520refinement%2520with%2520a%2520combined%2520force%2520field%2520and%2520shape%2520potential%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2006%26volume%3D62%26spage%3D741%26epage%3D749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">LeDonne, N. C.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rissolo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulgarelli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tini, L.</span><span> </span><span class="NLM_article-title">Use of structure–activity landscape index curves and curve integrals to evaluate the performance of multiple machine learning prediction models</span> <span class="citation_source-journal">J. Cheminf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1186%2F1758-2946-3-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXitFyit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=7&author=N.+C.+LeDonneauthor=K.+Rissoloauthor=J.+Bulgarelliauthor=L.+Tini&title=Use+of+structure%E2%80%93activity+landscape+index+curves+and+curve+integrals+to+evaluate+the+performance+of+multiple+machine+learning+prediction+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Use of structure-activity landscape index curves and curve integrals to evaluate the performance of multiple machine learning prediction models</span></div><div class="casAuthors">LeDonne, Norman C., Jr.; Rissolo, Kevin; Bulgarelli, James; Tini, Leonard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cheminformatics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7</span>CODEN:
                <span class="NLM_cas:coden">JCOHB3</span>;
        ISSN:<span class="NLM_cas:issn">1758-2946</span>.
    
            (<span class="NLM_cas:orgname">Chemistry Central Ltd.</span>)
        </div><div class="casAbstract">Background: Std. approaches to address the performance of predictive models that used common statistical measurements for the entire data set provide an overview of the av. performance of the models across the entire predictive space, but give little insight into applicability of the model across the prediction space.  Guha and Van Drie recently proposed the use of structure-activity landscape index (SALI) curves via the SALI curve integral (SCI) as a means to map the predictive power of computational models within the predictive space.  This approach evaluates model performance by assessing the accuracy of pairwise predictions, comparing compd. pairs in a manner similar to that done by medicinal chemists.  Results: The SALI approach was used to evaluate the performance of continuous prediction models for MDR1-MDCK in vitro efflux potential.  Efflux models were built with ADMET Predictor neural net, support vector machine, kernel partial least squares, and multiple linear regression engines, as well as SIMCA-P+ partial least squares, and random forest from Pipeline Pilot as implemented by AstraZeneca, using mol. descriptors from SimulationsPlus and AstraZeneca.  Conclusion: The results indicate that the choice of training sets used to build the prediction models is of great importance in the resulting model quality and that the SCI values calcd. for these models were very similar to their Kendall τ values, leading to our suggestion of an approach to use this SALI/SCI paradigm to evaluate predictive model performance that will allow more informed decisions regarding model utility.  The use of SALI graphs and curves provides an addnl. level of quality assessment for predictive models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9Id6r_IMYBrVg90H21EOLACvtfcHk0lge3yQvwdLvew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXitFyit7o%253D&md5=4dfebef8c41a954bdf84e2443bd63bb6</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1186%2F1758-2946-3-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1758-2946-3-7%26sid%3Dliteratum%253Aachs%26aulast%3DLeDonne%26aufirst%3DN.%2BC.%26aulast%3DRissolo%26aufirst%3DK.%26aulast%3DBulgarelli%26aufirst%3DJ.%26aulast%3DTini%26aufirst%3DL.%26atitle%3DUse%2520of%2520structure%25E2%2580%2593activity%2520landscape%2520index%2520curves%2520and%2520curve%2520integrals%2520to%2520evaluate%2520the%2520performance%2520of%2520multiple%2520machine%2520learning%2520prediction%2520models%26jtitle%3DJ.%2520Cheminf.%26date%3D2011%26volume%3D3%26spage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Friden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ljungqvist, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bredberg, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammarlund-Udenaes, M.</span><span> </span><span class="NLM_article-title">Improved measurement of drug exposure in the brain using drug-specific correction for residual blood</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1038%2Fjcbfm.2009.200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=19756019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1Sg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=150-161&author=M.+Fridenauthor=H.+Ljungqvistauthor=B.+Middletonauthor=U.+Bredbergauthor=M.+Hammarlund-Udenaes&title=Improved+measurement+of+drug+exposure+in+the+brain+using+drug-specific+correction+for+residual+blood"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Improved measurement of drug exposure in the brain using drug-specific correction for residual blood</span></div><div class="casAuthors">Friden, Markus; Ljungqvist, Helena; Middleton, Brian; Bredberg, Ulf; Hammarlund-Udenaes, Margareta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow & Metabolism</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">150-161</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A major challenge assocd. with the detn. of the unbound brain-to-plasma concn. ratio of a drug (Kp,uu,brain), is the error assocd. with correction for the drug in various vascular spaces of the brain, i.e., in residual blood.  The apparent brain vascular spaces of plasma water (Vwater, 10.3 μL/g brain), plasma proteins (Vprotein, 7.99 μL/g brain), and the vol. of erythrocytes (Ver, 2.13 μL/g brain) were detd. and incorporated into a novel, drug-specific correction model that took the drug-unbound fraction in the plasma (fu,p) into account.  The correction model was successfully applied for the detn. of Kp,uu,brain for indomethacin, loperamide, and moxalactam, which had potential problems assocd. with correction.  The influence on correction of the drug assocd. with erythrocytes was shown to be minimal.  Therefore, it is proposed that correction for residual blood can be performed using an effective plasma space in the brain (Veff), which is calcd. from the measured fu,p of the particular drug as well as from the ests. of Vwater and Vprotein, which are provided in this study.  Furthermore, the results highlight the value of detg. Kp,uu,brain with statistical precision to enable appropriate interpretation of brain exposure for drugs that appear to be restricted to the brain vascular spaces.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdAwudBZex47Vg90H21EOLACvtfcHk0lge3yQvwdLvew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1Sg&md5=e55b0e2ec8254fdd498061cf3a1dd015</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1038%2Fjcbfm.2009.200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjcbfm.2009.200%26sid%3Dliteratum%253Aachs%26aulast%3DFriden%26aufirst%3DM.%26aulast%3DLjungqvist%26aufirst%3DH.%26aulast%3DMiddleton%26aufirst%3DB.%26aulast%3DBredberg%26aufirst%3DU.%26aulast%3DHammarlund-Udenaes%26aufirst%3DM.%26atitle%3DImproved%2520measurement%2520of%2520drug%2520exposure%2520in%2520the%2520brain%2520using%2520drug-specific%2520correction%2520for%2520residual%2520blood%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2010%26volume%3D30%26spage%3D150%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Borgegard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jureus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosqvist, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabirsh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotticci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klintenberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stromberg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nord, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parpal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malinowsky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radesater, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundkvist, J.</span><span> </span><span class="NLM_article-title">First and second generation gamma-secretase modulators (GSMs) modulate amyloid-beta (Abeta) peptide production through different mechanisms</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">11810</span><span class="NLM_x">–</span> <span class="NLM_lpage">11819</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=11810-11819&author=T.+Borgegardauthor=A.+Jureusauthor=F.+Olssonauthor=S.+Rosqvistauthor=A.+Sabirshauthor=D.+Rotticciauthor=K.+Paulsenauthor=R.+Klintenbergauthor=H.+Yanauthor=M.+Waldmanauthor=K.+Strombergauthor=J.+Nordauthor=J.+Johanssonauthor=A.+Regnerauthor=S.+Parpalauthor=D.+Malinowskyauthor=A.+C.+Radesaterauthor=T.+Liauthor=R.+Singhauthor=H.+Erikssonauthor=J.+Lundkvist&title=First+and+second+generation+gamma-secretase+modulators+%28GSMs%29+modulate+amyloid-beta+%28Abeta%29+peptide+production+through+different+mechanisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorgegard%26aufirst%3DT.%26aulast%3DJureus%26aufirst%3DA.%26aulast%3DOlsson%26aufirst%3DF.%26aulast%3DRosqvist%26aufirst%3DS.%26aulast%3DSabirsh%26aufirst%3DA.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3DPaulsen%26aufirst%3DK.%26aulast%3DKlintenberg%26aufirst%3DR.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DWaldman%26aufirst%3DM.%26aulast%3DStromberg%26aufirst%3DK.%26aulast%3DNord%26aufirst%3DJ.%26aulast%3DJohansson%26aufirst%3DJ.%26aulast%3DRegner%26aufirst%3DA.%26aulast%3DParpal%26aufirst%3DS.%26aulast%3DMalinowsky%26aufirst%3DD.%26aulast%3DRadesater%26aufirst%3DA.%2BC.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DEriksson%26aufirst%3DH.%26aulast%3DLundkvist%26aufirst%3DJ.%26atitle%3DFirst%2520and%2520second%2520generation%2520gamma-secretase%2520modulators%2520%2528GSMs%2529%2520modulate%2520amyloid-beta%2520%2528Abeta%2529%2520peptide%2520production%2520through%2520different%2520mechanisms%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D11810%26epage%3D11819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Dayneka, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garg, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jusko, W. J.</span><span> </span><span class="NLM_article-title">Comparison of four basic models of indirect pharmacodynamic responses</span> <span class="citation_source-journal">J. Pharmacokinet. Biopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">478</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1007%2FBF01061691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=8133465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADyaK2cXitlGhsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1993&pages=457-478&author=N.+L.+Daynekaauthor=V.+Gargauthor=W.+J.+Jusko&title=Comparison+of+four+basic+models+of+indirect+pharmacodynamic+responses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of four basic models of indirect pharmacodynamic responses</span></div><div class="casAuthors">Dayneka, Natalie L.; Garg, Varun; Jusko, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacokinetics and Biopharmaceutics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">457-78</span>CODEN:
                <span class="NLM_cas:coden">JPBPBJ</span>;
        ISSN:<span class="NLM_cas:issn">0090-466X</span>.
    </div><div class="casAbstract">Four basic models for characterizing indirect pharmacodynamic responses after drug administration have been developed and compared.  The models are based on drug effects (inhibition or stimulation) on the factors controlling either the input or the dissipation of drug response.  Pharmacokinetic parameters of methylprednisolone were used to generate plasma concn. and response-time profiles using computer simulations.  It was found that the responses produced showed a slow onset and a slow return to baseline.  The time of maximal response was dependent on the model and dose.  In each case, hysteresis plots showed that drug concns. preceded the response.  When the responses were fitted with pharmacodynamic models based on distribution to a hypothetical effect compartment, the resulting parameters were dose-dependent and inferred biol. implausibility.  Indirect response models must be treated as distinct from conventional pharmacodynamic models which assume direct action of drugs.  The assumptions, equations, and data patterns for the four basic indirect response models provide a starting point for evaluation of pharmacol. effects where the site of action precedes or follows the measured response variable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptE7XtAvmESLVg90H21EOLACvtfcHk0liwF3XY2UEL9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitlGhsb0%253D&md5=906c542a76bbe718b8c5f61a2973fdea</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1007%2FBF01061691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01061691%26sid%3Dliteratum%253Aachs%26aulast%3DDayneka%26aufirst%3DN.%2BL.%26aulast%3DGarg%26aufirst%3DV.%26aulast%3DJusko%26aufirst%3DW.%2BJ.%26atitle%3DComparison%2520of%2520four%2520basic%2520models%2520of%2520indirect%2520pharmacodynamic%2520responses%26jtitle%3DJ.%2520Pharmacokinet.%2520Biopharm.%26date%3D1993%26volume%3D21%26spage%3D457%26epage%3D478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 55 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Bryan Li, Richard W. Barnhart, Amelie Dion, Steven Guinness, Alan Happe, Cheryl M. Hayward, Jeffrey Kohrt, Teresa Makowski, Mark Maloney, Jade D. Nelson, Asaad Nematalla, J. Christopher McWilliams, Zhihui Peng, Jeffrey Raggon, John Sagal, Gerald A. Weisenburger, Denghui Bao, Miguel Gonzalez, Jiangping Lu, Mark D. McLaws, Jian Tao, <span class="NLM_string-name hlFld-ContribAuthor">Baolin Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Process Development of a Second Generation β-Amyloid-Cleaving Enzyme Inhibitor—Improving the Robustness of a Halogen-Metal Exchange Using Continuous Stirred-Tank Reactors. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2021,</strong> <em>25 </em>
                                    (6)
                                     , 1440-1453. <a href="https://doi.org/10.1021/acs.oprd.1c00126" title="DOI URL">https://doi.org/10.1021/acs.oprd.1c00126</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.1c00126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.1c00126%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DProcess%252BDevelopment%252Bof%252Ba%252BSecond%252BGeneration%252B%2525CE%2525B2-Amyloid-Cleaving%252BEnzyme%252BInhibitor%2525E2%252580%252594Improving%252Bthe%252BRobustness%252Bof%252Ba%252BHalogen-Metal%252BExchange%252BUsing%252BContinuous%252BStirred-Tank%252BReactors%26aulast%3DLi%26aufirst%3DBryan%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D12042021%26date%3D24052021%26volume%3D25%26issue%3D6%26spage%3D1440%26epage%3D1453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Brian
T. O’Neill, Elizabeth M. Beck, Christopher R. Butler, Charles E. Nolan, Cathleen Gonzales, Lei Zhang, Shawn D. Doran, Kimberly Lapham, Leanne M. Buzon, Jason K. Dutra, Gabriela Barreiro, Xinjun Hou, Luis A. Martinez-Alsina, Bruce N. Rogers, Anabella Villalobos, John C. Murray, Kevin Ogilvie, Erik A. LaChapelle, Cheng Chang, Lorraine F. Lanyon, Claire M. Steppan, Ashley Robshaw, Katherine Hales, Germaine G. Boucher, Karamjeet Pandher, Christopher Houle, Claude W. Ambroise, David Karanian, David Riddell, Kelly R. Bales, <span class="NLM_string-name hlFld-ContribAuthor">Michael A. Brodney</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Clinical Candidate PF-06751979: A Potent, Brain Penetrant, β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor Lacking Hypopigmentation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (10)
                                     , 4476-4504. <a href="https://doi.org/10.1021/acs.jmedchem.8b00246" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00246</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00246%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BClinical%252BCandidate%252BPF-06751979%25253A%252BA%252BPotent%25252C%252BBrain%252BPenetrant%25252C%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B1%252B%252528BACE1%252529%252BInhibitor%252BLacking%252BHypopigmentation%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DBrian%2BT.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D13022018%26date%3D17042018%26date%3D03042018%26volume%3D61%26issue%3D10%26spage%3D4476%26epage%3D4504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Desiree Znidar, David Cantillo, Phillip Inglesby, Alistair Boyd, <span class="NLM_string-name hlFld-ContribAuthor">C. Oliver Kappe</span>. </span><span class="cited-content_cbyCitation_article-title">Process Intensification and Integration Studies for the Generation of a Key Aminoimidazole Intermediate in the Synthesis of Lanabecestat. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2018,</strong> <em>22 </em>
                                    (5)
                                     , 633-640. <a href="https://doi.org/10.1021/acs.oprd.8b00089" title="DOI URL">https://doi.org/10.1021/acs.oprd.8b00089</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.8b00089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.8b00089%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DProcess%252BIntensification%252Band%252BIntegration%252BStudies%252Bfor%252Bthe%252BGeneration%252Bof%252Ba%252BKey%252BAminoimidazole%252BIntermediate%252Bin%252Bthe%252BSynthesis%252Bof%252BLanabecestat%26aulast%3DZnidar%26aufirst%3DDesiree%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D26032018%26date%3D03052018%26date%3D26042018%26volume%3D22%26issue%3D5%26spage%3D633%26epage%3D640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Patrik Johansson, Karin Kaspersson, Ian K. Gurrell, Elisabeth Bäck, Susanna Eketjäll, Clay W. Scott, Gvido Cebers, Philip Thorne, Michael J. McKenzie, Haydn Beaton, Paul Davey, Karin Kolmodin, Jörg Holenz, Mark E. Duggan, Samantha Budd Haeberlein, <span class="NLM_string-name hlFld-ContribAuthor">Roland W. Bürli</span>. </span><span class="cited-content_cbyCitation_article-title">Toward β-Secretase-1 Inhibitors with Improved Isoform Selectivity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (8)
                                     , 3491-3502. <a href="https://doi.org/10.1021/acs.jmedchem.7b01716" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01716</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01716%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DToward%252B%2525CE%2525B2-Secretase-1%252BInhibitors%252Bwith%252BImproved%252BIsoform%252BSelectivity%26aulast%3DJohansson%26aufirst%3DPatrik%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D21112017%26date%3D10042018%26date%3D04042018%26volume%3D61%26issue%3D8%26spage%3D3491%26epage%3D3502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian  Taylor</span>, <span class="hlFld-ContribAuthor ">Cristina  Fernandez Barrat</span>, <span class="hlFld-ContribAuthor ">Robert L.  Woodward</span>, and <span class="hlFld-ContribAuthor ">Phillip A.  Inglesby</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2-Oxopropanethioamide for the Manufacture of Lanabecestat: A New Route for Control, Robustness, and Operational Improvements. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2017,</strong> <em>21 </em>
                                    (9)
                                     , 1404-1412. <a href="https://doi.org/10.1021/acs.oprd.7b00170" title="DOI URL">https://doi.org/10.1021/acs.oprd.7b00170</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.7b00170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.7b00170%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DSynthesis%252Bof%252B2-Oxopropanethioamide%252Bfor%252Bthe%252BManufacture%252Bof%252BLanabecestat%25253A%252BA%252BNew%252BRoute%252Bfor%252BControl%25252C%252BRobustness%25252C%252Band%252BOperational%252BImprovements%26aulast%3DTaylor%26aufirst%3DBrian%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D09052017%26date%3D07082017%26date%3D15092017%26date%3D06072017%26volume%3D21%26issue%3D9%26spage%3D1404%26epage%3D1412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhongzhi  Zhu</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Tang</span>, <span class="hlFld-ContribAuthor ">Jianxiao  Li</span>, <span class="hlFld-ContribAuthor ">Xianwei  Li</span>, <span class="hlFld-ContribAuthor ">Wanqing  Wu</span>, <span class="hlFld-ContribAuthor ">Guohua  Deng</span>, and <span class="hlFld-ContribAuthor ">Huanfeng  Jiang</span>  . </span><span class="cited-content_cbyCitation_article-title">Iron-Catalyzed Synthesis of 2H-Imidazoles from Oxime Acetates and Vinyl Azides under Redox-Neutral Conditions. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2017,</strong> <em>19 </em>
                                    (6)
                                     , 1370-1373. <a href="https://doi.org/10.1021/acs.orglett.7b00203" title="DOI URL">https://doi.org/10.1021/acs.orglett.7b00203</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.7b00203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.7b00203%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DIron-Catalyzed%252BSynthesis%252Bof%252B2H-Imidazoles%252Bfrom%252BOxime%252BAcetates%252Band%252BVinyl%252BAzides%252Bunder%252BRedox-Neutral%252BConditions%26aulast%3DZhu%26aufirst%3DZhongzhi%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D25012017%26date%3D01032017%26date%3D17032017%26volume%3D19%26issue%3D6%26spage%3D1370%26epage%3D1373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefan  Geschwindner</span>, <span class="hlFld-ContribAuthor ">Johan  Ulander</span>, and <span class="hlFld-ContribAuthor ">Patrik  Johansson</span>  . </span><span class="cited-content_cbyCitation_article-title">Ligand Binding Thermodynamics in Drug Discovery: Still a Hot Tip?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (16)
                                     , 6321-6335. <a href="https://doi.org/10.1021/jm501511f" title="DOI URL">https://doi.org/10.1021/jm501511f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501511f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501511f%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLigand%252BBinding%252BThermodynamics%252Bin%252BDrug%252BDiscovery%25253A%252BStill%252Ba%252BHot%252BTip%25253F%26aulast%3DGeschwindner%26aufirst%3DStefan%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D01102014%26date%3D11052015%26date%3D27082015%26date%3D27042015%26volume%3D58%26issue%3D16%26spage%3D6321%26epage%3D6335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuezhao  Xu</span>, <span class="hlFld-ContribAuthor ">Wen  Ding</span>, <span class="hlFld-ContribAuthor ">Yuanguang  Lin</span>, and <span class="hlFld-ContribAuthor ">Qiuling  Song</span>  . </span><span class="cited-content_cbyCitation_article-title">Cu-Catalyzed Aerobic Oxidative Esterification of Acetophenones with Alcohols to α-Ketoesters. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2015,</strong> <em>17 </em>
                                    (3)
                                     , 516-519. <a href="https://doi.org/10.1021/ol503472x" title="DOI URL">https://doi.org/10.1021/ol503472x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol503472x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol503472x%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCu-Catalyzed%252BAerobic%252BOxidative%252BEsterification%252Bof%252BAcetophenones%252Bwith%252BAlcohols%252Bto%252B%2525CE%2525B1-Ketoesters%26aulast%3DXu%26aufirst%3DXuezhao%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D07122014%26date%3D22012015%26date%3D06022015%26volume%3D17%26issue%3D3%26spage%3D516%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oleg  Epstein</span>, <span class="hlFld-ContribAuthor ">Marian C.  Bryan</span>, <span class="hlFld-ContribAuthor ">Alan C.  Cheng</span>, <span class="hlFld-ContribAuthor ">Katayoun  Derakhchan</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Dineen</span>, <span class="hlFld-ContribAuthor ">Dean  Hickman</span>, <span class="hlFld-ContribAuthor ">Zihao  Hua</span>, <span class="hlFld-ContribAuthor ">Jason B.  Human</span>, <span class="hlFld-ContribAuthor ">Charles  Kreiman</span>, <span class="hlFld-ContribAuthor ">Isaac E.  Marx</span>, <span class="hlFld-ContribAuthor ">Matthew M.  Weiss</span>, <span class="hlFld-ContribAuthor ">Robert C.  Wahl</span>, <span class="hlFld-ContribAuthor ">Paul H.  Wen</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Stephen  Wood</span>, <span class="hlFld-ContribAuthor ">Xiao Mei  Zheng</span>, <span class="hlFld-ContribAuthor ">Robert T.  Fremeau, Jr.</span>, <span class="hlFld-ContribAuthor ">Ryan D.  White</span>, and <span class="hlFld-ContribAuthor ">Vinod F.  Patel</span>  . </span><span class="cited-content_cbyCitation_article-title">Lead Optimization and Modulation of hERG Activity in a Series of Aminooxazoline Xanthene β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (23)
                                     , 9796-9810. <a href="https://doi.org/10.1021/jm501266w" title="DOI URL">https://doi.org/10.1021/jm501266w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501266w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501266w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLead%252BOptimization%252Band%252BModulation%252Bof%252BhERG%252BActivity%252Bin%252Ba%252BSeries%252Bof%252BAminooxazoline%252BXanthene%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B%252528BACE1%252529%252BInhibitors%26aulast%3DEpstein%26aufirst%3DOleg%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D18082014%26date%3D12112014%26date%3D11122014%26volume%3D57%26issue%3D23%26spage%3D9796%26epage%3D9810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas A.  Dineen</span>, <span class="hlFld-ContribAuthor ">Kui  Chen</span>, <span class="hlFld-ContribAuthor ">Alan C.  Cheng</span>, <span class="hlFld-ContribAuthor ">Katayoun  Derakhchan</span>, <span class="hlFld-ContribAuthor ">Oleg  Epstein</span>, <span class="hlFld-ContribAuthor ">Joel  Esmay</span>, <span class="hlFld-ContribAuthor ">Dean  Hickman</span>, <span class="hlFld-ContribAuthor ">Chuck E.  Kreiman</span>, <span class="hlFld-ContribAuthor ">Isaac E.  Marx</span>, <span class="hlFld-ContribAuthor ">Robert C.  Wahl</span>, <span class="hlFld-ContribAuthor ">Paul H.  Wen</span>, <span class="hlFld-ContribAuthor ">Matthew M.  Weiss</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Stephen  Wood</span>, <span class="hlFld-ContribAuthor ">Robert T.  Fremeau, Jr.</span>, <span class="hlFld-ContribAuthor ">Ryan D.  White</span>, and <span class="hlFld-ContribAuthor ">Vinod F.  Patel</span>  . </span><span class="cited-content_cbyCitation_article-title">Inhibitors of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1): Identification of (S)-7-(2-Fluoropyridin-3-yl)-3-((3-methyloxetan-3-yl)ethynyl)-5′H-spiro[chromeno[2,3-b]pyridine-5,4′-oxazol]-2′-amine (AMG-8718). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (23)
                                     , 9811-9831. <a href="https://doi.org/10.1021/jm5012676" title="DOI URL">https://doi.org/10.1021/jm5012676</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5012676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5012676%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInhibitors%252Bof%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B%252528BACE1%252529%25253A%252BIdentification%252Bof%252B%252528S%252529-7-%2525282-Fluoropyridin-3-yl%252529-3-%252528%2525283-methyloxetan-3-yl%252529ethynyl%252529-5%2525E2%252580%2525B2H-spiro%25255Bchromeno%25255B2%25252C3-b%25255Dpyridine-5%25252C4%2525E2%252580%2525B2-oxazol%25255D-2%2525E2%252580%2525B2-amine%252B%252528AMG-8718%252529%26aulast%3DDineen%26aufirst%3DThomas%2BA.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D18082014%26date%3D14112014%26date%3D11122014%26date%3D01112014%26volume%3D57%26issue%3D23%26spage%3D9811%26epage%3D9831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Allen A.  Thomas</span>, <span class="hlFld-ContribAuthor ">Kevin W.  Hunt</span>, <span class="hlFld-ContribAuthor ">Brad  Newhouse</span>, <span class="hlFld-ContribAuthor ">Ryan J.  Watts</span>, <span class="hlFld-ContribAuthor ">Xingrong  Liu</span>, <span class="hlFld-ContribAuthor ">Guy  Vigers</span>, <span class="hlFld-ContribAuthor ">Darin  Smith</span>, <span class="hlFld-ContribAuthor ">Susan P.  Rhodes</span>, <span class="hlFld-ContribAuthor ">Karin D.  Brown</span>, <span class="hlFld-ContribAuthor ">Jennifer N.  Otten</span>, <span class="hlFld-ContribAuthor ">Michael  Burkard</span>, <span class="hlFld-ContribAuthor ">April A.  Cox</span>, <span class="hlFld-ContribAuthor ">Mary K.  Geck Do</span>, <span class="hlFld-ContribAuthor ">Darrin  Dutcher</span>, <span class="hlFld-ContribAuthor ">Sumeet  Rana</span>, <span class="hlFld-ContribAuthor ">Robert K.  DeLisle</span>, <span class="hlFld-ContribAuthor ">Kelly  Regal</span>, <span class="hlFld-ContribAuthor ">Albion D.  Wright</span>, <span class="hlFld-ContribAuthor ">Robert  Groneberg</span>, <span class="hlFld-ContribAuthor ">Jiangpeng  Liao</span>, <span class="hlFld-ContribAuthor ">Kimberly  Scearce-Levie</span>, <span class="hlFld-ContribAuthor ">Michael  Siu</span>, <span class="hlFld-ContribAuthor ">Hans E.  Purkey</span>, and <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>  . </span><span class="cited-content_cbyCitation_article-title">8-Tetrahydropyran-2-yl Chromans: Highly Selective Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (23)
                                     , 10112-10129. <a href="https://doi.org/10.1021/jm5015132" title="DOI URL">https://doi.org/10.1021/jm5015132</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5015132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5015132%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D8-Tetrahydropyran-2-yl%252BChromans%25253A%252BHighly%252BSelective%252BBeta-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B1%252B%252528BACE1%252529%252BInhibitors%26aulast%3DThomas%26aufirst%3DAllen%2BA.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D01102014%26date%3D26112014%26date%3D11122014%26date%3D20112014%26volume%3D57%26issue%3D23%26spage%3D10112%26epage%3D10129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jenny  Viklund</span>, <span class="hlFld-ContribAuthor ">Karin  Kolmodin</span>, <span class="hlFld-ContribAuthor ">Gunnar  Nordvall</span>, <span class="hlFld-ContribAuthor ">Britt-Marie  Swahn</span>, <span class="hlFld-ContribAuthor ">Mats  Svensson</span>, <span class="hlFld-ContribAuthor ">Ylva  Gravenfors</span>, and <span class="hlFld-ContribAuthor ">Fredrik  Rahm</span>  . </span><span class="cited-content_cbyCitation_article-title">Creation of Novel Cores for β-Secretase (BACE-1) Inhibitors: A Multiparameter Lead Generation Strategy. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>5 </em>
                                    (4)
                                     , 440-445. <a href="https://doi.org/10.1021/ml5000433" title="DOI URL">https://doi.org/10.1021/ml5000433</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml5000433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml5000433%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCreation%252Bof%252BNovel%252BCores%252Bfor%252B%2525CE%2525B2-Secretase%252B%252528BACE-1%252529%252BInhibitors%25253A%252BA%252BMultiparameter%252BLead%252BGeneration%252BStrategy%26aulast%3DViklund%26aufirst%3DJenny%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D29012014%26date%3D03022014%26date%3D10022014%26date%3D10042014%26date%3D03022014%26volume%3D5%26issue%3D4%26spage%3D440%26epage%3D445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katarina  Roos</span>, <span class="hlFld-ContribAuthor ">Jenny  Viklund</span>, <span class="hlFld-ContribAuthor ">Johan  Meuller</span>, <span class="hlFld-ContribAuthor ">Karin  Kaspersson</span>, and <span class="hlFld-ContribAuthor ">Mats  Svensson</span>  . </span><span class="cited-content_cbyCitation_article-title">Potency Prediction of β-Secretase (BACE-1) Inhibitors Using Density Functional Methods. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2014,</strong> <em>54 </em>
                                    (3)
                                     , 818-825. <a href="https://doi.org/10.1021/ci400374z" title="DOI URL">https://doi.org/10.1021/ci400374z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci400374z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci400374z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DPotency%252BPrediction%252Bof%252B%2525CE%2525B2-Secretase%252B%252528BACE-1%252529%252BInhibitors%252BUsing%252BDensity%252BFunctional%252BMethods%26aulast%3DRoos%26aufirst%3DKatarina%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D28062013%26date%3D24022014%26date%3D24032014%26date%3D23012014%26volume%3D54%26issue%3D3%26spage%3D818%26epage%3D825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Koteswara Rao  Valasani</span>, <span class="hlFld-ContribAuthor ">Jhansi Rani  Vangavaragu</span>, <span class="hlFld-ContribAuthor ">Victor W.  Day</span>, and <span class="hlFld-ContribAuthor ">Shirley ShiDu  Yan</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure Based Design, Synthesis, Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Identification of Novel Cyclophilin D Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2014,</strong> <em>54 </em>
                                    (3)
                                     , 902-912. <a href="https://doi.org/10.1021/ci5000196" title="DOI URL">https://doi.org/10.1021/ci5000196</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci5000196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci5000196%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DStructure%252BBased%252BDesign%25252C%252BSynthesis%25252C%252BPharmacophore%252BModeling%25252C%252BVirtual%252BScreening%25252C%252Band%252BMolecular%252BDocking%252BStudies%252Bfor%252BIdentification%252Bof%252BNovel%252BCyclophilin%252BD%252BInhibitors%26aulast%3DValasani%26aufirst%3DKoteswara%2BRao%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D11012014%26date%3D28022014%26date%3D24032014%26date%3D20022014%26volume%3D54%26issue%3D3%26spage%3D902%26epage%3D912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Allen A.  Thomas</span>, <span class="hlFld-ContribAuthor ">Kevin W.  Hunt</span>, <span class="hlFld-ContribAuthor ">Matthew  Volgraf</span>, <span class="hlFld-ContribAuthor ">Ryan J.  Watts</span>, <span class="hlFld-ContribAuthor ">Xingrong  Liu</span>, <span class="hlFld-ContribAuthor ">Guy  Vigers</span>, <span class="hlFld-ContribAuthor ">Darin  Smith</span>, <span class="hlFld-ContribAuthor ">Douglas  Sammond</span>, <span class="hlFld-ContribAuthor ">Tony P.  Tang</span>, <span class="hlFld-ContribAuthor ">Susan P.  Rhodes</span>, <span class="hlFld-ContribAuthor ">Andrew T.  Metcalf</span>, <span class="hlFld-ContribAuthor ">Karin D.  Brown</span>, <span class="hlFld-ContribAuthor ">Jennifer N.  Otten</span>, <span class="hlFld-ContribAuthor ">Michael  Burkard</span>, <span class="hlFld-ContribAuthor ">April A.  Cox</span>, <span class="hlFld-ContribAuthor ">Mary K. Geck  Do</span>, <span class="hlFld-ContribAuthor ">Darrin  Dutcher</span>, <span class="hlFld-ContribAuthor ">Sumeet  Rana</span>, <span class="hlFld-ContribAuthor ">Robert K.  DeLisle</span>, <span class="hlFld-ContribAuthor ">Kelly  Regal</span>, <span class="hlFld-ContribAuthor ">Albion D.  Wright</span>, <span class="hlFld-ContribAuthor ">Robert  Groneberg</span>, <span class="hlFld-ContribAuthor ">Kimberly  Scearce-Levie</span>, <span class="hlFld-ContribAuthor ">Michael  Siu</span>, <span class="hlFld-ContribAuthor ">Hans E.  Purkey</span>, <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>, and <span class="hlFld-ContribAuthor ">Indrani W.  Gunawardana</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 7-Tetrahydropyran-2-yl Chromans: β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors That Reduce Amyloid β-Protein (Aβ) in the Central Nervous System. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (3)
                                     , 878-902. <a href="https://doi.org/10.1021/jm401635n" title="DOI URL">https://doi.org/10.1021/jm401635n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401635n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401635n%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B7-Tetrahydropyran-2-yl%252BChromans%25253A%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B1%252B%252528BACE1%252529%252BInhibitors%252BThat%252BReduce%252BAmyloid%252B%2525CE%2525B2-Protein%252B%252528A%2525CE%2525B2%252529%252Bin%252Bthe%252BCentral%252BNervous%252BSystem%26aulast%3DThomas%26aufirst%3DAllen%2BA.%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D21102013%26date%3D22012014%26date%3D13022014%26date%3D07012014%26volume%3D57%26issue%3D3%26spage%3D878%26epage%3D902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chun  Zhang</span>, <span class="hlFld-ContribAuthor ">Peng  Feng</span>, and <span class="hlFld-ContribAuthor ">Ning  Jiao</span>  . </span><span class="cited-content_cbyCitation_article-title">Cu-Catalyzed Esterification Reaction via Aerobic Oxygenation and C–C Bond Cleavage: An Approach to α-Ketoesters. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2013,</strong> <em>135 </em>
                                    (40)
                                     , 15257-15262. <a href="https://doi.org/10.1021/ja4085463" title="DOI URL">https://doi.org/10.1021/ja4085463</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja4085463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja4085463%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DCu-Catalyzed%252BEsterification%252BReaction%252Bvia%252BAerobic%252BOxygenation%252Band%252BC%2525E2%252580%252593C%252BBond%252BCleavage%25253A%252BAn%252BApproach%252Bto%252B%2525CE%2525B1-Ketoesters%26aulast%3DZhang%26aufirst%3DChun%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D18082013%26date%3D26092013%26date%3D09102013%26date%3D13092013%26volume%3D135%26issue%3D40%26spage%3D15257%26epage%3D15262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tobias  Ginman</span>, <span class="hlFld-ContribAuthor ">Jenny  Viklund</span>, <span class="hlFld-ContribAuthor ">Jonas  Malmström</span>, <span class="hlFld-ContribAuthor ">Jan  Blid</span>, <span class="hlFld-ContribAuthor ">Rikard  Emond</span>, <span class="hlFld-ContribAuthor ">Rickard  Forsblom</span>, <span class="hlFld-ContribAuthor ">Anh  Johansson</span>, <span class="hlFld-ContribAuthor ">Annika  Kers</span>, <span class="hlFld-ContribAuthor ">Fredrik  Lake</span>, <span class="hlFld-ContribAuthor ">Fernando  Sehgelmeble</span>, <span class="hlFld-ContribAuthor ">Karin J.  Sterky</span>, <span class="hlFld-ContribAuthor ">Margareta  Bergh</span>, <span class="hlFld-ContribAuthor ">Anders  Lindgren</span>, <span class="hlFld-ContribAuthor ">Patrik  Johansson</span>, <span class="hlFld-ContribAuthor ">Fredrik  Jeppsson</span>, <span class="hlFld-ContribAuthor ">Johanna  Fälting</span>, <span class="hlFld-ContribAuthor ">Ylva  Gravenfors</span>, and <span class="hlFld-ContribAuthor ">Fredrik  Rahm</span>  . </span><span class="cited-content_cbyCitation_article-title">Core Refinement toward Permeable β-Secretase (BACE-1) Inhibitors with Low hERG Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (11)
                                     , 4181-4205. <a href="https://doi.org/10.1021/jm3011349" title="DOI URL">https://doi.org/10.1021/jm3011349</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3011349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3011349%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCore%252BRefinement%252Btoward%252BPermeable%252B%2525CE%2525B2-Secretase%252B%252528BACE-1%252529%252BInhibitors%252Bwith%252BLow%252BhERG%252BActivity%26aulast%3DGinman%26aufirst%3DTobias%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D02082012%26date%3D20052013%26date%3D13062013%26date%3D05112012%26volume%3D56%26issue%3D11%26spage%3D4181%26epage%3D4205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Yuan</span>, <span class="hlFld-ContribAuthor ">Shankar  Venkatraman</span>, <span class="hlFld-ContribAuthor ">Yajun  Zheng</span>, <span class="hlFld-ContribAuthor ">Brian M.  McKeever</span>, <span class="hlFld-ContribAuthor ">Lawrence W.  Dillard</span>, and <span class="hlFld-ContribAuthor ">Suresh B.  Singh</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of β-Site APP Cleaving Enzyme 1 (BACE1) Inhibitors for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (11)
                                     , 4156-4180. <a href="https://doi.org/10.1021/jm301659n" title="DOI URL">https://doi.org/10.1021/jm301659n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301659n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301659n%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252B%2525CE%2525B2-Site%252BAPP%252BCleaving%252BEnzyme%252B1%252B%252528BACE1%252529%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DYuan%26aufirst%3DJing%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D09112012%26date%3D05042013%26date%3D13062013%26date%3D19032013%26volume%3D56%26issue%3D11%26spage%3D4156%26epage%3D4180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin W.  Hunt</span>, <span class="hlFld-ContribAuthor ">Adam W.  Cook</span>, <span class="hlFld-ContribAuthor ">Ryan J.  Watts</span>, <span class="hlFld-ContribAuthor ">Christopher T.  Clark</span>, <span class="hlFld-ContribAuthor ">Guy  Vigers</span>, <span class="hlFld-ContribAuthor ">Darin  Smith</span>, <span class="hlFld-ContribAuthor ">Andrew T.  Metcalf</span>, <span class="hlFld-ContribAuthor ">Indrani W.  Gunawardana</span>, <span class="hlFld-ContribAuthor ">Michael  Burkard</span>, <span class="hlFld-ContribAuthor ">April A.  Cox</span>, <span class="hlFld-ContribAuthor ">Mary K.  Geck Do</span>, <span class="hlFld-ContribAuthor ">Darrin  Dutcher</span>, <span class="hlFld-ContribAuthor ">Allen A.  Thomas</span>, <span class="hlFld-ContribAuthor ">Sumeet  Rana</span>, <span class="hlFld-ContribAuthor ">Nicholas C.  Kallan</span>, <span class="hlFld-ContribAuthor ">Robert K.  DeLisle</span>, <span class="hlFld-ContribAuthor ">James P.  Rizzi</span>, <span class="hlFld-ContribAuthor ">Kelly  Regal</span>, <span class="hlFld-ContribAuthor ">Douglas  Sammond</span>, <span class="hlFld-ContribAuthor ">Robert  Groneberg</span>, <span class="hlFld-ContribAuthor ">Michael  Siu</span>, <span class="hlFld-ContribAuthor ">Hans  Purkey</span>, <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>, <span class="hlFld-ContribAuthor ">Allison  Marlow</span>, <span class="hlFld-ContribAuthor ">Xingrong  Liu</span>, and <span class="hlFld-ContribAuthor ">Tony P.  Tang</span>  . </span><span class="cited-content_cbyCitation_article-title">Spirocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: From Hit to Lowering of Cerebrospinal Fluid (CSF) Amyloid β in a Higher Species. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (8)
                                     , 3379-3403. <a href="https://doi.org/10.1021/jm4002154" title="DOI URL">https://doi.org/10.1021/jm4002154</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4002154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4002154%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSpirocyclic%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B1%252B%252528BACE1%252529%252BInhibitors%25253A%252BFrom%252BHit%252Bto%252BLowering%252Bof%252BCerebrospinal%252BFluid%252B%252528CSF%252529%252BAmyloid%252B%2525CE%2525B2%252Bin%252Ba%252BHigher%252BSpecies%26aulast%3DHunt%26aufirst%3DKevin%2BW.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D13022013%26date%3D16042013%26date%3D25042013%26date%3D28032013%26volume%3D56%26issue%3D8%26spage%3D3379%26epage%3D3403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nefeli  Griboura</span>, <span class="hlFld-ContribAuthor ">Konstantinos  Gatzonas</span>, <span class="hlFld-ContribAuthor ">Constantinos G.  Neochoritis</span>. </span><span class="cited-content_cbyCitation_article-title">Still Relevant Today: The Asinger Multicomponent Reaction. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (13)
                                     , 1997-2020. <a href="https://doi.org/10.1002/cmdc.202100086" title="DOI URL">https://doi.org/10.1002/cmdc.202100086</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202100086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202100086%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DStill%252BRelevant%252BToday%25253A%252BThe%252BAsinger%252BMulticomponent%252BReaction%26aulast%3DGriboura%26aufirst%3DNefeli%26date%3D2021%26date%3D2021%26volume%3D16%26issue%3D13%26spage%3D1997%26epage%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Phuc Hoang  Pham</span>, <span class="hlFld-ContribAuthor ">Phuc Thai  Thien Nguyen</span>, <span class="hlFld-ContribAuthor ">Thuy Thu  Bui</span>, <span class="hlFld-ContribAuthor ">Hien Nhat  Tra</span>, <span class="hlFld-ContribAuthor ">Tung Thanh  Nguyen</span>, <span class="hlFld-ContribAuthor ">Nam Thanh  Son Phan</span>. </span><span class="cited-content_cbyCitation_article-title">Homo-condensation of acetophenones toward imidazothiones. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (66)
                                     , 40225-40228. <a href="https://doi.org/10.1039/D0RA03047C" title="DOI URL">https://doi.org/10.1039/D0RA03047C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA03047C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA03047C%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DHomo-condensation%252Bof%252Bacetophenones%252Btoward%252Bimidazothiones%26aulast%3DPham%26aufirst%3DPhuc%2BHoang%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D66%26spage%3D40225%26epage%3D40228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christiana  Bjorkli</span>, <span class="hlFld-ContribAuthor ">Axel  Sandvig</span>, <span class="hlFld-ContribAuthor ">Ioanna  Sandvig</span>. </span><span class="cited-content_cbyCitation_article-title">Bridging the Gap Between Fluid Biomarkers for Alzheimer’s Disease, Model Systems, and Patients. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Aging Neuroscience</span><span> <strong>2020,</strong> <em>12 </em><a href="https://doi.org/10.3389/fnagi.2020.00272" title="DOI URL">https://doi.org/10.3389/fnagi.2020.00272</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnagi.2020.00272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnagi.2020.00272%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Aging%2520Neuroscience%26atitle%3DBridging%252Bthe%252BGap%252BBetween%252BFluid%252BBiomarkers%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%25252C%252BModel%252BSystems%25252C%252Band%252BPatients%26aulast%3DBjorkli%26aufirst%3DChristiana%26date%3D2020%26date%3D2020%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ilia V.  Baranovsky</span>, <span class="hlFld-ContribAuthor ">Lidia S.  Konstantinova</span>, <span class="hlFld-ContribAuthor ">Mikhail A.  Tolmachev</span>, <span class="hlFld-ContribAuthor ">Vadim V.  Popov</span>, <span class="hlFld-ContribAuthor ">Konstantin  A. Lyssenko</span>, <span class="hlFld-ContribAuthor ">Oleg A.  Rakitin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2-((2-(Benzo[d]oxazol-2-yl)-2H-imidazol-4-yl)amino)-phenols from 2-((5H-1,2,3-Dithiazol-5-ylidene)amino)phenols through Unprecedented Formation of Imidazole Ring from Two Methanimino Groups. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (17)
                                     , 3768. <a href="https://doi.org/10.3390/molecules25173768" title="DOI URL">https://doi.org/10.3390/molecules25173768</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25173768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25173768%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Bof%252B2-%252528%2525282-%252528Benzo%25255Bd%25255Doxazol-2-yl%252529-2H-imidazol-4-yl%252529amino%252529-phenols%252Bfrom%252B2-%252528%2525285H-1%25252C2%25252C3-Dithiazol-5-ylidene%252529amino%252529phenols%252Bthrough%252BUnprecedented%252BFormation%252Bof%252BImidazole%252BRing%252Bfrom%252BTwo%252BMethanimino%252BGroups%26aulast%3DBaranovsky%26aufirst%3DIlia%2BV.%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D17%26spage%3D3768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhongzhi  Zhu</span>, <span class="hlFld-ContribAuthor ">Hanze  Lin</span>, <span class="hlFld-ContribAuthor ">Baihui  Liang</span>, <span class="hlFld-ContribAuthor ">Junjie  Huang</span>, <span class="hlFld-ContribAuthor ">Wanyi  Liang</span>, <span class="hlFld-ContribAuthor ">Lu  Chen</span>, <span class="hlFld-ContribAuthor ">Yubing  Huang</span>, <span class="hlFld-ContribAuthor ">Xiuwen  Chen</span>, <span class="hlFld-ContribAuthor ">Yibiao  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-catalyzed [2+3]-annulation of N–H imines with vinyl azides: access to polyaryl 2
              H
              -imidazoles. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2020,</strong> <em>56 </em>
                                    (42)
                                     , 5621-5624. <a href="https://doi.org/10.1039/C9CC10042C" title="DOI URL">https://doi.org/10.1039/C9CC10042C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CC10042C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CC10042C%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DCopper-catalyzed%252B%25255B2%25252B3%25255D-annulation%252Bof%252BN%2525E2%252580%252593H%252Bimines%252Bwith%252Bvinyl%252Bazides%25253A%252Baccess%252Bto%252Bpolyaryl%252B2%252BH%252B-imidazoles%26aulast%3DZhu%26aufirst%3DZhongzhi%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D42%26spage%3D5621%26epage%3D5624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Archana S.  Gurjar</span>, <span class="hlFld-ContribAuthor ">Vivek S.  Solanki</span>, <span class="hlFld-ContribAuthor ">Ankita R.  Meshram</span>, <span class="hlFld-ContribAuthor ">Suchita S.  Vishwakarma</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring beta amyloid cleavage enzyme‐1 inhibition and neuroprotective role of benzimidazole analogues as anti‐alzheimer agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Chinese Chemical Society</span><span> <strong>2020,</strong> <em>67 </em>
                                    (5)
                                     , 864-873. <a href="https://doi.org/10.1002/jccs.201900200" title="DOI URL">https://doi.org/10.1002/jccs.201900200</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jccs.201900200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjccs.201900200%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Chinese%2520Chemical%2520Society%26atitle%3DExploring%252Bbeta%252Bamyloid%252Bcleavage%252Benzyme%2525E2%252580%2525901%252Binhibition%252Band%252Bneuroprotective%252Brole%252Bof%252Bbenzimidazole%252Banalogues%252Bas%252Banti%2525E2%252580%252590alzheimer%252Bagents%26aulast%3DGurjar%26aufirst%3DArchana%2BS.%26date%3D2020%26date%3D2019%26volume%3D67%26issue%3D5%26spage%3D864%26epage%3D873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aida  Iraji</span>, <span class="hlFld-ContribAuthor ">Mahsima  Khoshneviszadeh</span>, <span class="hlFld-ContribAuthor ">Omidreza  Firuzi</span>, <span class="hlFld-ContribAuthor ">Mehdi  Khoshneviszadeh</span>, <span class="hlFld-ContribAuthor ">Najmeh  Edraki</span>. </span><span class="cited-content_cbyCitation_article-title">Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>97 </em>, 103649. <a href="https://doi.org/10.1016/j.bioorg.2020.103649" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103649</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103649%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DNovel%252Bsmall%252Bmolecule%252Btherapeutic%252Bagents%252Bfor%252BAlzheimer%252Bdisease%25253A%252BFocusing%252Bon%252BBACE1%252Band%252Bmulti-target%252Bdirected%252Bligands%26aulast%3DIraji%26aufirst%3DAida%26date%3D2020%26volume%3D97%26spage%3D103649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edward N.  Wilson</span>, <span class="hlFld-ContribAuthor ">Sonia  Do Carmo</span>, <span class="hlFld-ContribAuthor ">Lindsay A.  Welikovitch</span>, <span class="hlFld-ContribAuthor ">Hélène  Hall</span>, <span class="hlFld-ContribAuthor ">Lisi Flores  Aguilar</span>, <span class="hlFld-ContribAuthor ">Morgan K.  Foret</span>, <span class="hlFld-ContribAuthor ">M. Florencia  Iulita</span>, <span class="hlFld-ContribAuthor ">Dan Tong  Jia</span>, <span class="hlFld-ContribAuthor ">Adam R.  Marks</span>, <span class="hlFld-ContribAuthor ">Simon  Allard</span>, <span class="hlFld-ContribAuthor ">Joshua T.  Emmerson</span>, <span class="hlFld-ContribAuthor ">Adriana  Ducatenzeiler</span>, <span class="hlFld-ContribAuthor ">A. Claudio  Cuello</span>. </span><span class="cited-content_cbyCitation_article-title">NP03, a Microdose Lithium Formulation, Blunts Early Amyloid Post-Plaque Neuropathology in McGill-R-Thy1-APP Alzheimer-Like Transgenic Rats. </span><span class="cited-content_cbyCitation_journal-name">Journal of Alzheimer's Disease</span><span> <strong>2020,</strong> <em>73 </em>
                                    (2)
                                     , 723-739. <a href="https://doi.org/10.3233/JAD-190862" title="DOI URL">https://doi.org/10.3233/JAD-190862</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3233/JAD-190862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3233%2FJAD-190862%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Alzheimer%2527s%2520Disease%26atitle%3DNP03%25252C%252Ba%252BMicrodose%252BLithium%252BFormulation%25252C%252BBlunts%252BEarly%252BAmyloid%252BPost-Plaque%252BNeuropathology%252Bin%252BMcGill-R-Thy1-APP%252BAlzheimer-Like%252BTransgenic%252BRats%26aulast%3DWilson%26aufirst%3DEdward%2BN.%26date%3D2020%26volume%3D73%26issue%3D2%26spage%3D723%26epage%3D739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nalini  Schaduangrat</span>, <span class="hlFld-ContribAuthor ">Veda  Prachayasittikul</span>, <span class="hlFld-ContribAuthor ">Saowapak  Choomwattana</span>, <span class="hlFld-ContribAuthor ">Prapimpun  Wongchitrat</span>, <span class="hlFld-ContribAuthor ">Kamonrat  Phopin</span>, <span class="hlFld-ContribAuthor ">Wilasinee  Suwanjang</span>, <span class="hlFld-ContribAuthor ">Aijaz Ahmad  Malik</span>, <span class="hlFld-ContribAuthor ">Bruno  Vincent</span>, <span class="hlFld-ContribAuthor ">Chanin  Nantasenamat</span>. </span><span class="cited-content_cbyCitation_article-title">Multidisciplinary approaches for targeting the secretase protein family as a therapeutic route for Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (5)
                                     , 1730-1778. <a href="https://doi.org/10.1002/med.21563" title="DOI URL">https://doi.org/10.1002/med.21563</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21563%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DMultidisciplinary%252Bapproaches%252Bfor%252Btargeting%252Bthe%252Bsecretase%252Bprotein%252Bfamily%252Bas%252Ba%252Btherapeutic%252Broute%252Bfor%252BAlzheimer%252527s%252Bdisease%26aulast%3DSchaduangrat%26aufirst%3DNalini%26date%3D2019%26date%3D2019%26volume%3D39%26issue%3D5%26spage%3D1730%26epage%3D1778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiufeng  Xu</span>, <span class="hlFld-ContribAuthor ">Peng  Lü</span>, <span class="hlFld-ContribAuthor ">Junjie  Wang</span>, <span class="hlFld-ContribAuthor ">Fengrong  Xu</span>, <span class="hlFld-ContribAuthor ">Lei  Liang</span>, <span class="hlFld-ContribAuthor ">Chao  Wang</span>, <span class="hlFld-ContribAuthor ">Yan  Niu</span>, <span class="hlFld-ContribAuthor ">Ping  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of 4‐aminopyrimidine or 4,6‐diaminopyrimidine derivatives as beta amyloid cleaving enzyme‐1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2019,</strong> <em>93 </em>
                                    (5)
                                     , 926-933. <a href="https://doi.org/10.1111/cbdd.13489" title="DOI URL">https://doi.org/10.1111/cbdd.13489</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13489%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252B4%2525E2%252580%252590aminopyrimidine%252Bor%252B4%25252C6%2525E2%252580%252590diaminopyrimidine%252Bderivatives%252Bas%252Bbeta%252Bamyloid%252Bcleaving%252Benzyme%2525E2%252580%2525901%252Binhibitors%26aulast%3DXu%26aufirst%3DXiufeng%26date%3D2019%26date%3D2019%26volume%3D93%26issue%3D5%26spage%3D926%26epage%3D933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kejing  Lao</span>, <span class="hlFld-ContribAuthor ">Naichun  Ji</span>, <span class="hlFld-ContribAuthor ">Xiaohua  Zhang</span>, <span class="hlFld-ContribAuthor ">Wenwei  Qiao</span>, <span class="hlFld-ContribAuthor ">Zhishu  Tang</span>, <span class="hlFld-ContribAuthor ">Xingchun  Gou</span>. </span><span class="cited-content_cbyCitation_article-title">Drug development for Alzheimer’s disease: review. </span><span class="cited-content_cbyCitation_journal-name">Journal of Drug Targeting</span><span> <strong>2019,</strong> <em>27 </em>
                                    (2)
                                     , 164-173. <a href="https://doi.org/10.1080/1061186X.2018.1474361" title="DOI URL">https://doi.org/10.1080/1061186X.2018.1474361</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1061186X.2018.1474361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1061186X.2018.1474361%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Drug%2520Targeting%26atitle%3DDrug%252Bdevelopment%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%25253A%252Breview%26aulast%3DLao%26aufirst%3DKejing%26date%3D2019%26date%3D2018%26volume%3D27%26issue%3D2%26spage%3D164%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lucas J.  Gutiérrez</span>, <span class="hlFld-ContribAuthor ">Oscar  Parravicini</span>, <span class="hlFld-ContribAuthor ">Emilse  Sánchez</span>, <span class="hlFld-ContribAuthor ">Ricaurte  Rodríguez</span>, <span class="hlFld-ContribAuthor ">Justo  Cobo</span>, <span class="hlFld-ContribAuthor ">Ricardo D.  Enriz</span>. </span><span class="cited-content_cbyCitation_article-title">New substituted aminopyrimidine derivatives as BACE1 inhibitors: in silico design, synthesis and biological assays. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2019,</strong> <em>37 </em>
                                    (1)
                                     , 229-246. <a href="https://doi.org/10.1080/07391102.2018.1424036" title="DOI URL">https://doi.org/10.1080/07391102.2018.1424036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2018.1424036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2018.1424036%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DNew%252Bsubstituted%252Baminopyrimidine%252Bderivatives%252Bas%252BBACE1%252Binhibitors%25253A%252Bin%252Bsilico%252Bdesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bassays%26aulast%3DGuti%25C3%25A9rrez%26aufirst%3DLucas%2BJ.%26date%3D2019%26date%3D2018%26volume%3D37%26issue%3D1%26spage%3D229%26epage%3D246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">O.V.  Nevzglyadova</span>, <span class="hlFld-ContribAuthor ">E.V.  Mikhailova</span>, <span class="hlFld-ContribAuthor ">A.V.  Artemov</span>, <span class="hlFld-ContribAuthor ">Y.E.  Ozerova</span>, <span class="hlFld-ContribAuthor ">P.A.  Ivanova</span>, <span class="hlFld-ContribAuthor ">I.M.  Golomidov</span>, <span class="hlFld-ContribAuthor ">O.I.  Bolshakova</span>, <span class="hlFld-ContribAuthor ">V.V.  Zenin</span>, <span class="hlFld-ContribAuthor ">E.I.  Kostyleva</span>, <span class="hlFld-ContribAuthor ">T.R.  Soidla</span>, <span class="hlFld-ContribAuthor ">S.V.  Sarantseva</span>. </span><span class="cited-content_cbyCitation_article-title">Yeast red pigment modifies cloned human α-synuclein pathogenesis in Parkinson disease models in Saccharomyces cerevisiae and Drosophila melanogaster. </span><span class="cited-content_cbyCitation_journal-name">Neurochemistry International</span><span> <strong>2018,</strong> <em>120 </em>, 172-181. <a href="https://doi.org/10.1016/j.neuint.2018.08.002" title="DOI URL">https://doi.org/10.1016/j.neuint.2018.08.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuint.2018.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuint.2018.08.002%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurochemistry%2520International%26atitle%3DYeast%252Bred%252Bpigment%252Bmodifies%252Bcloned%252Bhuman%252B%2525CE%2525B1-synuclein%252Bpathogenesis%252Bin%252BParkinson%252Bdisease%252Bmodels%252Bin%252BSaccharomyces%252Bcerevisiae%252Band%252BDrosophila%252Bmelanogaster%26aulast%3DNevzglyadova%26aufirst%3DO.V.%26date%3D2018%26volume%3D120%26spage%3D172%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nallappan  Sundaravelu</span>, <span class="hlFld-ContribAuthor ">Ankush  Chakraborty</span>, <span class="hlFld-ContribAuthor ">Govindasamy  Sekar</span>. </span><span class="cited-content_cbyCitation_article-title">Domino Oxidative Esterification of 2-Oxo Alcohol Using 2-Iodoxybenzoic Acid/I
              2
              : A Route to Synthesize
              α
              -Ketoester. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2018,</strong> <em>3 </em>
                                    (28)
                                     , 8167-8170. <a href="https://doi.org/10.1002/slct.201800941" title="DOI URL">https://doi.org/10.1002/slct.201800941</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201800941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201800941%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DDomino%252BOxidative%252BEsterification%252Bof%252B2-Oxo%252BAlcohol%252BUsing%252B2-Iodoxybenzoic%252BAcid%25252FI%252B2%252B%25253A%252BA%252BRoute%252Bto%252BSynthesize%252B%2525CE%2525B1%252B-Ketoester%26aulast%3DSundaravelu%26aufirst%3DNallappan%26date%3D2018%26date%3D2018%26volume%3D3%26issue%3D28%26spage%3D8167%26epage%3D8170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Judite R. M.  Coimbra</span>, <span class="hlFld-ContribAuthor ">Daniela F. F.  Marques</span>, <span class="hlFld-ContribAuthor ">Salete J.  Baptista</span>, <span class="hlFld-ContribAuthor ">Cláudia M. F.  Pereira</span>, <span class="hlFld-ContribAuthor ">Paula I.  Moreira</span>, <span class="hlFld-ContribAuthor ">Teresa C. P.  Dinis</span>, <span class="hlFld-ContribAuthor ">Armanda E.  Santos</span>, <span class="hlFld-ContribAuthor ">Jorge A. R.  Salvador</span>. </span><span class="cited-content_cbyCitation_article-title">Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2018,</strong> <em>6 </em><a href="https://doi.org/10.3389/fchem.2018.00178" title="DOI URL">https://doi.org/10.3389/fchem.2018.00178</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2018.00178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2018.00178%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DHighlights%252Bin%252BBACE1%252BInhibitors%252Bfor%252BAlzheimer%252527s%252BDisease%252BTreatment%26aulast%3DCoimbra%26aufirst%3DJudite%2BR.%2BM.%26date%3D2018%26date%3D2018%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kamlesh S.  Vadagaonkar</span>, <span class="hlFld-ContribAuthor ">Hanuman P.  Kalmode</span>, <span class="hlFld-ContribAuthor ">Suresh L.  Shinde</span>, <span class="hlFld-ContribAuthor ">Atul C.  Chaskar</span>. </span><span class="cited-content_cbyCitation_article-title">An Efficient and Metal-free Synthesis of α-Ketoesters
              via
              Oxidative Cross Coupling of Arylglyoxals with Alcohols. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2017,</strong> <em>2 </em>
                                    (3)
                                     , 900-903. <a href="https://doi.org/10.1002/slct.201601825" title="DOI URL">https://doi.org/10.1002/slct.201601825</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201601825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201601825%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DAn%252BEfficient%252Band%252BMetal-free%252BSynthesis%252Bof%252B%2525CE%2525B1-Ketoesters%252Bvia%252BOxidative%252BCross%252BCoupling%252Bof%252BArylglyoxals%252Bwith%252BAlcohols%26aulast%3DVadagaonkar%26aufirst%3DKamlesh%2BS.%26date%3D2017%26date%3D2017%26volume%3D2%26issue%3D3%26spage%3D900%26epage%3D903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan D.  Low</span>, <span class="hlFld-ContribAuthor ">Michael D.  Bartberger</span>, <span class="hlFld-ContribAuthor ">Kui  Chen</span>, <span class="hlFld-ContribAuthor ">Yuan  Cheng</span>, <span class="hlFld-ContribAuthor ">Mark R.  Fielden</span>, <span class="hlFld-ContribAuthor ">Vijay  Gore</span>, <span class="hlFld-ContribAuthor ">Dean  Hickman</span>, <span class="hlFld-ContribAuthor ">Qingyian  Liu</span>, <span class="hlFld-ContribAuthor ">E.  Allen Sickmier</span>, <span class="hlFld-ContribAuthor ">Hugo M.  Vargas</span>, <span class="hlFld-ContribAuthor ">Jonathan  Werner</span>, <span class="hlFld-ContribAuthor ">Ryan D.  White</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Stephen  Wood</span>, <span class="hlFld-ContribAuthor ">Ana E.  Minatti</span>. </span><span class="cited-content_cbyCitation_article-title">Development of 2-aminooxazoline 3-azaxanthene β-amyloid cleaving enzyme (BACE) inhibitors with improved selectivity against Cathepsin D. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (6)
                                     , 1196-1206. <a href="https://doi.org/10.1039/C7MD00106A" title="DOI URL">https://doi.org/10.1039/C7MD00106A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MD00106A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MD00106A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDevelopment%252Bof%252B2-aminooxazoline%252B3-azaxanthene%252B%2525CE%2525B2-amyloid%252Bcleaving%252Benzyme%252B%252528BACE%252529%252Binhibitors%252Bwith%252Bimproved%252Bselectivity%252Bagainst%252BCathepsin%252BD%26aulast%3DLow%26aufirst%3DJonathan%2BD.%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D6%26spage%3D1196%26epage%3D1206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Susanna  Eketjäll</span>, <span class="hlFld-ContribAuthor ">Juliette  Janson</span>, <span class="hlFld-ContribAuthor ">Karin  Kaspersson</span>, <span class="hlFld-ContribAuthor ">Anna  Bogstedt</span>, <span class="hlFld-ContribAuthor ">Fredrik  Jeppsson</span>, <span class="hlFld-ContribAuthor ">Johanna  Fälting</span>, <span class="hlFld-ContribAuthor ">Samantha Budd  Haeberlein</span>, <span class="hlFld-ContribAuthor ">Alan R.  Kugler</span>, <span class="hlFld-ContribAuthor ">Robert C.  Alexander</span>, <span class="hlFld-ContribAuthor ">Gvido  Cebers</span>, . </span><span class="cited-content_cbyCitation_article-title">AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Alzheimer's Disease</span><span> <strong>2016,</strong> <em>50 </em>
                                    (4)
                                     , 1109-1123. <a href="https://doi.org/10.3233/JAD-150834" title="DOI URL">https://doi.org/10.3233/JAD-150834</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3233/JAD-150834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3233%2FJAD-150834%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Alzheimer%2527s%2520Disease%26atitle%3DAZD3293%25253A%252BA%252BNovel%25252C%252BOrally%252BActive%252BBACE1%252BInhibitor%252Bwith%252BHigh%252BPotency%252Band%252BPermeability%252Band%252BMarkedly%252BSlow%252BOff-Rate%252BKinetics%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DSusanna%26date%3D2016%26volume%3D50%26issue%3D4%26spage%3D1109%26epage%3D1123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nageshwar Rao  Penumati</span>, <span class="hlFld-ContribAuthor ">Lingayya  Rajaka</span>, <span class="hlFld-ContribAuthor ">Nagaiah  Kommu</span>. </span><span class="cited-content_cbyCitation_article-title">PEG-400 as an efficient and recyclable reaction medium for the synthesis of 2-aryl-2-methyl-4,5-diphenyl-2,3- dihydro-2
              H
              -imidazoles. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2016,</strong> <em>46 </em>
                                    (4)
                                     , 367-373. <a href="https://doi.org/10.1080/00397911.2016.1139721" title="DOI URL">https://doi.org/10.1080/00397911.2016.1139721</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2016.1139721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2016.1139721%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DPEG-400%252Bas%252Ban%252Befficient%252Band%252Brecyclable%252Breaction%252Bmedium%252Bfor%252Bthe%252Bsynthesis%252Bof%252B2-aryl-2-methyl-4%25252C5-diphenyl-2%25252C3-%252Bdihydro-2%252BH%252B-imidazoles%26aulast%3DPenumati%26aufirst%3DNageshwar%2BRao%26date%3D2016%26date%3D2016%26volume%3D46%26issue%3D4%26spage%3D367%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel F.  Wyss</span>, <span class="hlFld-ContribAuthor ">Jared N.  Cumming</span>, <span class="hlFld-ContribAuthor ">Corey O.  Strickland</span>, <span class="hlFld-ContribAuthor ">Andrew W.  Stamford</span>. </span><span class="cited-content_cbyCitation_article-title">BACE Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 327-354. <a href="https://doi.org/10.1002/9783527683604.ch14" title="DOI URL">https://doi.org/10.1002/9783527683604.ch14</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527683604.ch14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527683604.ch14%26sid%3Dliteratum%253Aachs%26atitle%3DBACE%252BInhibitors%26aulast%3DWyss%26aufirst%3DDaniel%2BF.%26date%3D2016%26date%3D2016%26spage%3D327%26epage%3D354%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DFragment-based%252BDrug%252BDiscovery%252BLessons%252Band%252BOutlook%26aulast%3DErlanson%26aufirst%3DDaniel%2BA.%26date%3D2016%26volume%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rachel K.  Chambers</span>, <span class="hlFld-ContribAuthor ">Tanweer A.  Khan</span>, <span class="hlFld-ContribAuthor ">David B.  Olsen</span>, <span class="hlFld-ContribAuthor ">Brad E.  Sleebs</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of amino heterocycle aspartyl protease inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (22)
                                     , 4970-4985. <a href="https://doi.org/10.1039/C5OB01842K" title="DOI URL">https://doi.org/10.1039/C5OB01842K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5OB01842K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5OB01842K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bamino%252Bheterocycle%252Baspartyl%252Bprotease%252Binhibitors%26aulast%3DChambers%26aufirst%3DRachel%2BK.%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D22%26spage%3D4970%26epage%3D4985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yue  He</span>, <span class="hlFld-ContribAuthor ">Jincheng  Mao</span>, <span class="hlFld-ContribAuthor ">Guangwei  Rong</span>, <span class="hlFld-ContribAuthor ">Hong  Yan</span>, <span class="hlFld-ContribAuthor ">Guoqi  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Iron-Catalyzed Esterification of Benzyl CH Bonds to Form α-Keto Benzyl Esters. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2015,</strong> <em>357 </em>
                                    (9)
                                     , 2125-2131. <a href="https://doi.org/10.1002/adsc.201500252" title="DOI URL">https://doi.org/10.1002/adsc.201500252</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201500252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201500252%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DIron-Catalyzed%252BEsterification%252Bof%252BBenzyl%252BC%2525EF%2525A3%2525BFH%252BBonds%252Bto%252BForm%252B%2525CE%2525B1-Keto%252BBenzyl%252BEsters%26aulast%3DHe%26aufirst%3DYue%26date%3D2015%26date%3D2015%26volume%3D357%26issue%3D9%26spage%3D2125%26epage%3D2131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Esteban Gabriel  Vega-Hissi</span>, <span class="hlFld-ContribAuthor ">Rodrigo  Tosso</span>, <span class="hlFld-ContribAuthor ">Ricardo Daniel  Enriz</span>, <span class="hlFld-ContribAuthor ">Lucas Joel  Gutierrez</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular insight into the interaction mechanisms of amino-2
              H
              -imidazole derivatives with BACE1 protease: A QM/MM and QTAIM study. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Quantum Chemistry</span><span> <strong>2015,</strong> <em>115 </em>
                                    (6)
                                     , 389-397. <a href="https://doi.org/10.1002/qua.24854" title="DOI URL">https://doi.org/10.1002/qua.24854</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/qua.24854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fqua.24854%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Quantum%2520Chemistry%26atitle%3DMolecular%252Binsight%252Binto%252Bthe%252Binteraction%252Bmechanisms%252Bof%252Bamino-2%252BH%252B-imidazole%252Bderivatives%252Bwith%252BBACE1%252Bprotease%25253A%252BA%252BQM%25252FMM%252Band%252BQTAIM%252Bstudy%26aulast%3DVega-Hissi%26aufirst%3DEsteban%2BGabriel%26date%3D2015%26date%3D2014%26volume%3D115%26issue%3D6%26spage%3D389%26epage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Biljana  Georgievska</span>, <span class="hlFld-ContribAuthor ">Susanne  Gustavsson</span>, <span class="hlFld-ContribAuthor ">Johan  Lundkvist</span>, <span class="hlFld-ContribAuthor ">Jan  Neelissen</span>, <span class="hlFld-ContribAuthor ">Susanna  Eketjäll</span>, <span class="hlFld-ContribAuthor ">Veronica  Ramberg</span>, <span class="hlFld-ContribAuthor ">Tjerk  Bueters</span>, <span class="hlFld-ContribAuthor ">Karin  Agerman</span>, <span class="hlFld-ContribAuthor ">Anders  Juréus</span>, <span class="hlFld-ContribAuthor ">Samuel  Svensson</span>, <span class="hlFld-ContribAuthor ">Stefan  Berg</span>, <span class="hlFld-ContribAuthor ">Johanna  Fälting</span>, <span class="hlFld-ContribAuthor ">Urban  Lendahl</span>. </span><span class="cited-content_cbyCitation_article-title">Revisiting the peripheral sink hypothesis: inhibiting BACE1 activity in the periphery does not alter β-amyloid levels in the CNS. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neurochemistry</span><span> <strong>2015,</strong> <em>132 </em>
                                    (4)
                                     , 477-486. <a href="https://doi.org/10.1111/jnc.12937" title="DOI URL">https://doi.org/10.1111/jnc.12937</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jnc.12937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjnc.12937%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neurochemistry%26atitle%3DRevisiting%252Bthe%252Bperipheral%252Bsink%252Bhypothesis%25253A%252Binhibiting%252BBACE1%252Bactivity%252Bin%252Bthe%252Bperiphery%252Bdoes%252Bnot%252Balter%252B%2525CE%2525B2-amyloid%252Blevels%252Bin%252Bthe%252BCNS%26aulast%3DGeorgievska%26aufirst%3DBiljana%26date%3D2015%26date%3D2014%26volume%3D132%26issue%3D4%26spage%3D477%26epage%3D486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rong-fu  Chen</span>, <span class="hlFld-ContribAuthor ">Ting  Zhang</span>, <span class="hlFld-ContribAuthor ">Yin-yi  Sun</span>, <span class="hlFld-ContribAuthor ">Ya-meng  Sun</span>, <span class="hlFld-ContribAuthor ">Wen-qi  Chen</span>, <span class="hlFld-ContribAuthor ">Nan  Shi</span>, <span class="hlFld-ContribAuthor ">Fang  Shen</span>, <span class="hlFld-ContribAuthor ">Yan  Zhang</span>, <span class="hlFld-ContribAuthor ">Kang-yong  Liu</span>, <span class="hlFld-ContribAuthor ">Xiao-jiang  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Oxygen-glucose deprivation regulates BACE1 expression through induction of autophagy in Neuro-2a/APP695 cells. </span><span class="cited-content_cbyCitation_journal-name">Neural Regeneration Research</span><span> <strong>2015,</strong> <em>10 </em>
                                    (9)
                                     , 1433. <a href="https://doi.org/10.4103/1673-5374.165511" title="DOI URL">https://doi.org/10.4103/1673-5374.165511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4103/1673-5374.165511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4103%2F1673-5374.165511%26sid%3Dliteratum%253Aachs%26jtitle%3DNeural%2520Regeneration%2520Research%26atitle%3DOxygen-glucose%252Bdeprivation%252Bregulates%252BBACE1%252Bexpression%252Bthrough%252Binduction%252Bof%252Bautophagy%252Bin%252BNeuro-2a%25252FAPP695%252Bcells%26aulast%3DChen%26aufirst%3DRong-fu%26date%3D2015%26volume%3D10%26issue%3D9%26spage%3D1433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Javier  López-Ogalla</span>, <span class="hlFld-ContribAuthor ">Esther  García-Palomero</span>, <span class="hlFld-ContribAuthor ">Jorge  Sánchez-Quesada</span>, <span class="hlFld-ContribAuthor ">Laura  Rubio</span>, <span class="hlFld-ContribAuthor ">Elena  Delgado</span>, <span class="hlFld-ContribAuthor ">Pablo  García</span>, <span class="hlFld-ContribAuthor ">Miguel  Medina</span>, <span class="hlFld-ContribAuthor ">Ana  Castro</span>, <span class="hlFld-ContribAuthor ">Pilar  Muñoz</span>. </span><span class="cited-content_cbyCitation_article-title">Bioactive prenylated phenyl derivatives derived from marine natural products: novel scaffolds for the design of BACE inhibitors. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2014,</strong> <em>5 </em>
                                    (4)
                                     , 474-488. <a href="https://doi.org/10.1039/C3MD00236E" title="DOI URL">https://doi.org/10.1039/C3MD00236E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C3MD00236E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC3MD00236E%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DBioactive%252Bprenylated%252Bphenyl%252Bderivatives%252Bderived%252Bfrom%252Bmarine%252Bnatural%252Bproducts%25253A%252Bnovel%252Bscaffolds%252Bfor%252Bthe%252Bdesign%252Bof%252BBACE%252Binhibitors%26aulast%3DL%25C3%25B3pez-Ogalla%26aufirst%3DJavier%26date%3D2014%26date%3D2014%26volume%3D5%26issue%3D4%26spage%3D474%26epage%3D488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juliette  Janson</span>, <span class="hlFld-ContribAuthor ">Susanna  Eketjäll</span>, <span class="hlFld-ContribAuthor ">Karin  Tunblad</span>, <span class="hlFld-ContribAuthor ">Fredrik  Jeppsson</span>, <span class="hlFld-ContribAuthor ">Stefan  Von Berg</span>, <span class="hlFld-ContribAuthor ">Camilla  Niva</span>, <span class="hlFld-ContribAuthor ">Ann-Cathrin  Radesäter</span>, <span class="hlFld-ContribAuthor ">Johanna  Fälting</span>, <span class="hlFld-ContribAuthor ">Sandra A. G.  Visser</span>. </span><span class="cited-content_cbyCitation_article-title">Population PKPD Modeling of BACE1 Inhibitor-Induced Reduction in Aβ Levels In Vivo and Correlation to In Vitro Potency in Primary Cortical Neurons from Mouse and Guinea Pig. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Research</span><span> <strong>2014,</strong> <em>31 </em>
                                    (3)
                                     , 670-683. <a href="https://doi.org/10.1007/s11095-013-1189-y" title="DOI URL">https://doi.org/10.1007/s11095-013-1189-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11095-013-1189-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11095-013-1189-y%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Research%26atitle%3DPopulation%252BPKPD%252BModeling%252Bof%252BBACE1%252BInhibitor-Induced%252BReduction%252Bin%252BA%2525CE%2525B2%252BLevels%252BIn%252BVivo%252Band%252BCorrelation%252Bto%252BIn%252BVitro%252BPotency%252Bin%252BPrimary%252BCortical%252BNeurons%252Bfrom%252BMouse%252Band%252BGuinea%252BPig%26aulast%3DJanson%26aufirst%3DJuliette%26date%3D2014%26date%3D2013%26volume%3D31%26issue%3D3%26spage%3D670%26epage%3D683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maged M.  Henary</span>, <span class="hlFld-ContribAuthor ">Tyler L.  Dost</span>, <span class="hlFld-ContribAuthor ">Eric A.  Owens</span>, <span class="hlFld-ContribAuthor ">Surendra Reddy  Punganuru</span>. </span><span class="cited-content_cbyCitation_article-title">Combining BACE1 Inhibition with Metal Chelation as Possible Therapy for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 547-565. <a href="https://doi.org/10.1016/B978-0-12-803959-5.50011-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-803959-5.50011-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-803959-5.50011-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-803959-5.50011-8%26sid%3Dliteratum%253Aachs%26atitle%3DCombining%252BBACE1%252BInhibition%252Bwith%252BMetal%252BChelation%252Bas%252BPossible%252BTherapy%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DHenary%26aufirst%3DMaged%2BM.%26date%3D2014%26spage%3D547%26epage%3D565%26pub%3DElsevier%26atitle%3DDrug%252BDesign%252Band%252BDiscovery%252Bin%252BAlzheimer%252527s%252BDisease%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arun K.  Ghosh</span>, <span class="hlFld-ContribAuthor ">Heather L.  Osswald</span>. </span><span class="cited-content_cbyCitation_article-title">BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Chem. Soc. Rev.</span><span> <strong>2014,</strong> <em>43 </em>
                                    (19)
                                     , 6765-6813. <a href="https://doi.org/10.1039/C3CS60460H" title="DOI URL">https://doi.org/10.1039/C3CS60460H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C3CS60460H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC3CS60460H%26sid%3Dliteratum%253Aachs%26jtitle%3DChem.%2520Soc.%2520Rev.%26atitle%3DBACE1%252B%252528%2525CE%2525B2-secretase%252529%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DGhosh%26aufirst%3DArun%2BK.%26date%3D2014%26date%3D2014%26volume%3D43%26issue%3D19%26spage%3D6765%26epage%3D6813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Sagar</span>, <span class="hlFld-ContribAuthor ">Shinde  Vidyacharan</span>, <span class="hlFld-ContribAuthor ">Duddu S.  Sharada</span>. </span><span class="cited-content_cbyCitation_article-title">I
              2
              -promoted cross-dehydrogenative coupling of α-carbonyl aldehydes with alcohols for the synthesis of α-ketoesters. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2014,</strong> <em>4 </em>
                                    (70)
                                     , 37047. <a href="https://doi.org/10.1039/C4RA06028H" title="DOI URL">https://doi.org/10.1039/C4RA06028H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4RA06028H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4RA06028H%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DI%252B2%252B-promoted%252Bcross-dehydrogenative%252Bcoupling%252Bof%252B%2525CE%2525B1-carbonyl%252Baldehydes%252Bwith%252Balcohols%252Bfor%252Bthe%252Bsynthesis%252Bof%252B%2525CE%2525B1-ketoesters%26aulast%3DSagar%26aufirst%3DA.%26date%3D2014%26date%3D2014%26volume%3D4%26issue%3D70%26spage%3D37047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chun  Zhang</span>, <span class="hlFld-ContribAuthor ">Ning  Jiao</span>. </span><span class="cited-content_cbyCitation_article-title">A Cu-catalyzed practical approach to α-ketoesters under air: an efficient aerobic oxidative dehydrogenative coupling of alcohols and α-carbonyl aldehydes. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2014,</strong> <em>1 </em>
                                    (1)
                                     , 109. <a href="https://doi.org/10.1039/c3qo00041a" title="DOI URL">https://doi.org/10.1039/c3qo00041a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3qo00041a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3qo00041a%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DA%252BCu-catalyzed%252Bpractical%252Bapproach%252Bto%252B%2525CE%2525B1-ketoesters%252Bunder%252Bair%25253A%252Ban%252Befficient%252Baerobic%252Boxidative%252Bdehydrogenative%252Bcoupling%252Bof%252Balcohols%252Band%252B%2525CE%2525B1-carbonyl%252Baldehydes%26aulast%3DZhang%26aufirst%3DChun%26date%3D2014%26volume%3D1%26issue%3D1%26spage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rutao  Liu</span>, <span class="hlFld-ContribAuthor ">Jing  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaofei  Ji</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic nucleic acids delivered by exosomes: a potential therapeutic for generelated metabolic brain diseases. </span><span class="cited-content_cbyCitation_journal-name">Metabolic Brain Disease</span><span> <strong>2013,</strong> <em>28 </em>
                                    (4)
                                     , 551-562. <a href="https://doi.org/10.1007/s11011-013-9434-y" title="DOI URL">https://doi.org/10.1007/s11011-013-9434-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11011-013-9434-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11011-013-9434-y%26sid%3Dliteratum%253Aachs%26jtitle%3DMetabolic%2520Brain%2520Disease%26atitle%3DSynthetic%252Bnucleic%252Bacids%252Bdelivered%252Bby%252Bexosomes%25253A%252Ba%252Bpotential%252Btherapeutic%252Bfor%252Bgenerelated%252Bmetabolic%252Bbrain%252Bdiseases%26aulast%3DLiu%26aufirst%3DRutao%26date%3D2013%26date%3D2013%26volume%3D28%26issue%3D4%26spage%3D551%26epage%3D562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuji  Yonezawa</span>, <span class="hlFld-ContribAuthor ">Kenichiro  Fujiwara</span>, <span class="hlFld-ContribAuthor ">Takahiko  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Kazunari  Hattori</span>, <span class="hlFld-ContribAuthor ">Hidekuni  Yamakawa</span>, <span class="hlFld-ContribAuthor ">Chie  Muto</span>, <span class="hlFld-ContribAuthor ">Motoko  Hosono</span>, <span class="hlFld-ContribAuthor ">Yoshikazu  Tanaka</span>, <span class="hlFld-ContribAuthor ">Toru  Nakano</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Takemoto</span>, <span class="hlFld-ContribAuthor ">Mitsuhiro  Arisawa</span>, <span class="hlFld-ContribAuthor ">Satoshi  Shuto</span>. </span><span class="cited-content_cbyCitation_article-title">Conformational restriction approach to β-secretase (BACE1) inhibitors III: Effective investigation of the binding mode by combinational use of X-ray analysis, isothermal titration calorimetry and theoretical calculations. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (21)
                                     , 6506-6522. <a href="https://doi.org/10.1016/j.bmc.2013.08.036" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.08.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.08.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.08.036%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DConformational%252Brestriction%252Bapproach%252Bto%252B%2525CE%2525B2-secretase%252B%252528BACE1%252529%252Binhibitors%252BIII%25253A%252BEffective%252Binvestigation%252Bof%252Bthe%252Bbinding%252Bmode%252Bby%252Bcombinational%252Buse%252Bof%252BX-ray%252Banalysis%25252C%252Bisothermal%252Btitration%252Bcalorimetry%252Band%252Btheoretical%252Bcalculations%26aulast%3DYonezawa%26aufirst%3DShuji%26date%3D2013%26volume%3D21%26issue%3D21%26spage%3D6506%26epage%3D6522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew  Stamford</span>, <span class="hlFld-ContribAuthor ">Corey  Strickland</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of BACE for treating Alzheimer's disease: a fragment-based drug discovery story. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Chemical Biology</span><span> <strong>2013,</strong> <em>17 </em>
                                    (3)
                                     , 320-328. <a href="https://doi.org/10.1016/j.cbpa.2013.04.016" title="DOI URL">https://doi.org/10.1016/j.cbpa.2013.04.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbpa.2013.04.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbpa.2013.04.016%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Chemical%2520Biology%26atitle%3DInhibitors%252Bof%252BBACE%252Bfor%252Btreating%252BAlzheimer%252527s%252Bdisease%25253A%252Ba%252Bfragment-based%252Bdrug%252Bdiscovery%252Bstory%26aulast%3DStamford%26aufirst%3DAndrew%26date%3D2013%26volume%3D17%26issue%3D3%26spage%3D320%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying-zi  Xu</span>, <span class="hlFld-ContribAuthor ">Shendong  Yuan</span>, <span class="hlFld-ContribAuthor ">Simeon  Bowers</span>, <span class="hlFld-ContribAuthor ">Roy K.  Hom</span>, <span class="hlFld-ContribAuthor ">Wayman  Chan</span>, <span class="hlFld-ContribAuthor ">Hing L.  Sham</span>, <span class="hlFld-ContribAuthor ">Yong L.  Zhu</span>, <span class="hlFld-ContribAuthor ">Paul  Beroza</span>, <span class="hlFld-ContribAuthor ">Hu  Pan</span>, <span class="hlFld-ContribAuthor ">Eric  Brecht</span>, <span class="hlFld-ContribAuthor ">Nanhua  Yao</span>, <span class="hlFld-ContribAuthor ">Julie  Lougheed</span>, <span class="hlFld-ContribAuthor ">Jiangli  Yan</span>, <span class="hlFld-ContribAuthor ">Danny  Tam</span>, <span class="hlFld-ContribAuthor ">Zhao  Ren</span>, <span class="hlFld-ContribAuthor ">Lany  Ruslim</span>, <span class="hlFld-ContribAuthor ">Michael P.  Bova</span>, <span class="hlFld-ContribAuthor ">Dean R.  Artis</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of thiophene dihydroisoquinolines as novel BACE1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (10)
                                     , 3075-3080. <a href="https://doi.org/10.1016/j.bmcl.2013.03.009" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.03.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.03.009%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bthiophene%252Bdihydroisoquinolines%252Bas%252Bnovel%252BBACE1%252Binhibitors%26aulast%3DXu%26aufirst%3DYing-zi%26date%3D2013%26volume%3D23%26issue%3D10%26spage%3D3075%26epage%3D3080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anders  Lindgren</span>, <span class="hlFld-ContribAuthor ">Göran  Eklund</span>, <span class="hlFld-ContribAuthor ">Dominika  Turek</span>, <span class="hlFld-ContribAuthor ">Jonas  Malmquist</span>, <span class="hlFld-ContribAuthor ">Britt-Marie  Swahn</span>, <span class="hlFld-ContribAuthor ">Jörg  Holenz</span>, <span class="hlFld-ContribAuthor ">Stefan  von Berg</span>, <span class="hlFld-ContribAuthor ">Sofia  Karlström</span>, <span class="hlFld-ContribAuthor ">Tjerk  Bueters</span>. </span><span class="cited-content_cbyCitation_article-title">Biotransformation of Two
              β
              -Secretase Inhibitors Including Ring Opening and Contraction of a Pyrimidine Ring. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2013,</strong> <em>41 </em>
                                    (5)
                                     , 1134-1147. <a href="https://doi.org/10.1124/dmd.112.050351" title="DOI URL">https://doi.org/10.1124/dmd.112.050351</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.112.050351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.112.050351%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DBiotransformation%252Bof%252BTwo%252B%2525CE%2525B2%252B-Secretase%252BInhibitors%252BIncluding%252BRing%252BOpening%252Band%252BContraction%252Bof%252Ba%252BPyrimidine%252BRing%26aulast%3DLindgren%26aufirst%3DAnders%26date%3D2013%26date%3D2013%26volume%3D41%26issue%3D5%26spage%3D1134%26epage%3D1147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/medium/jm-2012-00991n_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/large/jm-2012-00991n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300991n&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/medium/jm-2012-00991n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/large/jm-2012-00991n_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Examples of cyclic amidine cores of BACE-1 inhibitors previously investigated in-house: dihydroisocytosines, bicyclic aminoimidazoles, and aminoisoindoles (X = CH, CR, or N). (B) Amino-2<i>H</i>-imidazole, <b>core-1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/large/jm-2012-00991n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300991n&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/medium/jm-2012-00991n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/large/jm-2012-00991n_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. First Practical Synthesis of Amino-2<i>H</i>-imidazole Precursor <b>3</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/large/jm-2012-00991n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300991n&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/medium/jm-2012-00991n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/large/jm-2012-00991n_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Various Methods for Preparing Amino-2<i>H</i>-imidazoles <b>1</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/large/jm-2012-00991n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300991n&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>5</b>, 7 M NH<sub>3</sub> in methanol, 120 °C; (b) P<sub>2</sub>S<sub>5</sub>, pyridine; (c) <i>t</i>-BuOOH, NH<sub>3</sub>; (d) boronic acid or stannane reactant, Pd catalyst; (e) ethanebis(thioamide) <b>8</b>, 7 M NH<sub>3</sub> in methanol; (f) MeI, THF; (g) MeMgBr, ZnI<sub>2</sub>, cat. Pd<sub>2</sub>Cl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, THF or MeMgBr, cat. Ni(dppp)Cl<sub>2</sub>, PhMe; (h) H<sub>2</sub>S, Et<sub>3</sub>N, 2-methyl THF; (i) <b>4</b>, if X = O, 7 M NH<sub>3</sub> in methanol or if X = NH, methanol.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/medium/jm-2012-00991n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/large/jm-2012-00991n_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Amino-2<i>H</i>-imidazoles <b>1u</b> and <b>1v</b> were prepared using method C (see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/large/jm-2012-00991n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300991n&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/medium/jm-2012-00991n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/large/jm-2012-00991n_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structure of (<i>R</i>)-<b>1t</b> (orange) and (<i>S</i>)-<b>1m</b> (cyan) complexed with BACE-1. For ligand (<i>R</i>)-<b>1t</b> with a small substituent, (R<sup>2</sup> = cyclopropyl) the internal hydrogen bond between Trp76 and Tyr71 was retained. Also shown is the interaction of Trp76 with the R<sup>2</sup> 4-methoxy group for (<i>S</i>)-<b>1m</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/large/jm-2012-00991n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300991n&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/medium/jm-2012-00991n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/large/jm-2012-00991n_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Correlation between potency change (pIC<sub>50</sub> SH-SY5Y - pIC<sub>50</sub> TR-FRET) and p<i>K</i><sub>a</sub> for the compounds <b>1a</b>–<b>v</b> (correlation factor <i>R</i><sup>2</sup> = 0.55). R<sup>2</sup>-alkyl/heteroalkyl gives in general higher p<i>K</i><sub>a</sub> values than R<sup>2</sup>-aryl.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/large/jm-2012-00991n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300991n&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/medium/jm-2012-00991n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/large/jm-2012-00991n_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vivo efficacy of (<i>S</i>)-<b>1m</b>. Time response effect on brain Aβ40/42 (A) and plasma Aβ40/42 (B) after an oral dose, 100 μmol/kg, of (<i>S</i>)-<b>1m</b> to male guinea pigs. The right <i>y</i>-axes show free compound exposure in brain and plasma (open circles and dotted line, respectively). Time response effects on CSF Aβ40 (C). CSF Aβ40 reached a statistical significant reduction compared to vehicle 3 h after an 100 μmol/kg dose (∗, <i>P</i> < 0.05). Data shown are the mean and standard error of the mean (SEM) as % of vehicle Aβ levels.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300991n/production/images/large/jm-2012-00991n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300991n&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i58">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85576" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85576" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 62 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Querfurth, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFerla, F. M.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1056%2FNEJMra0909142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=20107219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1aqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2010&pages=329-344&author=H.+W.+Querfurthauthor=F.+M.+LaFerla&title=Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease</span></div><div class="casAuthors">Querfurth, Henry W.; LaFerla, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">329-344</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  The role of β-amyloid peptide in spontaneous self-aggregation in brain in Alzheimer's disease is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPeniV_Jn6orVg90H21EOLACvtfcHk0ljptMmCk-ul6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1aqt7s%253D&md5=c116f6a6b8fed9af9f5282cc4b755c70</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1056%2FNEJMra0909142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra0909142%26sid%3Dliteratum%253Aachs%26aulast%3DQuerfurth%26aufirst%3DH.%2BW.%26aulast%3DLaFerla%26aufirst%3DF.%2BM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D362%26spage%3D329%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span> </span><span class="NLM_article-title">2012 Alzheimer’s disease facts and figures</span>.  <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1016%2Fj.jalz.2012.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=22404854" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=2012+Alzheimer%E2%80%99s+disease+facts+and+figures.+Alzheimer%27s+Dementia+2012%2C+8%2C+131%E2%80%93168."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2012.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2012.02.001%26sid%3Dliteratum%253Aachs%26atitle%3D2012%2520Alzheimer%25E2%2580%2599s%2520disease%2520facts%2520and%2520figures%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2012%26volume%3D8%26spage%3D131%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allsop, D.</span><span> </span><span class="NLM_article-title">Amyloid deposition as the central event in the etiology of Alzheimer’s disease</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1991&pages=383-388&author=J.+Hardyauthor=D.+Allsop&title=Amyloid+deposition+as+the+central+event+in+the+etiology+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DAllsop%26aufirst%3DD.%26atitle%3DAmyloid%2520deposition%2520as%2520the%2520central%2520event%2520in%2520the%2520etiology%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1991%26volume%3D12%26spage%3D383%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goedert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span> </span><span class="NLM_article-title">Neurodegenerative tauopathies</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1121</span><span class="NLM_x">–</span> <span class="NLM_lpage">1159</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1146%2Fannurev.neuro.24.1.1121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=11520930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BD3MXls1Shsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2001&pages=1121-1159&author=V.+M.+Leeauthor=M.+Goedertauthor=J.+Q.+Trojanowski&title=Neurodegenerative+tauopathies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Neurodegenerative tauopathies</span></div><div class="casAuthors">Lee, Virginia M-Y.; Goedert, Michel; Trojanowski, John Q.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1121-1159</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with many refs.  The defining neuropathol. characteristics of Alzheimer's disease are abundant filamentous tau lesions and deposits of fibrillar amyloid β peptides.  Prominent filamentous tau inclusions and brain degeneration in the absence of β-amyloid deposits are also hallmarks of neurodegenerative tauopathies exemplified by sporadic corticobasal degeneration, progressive supra-nuclear palsy, and Pick's disease, as well as by hereditary frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).  Because multiple tau gene mutations are pathogenic for FTDP-17 and tau polymorphisms appear to be genetic risk factors for sporadic progressive supranuclear palsy and corticobasal degeneration, tau abnormalities are linked directly to the etiol. and pathogenesis of neurodegenerative disease.  Indeed, emerging data support the hypothesis that different tau gene mutations are pathogenic because they impair tau functions, promote tau fibrillization, or perturb tau gene splicing, thereby leading to formation of biochem. and structurally distinct aggregates of tau.  Nonetheless, different members of the same kindred often exhibit diverse FTDP-17 syndromes, which suggests that addnl. genetic or epigenetic factors influence the phenotypic manifestations of neurodegenerative tauopathies.  Although these and other hypothetical mechanisms of neurodegenerative tauopathies remain to be tested and validated, transgenic models are increasingly available for this purpose, and they will accelerate discovery of more effective therapies for neurodegenerative tauopathies and related disorders, including Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUKjqSk9glv7Vg90H21EOLACvtfcHk0ljGX8gjU_33zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXls1Shsbo%253D&md5=a40a15073de6597418ef7e93145c3245</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.24.1.1121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.24.1.1121%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DGoedert%26aufirst%3DM.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26atitle%3DNeurodegenerative%2520tauopathies%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D2001%26volume%3D24%26spage%3D1121%26epage%3D1159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics</span> <span class="citation_source-journal">Science (Washington, DC, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+Hardyauthor=D.+J.+Selkoe&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+progress+and+problems+on+the+road+to+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0ljGX8gjU_33zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520progress%2520and%2520problems%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DScience%2520%2528Washington%252C%2520DC%252C%2520U.%2520S.%2529%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Hussain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howlett, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tew, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meek, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gloger, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Southan, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingwall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christie, G.</span><span> </span><span class="NLM_article-title">Identification of a novel aspartic protease (Asp 2) as β-secretase</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">427</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1006%2Fmcne.1999.0811" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=10656250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADyaK1MXnt1Chsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1999&pages=419-427&author=I.+Hussainauthor=D.+Powellauthor=D.+R.+Howlettauthor=D.+G.+Tewauthor=T.+D.+Meekauthor=C.+Chapmanauthor=I.+S.+Glogerauthor=K.+E.+Murphyauthor=C.+D.+Southanauthor=D.+M.+Ryanauthor=T.+S.+Smithauthor=D.+L.+Simmonsauthor=F.+S.+Walshauthor=C.+Dingwallauthor=G.+Christie&title=Identification+of+a+novel+aspartic+protease+%28Asp+2%29+as+%CE%B2-secretase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase</span></div><div class="casAuthors">Hussain, Ishrut; Powell, David; Howlett, David R.; Tew, David G.; Meek, Thomas D.; Chapman, Conrad; Gloger, Israel S.; Murphy, Kay E.; Southan, Christopher D.; Ryan, Dominic M.; Smith, Trudi S.; Simmons, David L.; Walsh, Frank S.; Dingwall, Colin; Christie, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">419-427</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The Alzheimer's disease β-amyloid peptide (Aβ) is produced by excision from the type 1 integral membrane glycoprotein amyloid precursor protein (APP) by the sequential actions of β- and then γ-secretases.  Here we report that Asp 2, a novel transmembrane aspartic protease, has the key activities expected of β-secretase.  Transient expression of Asp 2 in cells expressing APP causes an increase in the secretion of the N-terminal fragment of APP and an increase in the cell-assocd. C-terminal β-secretase APP fragment.  Mutation of either of the putative catalytic aspartyl residues in Asp 2 abrogates the prodn. of the fragments characteristic of cleavage at the β-secretase site.  The enzyme is present in normal and Alzheimer's disease (AD) brain and is also found in cell lines known to produce Aβ.  Asp 2 localizes to the Golgi/endoplasmic reticulum in transfected cells and shows clear colocalization with APP in cells stably expressing the 751-amino-acid isoform of APP.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDUBbUoO6SgLVg90H21EOLACvtfcHk0lh1GtnGJEEY0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnt1Chsrs%253D&md5=aba834d907c5dae03f060d94729576e9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1006%2Fmcne.1999.0811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmcne.1999.0811%26sid%3Dliteratum%253Aachs%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DPowell%26aufirst%3DD.%26aulast%3DHowlett%26aufirst%3DD.%2BR.%26aulast%3DTew%26aufirst%3DD.%2BG.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26aulast%3DChapman%26aufirst%3DC.%26aulast%3DGloger%26aufirst%3DI.%2BS.%26aulast%3DMurphy%26aufirst%3DK.%2BE.%26aulast%3DSouthan%26aufirst%3DC.%2BD.%26aulast%3DRyan%26aufirst%3DD.%2BM.%26aulast%3DSmith%26aufirst%3DT.%2BS.%26aulast%3DSimmons%26aufirst%3DD.%2BL.%26aulast%3DWalsh%26aufirst%3DF.%2BS.%26aulast%3DDingwall%26aufirst%3DC.%26aulast%3DChristie%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520a%2520novel%2520aspartic%2520protease%2520%2528Asp%25202%2529%2520as%2520%25CE%25B2-secretase%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D1999%26volume%3D14%26spage%3D419%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Sinha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbour, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basi, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccavello, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dovey, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson-Croak, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewett, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keim, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knops, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberburg, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsuno, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seubert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suomensaari, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConlogue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, V.</span><span> </span><span class="NLM_article-title">Purification and cloning of amyloid precursor protein β-secretase from human brain</span> <span class="citation_source-journal">Nature (London)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">402</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1038%2F990114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=10591214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADyaK1MXotFKlsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=1999&pages=537-540&author=S.+Sinhaauthor=J.+P.+Andersonauthor=R.+Barbourauthor=G.+S.+Basiauthor=R.+Caccavelloauthor=D.+Davisauthor=M.+Doanauthor=H.+F.+Doveyauthor=N.+Frigonauthor=J.+Hongauthor=K.+Jacobson-Croakauthor=N.+Jewettauthor=P.+Keimauthor=J.+Knopsauthor=I.+Lieberburgauthor=M.+Powerauthor=H.+Tanauthor=G.+Tatsunoauthor=J.+Tungauthor=D.+Schenkauthor=P.+Seubertauthor=S.+M.+Suomensaariauthor=S.+Wangauthor=D.+Walkerauthor=J.+Zhaoauthor=L.+McConlogueauthor=V.+John&title=Purification+and+cloning+of+amyloid+precursor+protein+%CE%B2-secretase+from+human+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and cloning of amyloid precursor protein β-secretase from human brain</span></div><div class="casAuthors">Sinha, Sukanto; Anderson, John P.; Barbour, Robin; Basi, Guriqbal S.; Caccavello, Russell; Davis, David; Doan, Minhtam; Dovey, Harry F.; Frigon, Normand; Hong, Jin; Jacobson-Croak, Kirsten; Jewett, Nancy; Keim, Pamela; Knops, Jeroen; Lieberburg, Ivan; Power, Michael; Tan, Hua; Tatsuno, Gwen; Tung, Jay; Schenk, Dale; Seubert, Peter; Suomensaari, Susanna M.; Wang, Shuwen; Walker, Donald; Zhao, Jun; McConlogue, Lisa; John, Varghese</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">402</span>
        (<span class="NLM_cas:issue">6761</span>),
    <span class="NLM_cas:pages">537-540</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Proteolytic processing of the amyloid precursor protein (APP) generates amyloid β (AP) peptide, which is thought to be causal for the pathol. and subsequent cognitive decline in Alzheimer's disease.  Cleavage by β-secretase at the amino terminus of the Aβ peptide sequence, between residues 671 and 672 of APP, leads to the generation and extracellular release of β-cleaved sol. APP, and a corresponding cell-assocd. carboxy-terminal fragment.  Cleavage of the C-terminal fragment by γ-secretase(s) leads to the formation of Aβ.  The pathogenic mutation K670M671 → N670L671 at the β-secretase cleavage site in APP, which was discovered in a Swedish family with familial Alzheimer's disease, leads to increased β-secretase cleavage of the mutant substrate.  Here the authors describe a membrane-bound enzyme activity that cleaves full-length APP at the β-secretase cleavage site, and find it to be the predominant β-cleavage activity in human brain.  The authors have purified this enzyme activity to homogeneity from human brain using a new substrate analog inhibitor of the enzyme activity, and show that the purified enzyme has all the properties predicted for β-secretase.  Cloning and expression of the enzyme reveals that human brain β-secretase is a new membrane-bound aspartic proteinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDI4TZ3cM4orVg90H21EOLACvtfcHk0lg3CwU_PnwN5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXotFKlsrc%253D&md5=819ccc5a27ec4c56128d6b6944878c42</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F990114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F990114%26sid%3Dliteratum%253Aachs%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DJ.%2BP.%26aulast%3DBarbour%26aufirst%3DR.%26aulast%3DBasi%26aufirst%3DG.%2BS.%26aulast%3DCaccavello%26aufirst%3DR.%26aulast%3DDavis%26aufirst%3DD.%26aulast%3DDoan%26aufirst%3DM.%26aulast%3DDovey%26aufirst%3DH.%2BF.%26aulast%3DFrigon%26aufirst%3DN.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DJacobson-Croak%26aufirst%3DK.%26aulast%3DJewett%26aufirst%3DN.%26aulast%3DKeim%26aufirst%3DP.%26aulast%3DKnops%26aufirst%3DJ.%26aulast%3DLieberburg%26aufirst%3DI.%26aulast%3DPower%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DTatsuno%26aufirst%3DG.%26aulast%3DTung%26aufirst%3DJ.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DSeubert%26aufirst%3DP.%26aulast%3DSuomensaari%26aufirst%3DS.%2BM.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DMcConlogue%26aufirst%3DL.%26aulast%3DJohn%26aufirst%3DV.%26atitle%3DPurification%2520and%2520cloning%2520of%2520amyloid%2520precursor%2520protein%2520%25CE%25B2-secretase%2520from%2520human%2520brain%26jtitle%3DNature%2520%2528London%2529%26date%3D1999%26volume%3D402%26spage%3D537%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendiaz, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teplow, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amarante, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeloff, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edenson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lile, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarosinski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biere, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treanor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">β-Secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE</span> <span class="citation_source-journal">Science (Washington, DC, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">735</span><span class="NLM_x">–</span> <span class="NLM_lpage">741</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1126%2Fscience.286.5440.735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=10531052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=735-741&author=R.+Vassarauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=S.+Kahnauthor=E.+A.+Mendiazauthor=P.+Denisauthor=D.+B.+Teplowauthor=S.+Rossauthor=P.+Amaranteauthor=R.+Loeloffauthor=Y.+Luoauthor=S.+Fisherauthor=J.+Fullerauthor=S.+Edensonauthor=J.+Lileauthor=M.+A.+Jarosinskiauthor=A.+L.+Biereauthor=E.+Curranauthor=T.+Burgessauthor=J.+Louisauthor=F.+Collinsauthor=J.+Treanorauthor=G.+Rogersauthor=M.+Citron&title=%CE%B2-Secretase+cleavage+of+Alzheimer%E2%80%99s+amyloid+precursor+protein+by+the+transmembrane+aspartic+protease+BACE"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE</span></div><div class="casAuthors">Vassar, Robert; Bennett, Brian D.; Babu-Khan, Safura; Kahn, Steve; Mendiaz, Elizabeth A.; Denis, Paul; Teplow, David B.; Ross, Sandra; Amarante, Patricia; Loeloff, Richard; Luo, Yi; Fisher, Seth; Fuller, Janis; Edenson, Steven; Lile, Jackson; Jarosinski, Mark A.; Biere, Anja Leona; Curran, Eileen; Burgess, Teresa; Louis, Jean-Claude; Collins, Frank; Treanor, James; Rogers, Gary; Citron, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5440</span>),
    <span class="NLM_cas:pages">735-741</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cerebral deposition of amyloid β peptide (Aβ) is an early and crit. feature of Alzheimer's disease.  Aβ generation depends on proteolytic cleavage of the amyloid precursor protein (APP) by two unknown proteases: β-secretase and γ-secretase.  These proteases are prime therapeutic targets.  A transmembrane aspartic protease with all the known characteristics of β-secretase was cloned and characterized.  Overexpression of this protease, termed BACE (for beta-site APP-cleaving enzyme) increased the amt. of β-secretase cleavage products, and these were cleaved exactly and only at known β-secretase positions.  Antisense inhibition of endogenous BACE mRNA decreased the amt. of β-secretase cleavage products, and purified BACE protein cleaved APP-derived substrates with the same sequence specificity as β-secretase.  Finally, the expression pattern and subcellular localization of BACE were consistent with that expected for β-secretase.  Future development of BACE inhibitors may prove beneficial for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSx3s1NFyByrVg90H21EOLACvtfcHk0lgbT6x6i8hJdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D&md5=3f36e8e5b5e9441c7670ccaeb0d2dd4f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5440.735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5440.735%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DMendiaz%26aufirst%3DE.%2BA.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DTeplow%26aufirst%3DD.%2BB.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DAmarante%26aufirst%3DP.%26aulast%3DLoeloff%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DFisher%26aufirst%3DS.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DEdenson%26aufirst%3DS.%26aulast%3DLile%26aufirst%3DJ.%26aulast%3DJarosinski%26aufirst%3DM.%2BA.%26aulast%3DBiere%26aufirst%3DA.%2BL.%26aulast%3DCurran%26aufirst%3DE.%26aulast%3DBurgess%26aufirst%3DT.%26aulast%3DLouis%26aufirst%3DJ.%26aulast%3DCollins%26aufirst%3DF.%26aulast%3DTreanor%26aufirst%3DJ.%26aulast%3DRogers%26aufirst%3DG.%26aulast%3DCitron%26aufirst%3DM.%26atitle%3D%25CE%25B2-Secretase%2520cleavage%2520of%2520Alzheimer%25E2%2580%2599s%2520amyloid%2520precursor%2520protein%2520by%2520the%2520transmembrane%2520aspartic%2520protease%2520BACE%26jtitle%3DScience%2520%2528Washington%252C%2520DC%252C%2520U.%2520S.%2529%26date%3D1999%26volume%3D286%26spage%3D735%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Yan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bienkowski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuck, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tory, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauley, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brashler, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratman, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhl, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomasselli, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parodi, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrikson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurney, M. E.</span><span> </span><span class="NLM_article-title">Membrane-anchored aspartyl protease with Alzheimer’s disease β-secretase activity</span> <span class="citation_source-journal">Nature (London)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">402</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1038%2F990107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=10591213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADyaK1MXotFKmu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=1999&pages=533-537&author=R.+Yanauthor=M.+J.+Bienkowskiauthor=M.+E.+Shuckauthor=H.+Miaoauthor=M.+C.+Toryauthor=A.+M.+Pauleyauthor=J.+R.+Brashlerauthor=N.+C.+Stratmanauthor=W.+R.+Mathewsauthor=A.+E.+Buhlauthor=D.+B.+Carterauthor=A.+G.+Tomasselliauthor=L.+A.+Parodiauthor=R.+L.+Heinriksonauthor=M.+E.+Gurney&title=Membrane-anchored+aspartyl+protease+with+Alzheimer%E2%80%99s+disease+%CE%B2-secretase+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity</span></div><div class="casAuthors">Yan, Riqiang; Bienkowski, Michael J.; Shuck, Mary E.; Miao, Huiyi; Tory, Monica C.; Pauley, Adele M.; Brashler, John R.; Stratman, Nancy C.; Mathews, W. Rodney; Buhl, Allen E.; Carter, Donald B.; Tomasselli, Alfredo G.; Parodi, Luis A.; Heinrikson, Robert L.; Gurney, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">402</span>
        (<span class="NLM_cas:issue">6761</span>),
    <span class="NLM_cas:pages">533-537</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Mutations in the gene encoding the amyloid protein precursor (APP) cause autosomal dominant Alzheimer's disease.  Cleavage of APP by unidentified proteases, referred to as β- and γ-secretases, generates the amyloid β-peptide, the main component of the amyloid plaques found in Alzheimer's disease patients.  The disease-causing mutations flank the protease cleavage sites in APP and facilitate its cleavage.  Here the authors identify a new membrane-bound aspartyl protease (Asp2) with β-secretase activity.  The Asp2 gene is expressed widely in brain and other tissues.  Decreasing the expression of Asp2 in cells reduces amyloid β-peptide prodn. and blocks the accumulation of the carboxy-terminal APP fragment that is created by β-secretase cleavage.  Solubilized Asp2 protein cleaves a synthetic APP peptide substrate at the β-secretase site, and the rate of cleavage is increased tenfold by a mutation assocd. with early-onset Alzheimer's disease in Sweden.  Thus, Asp2 is a new protein target for drugs that are designed to block the prodn. of amyloid β-peptide peptide and the consequent formation of amyloid plaque in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd6iE74jtk5LVg90H21EOLACvtfcHk0lgbT6x6i8hJdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXotFKmu7k%253D&md5=96af7cd9b7c3315de029937497f04616</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2F990107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F990107%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26aulast%3DBienkowski%26aufirst%3DM.%2BJ.%26aulast%3DShuck%26aufirst%3DM.%2BE.%26aulast%3DMiao%26aufirst%3DH.%26aulast%3DTory%26aufirst%3DM.%2BC.%26aulast%3DPauley%26aufirst%3DA.%2BM.%26aulast%3DBrashler%26aufirst%3DJ.%2BR.%26aulast%3DStratman%26aufirst%3DN.%2BC.%26aulast%3DMathews%26aufirst%3DW.%2BR.%26aulast%3DBuhl%26aufirst%3DA.%2BE.%26aulast%3DCarter%26aufirst%3DD.%2BB.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DParodi%26aufirst%3DL.%2BA.%26aulast%3DHeinrikson%26aufirst%3DR.%2BL.%26aulast%3DGurney%26aufirst%3DM.%2BE.%26atitle%3DMembrane-anchored%2520aspartyl%2520protease%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%2520%25CE%25B2-secretase%2520activity%26jtitle%3DNature%2520%2528London%2529%26date%3D1999%26volume%3D402%26spage%3D533%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koelsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downs, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dashti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor protein</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">1456</span><span class="NLM_x">–</span> <span class="NLM_lpage">1460</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=1456-1460&author=X.+Linauthor=G.+Koelschauthor=S.+Wuauthor=D.+Downsauthor=A.+Dashtiauthor=J.+Tang&title=Human+aspartic+protease+memapsin+2+cleaves+the+%CE%B2-secretase+site+of+%CE%B2-amyloid+precursor+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DX.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DDowns%26aufirst%3DD.%26aulast%3DDashti%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DHuman%2520aspartic%2520protease%2520memapsin%25202%2520cleaves%2520the%2520%25CE%25B2-secretase%2520site%2520of%2520%25CE%25B2-amyloid%2520precursor%2520protein%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D1456%26epage%3D1460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Price, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisodia, S. S.</span><span> </span><span class="NLM_article-title">Mutant genes in familial Alzheimer’s disease and transgenic models</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">479</span><span class="NLM_x">–</span> <span class="NLM_lpage">505</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1146%2Fannurev.neuro.21.1.479" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=9530504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADyaK1cXhsFyhtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1998&pages=479-505&author=D.+L.+Priceauthor=S.+S.+Sisodia&title=Mutant+genes+in+familial+Alzheimer%E2%80%99s+disease+and+transgenic+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Mutant genes in familial Alzheimer's disease and transgenic models</span></div><div class="casAuthors">Price, Donald L.; Sisodia, Sangram S.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">479-505</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review, with 163 refs.  The most common cause of dementia occurring in mid- to late-life is Alzheimer's disease (AD).  Some cases of AD, particularly those of early onset, are familial and inherited as autosomal dominant disorders linked to the presence of mutant genes that encode the amyloid precursor protein (APP) or the presenilins (PS1 or PS2).  These mutant gene products cause dysfunction/death of vulnerable populations of nerve cells important in memory, higher cognitive processes, and behavior.  AD affects 7-10% of individuals >65 yr of age and perhaps 40% of individuals >80 yr of age.  For the late-onset cases, the principal risk factors are age and apolipoprotein (apoE) allele type, with apoE4 allele being a susceptibility factor.  In this review, we briefly discuss the clin. syndrome of AD and the neurobiol./neuropathol. of the disease and then focus attention on mutant genes linked to autosomal dominant familial AD (FAD), the biol. of the proteins encoded by these genes, and the recent exciting progress in investigations of genetically engineered animal models that express these mutant genes and develop some features of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowUt4ulmJ7ErVg90H21EOLACvtfcHk0lg9q7pMGTzXcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhsFyhtLY%253D&md5=fa1bf9dbad95faabcd6854eca46bad83</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.21.1.479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.21.1.479%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DD.%2BL.%26aulast%3DSisodia%26aufirst%3DS.%2BS.%26atitle%3DMutant%2520genes%2520in%2520familial%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520transgenic%2520models%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D1998%26volume%3D21%26spage%3D479%26epage%3D505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Hardy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, G. A.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: the amyloid cascade hypothesis</span> <span class="citation_source-journal">Science (Washington, DC, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">256</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1126%2Fscience.1566067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=1566067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADyaK38Xitlarurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1992&pages=184-185&author=J.+A.+Hardyauthor=G.+A.+Higgins&title=Alzheimer%E2%80%99s+disease%3A+the+amyloid+cascade+hypothesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease:  the amyloid cascade hypothesis</span></div><div class="casAuthors">Hardy, John A.; Higgins, Gerald A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">256</span>
        (<span class="NLM_cas:issue">5054</span>),
    <span class="NLM_cas:pages">184-5</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A review with 28 refs.  The hypotheses that deposition of amyloid β protein (AβP), the main component of the plaques, is the causative agent of Alzheimer's pathol. and that the neurofibrillary tangles, cell loss, vascular damage, and dementia follow as a direct result of this deposition are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqemkoU65i2CrVg90H21EOLACvtfcHk0lhFnnBe5_KRxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xitlarurg%253D&md5=0ad307ce9ecab261ed7b01e6d288682a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.1566067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1566067%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%2BA.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520the%2520amyloid%2520cascade%2520hypothesis%26jtitle%3DScience%2520%2528Washington%252C%2520DC%252C%2520U.%2520S.%2529%26date%3D1992%26volume%3D256%26spage%3D184%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Albert, J. S.</span><span> </span><span class="NLM_article-title">Progress in the development of β-secretase inhibitors for Alzheimer’s disease</span> <span class="citation_source-journal">Prog. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1016%2FS0079-6468%2809%2904804-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=21544959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVegs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=133-161&author=J.+S.+Albert&title=Progress+in+the+development+of+%CE%B2-secretase+inhibitors+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the development of β-secretase inhibitors for Alzheimer's disease</span></div><div class="casAuthors">Albert, Jeffrey S.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">133-161</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review on discovery and research developments toward identifying and optimizing β-secretase inhibitors for Alzheimer's disease since 2007.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgb4XX26zvcbVg90H21EOLACvtfcHk0lhFnnBe5_KRxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVegs7w%253D&md5=85997883f302b45734ba5690c1e98239</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2809%2904804-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252809%252904804-8%26sid%3Dliteratum%253Aachs%26aulast%3DAlbert%26aufirst%3DJ.%2BS.%26atitle%3DProgress%2520in%2520the%2520development%2520of%2520%25CE%25B2-secretase%2520inhibitors%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D48%26spage%3D133%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Evin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lessene, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkins, S.</span><span> </span><span class="NLM_article-title">BACE inhibitors as potential drugs for the treatment of Alzheimer’s disease: focus on bioactivity</span> <span class="citation_source-journal">Recent Pat. CNS Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=91-106&author=G.+Evinauthor=G.+Lesseneauthor=S.+Wilkins&title=BACE+inhibitors+as+potential+drugs+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+focus+on+bioactivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEvin%26aufirst%3DG.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DWilkins%26aufirst%3DS.%26atitle%3DBACE%2520inhibitors%2520as%2520potential%2520drugs%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520focus%2520on%2520bioactivity%26jtitle%3DRecent%2520Pat.%2520CNS%2520Drug%2520Discovery%26date%3D2011%26volume%3D6%26spage%3D91%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Probst, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span> </span><span class="NLM_article-title">Small-molecule BACE1 inhibitors: a patent literature review (2006–2011)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1517%2F13543776.2012.681302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=22512789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvFais7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=511-540&author=G.+Probstauthor=Y.+Xu&title=Small-molecule+BACE1+inhibitors%3A+a+patent+literature+review+%282006%E2%80%932011%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule BACE1 inhibitors: a patent literature review (2006 - 2011)</span></div><div class="casAuthors">Probst, Gary; Xu, Ying-zi</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">511-540</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Alzheimer's disease is a devastating neurodegenerative disorder for which no disease-modifying therapy exists.  The amyloid hypothesis, which implicates Aβ as the toxin initiating a biol. cascade leading to neurodegeneration, is the most prominent theory concerning the underlying cause of the disease.  BACE1 is one of two aspartyl proteinases that generate Aβ, thus inhibition of BACE1 has the potential to ameliorate the progression of Alzheimer's disease by abating the prodn. of Aβ.  Areas covered: This review chronicles small-mol. BACE1 inhibitors as described in the patent literature between 2006 and 2011 and their potential use as disease-modifying treatments for Alzheimer's disease.  Over the past half a dozen years, numerous BACE1 inhibitors have been published in the patent applications, but often these contain a paltry amt. of pertinent biol. data (e.g. potency, selectivity, and efficacy).  Fortunately, numerous relevant publications contg. important data have appeared in the journal literature during this period.  The goal in this effort was to create an amalgam of the two records to add value to this review.  Expert opinion: The pharmaceutical industry has made tremendous progress in the development of small-mol. BACE1 inhibitors that lower Aβ in the central nervous system.  Assuming the amyloid hypothesis is veracious, we anticipate a disease-modifying therapy to combat Alzheimer's disease is near.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp89KaCi3q5Z7Vg90H21EOLACvtfcHk0ljhdfYWDXUDKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvFais7g%253D&md5=174bdc47fbca5aa1f8248dbf03ce402b</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1517%2F13543776.2012.681302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2012.681302%26sid%3Dliteratum%253Aachs%26aulast%3DProbst%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DY.%26atitle%3DSmall-molecule%2520BACE1%2520inhibitors%253A%2520a%2520patent%2520literature%2520review%2520%25282006%25E2%2580%25932011%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2012%26volume%3D22%26spage%3D511%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downs, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koelsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ermolieff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Design of potent inhibitors for human brain memapsin 2 (β-secretase)</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">3522</span><span class="NLM_x">–</span> <span class="NLM_lpage">3523</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja000300g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2000&pages=3522-3523&author=A.+K.+Ghoshauthor=D.+Shinauthor=D.+Downsauthor=G.+Koelschauthor=X.+Linauthor=J.+Ermolieffauthor=J.+Tang&title=Design+of+potent+inhibitors+for+human+brain+memapsin+2+%28%CE%B2-secretase%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fja000300g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja000300g%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DShin%26aufirst%3DD.%26aulast%3DDowns%26aufirst%3DD.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DErmolieff%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DDesign%2520of%2520potent%2520inhibitors%2520for%2520human%2520brain%2520memapsin%25202%2520%2528%25CE%25B2-secretase%2529%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2000%26volume%3D122%26spage%3D3522%26epage%3D3523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span> </span><span class="NLM_article-title">Design and development of BACE-1 inhibitors</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">536</span><span class="NLM_x">–</span> <span class="NLM_lpage">556</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2004&pages=536-556&author=J.+N.+Cummingauthor=U.+Iserlohauthor=M.+E.+Kennedy&title=Design+and+development+of+BACE-1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26atitle%3DDesign%2520and%2520development%2520of%2520BACE-1%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2004%26volume%3D7%26spage%3D536%26epage%3D556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span> </span><span class="NLM_article-title">Design and synthesis of 5,5′-disubstituted aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1146</span><span class="NLM_x">–</span> <span class="NLM_lpage">1158</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901414e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1146-1158&author=M.+S.+Malamasauthor=J.+Erdeiauthor=I.+Gunawanauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=R.+Chopraauthor=A.+Ollandauthor=J.+Bardauthor=S.+Jacobsenauthor=R.+L.+Magoldaauthor=M.+Pangalosauthor=A.+J.+Robichaud&title=Design+and+synthesis+of+5%2C5%E2%80%B2-disubstituted+aminohydantoins+as+potent+and+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of 5,5'-Disubstituted Aminohydantoins as Potent and Selective Human β-Secretase (BACE1) Inhibitors</span></div><div class="casAuthors">Malamas, Michael S.; Erdei, Jim; Gunawan, Iwan; Turner, Jim; Hu, Yun; Wagner, Erik; Fan, Kristi; Chopra, Rajiv; Olland, Andrea; Bard, Jonathan; Jacobsen, Steve; Magolda, Ronald L.; Pangalos, Menelas; Robichaud, Albert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1146-1158</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of small mol. aminohydantoins as potent and selective human β-secretase inhibitors is reported.  These analogs exhibit low nanomolar potency for BACE1, show comparable activity in a cell-based (ELISA) assay, and demonstrate > 100 × selectivity for the other structurally related aspartyl proteases BACE2, cathepsinD, renin, and pepsin.  On the basis of the cocrystal structure of the HTS-hit I in the BACE1 active site and by use of a structure-based drug design approach, we methodically explored the comparatively large binding pocket of the BACE1 enzyme and identified key interactions between the ligand and the protein that contributed to the affinity.  One of the more potent compds., (S)-II, displayed an IC50 value for BACE1 of 10 nM and exhibited comparable cellular activity (EC50 = 20 nM) in the ELISA assay.  Acute oral administration of (S)-II at 100 mg/kg resulted in a 69% redn. of plasma Aβ40 at 8 h in a Tg2576 mouse (p < 0.001).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovSHqfBBe70bVg90H21EOLACvtfcHk0ljhdfYWDXUDKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrzN&md5=a27e4fbd64ed167ca7baae773c178fbc</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm901414e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901414e%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DJacobsen%26aufirst%3DS.%26aulast%3DMagolda%26aufirst%3DR.%2BL.%26aulast%3DPangalos%26aufirst%3DM.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%25205%252C5%25E2%2580%25B2-disubstituted%2520aminohydantoins%2520as%2520potent%2520and%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1146%26epage%3D1158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Swahn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plobeck, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotticci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehgelmeble, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S. v.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georgievska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustavsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neelissen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span> </span><span class="NLM_article-title">Aminoimidazoles as BACE-1 inhibitors: the challenge to achieve in vivo brain efficacy</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1854</span><span class="NLM_x">–</span> <span class="NLM_lpage">1859</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1854-1859&author=B.+Swahnauthor=J.+Holenzauthor=J.+Kihlstromauthor=K.+Kolmodinauthor=J.+Lindstromauthor=N.+Plobeckauthor=D.+Rotticciauthor=F.+Sehgelmebleauthor=M.+Sundstromauthor=S.+v.+Bergauthor=J.+Faltingauthor=B.+Georgievskaauthor=S.+Gustavssonauthor=J.+Neelissenauthor=M.+Ekauthor=L.+Olssonauthor=S.+Berg&title=Aminoimidazoles+as+BACE-1+inhibitors%3A+the+challenge+to+achieve+in+vivo+brain+efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwahn%26aufirst%3DB.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DKihlstrom%26aufirst%3DJ.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DLindstrom%26aufirst%3DJ.%26aulast%3DPlobeck%26aufirst%3DN.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3DSehgelmeble%26aufirst%3DF.%26aulast%3DSundstrom%26aufirst%3DM.%26aulast%3DBerg%26aufirst%3DS.%2Bv.%26aulast%3DFalting%26aufirst%3DJ.%26aulast%3DGeorgievska%26aufirst%3DB.%26aulast%3DGustavsson%26aufirst%3DS.%26aulast%3DNeelissen%26aufirst%3DJ.%26aulast%3DEk%26aufirst%3DM.%26aulast%3DOlsson%26aufirst%3DL.%26aulast%3DBerg%26aufirst%3DS.%26atitle%3DAminoimidazoles%2520as%2520BACE-1%2520inhibitors%253A%2520the%2520challenge%2520to%2520achieve%2520in%2520vivo%2520brain%2520efficacy%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1854%26epage%3D1859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martenyi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monk, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathes, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergott, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timm, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaBell, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhee, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ereshefsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocke, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span> </span><span class="NLM_article-title">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">16507</span><span class="NLM_x">–</span> <span class="NLM_lpage">16516</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1523%2FJNEUROSCI.3647-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=22090477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=16507-16516&author=P.+C.+Mayauthor=R.+A.+Deanauthor=S.+L.+Loweauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=L.+N.+Boggsauthor=S.+A.+Monkauthor=B.+M.+Mathesauthor=D.+J.+Mergottauthor=B.+M.+Watsonauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=E.+S.+LaBellauthor=C.+R.+Gonzalesauthor=M.+Nakanoauthor=S.+S.+Jheeauthor=M.+Yenauthor=L.+Ereshefskyauthor=T.+D.+Lindstromauthor=D.+O.+Calligaroauthor=P.+J.+Cockeauthor=D.+G.+Hallauthor=S.+Friedrichauthor=M.+Citronauthor=J.+E.+Audia&title=Robust+central+reduction+of+amyloid-%CE%B2+in+humans+with+an+orally+available%2C+non-peptidic+%CE%B2-secretase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span></div><div class="casAuthors">May, Patrick C.; Dean, Robert A.; Lowe, Stephen L.; Martenyi, Ferenc; Sheehan, Scott M.; Boggs, Leonard N.; Monk, Scott A.; Mathes, Brian M.; Mergott, Dustin J.; Watson, Brian M.; Stout, Stephanie L.; Timm, David E.; LaBell, Elizabeth Smith; Gonzales, Celedon R.; Nakano, Masako; Jhee, Stanford S.; Yen, Mark; Ereshefsky, Larry; Lindstrom, Terry D.; Calligaro, David O.; Cocke, Patrick J.; Hall, D. Greg; Friedrich, Stuart; Citron, Martin; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16507-16516</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">According to the amyloid cascade hypothesis, cerebral deposition of amyloid-β peptide (Aβ) is crit. for Alzheimer's disease (AD) pathogenesis.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  For more than a decade, BACE1 has been a prime target for designing drugs to prevent or treat AD.  However, development of such agents has turned out to be extremely challenging, with major hurdles in cell penetration, oral bioavailability/metabolic clearance, and brain access.  Using a fragment-based chem. strategy, we have generated LY2811376 [(S)-4-(2,4-difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazin-2-ylamine], the first orally available non-peptidic BACE1 inhibitor that produces profound Aβ-lowering effects in animals.  The biomarker changes obtained in preclin. animal models translate into man at doses of LY2811376 that were safe and well tolerated in healthy volunteers.  Prominent and long-lasting Aβ redns. in lumbar CSF were measured after oral dosing of 30 or 90 mg of LY2811376.  This represents the first translation of BACE1-driven biomarker changes in CNS from preclin. animal models to man.  Because of toxicol. findings identified in longer-term preclin. studies, this compd. is no longer progressing in clin. development.  However, BACE1 remains a viable target because the adverse effects reported here were recapitulated in LY2811376-treated BACE1 KO mice and thus are unrelated to BACE1 inhibition.  The magnitude and duration of central Aβ redn. obtainable with BACE1 inhibition positions this protease as a tractable small-mol. target through which to test the amyloid hypothesis in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqns_TvT2bZrVg90H21EOLACvtfcHk0lhHbUJ8ieR1Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F&md5=8f21f91ebd77e5fcf8b58b51c73a1a6b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3647-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3647-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DLaBell%26aufirst%3DE.%2BS.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DHall%26aufirst%3DD.%2BG.%26aulast%3DFriedrich%26aufirst%3DS.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DRobust%2520central%2520reduction%2520of%2520amyloid-%25CE%25B2%2520in%2520humans%2520with%2520an%2520orally%2520available%252C%2520non-peptidic%2520%25CE%25B2-secretase%2520inhibitor%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D16507%26epage%3D16516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rombouts, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spurlino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Gool, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span> </span><span class="NLM_article-title">Rational design and synthesis of aminopiperazinones as beta-secretase (BACE) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">7255</span><span class="NLM_x">–</span> <span class="NLM_lpage">7260</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1016%2Fj.bmcl.2011.10.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=22071305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFSqt7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=7255-7260&author=G.+Tresadernauthor=F.+Delgadoauthor=O.+Delgadoauthor=H.+Gijsenauthor=G.+J.+Macdonaldauthor=D.+Moecharsauthor=F.+Romboutsauthor=R.+Alexanderauthor=J.+Spurlinoauthor=M.+Van+Goolauthor=J.+A.+Vegaauthor=A.+A.+Trabanco&title=Rational+design+and+synthesis+of+aminopiperazinones+as+beta-secretase+%28BACE%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design and synthesis of aminopiperazinones as β-secretase (BACE) inhibitors</span></div><div class="casAuthors">Tresadern, Gary; Delgado, Francisca; Delgado, Oscar; Gijsen, Harrie; Macdonald, Gregor J.; Moechars, Dieder; Rombouts, Frederik; Alexander, Richard; Spurlino, John; Van Gool, Michiel; Vega, Juan Antonio; Trabanco, Andres A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7255-7260</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aminopiperazinone inhibitors of BACE were identified by rational design.  Structure based design guided idea prioritization and initial racemic hit I showed good activity.  Modification in decoration and chiral sepn. resulted in the 40 nM inhibitor, (-)-II, which showed in vivo redn. of amyloid beta peptides.  The crystal structure of (R)-I with BACE showed a binding mode driven by interaction with the catalytic aspartate dyad and distribution of the biaryl amide decoration towards S1 and S3 pockets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHSIy3VkZzlLVg90H21EOLACvtfcHk0lhHbUJ8ieR1Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFSqt7fF&md5=f8f1f7b83fae2fba7f2d0e553a8cb49d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.10.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.10.050%26sid%3Dliteratum%253Aachs%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DDelgado%26aufirst%3DF.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DRombouts%26aufirst%3DF.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DSpurlino%26aufirst%3DJ.%26aulast%3DVan%2BGool%26aufirst%3DM.%26aulast%3DVega%26aufirst%3DJ.%2BA.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3DRational%2520design%2520and%2520synthesis%2520of%2520aminopiperazinones%2520as%2520beta-secretase%2520%2528BACE%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D7255%26epage%3D7260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Swahn, B.; Kolmodin, K.; Karlström, S.; von Berg, S.; Söderman, P.; Holenz, J.; Berg, S.; Lindström, J.; Sundström, M.; Turek, D.; Kihlström, J.; Slivo, C.; Andersson, L.; Pyring, D.; Rotticci, D.; Öhberg, L.; Kers, A.; Bogar, K.; Bergh, M.; Olsson, L.; Janson, J.; Eketjäll, S.; Georgievska, B.; Jeppsson, F.; Fälting, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of β-secretase (bace1) inhibitors with in vivo brain reduction of β-amyloid peptides</span>.  <span class="citation_source-journal">J. Med. Chem.</span> [Online early access]. DOI: <span class="refDoi"> DOI: 10.1021/jm3009025</span> . Published Online: Aug 27,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/jm3009025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=B.+Swahn&author=K.+Kolmodin&author=S.+Karlstr%C3%B6m&author=S.+von+Berg&author=P.+S%C3%B6derman&author=J.+Holenz&author=S.+Berg&author=J.+Lindstr%C3%B6m&author=M.+Sundstr%C3%B6m&author=D.+Turek&author=J.+Kihlstr%C3%B6m&author=C.+Slivo&author=L.+Andersson&author=D.+Pyring&author=D.+Rotticci&author=L.+%C3%96hberg&author=A.+Kers&author=K.+Bogar&author=M.+Bergh&author=L.+Olsson&author=J.+Janson&author=S.+Eketj%C3%A4ll&author=B.+Georgievska&author=F.+Jeppsson&author=J.+F%C3%A4lting&title=Design+and+synthesis+of+%CE%B2-secretase+%28bace1%29+inhibitors+with+in+vivo+brain+reduction+of+%CE%B2-amyloid+peptides&doi=10.1021%2Fjm3009025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm3009025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3009025%26sid%3Dliteratum%253Aachs%26aulast%3DSwahn%26aufirst%3DB.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520%25CE%25B2-secretase%2520%2528bace1%2529%2520inhibitors%2520with%2520in%2520vivo%2520brain%2520reduction%2520of%2520%25CE%25B2-amyloid%2520peptides%26jtitle%3DJ.%2520Med.%2520Chem.%26doi%3D10.1021%2Fjm3009025%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiaszek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Structure based design of iminohydantoin BACE1 inhibitors: identification of an orally available, centrally active BACE1 inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2444</span><span class="NLM_x">–</span> <span class="NLM_lpage">2449</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1016%2Fj.bmcl.2012.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=22390835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1ektbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2444-2449&author=J.+N.+Cummingauthor=E.+M.+Smithauthor=L.+Wangauthor=J.+Misiaszekauthor=J.+Durkinauthor=J.+Panauthor=U.+Iserlohauthor=Y.+Wuauthor=Z.+Zhuauthor=C.+Stricklandauthor=J.+Voigtauthor=X.+Chenauthor=M.+E.+Kennedyauthor=R.+Kuvelkarauthor=L.+A.+Hydeauthor=K.+Coxauthor=L.+Favreauauthor=M.+F.+Czarnieckiauthor=W.+J.+Greenleeauthor=B.+A.+McKittrickauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Structure+based+design+of+iminohydantoin+BACE1+inhibitors%3A+identification+of+an+orally+available%2C+centrally+active+BACE1+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Structure based design of iminohydantoin BACE1 inhibitors: Identification of an orally available, centrally active BACE1 inhibitor</span></div><div class="casAuthors">Cumming, Jared N.; Smith, Elizabeth M.; Wang, Lingyan; Misiaszek, Jeffrey; Durkin, James; Pan, Jianping; Iserloh, Ulrich; Wu, Yusheng; Zhu, Zhaoning; Strickland, Corey; Voigt, Johannes; Chen, Xia; Kennedy, Matthew E.; Kuvelkar, Reshma; Hyde, Lynn A.; Cox, Kathleen; Favreau, Leonard; Czarniecki, Michael F.; Greenlee, William J.; McKittrick, Brian A.; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2444-2449</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">From an initial lead 2-imino-1-methyl-4,4-diphenyl-5-imidazolidinone, a structure-based design approach led to identification of the novel, high-affinity iminohydantoin BACE1 inhibitor I that lowers CNS-derived Aβ following oral administration to rats.  SAR development in the S3 and F' subsites of BACE1 for this series, the synthetic approaches employed in this effort, and in vivo data for I are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3tWBE09QKNLVg90H21EOLACvtfcHk0lg08OpUcfO7cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1ektbY%253D&md5=783b6cb9a6d9608ff5e9dc4f5d634397</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DSmith%26aufirst%3DE.%2BM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DDurkin%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCzarniecki%26aufirst%3DM.%2BF.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DStructure%2520based%2520design%2520of%2520iminohydantoin%2520BACE1%2520inhibitors%253A%2520identification%2520of%2520an%2520orally%2520available%252C%2520centrally%2520active%2520BACE1%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2444%26epage%3D2449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croghan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dineen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esmay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harried, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbeah-Ampiah, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaller, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreiman, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monenschein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rattan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">San, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sickmier, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, W.</span><span> </span><span class="NLM_article-title">Design and preparation of a potent series of hydroxyethylamine containing beta-secretase inhibitors that demonstrate robust reduction of central ss-amyloid</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6243</span><span class="NLM_x">–</span> <span class="NLM_lpage">6644</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6243-6644&author=M.+M.+Weissauthor=T.+Williamsonauthor=S.+Babu-Khanauthor=M.+D.+Bartbergerauthor=J.+Brownauthor=K.+Chenauthor=Y.+Chengauthor=M.+Citronauthor=M.+D.+Croghanauthor=T.+A.+Dineenauthor=J.+Esmayauthor=R.+F.+Graceffaauthor=S.+Harriedauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=D.+B.+Horneauthor=H.+Huangauthor=R.+Imbeah-Ampiahauthor=T.+Juddauthor=M.+R.+Kallerauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=V.+Liauthor=P.+Lopezauthor=S.+Louieauthor=H.+Monenscheinauthor=T.+T.+Nguyenauthor=L.+D.+Penningtonauthor=C.+Rattanauthor=M.+T.+Sanauthor=E.+A.+Sickmierauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Woodauthor=Q.+Xueauthor=B.+H.+Yangauthor=V.+F.+Patelauthor=W.+Zhong&title=Design+and+preparation+of+a+potent+series+of+hydroxyethylamine+containing+beta-secretase+inhibitors+that+demonstrate+robust+reduction+of+central+ss-amyloid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWilliamson%26aufirst%3DT.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DCroghan%26aufirst%3DM.%2BD.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DEsmay%26aufirst%3DJ.%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DHarried%26aufirst%3DS.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DHorne%26aufirst%3DD.%2BB.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DImbeah-Ampiah%26aufirst%3DR.%26aulast%3DJudd%26aufirst%3DT.%26aulast%3DKaller%26aufirst%3DM.%2BR.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DLouie%26aufirst%3DS.%26aulast%3DMonenschein%26aufirst%3DH.%26aulast%3DNguyen%26aufirst%3DT.%2BT.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DRattan%26aufirst%3DC.%26aulast%3DSan%26aufirst%3DM.%2BT.%26aulast%3DSickmier%26aufirst%3DE.%2BA.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DXue%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DB.%2BH.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DZhong%26aufirst%3DW.%26atitle%3DDesign%2520and%2520preparation%2520of%2520a%2520potent%2520series%2520of%2520hydroxyethylamine%2520containing%2520beta-secretase%2520inhibitors%2520that%2520demonstrate%2520robust%2520reduction%2520of%2520central%2520ss-amyloid%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6243%26epage%3D6644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Rueeger, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lueoend, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogel, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rondeau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobitz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machauer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staufenbiel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desrayaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumann, U.</span><span> </span><span class="NLM_article-title">Discovery of cyclic sulfone hydroxyethylamines as potent and selective β-site APP-cleaving enzyme 1 (BACE1) inhibitors: structure-based design and in vivo reduction of amyloid β-peptides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">3364</span><span class="NLM_x">–</span> <span class="NLM_lpage">3386</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300069y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3364-3386&author=H.+Rueegerauthor=R.+Lueoendauthor=O.+Rogelauthor=J.+Rondeauauthor=H.+Mobitzauthor=R.+Machauerauthor=L.+Jacobsonauthor=M.+Staufenbielauthor=S.+Desrayaudauthor=U.+Neumann&title=Discovery+of+cyclic+sulfone+hydroxyethylamines+as+potent+and+selective+%CE%B2-site+APP-cleaving+enzyme+1+%28BACE1%29+inhibitors%3A+structure-based+design+and+in+vivo+reduction+of+amyloid+%CE%B2-peptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm300069y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300069y%26sid%3Dliteratum%253Aachs%26aulast%3DRueeger%26aufirst%3DH.%26aulast%3DLueoend%26aufirst%3DR.%26aulast%3DRogel%26aufirst%3DO.%26aulast%3DRondeau%26aufirst%3DJ.%26aulast%3DMobitz%26aufirst%3DH.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DJacobson%26aufirst%3DL.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DDesrayaud%26aufirst%3DS.%26aulast%3DNeumann%26aufirst%3DU.%26atitle%3DDiscovery%2520of%2520cyclic%2520sulfone%2520hydroxyethylamines%2520as%2520potent%2520and%2520selective%2520%25CE%25B2-site%2520APP-cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520structure-based%2520design%2520and%2520in%2520vivo%2520reduction%2520of%2520amyloid%2520%25CE%25B2-peptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3364%26epage%3D3386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Chang, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downs, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirrito, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koelsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holtzman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Beta-secretase inhibitor GRL-8234 rescues age-related cognitive decline in APP transgenic mice</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">–</span> <span class="NLM_lpage">784</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=775-784&author=W.+P.+Changauthor=X.+Huangauthor=D.+Downsauthor=J.+R.+Cirritoauthor=G.+Koelschauthor=D.+M.+Holtzmanauthor=A.+K.+Ghoshauthor=J.+Tang&title=Beta-secretase+inhibitor+GRL-8234+rescues+age-related+cognitive+decline+in+APP+transgenic+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DW.%2BP.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DDowns%26aufirst%3DD.%26aulast%3DCirrito%26aufirst%3DJ.%2BR.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DHoltzman%26aufirst%3DD.%2BM.%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DBeta-secretase%2520inhibitor%2520GRL-8234%2520rescues%2520age-related%2520cognitive%2520decline%2520in%2520APP%2520transgenic%2520mice%26jtitle%3DFASEB%2520J.%26date%3D2011%26volume%3D25%26spage%3D775%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Edwards, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sylvester, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aharony, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andisik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederickson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folmer, R. H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geschwindner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koether, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krumrine, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauger, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spear, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, G.</span><span> </span><span class="NLM_article-title">Application of fragment-based lead generation to the discovery of novel, cyclic amidine β-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5912</span><span class="NLM_x">–</span> <span class="NLM_lpage">5925</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070829p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1KitrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5912-5925&author=P.+D.+Edwardsauthor=J.+S.+Albertauthor=M.+Sylvesterauthor=D.+Aharonyauthor=D.+Andisikauthor=O.+Callaghanauthor=J.+B.+Campbellauthor=R.+A.+Carrauthor=G.+Chessariauthor=M.+Congreveauthor=M.+Fredericksonauthor=R.+H.+A.+Folmerauthor=S.+Geschwindnerauthor=G.+Koetherauthor=K.+Kolmodinauthor=J.+Krumrineauthor=R.+C.+Maugerauthor=C.+W.+Murrayauthor=L.+Olssonauthor=S.+Patelauthor=N.+Spearauthor=G.+Tian&title=Application+of+fragment-based+lead+generation+to+the+discovery+of+novel%2C+cyclic+amidine+%CE%B2-secretase+inhibitors+with+nanomolar+potency%2C+cellular+activity%2C+and+high+ligand+efficiency"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Application of fragment-based lead generation to the discovery of novel, cyclic amidine β-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency</span></div><div class="casAuthors">Edwards, Philip D.; Albert, Jeffrey S.; Sylvester, Mark; Aharony, David; Andisik, Donald; Callaghan, Owen; Campbell, James B.; Carr, Robin A.; Chessari, Gianni; Congreve, Miles; Frederickson, Martyn; Folmer, Rutger H. A.; Geschwindner, Stefan; Koether, Gerard; Kolmodin, Karin; Krumrine, Jennifer; Mauger, Russell C.; Murray, Christopher W.; Olsson, Lise-Lotte; Patel, Sahil; Spear, Nate; Tian, Gaochao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5912-5925</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based lead generation has led to the discovery of a novel series of cyclic amidine-based inhibitors of β-secretase (BACE-1).  Initial fragment hits with an isocytosine core having millimolar potency were identified via NMR affinity screening.  Structure-guided evolution of these fragments using x-ray crystallog. together with potency detn. using surface plasmon resonance and functional enzyme inhibition assays afforded micromolar inhibitors.  Similarity searching around the isocytosine core led to the identification of a related series of inhibitors, the dihydroisocytosines.  By leveraging the knowledge of the ligand-BACE-1 recognition features generated from the isocytosines, the dihydroisocytosines were efficiently optimized to submicromolar potency.  Compd. (I), with an IC50 of 80 nM, a ligand efficiency of 0.37, and cellular activity of 470 nM, emerged as the lead structure for future optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmm71A2gRltrVg90H21EOLACvtfcHk0lhexqKz1GSX2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1KitrbP&md5=140f3ade2b7754f62eb73589c5de4d7b</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm070829p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070829p%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3DAlbert%26aufirst%3DJ.%2BS.%26aulast%3DSylvester%26aufirst%3DM.%26aulast%3DAharony%26aufirst%3DD.%26aulast%3DAndisik%26aufirst%3DD.%26aulast%3DCallaghan%26aufirst%3DO.%26aulast%3DCampbell%26aufirst%3DJ.%2BB.%26aulast%3DCarr%26aufirst%3DR.%2BA.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DFolmer%26aufirst%3DR.%2BH.%2BA.%26aulast%3DGeschwindner%26aufirst%3DS.%26aulast%3DKoether%26aufirst%3DG.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DKrumrine%26aufirst%3DJ.%26aulast%3DMauger%26aufirst%3DR.%2BC.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DOlsson%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DSpear%26aufirst%3DN.%26aulast%3DTian%26aufirst%3DG.%26atitle%3DApplication%2520of%2520fragment-based%2520lead%2520generation%2520to%2520the%2520discovery%2520of%2520novel%252C%2520cyclic%2520amidine%2520%25CE%25B2-secretase%2520inhibitors%2520with%2520nanomolar%2520potency%252C%2520cellular%2520activity%252C%2520and%2520high%2520ligand%2520efficiency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5912%26epage%3D5925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">White, R.; Amegadzie, A.; Bryan, M. C.; Chen, J. J.; Cheng, A. C.; Dineen, T.; Epstein, O.; Gore, V. K.; Hua, Z.; Human, J. B.; Huang, H.; Kreiman, C.; La, D.; Liu, Q.; Ma, V. V.; Marx, I.; Patel, V. F.; Qian, W.; Weiss, M.; Yuan, C. C.</span>WO2010030954A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=White%2C+R.%3B+Amegadzie%2C+A.%3B+Bryan%2C+M.+C.%3B+Chen%2C+J.+J.%3B+Cheng%2C+A.+C.%3B+Dineen%2C+T.%3B+Epstein%2C+O.%3B+Gore%2C+V.+K.%3B+Hua%2C+Z.%3B+Human%2C+J.+B.%3B+Huang%2C+H.%3B+Kreiman%2C+C.%3B+La%2C+D.%3B+Liu%2C+Q.%3B+Ma%2C+V.+V.%3B+Marx%2C+I.%3B+Patel%2C+V.+F.%3B+Qian%2C+W.%3B+Weiss%2C+M.%3B+Yuan%2C+C.+C.WO2010030954A1%2C+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DR.%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Takahashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terauchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, M.</span><span> </span><span class="NLM_article-title">Ameliorative effects of a non-competitive BACE1 inhibitor TAK-070 on Aβ peptide levels and impaired learning behavior in aged rats</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1361</span><span class="NLM_x">, </span> <span class="NLM_fpage">146</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1016%2Fj.brainres.2010.09.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=20849831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtleqtLzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1361&publication_year=2010&pages=146-156&author=H.+Takahashiauthor=H.+Fukumotoauthor=R.+Maedaauthor=J.+Terauchiauthor=K.+Katoauthor=M.+Miyamoto&title=Ameliorative+effects+of+a+non-competitive+BACE1+inhibitor+TAK-070+on+A%CE%B2+peptide+levels+and+impaired+learning+behavior+in+aged+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Ameliorative effects of a non-competitive BACE1 inhibitor TAK-070 on Aβ peptide levels and impaired learning behavior in aged rats</span></div><div class="casAuthors">Takahashi, Hideki; Fukumoto, Hiroaki; Maeda, Ryouta; Terauchi, Jun; Kato, Kaneyoshi; Miyamoto, Masaomi</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1361</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">146-156</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We examd. the effects of TAK-070, a novel non-competitive β-secretase (BACE1) inhibitor, on the levels of Aβ peptides and behavioral deficits in rats.  TAK-070 reduced sol. Aβ40 and Aβ42 levels of the cerebral cortex in a time- and dose-dependent manner in young rats.  We found that the insol. Aβ42 content increased significantly with aging from 22 mo old without changing Aβ40 content.  TAK-070 normalized the Aβ42 levels to those in young rats when they were fed chow contg. TAK-070 starting at 19 mo old for 6.5 mo.  Repeated administration of TAK-070 to aged rats for 2 wk ameliorated the impaired spatial learning in the Morris water maze task and reduced the levels of sol. and insol. Aβ peptides at doses of 0.3-1 mg/kg, (p.o.).  Interestingly, TAK-070 significantly recovered the reduced brain synaptophysin levels in aged rats to those in young rats.  Our findings support the idea that partial inhibition of BACE1 by TAK-070 exerts symptomatic as well as disease-modifying effects for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiylMf9raud7Vg90H21EOLACvtfcHk0lhexqKz1GSX2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtleqtLzJ&md5=42b672a7a3b1c3bffbe1954003893550</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2010.09.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2010.09.032%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DH.%26aulast%3DFukumoto%26aufirst%3DH.%26aulast%3DMaeda%26aufirst%3DR.%26aulast%3DTerauchi%26aufirst%3DJ.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DMiyamoto%26aufirst%3DM.%26atitle%3DAmeliorative%2520effects%2520of%2520a%2520non-competitive%2520BACE1%2520inhibitor%2520TAK-070%2520on%2520A%25CE%25B2%2520peptide%2520levels%2520and%2520impaired%2520learning%2520behavior%2520in%2520aged%2520rats%26jtitle%3DBrain%2520Res.%26date%3D2010%26volume%3D1361%26spage%3D146%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Fukumoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarui, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirode, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagayama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terauchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakihana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, M.</span><span> </span><span class="NLM_article-title">A noncompetitive BACE1 inhibitor TAK-070 ameliorates Aβ pathology and behavioral deficits in a mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">11157</span><span class="NLM_x">–</span> <span class="NLM_lpage">11166</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1523%2FJNEUROSCI.2884-10.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=20720123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFWms73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=11157-11166&author=H.+Fukumotoauthor=H.+Takahashiauthor=N.+Taruiauthor=J.+Matsuiauthor=T.+Tomitaauthor=M.+Hirodeauthor=M.+Sagayamaauthor=R.+Maedaauthor=M.+Kawamotoauthor=K.+Hiraiauthor=J.+Terauchiauthor=Y.+Sakuraauthor=M.+Kakihanaauthor=K.+Katoauthor=T.+Iwatsuboauthor=M.+Miyamoto&title=A+noncompetitive+BACE1+inhibitor+TAK-070+ameliorates+A%CE%B2+pathology+and+behavioral+deficits+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A noncompetitive BACE1 inhibitor TAK-070 ameliorates Aβ pathology and behavioral deficits in a mouse model of Alzheimer's disease</span></div><div class="casAuthors">Fukumoto, Hiroaki; Takahashi, Hideki; Tarui, Naoki; Matsui, Junji; Tomita, Taisuke; Hirode, Mitsuhiro; Sagayama, Masumi; Maeda, Ryouta; Kawamoto, Makiko; Hirai, Kazuko; Terauchi, Jun; Sakura, Yasufumi; Kakihana, Mitsuru; Kato, Kaneyoshi; Iwatsubo, Takeshi; Miyamoto, Masaomi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">11157-11166</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">We discovered a nonpeptidic compd., TAK-070, that inhibited BACE1, a rate-limiting protease for the generation of Aβ peptides that are considered causative for Alzheimer's disease (AD), in a noncompetitive manner.  TAK-070 bound to full-length BACE1, but not to truncated BACE1 lacking the transmembrane domain.  Short-term oral administration of TAK-070 decreased the brain levels of sol. Aβ, increased that of neurotrophic sAPPα by ∼20%, and normalized the behavioral impairments in cognitive tests in Tg2576 mice, an APP transgenic mouse model of AD.  Six-month chronic treatment decreased cerebral Aβ deposition by ∼60%, preserving the pharmacol. efficacy on sol. Aβ and sAPPα levels.  These results support the feasibility of BACE1 inhibition with a noncompetitive inhibitor as disease-modifying as well as symptomatic therapy for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3rSO_LMTWu7Vg90H21EOLACvtfcHk0liK8vBRpRyAYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFWms73E&md5=195c706b0243c84824d3c84ec0123bba</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2884-10.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2884-10.2010%26sid%3Dliteratum%253Aachs%26aulast%3DFukumoto%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DH.%26aulast%3DTarui%26aufirst%3DN.%26aulast%3DMatsui%26aufirst%3DJ.%26aulast%3DTomita%26aufirst%3DT.%26aulast%3DHirode%26aufirst%3DM.%26aulast%3DSagayama%26aufirst%3DM.%26aulast%3DMaeda%26aufirst%3DR.%26aulast%3DKawamoto%26aufirst%3DM.%26aulast%3DHirai%26aufirst%3DK.%26aulast%3DTerauchi%26aufirst%3DJ.%26aulast%3DSakura%26aufirst%3DY.%26aulast%3DKakihana%26aufirst%3DM.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DMiyamoto%26aufirst%3DM.%26atitle%3DA%2520noncompetitive%2520BACE1%2520inhibitor%2520TAK-070%2520ameliorates%2520A%25CE%25B2%2520pathology%2520and%2520behavioral%2520deficits%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26spage%3D11157%26epage%3D11166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quagliato, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solvibile, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhart, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M.</span><span> </span><span class="NLM_article-title">Design and synthesis of aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors with enhanced brain permeability</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6597</span><span class="NLM_x">–</span> <span class="NLM_lpage">6605</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1016%2Fj.bmcl.2010.09.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=20880704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSmsL7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6597-6605&author=M.+S.+Malamasauthor=A.+Robichaudauthor=J.+Erdeiauthor=D.+Quagliatoauthor=W.+Solvibileauthor=P.+Zhouauthor=K.+Morrisauthor=J.+Turnerauthor=E.+Wagnerauthor=K.+Fanauthor=A.+Ollandauthor=S.+Jacobsenauthor=P.+Reinhartauthor=D.+Riddellauthor=M.+Pangalos&title=Design+and+synthesis+of+aminohydantoins+as+potent+and+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors+with+enhanced+brain+permeability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors with enhanced brain permeability</span></div><div class="casAuthors">Malamas, Michael S.; Robichaud, Albert; Erdei, Jim; Quagliato, Dominick; Solvibile, William; Zhou, Ping; Morris, Koi; Turner, Jim; Wagner, Erik; Fan, Kristi; Olland, Andrea; Jacobsen, Steve; Reinhart, Peter; Riddell, David; Pangalos, Menelas</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6597-6605</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The identification of small mol. aminohydantoins as potent and selective human β-secretase inhibitors is reported.  These analogs exhibit good brain permeability (40-70%), low nanomolar potency for BACE1, and demonstrate >100-fold selectivity for the structurally related aspartyl proteases cathepsin D, renin and pepsin.  Alkyl and alkoxy groups at the meta-position of the P1 Ph, which extend toward the S3 region of the enzyme, have contributed to the ligand's reduced affinity for the efflux transporter protein P-gp, and decreased topol. polar surface area, thus resulting in enhanced brain permeability.  A fluorine substitution at the para-position of the P1 Ph has contributed to 100-fold decrease of CYP3A4 inhibition and enhancement of compd. metabolic stability.  The plasma and brain protein binding properties of these new analogs are affected by substitutions at the P1 Ph moiety.  Higher compd. protein binding was obsd. in the brain than in the plasma.  Two structurally diverse potent BACE1 inhibitors (84 and 89) reduced 30% plasma Aβ40 in the Tg2576 mice in vivo model at 30 mg/kg po.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSYkNat5QUjrVg90H21EOLACvtfcHk0liK8vBRpRyAYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSmsL7I&md5=848a1bfa79278b0c7a72749f9be45ad8</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.09.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.09.029%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DRobichaud%26aufirst%3DA.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DQuagliato%26aufirst%3DD.%26aulast%3DSolvibile%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DMorris%26aufirst%3DK.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DJacobsen%26aufirst%3DS.%26aulast%3DReinhart%26aufirst%3DP.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DPangalos%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520aminohydantoins%2520as%2520potent%2520and%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%2520with%2520enhanced%2520brain%2520permeability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6597%26epage%3D6605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Roden, D. M.</span><span> </span><span class="NLM_article-title">Drug-induced prolongation of the QT interval</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1022</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1056%2FNEJMra032426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=14999113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFGjs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2004&pages=1013-1022&author=D.+M.+Roden&title=Drug-induced+prolongation+of+the+QT+interval"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-induced prolongation of the QT interval</span></div><div class="casAuthors">Roden, Dan M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1013-1022</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA8PoMXlMg57Vg90H21EOLACvtfcHk0liK8vBRpRyAYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFGjs7Y%253D&md5=a020a545700649d9914ed8dc61910244</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1056%2FNEJMra032426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra032426%26sid%3Dliteratum%253Aachs%26aulast%3DRoden%26aufirst%3DD.%2BM.%26atitle%3DDrug-induced%2520prolongation%2520of%2520the%2520QT%2520interval%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D350%26spage%3D1013%26epage%3D1022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Ekins, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crumb, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarazan, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikel, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrighton, S. A.</span><span> </span><span class="NLM_article-title">Three-dimensional quantitative structure–activity relationship for inhibition of human ether-a-go-go-related gene potassium channel</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">301</span><span class="NLM_x">, </span> <span class="NLM_fpage">427</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1124%2Fjpet.301.2.427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=11961040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtlKjur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2002&pages=427-434&author=S.+Ekinsauthor=W.+J.+Crumbauthor=R.+D.+Sarazanauthor=J.+H.+Wikelauthor=S.+A.+Wrighton&title=Three-dimensional+quantitative+structure%E2%80%93activity+relationship+for+inhibition+of+human+ether-a-go-go-related+gene+potassium+channel"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Three-dimensional quantitative structure-activity relationship for inhibition of human ether-a-go-go-related gene potassium channel</span></div><div class="casAuthors">Ekins, Sean; Crumb, William J.; Sarazan, R. Dustan; Wikel, James H.; Wrighton, Steven A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">301</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">427-434</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The protein product of the human ether-a-go-go gene (hERG) is a potassium channel that when inhibited by some drugs may lead to cardiac arrhythmia.  Previously, a three-dimensional quant. structure-activity relationship (3D-QSAR) pharmacophore model was constructed using Catalyst with in vitro inhibition data for antipsychotic agents.  The rationale of the current study was to use a combination of in vitro and in silico technologies to further test the pharmacophore model and qual. predict whether mols. are likely to inhibit this potassium channel.  These predictions were assessed with the exptl. data using the Spearman's rho rank correlation.  The antipsychotic-based hERG inhibitor model produced a statistically significant Spearman's rho of 0.71 for 11 mols.  In addn., 15 mols. from the literature were used as a further test set and were also well ranked by the same model with a statistically significant Spearman's rho value of 0.76.  A Catalyst General hERG pharmacophore model was generated with these literature mols., which contained four hydrophobic features and one pos. ionizable feature.  Linear regression of log-transformed obsd. vs. predicted IC50 values for this training set resulted in an r2 value of 0.90.  The model based on literature data was evaluated with the in vitro data generated for the original 22 mols. (including the antipsychotics) and illustrated a significant Spearman's rho of 0.77.  Thus, the Catalyst 3D-QSAR approach provides useful qual. predictions for test set mols.  The model based on literature data therefore provides a potentially valuable tool for discovery chem. as future mols. may be synthesized that are less likely to inhibit hERG based on information provided by a pharmacophore for the inhibition of this potassium channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5gBvozbTJ2bVg90H21EOLACvtfcHk0lg8_Bnry6_pwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtlKjur0%253D&md5=387bde56bd5e4c2a658de61d205395fd</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1124%2Fjpet.301.2.427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.301.2.427%26sid%3Dliteratum%253Aachs%26aulast%3DEkins%26aufirst%3DS.%26aulast%3DCrumb%26aufirst%3DW.%2BJ.%26aulast%3DSarazan%26aufirst%3DR.%2BD.%26aulast%3DWikel%26aufirst%3DJ.%2BH.%26aulast%3DWrighton%26aufirst%3DS.%2BA.%26atitle%3DThree-dimensional%2520quantitative%2520structure%25E2%2580%2593activity%2520relationship%2520for%2520inhibition%2520of%2520human%2520ether-a-go-go-related%2520gene%2520potassium%2520channel%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D301%26spage%3D427%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Diller, J. D.</span><span> </span><span class="NLM_article-title">In silico hERG modelling: challenges and progress</span> <span class="citation_source-journal">Curr. Comput.-Aided Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">106</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.2174%2F157340909788451928" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvVWrtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=106-121&author=J.+D.+Diller&title=In+silico+hERG+modelling%3A+challenges+and+progress"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">In silico hERG modeling: challenges and progress</span></div><div class="casAuthors">Diller, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Computer-Aided Drug Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">106-121</span>CODEN:
                <span class="NLM_cas:coden">CCDDAS</span>;
        ISSN:<span class="NLM_cas:issn">1573-4099</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The first generation of in silico hERG models have focused on key driving forces for hERG/ligand binding: basicity and lipophilicity.  While reducing basicity and lipophilicity are typically the first line approaches to eliminating hERG blocking activity, in many programs these are not feasible approaches because basicity and lipophilicity are frequently necessary for achieving good pharmacokinetics or primary target binding.  Thus for the second, generation of in silico hERG models, a focus on understanding the more subtle aspects of hERG binding is necessary.  Thus, the focus of this review is on extg. ideas, either qual. or quant., from the various modeling efforts as to how hERG activity might be eliminated or diminished beyond simply reducing basicity and lipophilicity.  In addn., several areas where key questions around hERG binding have not been adequately addressed by in silico work are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7wUQpyBUN-rVg90H21EOLACvtfcHk0lg8_Bnry6_pwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvVWrtbY%253D&md5=cc2f2623d70bc07fa408e83185e428fe</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.2174%2F157340909788451928&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157340909788451928%26sid%3Dliteratum%253Aachs%26aulast%3DDiller%26aufirst%3DJ.%2BD.%26atitle%3DIn%2520silico%2520hERG%2520modelling%253A%2520challenges%2520and%2520progress%26jtitle%3DCurr.%2520Comput.-Aided%2520Drug%2520Des.%26date%3D2009%26volume%3D5%26spage%3D106%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Asinger, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumgarte, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueting, P. F.</span><span> </span><span class="NLM_article-title">Concomitant action of elementary sulfur and gaseous ammonia on ketones. XXXVI. Action of sulfur and ammonia on acetophenone. II. Synthesis of 3-imidazoline-5-thiones</span> <span class="citation_source-journal">Ann.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1963</span><span class="NLM_x">, </span> <span class="NLM_volume">661</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADyaF3sXktVyqtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=661&publication_year=1963&pages=95-110&author=F.+Asingerauthor=W.+Schaeferauthor=G.+Baumgarteauthor=P.+F.+Mueting&title=Concomitant+action+of+elementary+sulfur+and+gaseous+ammonia+on+ketones.+XXXVI.+Action+of+sulfur+and+ammonia+on+acetophenone.+II.+Synthesis+of+3-imidazoline-5-thiones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Concomitant action of elementary sulfur and gaseous ammonia on ketones. XXXVI. Action of sulfur and ammonia on acetophenone. II. Synthesis of 3-imidazoline-5-thiones</span></div><div class="casAuthors">Asinger, Friedrich; Schaefer, Wofgang; Baumgarte, Guenter; Mueting, Peter F.</div><div class="citationInfo"><span class="NLM_cas:title">Annalen der Chemie, Justus Liebigs</span>
        (<span class="NLM_cas:date">1963</span>),
    <span class="NLM_cas:volume">661</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">95-110</span>CODEN:
                <span class="NLM_cas:coden">9X224Y</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">cf. CA 58, 9058c.  3-Imidazoline-5-thiones were prepd. in good yields from aryl methyl ketones and excess NH3 and S at room temp.  The reaction mechanism was discussed.  Also reported was a concurrent rearrangement of unstable primary α-oxosulfenamides, RCOCH2SNR1R2, to thioglyoxylamides, RCOCSNR1R2 (I) by the dehydrogenating influence of elementary S at room temp.  By the procedure of A., et al. (loc. cit.) was prepd. (RCOCH2S)2 (II) (R = Ph).  H2S (45 l.) introduced into 80 g. NaOH in 500 cc. H2O at 0° and the soln. treated dropwise with 185 g. AcCH2Cl at 0° with stirring gave 110 g. AcCH2SH (III), m. 95-7°. III (45 g.) suspended in 1.5 l. H2O treated with N KI-iodine at 5° to a persistent iodine reaction, the ppt. filtered off, the filtrate extd. with Et2O, the ext. dried, and evapd. in vacuo gave 22 g. II (R = Me), oil.  S (16 g.) treated with 1 drop BuNH2 and then portionwise with 52.5 g. EtCOCH2SH (CA 52, 9141c) with stirring, towards the end of H2S evolution the whole heated 1 hr. at 40°, and distd. gave 24 g. II (R =Et), b0.4 74.6° (slight decompn.).  Me2CHCOCH2SH (CA 52, 11855h) (133 g.) added to 45 g. NaOH in 450 cc. H2O, the whole treated dropwise with 135 g. (NH4)2S2O8 in 150 cc. H2O at 0° with stirring, the resulting oil isolated with Et2O, and purified by repeated freezing at -60° gave 90 g. II (R = Me2CH), oil.  To 30.2 g. II (R = Ph) in 700 cc. dry CH2Cl2 was added slowly 7.1 g. Cl (previously condensed in a cold trap and exactly weighed) at -70° with stirring by means of a current of N, the whole treated dropwise with 38 g. morpholine, kept overnight at room temp., washed with 2N HCl and H2O, dried, concd., the residue dissolved in Et2O, and the soln. cooled in ice to give 12 g. I (R = Ph, NR1R2 = morpholino) (IV), m. 113-14° (MeOH); the combined Et2O and MeOH phases concd. in vacuo, the residue (oil plus crystals) dissolved in C6H6, the soln. treated with ligroine while hot until turbid, cooled, decanted repeatedly from an oil which sepd. until solid began to sep. from soln., and the solid collected gave 7.7 g. unchanged II (R = Ph), m. 80-1° (MeOH).  II in dry CH2Cl2 treated with an exact amt. Cl (mole ratio II-Cl 1:1) at -70° with stirring by means of a stream of N, the soln. treated dropwise with the appropriate amine followed by finely powd. S, kept overnight at room temp., washed neutral with H2O, dried, concd., in vacuo, and the residue triturated with Et2O gave I.  Thus were prepd. the following I [R, NR1R2, g. II, g. I, and m.p. given]: Ph, morpholino (IV), 50.4, 49, 113-14° (MeOH); Ph, piperidino, 25.2, 8.6, 73-4° (Et2OMeOH); Ph, Me2N, 25.2, 7, 83-4°; Me, morpholino, 17.8, 7, 127° (Et2O); Et, morpholino, 10.8, 12 (the mixt. was worked up by the general procedure 3 hrs. after removal of the ice bath), 73° (petr. ether); Me2CH, morpholino, 11.7, 8 (after removal of CH2Cl2, the residue was dissolved in petr. ether, the soln. filtered through Al2O3, and the filtrate concd.), 42° (iso-Pr2O); Me2CH, Me2N, 11.7, 8 (after removal of the CH2Cl2, the residual oil was repeatedly repptd. from Et2O with petr. ether), oil.  PhAc (180 g.), 96 g. S, and the appropriate additive treated 5 hrs. with NH3 (50 l./hr.) with stirring, the mixt. treated with 1.2 l. C6H6 and 400 cc. NH4SH soln. (prepd. by satg. concd. aq. NH3 with H2S and dilg. with an equal vol. concd. aq. NH3), the phases sepd., the aq. layer extd. with 600 cc. C6H6, the combined C6H6 solns. washed with 400 cc. NH4SH soln. and with 3 1 l. portions H2O, kept 30 min., the ppt. filtered off, and washed with petr. ether gave 2-methyl-2,4-diphenyl-3-imidazoline-5-thione (V); the combined C6H6 filtrate and petr. ether washings evapd. in vacuo on a water bath, the residue triturated with 300 cc. hot petr. ether, and the whole cooled gave addnl. V, m. 182° (MeOH); the petr. ether filtrate concd. in vacuo and the residue distd. in vacuo gave unchanged PhAc and (as distn. residue) 2-methyl-2,4-diphenyl-3-thiazoline (VI) in most cases, the chief by-product of the reaction.  The following results were obtained [additive, NH3 soly. (millimoles NH3/l. at 40°), % total yield, % yield V (the difference between % total yield and % yield V was chiefly due to the formation of VI) given]: 75 cc. C6H6, 230, 20, 8; 75 cc. pyridine, 679, 74, 23; 75 cc. dioxane, 806, 45, 15; 75 cc. HCONMe2 (VII), 1186, 72, 22; 7.5 cc. VII, --, 42, 13; 75 co. MeOH, 5976, 62, 27; -- --, 37, 21; 75 g. NH4NO3, --, 53, 23; 75 g. betaine, --, 25, 6.  Varying the S content in the above reaction (1.5 moles PhAc) gave the following results [additive (75 cc.), mole ratio PhAc-S, % total yield, % yield V given]: VII, 1:0.73,47, 10; VII, 1:2, 72,22; VII, 1:4, 100,42; MeOH, 1:0.73, 30, 10; MeOH, 1:2, 62, 27; MeOH, 1:4, 80, 39.  The results of varying the MeOH content on the reaction of 0.3 mole PhAc with 1.2 g. atoms S and NH3 (30 l./hr.) at 30° during a reaction time of 5 hrs. were as follows (cc. MeOH, % total yield, and % yield V given): 15, 80, 39; 30, 84, 55; 55, 78, 55; 80, 72, 53; 150, 45, 34.  The effect of varying the duration of reaction on the reaction of 0.3 mole PhAc and S and NH3 at 30° and an excess pressure of 65 mm. NH3 was as follows [cc. MeOH, duration of reaction (hrs.), mole ratio PhAc-S, % total yield, % yield V given]: 55, 5, 1:4, 74, 55; 55, 15, 1:4, 88, 56; 80, 5, 1:8, 72, 59; 80, 24, 1:8, 99, 86; 80, 48, 1:8, 100, 86.  The effect of varying the temp. on the reaction of 0.3 mole PhAc with 2.4 g.-atoms S and an excess pressure of 65 mm. NH3 in 80 cc. MeOH for a 24-hr. reaction time was as follows (temp., % total yield, and % yield V given): 0° 57, 50; 15°, 98, 92; 30°, 99, 86; 45°, 95, 27 [in addn. to VI, 18.4% 2-methyl-2,4-diphenyl-5-imino-3-imidazoline (VIII) was also formed as by-product]; 60°, 81, 10.  By the general reaction procedure was prepd. 19 g. mixt. (IX) of V and VIII.  IX (5 g.) dissolved in 30 cc. AcOH at 100°, the hot soln. poured into 250 cc. boiling 20% AcOH with stirring, boiled until the ppt. coagulated, the ppt. filtered off, washed neutral with H2O, and dried at 90° gave 2.8 g. V, m. 181°; the AcOH filtrate neutralized with concd. aq. NaOH at the b.p., boiled, and cooled gave 1.8 g. VIII, m. 147° (cyclohexane-petr. ether).  The aryl methyl ketone (0.3 mole), 80 cc. MeOH, and 77 g. S were charged to a 250-cc. flask, an NH3 stream was introduced into the mixt. at 30°, after 24 hrs. the mixt. was shaken with 400 cc. C6H6 and 100 cc. NH4SH soln., the layers were sepd., the aq. layer was extd. with 200 cc. C6H6, the combined C6H6 solns. washed with 400 cc. H2O, kept 30 min., the ppt. (1st crop) filtered off, washed with petr. ether, the combined filtrate and washings evapd. in vacuo, the residue treated with 200 cc. warm (50°) petr. ether, the mixt. cooled, the ppt. (2nd crop) filtered off, combined with the 1st crop, and recrystd. to give the 3-imidazoline-5-thione.  The following X were thus prepd. [R, m.p. (cor), recrystn. solvent, % yield given]: Ph, 182°, EtOH, 85; 4-FC6H4, 186°, MeOH, 69; 4-ClC6H4, 161°, iso-Pr2O-MeOH, 89; 4-BrC6H4 (XI), 174°, PhMe, 75; 4IC6H4 (XII), 201°, EtOH, 82; 4-MeC6H4, 182°, MeOH, 78; 4-MeOC6H4, 187°, MeOH-Me2CO, 96; 4-EtOC6H4, 132°, isoBu2O-MeOH, 93; 4-H2NC6H4, 171°, iso-PrOH-EtOH, 74; 2-MeOC6H4, 188°, Me2CO-MeOH, 90; 4,2-Me(MeO)C6H3 (XIII), 180°, Me2CO-MeOH, 73; 3-ClC6H4, 117°, iso-Pr2OMeOH, 85; 2-thienyl, 174°, C6H6-MeOH, 38; 2-naphthyl, 185°, PhMe, 85; 1-naphthyl, 247°, PhMe, 40.  In the prepn. of XI, there was obtained 54 g. mixt. (XIV) of XI and 2-methyl-2,4-bis(4-bromophenyl)-5-imino-3-imidazoline (XV).  XIV (5 g.) dissolved in 30 cc. hot AcOH, the soln. poured into 250 cc. boiling 20% AcOH, boiled until the ppt. coagulated, and cooled gave 4.1 g. XI; the AcOH filtrate neutralized with aq. NaOH at the b.p., boiled to coagulate the ppt., and cooled gave 0.6 g. XV, m. 206° (C6H6).  In the prepn. of XII, there was obtained 71 g. mixt. (XVI) of XII and 2-methyl-2,4-bis(4-iodophenyl)-5imino-3-imidazoline (XVII), similarly sepd. to give, from 10 g. XVI, 9 g. XII, and 0.9 g. XVII, m. 224° (PhMe).  In the prepn. of XIII, there was isolated 13 g. residue which was crystd. from MeOH-EtOH-Et2CO to give 11 g. 2-methyl-2,4-bis(2-methoxy-4-methylphenyl)-3-thiazoline, m. 119°.  NH3 introduced 80 min. into 140 g. 2-HOC6H4Ac (XVIII), 100 cc. CCl4, and 50 cc. piperidine with stirring gave 123 g. XIX (R = R1 = H), m. 141° (Me2CO).  XVIII (68 g.), 50 cc. CCl4, and 44 g. BuNH2 kept 1 hr. gave 90 g. XIX (R = H, R1 = Bu), m. 70° (CCl4); picrate m. 177°. NH3 introduced 8 hrs. into 50 cc. CCl4 contg. 4,2-Me(HO)C6H4Ac gave 47 g. XIX (R = Me, R1 = H), m. 181° (Me2CO); picrate m. 200°.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozEeLMlHfD_rVg90H21EOLACvtfcHk0lg8_Bnry6_pwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3sXktVyqtrc%253D&md5=ba357687e9e51af90c5ab5e8a46f4b21</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAsinger%26aufirst%3DF.%26aulast%3DSchaefer%26aufirst%3DW.%26aulast%3DBaumgarte%26aufirst%3DG.%26aulast%3DMueting%26aufirst%3DP.%2BF.%26atitle%3DConcomitant%2520action%2520of%2520elementary%2520sulfur%2520and%2520gaseous%2520ammonia%2520on%2520ketones.%2520XXXVI.%2520Action%2520of%2520sulfur%2520and%2520ammonia%2520on%2520acetophenone.%2520II.%2520Synthesis%2520of%25203-imidazoline-5-thiones%26jtitle%3DAnn.%26date%3D1963%26volume%3D661%26spage%3D95%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Asinger, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Offermanns, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, H. D.</span><span> </span><span class="NLM_article-title">Concomitant action of elementary sulfur and gaseous ammonia on ketones. LII. Synthesis of α-oxo thio amides and substituted 3-imidazoline-5-thiones</span> <span class="citation_source-journal">Justus Liebigs Ann. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">691</span><span class="NLM_x">, </span> <span class="NLM_fpage">92</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=691&publication_year=1966&pages=92-108&author=F.+Asingerauthor=A.+Sausauthor=H.+Offermannsauthor=H.+D.+Hahn&title=Concomitant+action+of+elementary+sulfur+and+gaseous+ammonia+on+ketones.+LII.+Synthesis+of+%CE%B1-oxo+thio+amides+and+substituted+3-imidazoline-5-thiones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAsinger%26aufirst%3DF.%26aulast%3DSaus%26aufirst%3DA.%26aulast%3DOffermanns%26aufirst%3DH.%26aulast%3DHahn%26aufirst%3DH.%2BD.%26atitle%3DConcomitant%2520action%2520of%2520elementary%2520sulfur%2520and%2520gaseous%2520ammonia%2520on%2520ketones.%2520LII.%2520Synthesis%2520of%2520%25CE%25B1-oxo%2520thio%2520amides%2520and%2520substituted%25203-imidazoline-5-thiones%26jtitle%3DJustus%2520Liebigs%2520Ann.%2520Chem.%26date%3D1966%26volume%3D691%26spage%3D92%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Asinger, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haaf, F.</span><span> </span><span class="NLM_article-title">Concomitant action of elementary sulfur and gaseous ammonia on ketones. XXXVIII. Action of sulfur and ammonia on acetophenone. 3. Proof of structure and reactions of Δ-3-imidazoline-5-thiones</span> <span class="citation_source-journal">Justus Liebigs Ann. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">672</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=672&publication_year=1964&pages=134-155&author=F.+Asingerauthor=W.+Schaeferauthor=F.+Haaf&title=Concomitant+action+of+elementary+sulfur+and+gaseous+ammonia+on+ketones.+XXXVIII.+Action+of+sulfur+and+ammonia+on+acetophenone.+3.+Proof+of+structure+and+reactions+of+%CE%94-3-imidazoline-5-thiones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAsinger%26aufirst%3DF.%26aulast%3DSchaefer%26aufirst%3DW.%26aulast%3DHaaf%26aufirst%3DF.%26atitle%3DConcomitant%2520action%2520of%2520elementary%2520sulfur%2520and%2520gaseous%2520ammonia%2520on%2520ketones.%2520XXXVIII.%2520Action%2520of%2520sulfur%2520and%2520ammonia%2520on%2520acetophenone.%25203.%2520Proof%2520of%2520structure%2520and%2520reactions%2520of%2520%25CE%2594-3-imidazoline-5-thiones%26jtitle%3DJustus%2520Liebigs%2520Ann.%2520Chem.%26date%3D1964%26volume%3D672%26spage%3D134%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Blid, J.; Ginman, T.; Gravenfors, Y.; Karlstroem, S.; Kihlstroem, J.; Kolmodin, K.; Lindstroem, J.; Rahm, F.; Sundstroem, M.; Swahn, B.; Viklund, J.; von Berg, S.; von Kieseritzky, F.</span>WO 2011/002408 A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Blid%2C+J.%3B+Ginman%2C+T.%3B+Gravenfors%2C+Y.%3B+Karlstroem%2C+S.%3B+Kihlstroem%2C+J.%3B+Kolmodin%2C+K.%3B+Lindstroem%2C+J.%3B+Rahm%2C+F.%3B+Sundstroem%2C+M.%3B+Swahn%2C+B.%3B+Viklund%2C+J.%3B+von+Berg%2C+S.%3B+von+Kieseritzky%2C+F.WO+2011%2F002408+A1%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBlid%26aufirst%3DJ.%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Blid, J.; Ginman, T.; Gravenfors, Y.; Karlstroem, S.; Kolmodin, K.; Lindstroem, J.; Plobeck, N.; Rahm, F.; Swahn, B.; Viklund, J.; von Berg, S.; von Kieseritzky, D.</span>WO 2011/002407 A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Blid%2C+J.%3B+Ginman%2C+T.%3B+Gravenfors%2C+Y.%3B+Karlstroem%2C+S.%3B+Kolmodin%2C+K.%3B+Lindstroem%2C+J.%3B+Plobeck%2C+N.%3B+Rahm%2C+F.%3B+Swahn%2C+B.%3B+Viklund%2C+J.%3B+von+Berg%2C+S.%3B+von+Kieseritzky%2C+D.WO+2011%2F002407+A1%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBlid%26aufirst%3DJ.%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shalaeva, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tupper, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, F.</span><span> </span><span class="NLM_article-title">ElogDoct: a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2490</span><span class="NLM_x">–</span> <span class="NLM_lpage">2497</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0100990" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2490-2497&author=F.+Lombardoauthor=M.+Y.+Shalaevaauthor=K.+A.+Tupperauthor=F.+Gao&title=ElogDoct%3A+a+tool+for+lipophilicity+determination+in+drug+discovery.+2.+Basic+and+neutral+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm0100990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0100990%26sid%3Dliteratum%253Aachs%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DShalaeva%26aufirst%3DM.%2BY.%26aulast%3DTupper%26aufirst%3DK.%2BA.%26aulast%3DGao%26aufirst%3DF.%26atitle%3DElogDoct%253A%2520a%2520tool%2520for%2520lipophilicity%2520determination%2520in%2520drug%2520discovery.%25202.%2520Basic%2520and%2520neutral%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2490%26epage%3D2497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Bridgland-Taylor, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hargreaves, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orme, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henthorn, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heapy, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abi-Gerges, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albertson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentin, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollard, C. E.</span><span> </span><span class="NLM_article-title">Optimisation and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HT</span> <span class="citation_source-journal">J. Pharmacol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">199</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1016%2Fj.vascn.2006.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=16563806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BD28XptFChtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2006&pages=189-199&author=M.+H.+Bridgland-Taylorauthor=A.+C.+Hargreavesauthor=A.+Easterauthor=A.+Ormeauthor=D.+C.+Henthornauthor=M.+Dingauthor=A.+M.+Davisauthor=B.+G.+Smallauthor=C.+G.+Heapyauthor=N.+Abi-Gergesauthor=F.+Perssonauthor=I.+Jacobsonauthor=M.+Sullivanauthor=N.+Albertsonauthor=T.+G.+Hammondauthor=E.+Sullivanauthor=J.+P.+Valentinauthor=C.+E.+Pollard&title=Optimisation+and+validation+of+a+medium-throughput+electrophysiology-based+hERG+assay+using+IonWorks+HT"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HT</span></div><div class="casAuthors">Bridgland-Taylor, M. H.; Hargreaves, A. C.; Easter, A.; Orme, A.; Henthorn, D. C.; Ding, M.; Davis, A. M.; Small, B. G.; Heapy, C. G.; Abi-Gerges, N.; Persson, F.; Jacobson, I.; Sullivan, M.; Albertson, N.; Hammond, T. G.; Sullivan, E.; Valentin, J.-P.; Pollard, C. E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">189-199</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Introduction: Regulatory and competitive pressure to reduce the QT interval prolongation risk of potential new drugs has led to focus on methods to test for inhibition of the human ether-a-go-go-related gene (hERG)-encoded K+ channel, the primary mol. target underlying this safety issue.  Here we describe the validation of a method that combines medium-throughput with direct assessment of channel function.  Methods: The electrophysiol. and pharmacol. properties of hERG were compared using two methods: conventional, low-throughput electrophysiol. and planar-array-based, medium-throughput electrophysiol. (IonWorks HT).  A pharmacol. comparison was also made between IonWorks HT and an indirect assay (Rb+ efflux).  Results: Basic electrophysiol. properties of hERG were similar whether recorded conventionally (HEK cells) or using IonWorks HT (CHO cells): for example, tail current V1/2 - 12.1 ± 5.0 mV (32) for conventional and - 9.5 ± 6.0 mV (46) for IonWorks HT (mean ± S.D. (n)).  A key finding was that as the no. of cells per well was increased in IonWorks HT, the potency reported for a given compd. decreased.  Using the lowest possible cell concn. (250,000 cells/mL) and 89 compds. spanning a broad potency range, the pIC50 values from IonWorks HT (CHO-hERG) were found to correlate well with those obtained using conventional methodol. (HEK-hERG)(r = 0.90; p < 0.001).  Further validation using CHO-hERG cells with both methods confirmed the correlation (r = 0.94; p < 0.001).  In contrast, a comparison of IonWorks HT and Rb+ efflux data with 649 compds. using CHO-hERG cells showed that the indirect assay consistently reported compds. as being, on av., 6-fold less potent, though the differences varied depending on chem. series.  Discussion: The main finding of this work is that providing a relatively low cell concn. is used in IonWorks HT, the potency information generated correlates well with that detd. using conventional electrophysiol.  The effect on potency of increasing cell concn. may relate to a reduced free concn. of test compd. owing to partitioning into cell membranes.  In summary, the IonWorks HT hERG assay can generate pIC50 values based on a direct assessment of channel function in a timeframe short enough to influence chem. design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcBXhwRw0nLVg90H21EOLACvtfcHk0lhqdd_kd3CXgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptFChtbw%253D&md5=730258a42517947c0b972ca87cef46b6</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2006.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2006.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DBridgland-Taylor%26aufirst%3DM.%2BH.%26aulast%3DHargreaves%26aufirst%3DA.%2BC.%26aulast%3DEaster%26aufirst%3DA.%26aulast%3DOrme%26aufirst%3DA.%26aulast%3DHenthorn%26aufirst%3DD.%2BC.%26aulast%3DDing%26aufirst%3DM.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DSmall%26aufirst%3DB.%2BG.%26aulast%3DHeapy%26aufirst%3DC.%2BG.%26aulast%3DAbi-Gerges%26aufirst%3DN.%26aulast%3DPersson%26aufirst%3DF.%26aulast%3DJacobson%26aufirst%3DI.%26aulast%3DSullivan%26aufirst%3DM.%26aulast%3DAlbertson%26aufirst%3DN.%26aulast%3DHammond%26aufirst%3DT.%2BG.%26aulast%3DSullivan%26aufirst%3DE.%26aulast%3DValentin%26aufirst%3DJ.%2BP.%26aulast%3DPollard%26aufirst%3DC.%2BE.%26atitle%3DOptimisation%2520and%2520validation%2520of%2520a%2520medium-throughput%2520electrophysiology-based%2520hERG%2520assay%2520using%2520IonWorks%2520HT%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2006%26volume%3D54%26spage%3D189%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Wan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindberg, W.</span><span> </span><span class="NLM_article-title">Rapid screening of p<i>K</i><sub>a</sub> values of pharmaceuticals by pressure-assisted capillary electrophoresis combined with short-end injection</span> <span class="citation_source-journal">J. Chromatogr., A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">979</span><span class="NLM_x">, </span> <span class="NLM_fpage">369</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=979&publication_year=2002&pages=369-377&author=H.+Wanauthor=A.+Holmenauthor=M.+Nagardauthor=W.+Lindberg&title=Rapid+screening+of+pKa+values+of+pharmaceuticals+by+pressure-assisted+capillary+electrophoresis+combined+with+short-end+injection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DH.%26aulast%3DHolmen%26aufirst%3DA.%26aulast%3DNagard%26aufirst%3DM.%26aulast%3DLindberg%26aufirst%3DW.%26atitle%3DRapid%2520screening%2520of%2520pKa%2520values%2520of%2520pharmaceuticals%2520by%2520pressure-assisted%2520capillary%2520electrophoresis%2520combined%2520with%2520short-end%2520injection%26jtitle%3DJ.%2520Chromatogr.%252C%2520A%26date%3D2002%26volume%3D979%26spage%3D369%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Wan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmen, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindberg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Englund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagard, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, R. A.</span><span> </span><span class="NLM_article-title">High-throughput screening of p<i>K</i><sub>a</sub> values of pharmaceuticals by pressure-assisted capillary electrophoresis and mass spectrometry</span> <span class="citation_source-journal">Rapid Commun. Mass Spectrom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2639</span><span class="NLM_x">–</span> <span class="NLM_lpage">2648</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1002%2Frcm.1229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=14648902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpslSiurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=2639-2648&author=H.+Wanauthor=A.+G.+Holmenauthor=Y.+Wangauthor=W.+Lindbergauthor=M.+Englundauthor=M.+B.+Nagardauthor=R.+A.+Thompson&title=High-throughput+screening+of+pKa+values+of+pharmaceuticals+by+pressure-assisted+capillary+electrophoresis+and+mass+spectrometry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput screening of pKa values of pharmaceuticals by pressure-assisted capillary electrophoresis and mass spectrometry</span></div><div class="casAuthors">Wan, Hong; Holmen, Anders G.; Wang, Yudong; Lindberg, Walter; Englund, Marie; Nagard, Mats B.; Thompson, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Rapid Communications in Mass Spectrometry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2639-2648</span>CODEN:
                <span class="NLM_cas:coden">RCMSEF</span>;
        ISSN:<span class="NLM_cas:issn">0951-4198</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A high-throughput pKa screening method based on pressure-assisted capillary electrophoresis (CE) and mass spectrometry (MS) is presented.  Effects of buffer type and ionic strength on sensitivity and pKa values were investigated.  Influence of DMSO concn. present in the sample on effective mobility measurement was examd.  A series of ten volatile buffers, covering a pH range from 2.5 to 10.5 with the same ionic strength, was employed.  The application of volatile background electrolytes resulted in significant signal increase as compared with commonly used non-volatile phosphate buffers.  In general, the CE/MS system provided a ten-fold higher sensitivity than conventional UV detection.  The newly developed CE/MS method offers high-throughput capacity by pooling a no. of compds. into a single sample.  Simultaneous measurement of more than 50 compds. was readily achieved in less than 150 min.  The measured pKa values are consistent with the published data obtained from the CE/UV method and are also in good agreement with data generated by other methods.  Other advantages of using CE/MS for pKa screening are illustrated with typical examples, including poorly sol. compds. and non-UV-absorbing compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgfrtqeDn-8LVg90H21EOLACvtfcHk0liWl0buPfuN7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpslSiurs%253D&md5=28bdb030bf255c19b5f98de12d5d9310</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Frcm.1229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Frcm.1229%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DH.%26aulast%3DHolmen%26aufirst%3DA.%2BG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLindberg%26aufirst%3DW.%26aulast%3DEnglund%26aufirst%3DM.%26aulast%3DNagard%26aufirst%3DM.%2BB.%26aulast%3DThompson%26aufirst%3DR.%2BA.%26atitle%3DHigh-throughput%2520screening%2520of%2520pKa%2520values%2520of%2520pharmaceuticals%2520by%2520pressure-assisted%2520capillary%2520electrophoresis%2520and%2520mass%2520spectrometry%26jtitle%3DRapid%2520Commun.%2520Mass%2520Spectrom.%26date%3D2003%26volume%3D17%26spage%3D2639%26epage%3D2648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Alelyunas, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelosi-Kilby, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, C.</span><span> </span><span class="NLM_article-title">Application of a dried-DMSO rapid throughput 24-h equilibrium solubility in advancing discovery candidates</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">172</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1016%2Fj.ejps.2009.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=19429424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvV2ms7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=172-182&author=Y.+W.+Alelyunasauthor=R.+Liuauthor=L.+Pelosi-Kilbyauthor=C.+Shen&title=Application+of+a+dried-DMSO+rapid+throughput+24-h+equilibrium+solubility+in+advancing+discovery+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Application of a dried-DMSO rapid throughput 24-h equilibrium solubility in advancing discovery candidates</span></div><div class="casAuthors">Alelyunas, Yun W.; Liu, Ruifeng; Pelosi-Kilby, Luciana; Shen, Cindy</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">172-182</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A rapid throughput equil. soly. measurement is described.  The method utilizes central liq. storage where compds. are stored as 10 mM soln. in DMSO.  The DMSO is subsequently removed to generate solid like material used for soly. measurement.  A full range of available technologies is used including automated liq. handling, automated data collection using both HPLC/UV and LC/MS/MS.  The method is fully validated and has been used to measure soly. for over 20,000 compds. across all phases of drug discovery.  A detailed discussion on data interpretation and comparison to traditional soly. measurement using solid material is presented.  An inhouse soly. predictive model has been developed from the vast data set and has been employed successfully as part of compd. design resulting in over 30% redn. in the no. of poorly sol. compd. synthesized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqUrCZlVKS_bVg90H21EOLACvtfcHk0liWl0buPfuN7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvV2ms7k%253D&md5=6ee437462b50cc0c4acfd6d2f27b6405</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2009.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2009.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DAlelyunas%26aufirst%3DY.%2BW.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DPelosi-Kilby%26aufirst%3DL.%26aulast%3DShen%26aufirst%3DC.%26atitle%3DApplication%2520of%2520a%2520dried-DMSO%2520rapid%2520throughput%252024-h%2520equilibrium%2520solubility%2520in%2520advancing%2520discovery%2520candidates%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2009%26volume%3D37%26spage%3D172%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eYFathqxk7Yorntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Stachel, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coburn, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajapakse, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katharine, H., M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allison, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espeseth, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colussi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrak, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Discovery of aminoheterocycles as a novel β-secretase inhibitor class: pH dependence on binding activity part 1</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2977</span><span class="NLM_x">–</span> <span class="NLM_lpage">2980</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2977-2980&author=S.+J.+Stachelauthor=C.+A.+Coburnauthor=D.+Rushauthor=K.+L.+G.+Jonesauthor=H.+Zhuauthor=H.+Rajapakseauthor=S.+L.+Grahamauthor=A.+Simonauthor=H.%2C+M.+Katharineauthor=T.+J.+Allisonauthor=S.+K.+Munshiauthor=A.+S.+Espesethauthor=P.+Zuckauthor=D.+Colussiauthor=A.+Wolfeauthor=B.+L.+Pietrakauthor=M.+Laiauthor=J.+P.+Vacca&title=Discovery+of+aminoheterocycles+as+a+novel+%CE%B2-secretase+inhibitor+class%3A+pH+dependence+on+binding+activity+part+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStachel%26aufirst%3DS.%2BJ.%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DRush%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DK.%2BL.%2BG.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DRajapakse%26aufirst%3DH.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DSimon%26aufirst%3DA.%26aulast%3DKatharine%26aufirst%3DH.%252C%2BM.%26aulast%3DAllison%26aufirst%3DT.%2BJ.%26aulast%3DMunshi%26aufirst%3DS.%2BK.%26aulast%3DEspeseth%26aufirst%3DA.%2BS.%26aulast%3DZuck%26aufirst%3DP.%26aulast%3DColussi%26aufirst%3DD.%26aulast%3DWolfe%26aufirst%3DA.%26aulast%3DPietrak%26aufirst%3DB.%2BL.%26aulast%3DLai%26aufirst%3DM.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DDiscovery%2520of%2520aminoheterocycles%2520as%2520a%2520novel%2520%25CE%25B2-secretase%2520inhibitor%2520class%253A%2520pH%2520dependence%2520on%2520binding%2520activity%2520part%25201%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2977%26epage%3D2980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Waring, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, C.</span><span> </span><span class="NLM_article-title">A quantitative assessment of hERG liability as a function of lipophilicity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1759</span><span class="NLM_x">–</span> <span class="NLM_lpage">1764</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1016%2Fj.bmcl.2006.12.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=17239590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1yrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1759-1764&author=M.+J.+Waringauthor=C.+Johnstone&title=A+quantitative+assessment+of+hERG+liability+as+a+function+of+lipophilicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative assessment of hERG liability as a function of lipophilicity</span></div><div class="casAuthors">Waring, Michael J.; Johnstone, Craig</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1759-1764</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The impact of lipophilicity as a factor contributing to hERG potency is assessed for a large dataset of compds. of differing ionization type.  This dataset is derived from compds. tested in the Ionworks-based in vitro electrophysiol. hERG assay at AstraZeneca.  Using logistic regression, a quantification of the risk assocd. with increasing lipophilicity is presented.  The anticipated differences between acidic, basic and neutral compds. are apparent in the data but lipophilicity is shown to be a stronger driver for hERG potency than might have been expected.  Simple rules defining target lipophilicity values for minimizing hERG liability are derived.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlCr9mVGL2-LVg90H21EOLACvtfcHk0livfnVrYZisRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1yrtb8%253D&md5=3819e045d7b773f129773f1ff567b980</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.12.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.12.061%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26aulast%3DJohnstone%26aufirst%3DC.%26atitle%3DA%2520quantitative%2520assessment%2520of%2520hERG%2520liability%2520as%2520a%2520function%2520of%2520lipophilicity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1759%26epage%3D1764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Denora, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laquintana, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopedota, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapani, G.</span><span> </span><span class="NLM_article-title">Recent advances in medicinal chemistry and pharmaceutical technology—strategies for drug delivery to the brain</span> <span class="citation_source-journal">Curr. Top. Med. Chem. (Sharjah, United Arab Emirates)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.2174%2F156802609787521571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=19200004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvVSgtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=182-196&author=N.+Denoraauthor=A.+Trapaniauthor=V.+Laquintanaauthor=A.+Lopedotaauthor=G.+Trapani&title=Recent+advances+in+medicinal+chemistry+and+pharmaceutical+technology%E2%80%94strategies+for+drug+delivery+to+the+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in medicinal chemistry and pharmaceutical technology - strategies for drug delivery to the brain</span></div><div class="casAuthors">Denora, Nunzio; Trapani, Adriana; Laquintana, Valentino; Lopedota, Angela; Trapani, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">182-196</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This paper provides a mini-review of some recent approaches for the treatment of brain pathologies examg. both medicinal chem. and pharmaceutical technol. contributions.  Medicinal chem.-based strategies are essentially aimed at the chem. modification of low mol. wt. drugs in order to increase their lipophilicity or the design of appropriate prodrugs, although this review will focus primarily on the use of prodrugs and not analog development.  Recently, interest has been focused on the design and evaluation of prodrugs that are capable of exploiting one or more of the various endogenous transport systems at the level of the blood brain barrier (BBB).  The technol. strategies are essentially non-invasive methods of drug delivery to malignancies of the central nervous system (CNS) and are based on the use of nanosystems (colloidal carriers) such as liposomes, polymeric nanoparticles, solid lipid nanoparticles, polymeric micelles and dendrimers.  The biodistribution of these nanocarriers can be manipulated by modifying their surface physico-chem. properties or by coating them with surfactants and polyethylene-glycols (PEGs).  Liposomes, surfactant coated polymeric nanoparticles, and solid lipid nanoparticles are promising systems for delivery of drugs to tumors of the CNS.  This mini-review discusses issues concerning the scope and limitations of both the medicinal chem. and technol. approaches.  Based on the current findings, it can be concluded that crossing of the BBB and drug delivery to CNS is extremely complex and requires a multidisciplinary approach such as a close collaboration and common efforts among researchers of several scientific areas, particularly medicinal chemists, biologists and pharmaceutical technologists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKLD3NcuTLa7Vg90H21EOLACvtfcHk0livfnVrYZisRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvVSgtb0%253D&md5=61feb73997d2974a7c792cdf8c47608a</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.2174%2F156802609787521571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802609787521571%26sid%3Dliteratum%253Aachs%26aulast%3DDenora%26aufirst%3DN.%26aulast%3DTrapani%26aufirst%3DA.%26aulast%3DLaquintana%26aufirst%3DV.%26aulast%3DLopedota%26aufirst%3DA.%26aulast%3DTrapani%26aufirst%3DG.%26atitle%3DRecent%2520advances%2520in%2520medicinal%2520chemistry%2520and%2520pharmaceutical%2520technology%25E2%2580%2594strategies%2520for%2520drug%2520delivery%2520to%2520the%2520brain%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%2520%2528Sharjah%252C%2520United%2520Arab%2520Emirates%2529%26date%3D2009%26volume%3D9%26spage%3D182%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Alex, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millan, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakenhut, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitlock, G. A.</span><span> </span><span class="NLM_article-title">Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1039%2Fc1md00093d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotl2gt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=669-674&author=A.+Alexauthor=D.+S.+Millanauthor=M.+Perezauthor=F.+Wakenhutauthor=G.+A.+Whitlock&title=Intramolecular+hydrogen+bonding+to+improve+membrane+permeability+and+absorption+in+beyond+rule+of+five+chemical+space"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space</span></div><div class="casAuthors">Alex, Alexander; Millan, David S.; Perez, Manuel; Wakenhut, Florian; Whitlock, Gavin A.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">669-674</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Utilizing 'beyond rule of five' chem. space is becoming increasingly important in drug design, but is usually at odds with good oral absorption.  The formation of intramol. hydrogen bonds in drug mols. is hypothesised to shield polarity facilitating improved membrane permeability and intestinal absorption.  NMR based evidence for intramol. hydrogen bonding in several 'beyond rule of five' oral drugs is described.  Furthermore, the propensity for these drugs to form intramol. hydrogen bonds could be predicted for through modeling the lowest energy conformation in the gas phase.  The modulation of apparent lipophilicity through intramol. hydrogen bonding in these mols. is supported by intrinsic cell permeability and intestinal absorption data in rat and human.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp93l2KJMdB2bVg90H21EOLACvtfcHk0livfnVrYZisRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotl2gt7o%253D&md5=3effbdd29832ac7b57eabbc26c66217b</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1039%2Fc1md00093d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00093d%26sid%3Dliteratum%253Aachs%26aulast%3DAlex%26aufirst%3DA.%26aulast%3DMillan%26aufirst%3DD.%2BS.%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DWakenhut%26aufirst%3DF.%26aulast%3DWhitlock%26aufirst%3DG.%2BA.%26atitle%3DIntramolecular%2520hydrogen%2520bonding%2520to%2520improve%2520membrane%2520permeability%2520and%2520absorption%2520in%2520beyond%2520rule%2520of%2520five%2520chemical%2520space%26jtitle%3DMedChemComm%26date%3D2011%26volume%3D2%26spage%3D669%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span> </span><span class="NLM_article-title">Intramolecular hydrogen bonding in medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2601</span><span class="NLM_x">–</span> <span class="NLM_lpage">2611</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100087s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1Clur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2601-2611&author=B.+Kuhnauthor=P.+Mohrauthor=M.+Stahl&title=Intramolecular+hydrogen+bonding+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular Hydrogen Bonding in Medicinal Chemistry</span></div><div class="casAuthors">Kuhn, Bernd; Mohr, Peter; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2601-2611</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The formation of intramol. hydrogen bonds has a very pronounced effect on mol. structure and properties.  We study both aspects in detail with the aim of enabling a more rational use of this class of interactions in medicinal chem.  On the basis of exhaustive searches in crystal structure databases, we derive propensities for intramol. hydrogen bond formation of five- to eight-membered ring systems of relevance in drug discovery.  A no. of motifs, several of which are clearly underutilized in drug discovery, are analyzed in more detail by comparing small mol. and protein-ligand X-ray structures.  To investigate effects on physicochem. properties, sets of closely related structures with and without the ability to form intramol. hydrogen bonds were designed, synthesized, and characterized with respect to membrane permeability, water soly., and lipophilicity.  We find that changes in these properties depend on a subtle balance between the strength of the hydrogen bond interaction, geometry of the newly formed ring system, and the relative energies of the open and closed conformations in polar and unpolar environments.  A no. of general guidelines for medicinal chemists emerge from this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdaV7tFRU4k7Vg90H21EOLACvtfcHk0lgOD1_IhqosCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1Clur8%253D&md5=b9b6865dfcc9bdf7796d15218f6e8ff2</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm100087s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100087s%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DMohr%26aufirst%3DP.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DIntramolecular%2520hydrogen%2520bonding%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2601%26epage%3D2611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuillard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleasby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yon, J.</span><span> </span><span class="NLM_article-title">Apo and inhibitor complex structures of BACE (beta-secretase)</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">416</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2004&pages=407-416&author=S.+Patelauthor=L.+Vuillardauthor=A.+Cleasbyauthor=C.+W.+Murrayauthor=J.+Yon&title=Apo+and+inhibitor+complex+structures+of+BACE+%28beta-secretase%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DVuillard%26aufirst%3DL.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DYon%26aufirst%3DJ.%26atitle%3DApo%2520and%2520inhibitor%2520complex%2520structures%2520of%2520BACE%2520%2528beta-secretase%2529%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D343%26spage%3D407%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Leslie, A. G. W.</span><span> </span><span class="NLM_article-title">Recent changes to the MOSFLM package for processing film and image plate data</span> <span class="citation_source-journal">Jt. CCP4 ESF-EAMCB Newsl. Protein Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1992&pages=27&author=A.+G.+W.+Leslie&title=Recent+changes+to+the+MOSFLM+package+for+processing+film+and+image+plate+data"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26atitle%3DRecent%2520changes%2520to%2520the%2520MOSFLM%2520package%2520for%2520processing%2520film%2520and%2520image%2520plate%2520data%26jtitle%3DJt.%2520CCP4%2520ESF-EAMCB%2520Newsl.%2520Protein%2520Crystallogr.%26date%3D1992%26volume%3D26%26spage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Evans, P.</span><span> </span><span class="NLM_article-title">Scaling and assessment of data quality</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">D62</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1107%2FS0907444905036693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlant7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D62&publication_year=2006&pages=72-82&author=P.+Evans&title=Scaling+and+assessment+of+data+quality"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Scaling and assessment of data quality</span></div><div class="casAuthors">Evans, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">D62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-82</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The various phys. factors affecting measured diffraction intensities are discussed, as are the scaling models which may be used to put the data on a consistent scale.  After scaling, the intensities can be analyzed to set the real resoln. of the data set, to detect bad regions (e.g. bad images), to analyze radiation damage and to assess the overall quality of the data set.  The significance of any anomalous signal may be assessed by probability and correlation anal.  The algorithms used by the CCP4 scaling program SCALA are described.  A requirement for the scaling and merging of intensities is knowledge of the Laue group and point-group symmetries: the possible symmetry of the diffraction pattern may be detd. from scores such as correlation coeffs. between observations which might be symmetry-related.  These scoring functions are implemented in a new program POINTLESS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGravLSLU62RhLVg90H21EOLACvtfcHk0lgOD1_IhqosCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlant7jM&md5=293d3876e534c0c57813990515bb3c76</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1107%2FS0907444905036693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444905036693%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DP.%26atitle%3DScaling%2520and%2520assessment%2520of%2520data%2520quality%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2006%26volume%3DD62%26spage%3D72%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koelsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terzyan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2000&pages=150-153&author=L.+Hongauthor=G.+Koelschauthor=X.+Linauthor=S.+Wuauthor=S.+Terzyanauthor=A.+K.+Ghoshauthor=X.+C.+Zhangauthor=J.+Tang&title=Structure+of+the+protease+domain+of+memapsin+2+%28beta-secretase%29+complexed+with+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DL.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DTerzyan%26aufirst%3DS.%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DZhang%26aufirst%3DX.%2BC.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DStructure%2520of%2520the%2520protease%2520domain%2520of%2520memapsin%25202%2520%2528beta-secretase%2529%2520complexed%2520with%2520inhibitor%26jtitle%3DScience%26date%3D2000%26volume%3D290%26spage%3D150%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span> </span><span class="NLM_article-title">Refinement of macromolecular structures by the maximum-likelihood method</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=15299926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=240-255&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+macromolecular+structures+by+the+maximum-likelihood+method"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. σA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial α-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0lgOD1_IhqosCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520macromolecular%2520structures%2520by%2520the%2520maximum-likelihood%2520method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3D53%26spage%3D240%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0lhWx3keXFvM3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span> <span class="citation_source-book">BUSTER</span>, version <span class="NLM_edition">2.11.1</span>; <span class="NLM_publisher-name">Global Phasing Ltd.</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=BUSTER%2C+version+2.11.1%3B+Global+Phasing+Ltd.%3A+Cambridge%2C+U.K.%2C+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DBUSTER%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Wlodek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skillman, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholls, A.</span><span> </span><span class="NLM_article-title">Automated ligand placement and refinement with a combined force field and shape potential</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">741</span><span class="NLM_x">–</span> <span class="NLM_lpage">749</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1107%2FS0907444906016076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=16790930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtVSnur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=741-749&author=S.+Wlodekauthor=A.+G.+Skillmanauthor=A.+Nicholls&title=Automated+ligand+placement+and+refinement+with+a+combined+force+field+and+shape+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Automated ligand placement and refinement with a combined force field and shape potential</span></div><div class="casAuthors">Wlodek, S.; Skillman, A. G.; Nicholls, A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">D62</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">741-749</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">An automated computational procedure for fitting a ligand into its electron d. with the use of the MMFF94 force field and a Gaussian shape description has been developed.  It employs a series of adiabatic optimizations of gradually increasing shape potential.  Starting from a set of energy-relaxed ligand conformations, the final results are structures realistically strained to fit the crystallog. data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbAunEGTbprrVg90H21EOLACvtfcHk0lhWx3keXFvM3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtVSnur0%253D&md5=1571b77a211aec76fb4e3a376fc95d8a</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1107%2FS0907444906016076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444906016076%26sid%3Dliteratum%253Aachs%26aulast%3DWlodek%26aufirst%3DS.%26aulast%3DSkillman%26aufirst%3DA.%2BG.%26aulast%3DNicholls%26aufirst%3DA.%26atitle%3DAutomated%2520ligand%2520placement%2520and%2520refinement%2520with%2520a%2520combined%2520force%2520field%2520and%2520shape%2520potential%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2006%26volume%3D62%26spage%3D741%26epage%3D749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">LeDonne, N. C.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rissolo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulgarelli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tini, L.</span><span> </span><span class="NLM_article-title">Use of structure–activity landscape index curves and curve integrals to evaluate the performance of multiple machine learning prediction models</span> <span class="citation_source-journal">J. Cheminf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1186%2F1758-2946-3-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXitFyit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=7&author=N.+C.+LeDonneauthor=K.+Rissoloauthor=J.+Bulgarelliauthor=L.+Tini&title=Use+of+structure%E2%80%93activity+landscape+index+curves+and+curve+integrals+to+evaluate+the+performance+of+multiple+machine+learning+prediction+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Use of structure-activity landscape index curves and curve integrals to evaluate the performance of multiple machine learning prediction models</span></div><div class="casAuthors">LeDonne, Norman C., Jr.; Rissolo, Kevin; Bulgarelli, James; Tini, Leonard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cheminformatics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7</span>CODEN:
                <span class="NLM_cas:coden">JCOHB3</span>;
        ISSN:<span class="NLM_cas:issn">1758-2946</span>.
    
            (<span class="NLM_cas:orgname">Chemistry Central Ltd.</span>)
        </div><div class="casAbstract">Background: Std. approaches to address the performance of predictive models that used common statistical measurements for the entire data set provide an overview of the av. performance of the models across the entire predictive space, but give little insight into applicability of the model across the prediction space.  Guha and Van Drie recently proposed the use of structure-activity landscape index (SALI) curves via the SALI curve integral (SCI) as a means to map the predictive power of computational models within the predictive space.  This approach evaluates model performance by assessing the accuracy of pairwise predictions, comparing compd. pairs in a manner similar to that done by medicinal chemists.  Results: The SALI approach was used to evaluate the performance of continuous prediction models for MDR1-MDCK in vitro efflux potential.  Efflux models were built with ADMET Predictor neural net, support vector machine, kernel partial least squares, and multiple linear regression engines, as well as SIMCA-P+ partial least squares, and random forest from Pipeline Pilot as implemented by AstraZeneca, using mol. descriptors from SimulationsPlus and AstraZeneca.  Conclusion: The results indicate that the choice of training sets used to build the prediction models is of great importance in the resulting model quality and that the SCI values calcd. for these models were very similar to their Kendall τ values, leading to our suggestion of an approach to use this SALI/SCI paradigm to evaluate predictive model performance that will allow more informed decisions regarding model utility.  The use of SALI graphs and curves provides an addnl. level of quality assessment for predictive models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9Id6r_IMYBrVg90H21EOLACvtfcHk0lhWx3keXFvM3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXitFyit7o%253D&md5=4dfebef8c41a954bdf84e2443bd63bb6</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1186%2F1758-2946-3-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1758-2946-3-7%26sid%3Dliteratum%253Aachs%26aulast%3DLeDonne%26aufirst%3DN.%2BC.%26aulast%3DRissolo%26aufirst%3DK.%26aulast%3DBulgarelli%26aufirst%3DJ.%26aulast%3DTini%26aufirst%3DL.%26atitle%3DUse%2520of%2520structure%25E2%2580%2593activity%2520landscape%2520index%2520curves%2520and%2520curve%2520integrals%2520to%2520evaluate%2520the%2520performance%2520of%2520multiple%2520machine%2520learning%2520prediction%2520models%26jtitle%3DJ.%2520Cheminf.%26date%3D2011%26volume%3D3%26spage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Friden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ljungqvist, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bredberg, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammarlund-Udenaes, M.</span><span> </span><span class="NLM_article-title">Improved measurement of drug exposure in the brain using drug-specific correction for residual blood</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1038%2Fjcbfm.2009.200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=19756019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1Sg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=150-161&author=M.+Fridenauthor=H.+Ljungqvistauthor=B.+Middletonauthor=U.+Bredbergauthor=M.+Hammarlund-Udenaes&title=Improved+measurement+of+drug+exposure+in+the+brain+using+drug-specific+correction+for+residual+blood"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Improved measurement of drug exposure in the brain using drug-specific correction for residual blood</span></div><div class="casAuthors">Friden, Markus; Ljungqvist, Helena; Middleton, Brian; Bredberg, Ulf; Hammarlund-Udenaes, Margareta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow & Metabolism</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">150-161</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A major challenge assocd. with the detn. of the unbound brain-to-plasma concn. ratio of a drug (Kp,uu,brain), is the error assocd. with correction for the drug in various vascular spaces of the brain, i.e., in residual blood.  The apparent brain vascular spaces of plasma water (Vwater, 10.3 μL/g brain), plasma proteins (Vprotein, 7.99 μL/g brain), and the vol. of erythrocytes (Ver, 2.13 μL/g brain) were detd. and incorporated into a novel, drug-specific correction model that took the drug-unbound fraction in the plasma (fu,p) into account.  The correction model was successfully applied for the detn. of Kp,uu,brain for indomethacin, loperamide, and moxalactam, which had potential problems assocd. with correction.  The influence on correction of the drug assocd. with erythrocytes was shown to be minimal.  Therefore, it is proposed that correction for residual blood can be performed using an effective plasma space in the brain (Veff), which is calcd. from the measured fu,p of the particular drug as well as from the ests. of Vwater and Vprotein, which are provided in this study.  Furthermore, the results highlight the value of detg. Kp,uu,brain with statistical precision to enable appropriate interpretation of brain exposure for drugs that appear to be restricted to the brain vascular spaces.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdAwudBZex47Vg90H21EOLACvtfcHk0liCjbaWw1QB7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1Sg&md5=e55b0e2ec8254fdd498061cf3a1dd015</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1038%2Fjcbfm.2009.200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjcbfm.2009.200%26sid%3Dliteratum%253Aachs%26aulast%3DFriden%26aufirst%3DM.%26aulast%3DLjungqvist%26aufirst%3DH.%26aulast%3DMiddleton%26aufirst%3DB.%26aulast%3DBredberg%26aufirst%3DU.%26aulast%3DHammarlund-Udenaes%26aufirst%3DM.%26atitle%3DImproved%2520measurement%2520of%2520drug%2520exposure%2520in%2520the%2520brain%2520using%2520drug-specific%2520correction%2520for%2520residual%2520blood%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2010%26volume%3D30%26spage%3D150%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Borgegard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jureus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosqvist, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabirsh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotticci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klintenberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stromberg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nord, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parpal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malinowsky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radesater, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundkvist, J.</span><span> </span><span class="NLM_article-title">First and second generation gamma-secretase modulators (GSMs) modulate amyloid-beta (Abeta) peptide production through different mechanisms</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">11810</span><span class="NLM_x">–</span> <span class="NLM_lpage">11819</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=11810-11819&author=T.+Borgegardauthor=A.+Jureusauthor=F.+Olssonauthor=S.+Rosqvistauthor=A.+Sabirshauthor=D.+Rotticciauthor=K.+Paulsenauthor=R.+Klintenbergauthor=H.+Yanauthor=M.+Waldmanauthor=K.+Strombergauthor=J.+Nordauthor=J.+Johanssonauthor=A.+Regnerauthor=S.+Parpalauthor=D.+Malinowskyauthor=A.+C.+Radesaterauthor=T.+Liauthor=R.+Singhauthor=H.+Erikssonauthor=J.+Lundkvist&title=First+and+second+generation+gamma-secretase+modulators+%28GSMs%29+modulate+amyloid-beta+%28Abeta%29+peptide+production+through+different+mechanisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorgegard%26aufirst%3DT.%26aulast%3DJureus%26aufirst%3DA.%26aulast%3DOlsson%26aufirst%3DF.%26aulast%3DRosqvist%26aufirst%3DS.%26aulast%3DSabirsh%26aufirst%3DA.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3DPaulsen%26aufirst%3DK.%26aulast%3DKlintenberg%26aufirst%3DR.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DWaldman%26aufirst%3DM.%26aulast%3DStromberg%26aufirst%3DK.%26aulast%3DNord%26aufirst%3DJ.%26aulast%3DJohansson%26aufirst%3DJ.%26aulast%3DRegner%26aufirst%3DA.%26aulast%3DParpal%26aufirst%3DS.%26aulast%3DMalinowsky%26aufirst%3DD.%26aulast%3DRadesater%26aufirst%3DA.%2BC.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DEriksson%26aufirst%3DH.%26aulast%3DLundkvist%26aufirst%3DJ.%26atitle%3DFirst%2520and%2520second%2520generation%2520gamma-secretase%2520modulators%2520%2528GSMs%2529%2520modulate%2520amyloid-beta%2520%2528Abeta%2529%2520peptide%2520production%2520through%2520different%2520mechanisms%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D11810%26epage%3D11819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Dayneka, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garg, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jusko, W. J.</span><span> </span><span class="NLM_article-title">Comparison of four basic models of indirect pharmacodynamic responses</span> <span class="citation_source-journal">J. Pharmacokinet. Biopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">478</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm300991n&amp;key=10.1007%2FBF01061691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm300991n&amp;key=8133465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm300991n&amp;key=1%3ACAS%3A528%3ADyaK2cXitlGhsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1993&pages=457-478&author=N.+L.+Daynekaauthor=V.+Gargauthor=W.+J.+Jusko&title=Comparison+of+four+basic+models+of+indirect+pharmacodynamic+responses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of four basic models of indirect pharmacodynamic responses</span></div><div class="casAuthors">Dayneka, Natalie L.; Garg, Varun; Jusko, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacokinetics and Biopharmaceutics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">457-78</span>CODEN:
                <span class="NLM_cas:coden">JPBPBJ</span>;
        ISSN:<span class="NLM_cas:issn">0090-466X</span>.
    </div><div class="casAbstract">Four basic models for characterizing indirect pharmacodynamic responses after drug administration have been developed and compared.  The models are based on drug effects (inhibition or stimulation) on the factors controlling either the input or the dissipation of drug response.  Pharmacokinetic parameters of methylprednisolone were used to generate plasma concn. and response-time profiles using computer simulations.  It was found that the responses produced showed a slow onset and a slow return to baseline.  The time of maximal response was dependent on the model and dose.  In each case, hysteresis plots showed that drug concns. preceded the response.  When the responses were fitted with pharmacodynamic models based on distribution to a hypothetical effect compartment, the resulting parameters were dose-dependent and inferred biol. implausibility.  Indirect response models must be treated as distinct from conventional pharmacodynamic models which assume direct action of drugs.  The assumptions, equations, and data patterns for the four basic indirect response models provide a starting point for evaluation of pharmacol. effects where the site of action precedes or follows the measured response variable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptE7XtAvmESLVg90H21EOLACvtfcHk0liCjbaWw1QB7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitlGhsb0%253D&md5=906c542a76bbe718b8c5f61a2973fdea</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1007%2FBF01061691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01061691%26sid%3Dliteratum%253Aachs%26aulast%3DDayneka%26aufirst%3DN.%2BL.%26aulast%3DGarg%26aufirst%3DV.%26aulast%3DJusko%26aufirst%3DW.%2BJ.%26atitle%3DComparison%2520of%2520four%2520basic%2520models%2520of%2520indirect%2520pharmacodynamic%2520responses%26jtitle%3DJ.%2520Pharmacokinet.%2520Biopharm.%26date%3D1993%26volume%3D21%26spage%3D457%26epage%3D478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4b1d" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4b1d','PDB','4b1d'); return false;">PDB: 4b1d</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4b1c" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4b1c','PDB','4b1c'); return false;">PDB: 4b1c</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FKN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FKN','PDB','1FKN'); return false;">PDB: 1FKN</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i54"><a href="/doi/suppl/10.1021/jm300991n">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_86481"></div></div></div></div></div><hr /></hr><p class="last">Synthetic procedures and analytical data for intermediates <b>2</b>, <b>3l</b>,<b>p</b>, <b>4h</b>,<b>i</b>,<b>l</b>, <b>6c</b>,<b>b</b>, <b>7b</b>,<b>l</b>,<b>p</b>, <b>9j</b>, <b>10j</b>, <b>6a</b>, <b>11</b>–<b>15</b> (intermediates named after the corresponding compounds <b>1</b>); Table 1 listing crystallographic data; Figures 1 and 2 showing compounds bound to BACE-1 active site. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300991n/suppl_file/jm300991n_si_001.pdf">jm300991n_si_001.pdf (376.64 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm300991n&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-21%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm300991n%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm300991n" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679962e22de81248","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
